Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AARS2 "AARSL, bA444E17.1, KIAA1270" ENSG00000124608 "Alanyl-tRNA synthetase 2, mitochondrial" Q5JTZ9 6 44299654-44313326 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Cancer-related genes, Cardiomyopathy, Disease mutation, Premature ovarian failure, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035636, HPA061396" Approved Enhanced Mitochondria Mitochondria "HPA035636: AB_10670837, HPA061396: " "unprognostic (1.56e-1)" "unprognostic (3.24e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (8.83e-3)" "unprognostic (5.12e-2)" "unprognostic (3.64e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" 8.6 10.7 15.9 16.2 11.8 11.4 9.9 23.5 19.8 11.4 14.5 11.4 13.0 15.3 14.1 10.4 17.2 13.4 15.9 10.4 13.2 8.9 10.3 12.6 10.9 13.4 12.4 14.3 17.1 13.8 16.2 14.2 10.1 11.1 13.2 9.8 11.2 14.4 14.6 10.2 16.8 18.3 12.1 8.8 14.1 12.3 12.9 14.1 14.7 12.3 10.4 13.4 10.2 13.9 7.1 3.2 3.7 3.4 3.7 5.5 2.8 10.4 7.9 10.3 19.0 6.1 5.7 13.7 8.7 4.5 9.2 8.9 8.5 5.7 11.5 13.9 3.7 7.9 11.4 12.4 3.6 8.1 18.3 13.4 7.7 10.0 4.0 12.4 11.9 4.8 7.9 7.4 7.9 7.8 15.8 11.3 4.9 11.7 10.4 10.7 7.7 7.7 12.4 6.3 7.9 4.8 9.5 24.6 8.9 7.5 8.4 11.6 7.8 16.2 6.6 10.0 10.0 6.1 10.8 6.7 6.2 11.9 5.6 11.0 17.1 3.7 2.4 0.0 3.4 3.3 5.5 3.6 4.8 4.4 2.6 7.1 4.7 4.3 0.7 3.7 3.4 3.2 3.0 2.8 15.9 11.8 23.5 19.8 13.2 8.9 12.4 14.3 11.1 14.1 AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122075647-122144280 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.1;NTERA-2: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Enhanced Vesicles,Mitochondria 17000 Mitochondria Vesicles "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favourable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 13.9 9.5 7.4 4.8 11.8 1.6 11.2 2.7 9.8 16.0 8.1 12.5 8.2 2.2 16.8 11.6 6.4 14.9 6.7 12.6 8.8 3.7 14.4 35.8 9.1 3.3 15.2 5.0 36.7 10.7 14.9 10.4 7.1 9.9 9.2 3.8 9.2 5.4 10.4 11.3 4.4 5.5 9.3 12.1 5.2 9.0 5.1 13.2 0.8 7.8 8.3 3.1 11.0 9.0 1.0 0.4 3.5 0.1 0.3 1.2 0.1 0.1 0.0 16.2 26.1 13.5 8.7 6.3 4.4 4.7 4.6 6.7 7.4 0.2 0.0 0.3 3.1 2.8 18.6 8.4 6.3 0.0 6.8 5.6 3.6 4.8 11.1 0.0 1.8 7.6 0.2 5.5 5.8 11.0 1.5 10.3 3.1 0.0 0.5 0.0 25.5 1.0 8.4 8.6 0.3 2.1 1.8 1.6 0.5 1.4 0.0 2.7 0.4 0.0 5.0 9.0 2.7 4.1 4.2 2.2 1.6 0.0 3.3 0.5 3.4 3.5 0.1 0.0 0.7 0.0 0.1 0.5 0.8 0.0 0.4 1.0 1.2 0.5 0.0 0.3 0.0 0.0 0.7 0.1 7.4 11.8 2.7 7.3 8.8 3.7 15.2 5.0 9.9 13.2 ABAT GABAT ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674565-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.3;liver: 136.5;pancreas: 54.2" "Cell line enhanced" "Detected in many" "Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria 1500000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favourable (5.36e-5)" "prognostic favourable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favourable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 2.1 12.6 26.1 2.7 39.3 1.7 3.2 19.9 43.3 2.2 5.2 10.9 0.1 17.5 2.1 5.0 3.0 2.8 2.7 6.2 20.4 30.9 53.3 136.5 2.8 2.8 24.5 26.1 5.3 54.2 4.0 22.1 2.3 14.3 9.9 4.2 2.6 2.6 2.5 1.4 2.1 8.4 2.1 14.1 2.5 3.9 6.3 11.8 1.0 12.7 0.4 3.3 6.4 1.1 2.2 1.9 8.8 5.8 1.6 2.5 1.8 0.2 0.0 11.8 6.7 1.9 0.6 0.5 1.4 0.8 0.7 0.2 4.4 0.3 1.4 0.5 0.8 3.0 0.7 2.8 0.9 0.8 0.6 1.9 0.0 44.3 3.1 0.4 3.0 2.5 1.2 1.2 0.5 0.2 0.3 1.0 0.2 28.5 0.7 0.2 1.0 0.1 3.4 25.1 0.6 0.4 7.0 1.9 5.7 0.6 0.4 0.0 15.6 1.2 0.2 0.2 2.0 0.9 0.0 1.1 0.1 0.3 0.3 2.0 1.4 1.1 3.1 4.1 2.5 3.6 1.1 0.8 1.7 1.7 1.9 2.2 1.1 1.8 8.8 1.6 5.8 0.3 1.6 1.8 26.1 39.3 19.9 35.1 20.4 30.9 24.5 26.1 14.3 11.8 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: " "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavourable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavourable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 10.0 2.0 12.6 14.1 5.0 12.4 3.7 3.5 4.1 4.1 15.3 2.2 0.1 19.3 3.6 21.6 0.2 1.5 1.3 6.4 2.2 15.6 11.0 28.2 17.0 0.0 5.2 7.4 1.8 2.7 0.0 7.2 13.3 1.9 2.8 5.1 1.0 0.1 3.2 4.1 5.2 6.4 0.6 2.2 0.2 7.4 7.9 7.8 18.5 8.2 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.1 4.0 0.0 6.3 0.1 7.4 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 ABCB7 "ABC7, ASAT, Atm1p, EST140535" ENSG00000131269 "ATP binding cassette subfamily B member 7" O75027 X 75051554-75156732 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034982 Approved Supported Mitochondria Mitochondria "HPA034982: AB_10601010" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.83e-3)" "unprognostic (4.44e-3)" "unprognostic (1.33e-2)" "unprognostic (6.31e-2)" "unprognostic (4.39e-2)" "unprognostic (1.47e-1)" "unprognostic (2.17e-1)" "unprognostic (4.14e-2)" "unprognostic (2.55e-2)" "prognostic favourable (5.31e-6)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" 15.1 18.0 12.3 14.7 14.3 13.0 14.6 26.0 16.2 11.6 15.2 12.0 13.7 19.0 14.7 13.6 14.7 11.7 10.0 21.4 11.7 7.1 15.6 22.4 12.2 15.9 13.0 8.5 16.4 12.4 14.7 22.6 11.5 14.0 10.6 15.4 9.5 12.9 15.5 34.6 15.3 15.9 14.9 12.2 13.9 14.8 5.4 16.2 19.7 12.4 19.3 16.0 13.9 13.3 19.4 19.3 7.0 18.7 12.2 21.5 12.4 11.4 11.2 11.5 14.5 7.6 18.9 5.5 8.1 9.1 7.4 12.7 13.9 17.0 18.0 15.6 6.6 12.0 22.2 10.3 12.6 19.3 18.4 12.1 22.5 10.3 6.3 19.6 10.5 13.4 9.8 10.0 13.1 16.0 13.1 23.3 8.0 6.9 14.8 14.4 19.5 15.7 15.0 22.1 21.0 9.6 11.4 13.8 9.1 19.1 17.5 10.9 7.8 13.8 8.3 7.6 14.8 15.8 7.8 7.6 19.3 16.3 7.4 23.6 8.0 5.9 18.7 7.0 11.5 17.7 12.3 18.1 12.8 12.4 19.3 19.4 21.5 16.0 2.2 12.2 13.4 11.9 17.4 12.4 12.3 14.3 26.0 16.2 11.7 7.1 13.0 8.5 14.0 16.2 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favourable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favourable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favourable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.4 19.6 5.0 15.9 8.0 4.7 10.1 6.6 6.8 10.5 11.1 7.8 20.8 6.5 8.8 6.9 13.2 7.3 13.6 4.7 8.1 8.0 5.2 7.8 9.3 5.2 4.0 12.9 8.0 10.3 12.4 5.2 10.4 27.1 9.0 7.8 27.8 15.1 7.5 3.4 22.3 7.2 3.2 23.2 7.0 5.3 4.9 9.8 7.0 20.0 6.3 7.9 5.2 6.4 9.8 2.6 7.0 9.8 9.1 4.5 4.7 13.8 9.6 9.9 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 ABHD11 "PP1226, WBSCR21" ENSG00000106077 "Abhydrolase domain containing 11" Q8NFV4 7 73736094-73738867 "Disease related genes, Predicted intracellular proteins" Hydrolase "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.1;SK-BR-3: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024042, HPA049641" Approved Supported Mitochondria 450000 Mitochondria "HPA024042: AB_1844445, HPA049641: " "unprognostic (4.74e-2)" "unprognostic (8.62e-3)" "unprognostic (1.42e-1)" "unprognostic (2.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-3)" "unprognostic (1.91e-2)" "unprognostic (9.32e-2)" "unprognostic (7.79e-2)" "unprognostic (1.74e-1)" "prognostic favourable (3.66e-7)" "unprognostic (3.61e-3)" "unprognostic (4.44e-2)" "unprognostic (1.02e-1)" "unprognostic (7.29e-2)" 5.6 8.9 7.7 11.5 8.7 4.2 12.2 8.8 9.2 8.1 28.5 8.3 14.8 15.7 6.0 12.7 8.3 14.0 17.0 20.1 7.1 8.1 21.6 6.6 8.4 6.9 8.6 5.6 5.0 18.9 7.3 10.8 40.2 10.0 14.7 17.5 7.8 23.9 22.2 9.8 7.9 28.1 5.6 5.9 5.2 8.3 6.1 5.6 6.9 20.1 8.4 12.6 5.8 5.4 8.3 12.9 12.2 21.0 9.7 6.7 8.0 17.2 4.0 2.7 6.3 1.4 2.0 15.3 8.0 3.3 4.9 5.8 4.9 19.5 8.2 2.4 3.3 7.6 1.2 4.6 3.4 3.0 5.9 4.0 2.7 3.0 2.6 4.3 4.4 1.8 1.9 6.2 3.0 3.5 5.4 4.7 4.6 34.1 3.3 5.5 3.2 14.9 1.8 4.4 15.1 11.3 8.2 7.0 3.0 6.4 43.4 2.6 14.1 2.9 3.4 4.2 4.0 17.8 8.2 2.9 1.5 5.5 6.7 4.2 7.7 6.1 13.1 12.2 6.0 21.0 4.8 6.3 6.7 6.2 12.9 8.3 6.3 4.4 10.5 9.7 20.7 6.3 4.4 8.0 7.7 8.7 8.8 9.2 7.1 8.1 8.6 5.6 10.0 5.6 AC004556.1 ENSG00000276345 Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.0" "Cell line enhanced" "Detected in some" "CACO-2: 25.2;K-562: 21.1;MOLT-4: 23.7;NB-4: 45.7;PC-3: 42.6;WM-115: 30.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA050406: " 0.9 0.0 0.9 0.0 8.3 3.7 0.0 3.8 0.0 1.3 5.9 0.0 1.5 1.7 9.3 1.6 3.0 0.0 0.0 2.4 2.0 0.0 0.0 1.5 0.0 2.2 0.0 6.1 1.4 3.6 0.0 0.9 1.2 0.0 0.3 0.0 1.4 2.8 4.7 13.0 9.6 3.2 6.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 8.3 11.8 12.8 9.2 25.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 8.5 21.1 11.6 0.1 0.1 23.7 45.7 0.0 42.6 0.1 7.5 0.0 11.9 7.2 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 30.7 13.0 5.6 3.1 2.8 9.6 2.4 2.5 4.5 6.0 4.1 2.8 4.5 5.2 1.0 3.2 4.0 4.7 5.9 4.0 AC139530.2 ENSG00000262660 17 81703371-81720539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.4;MOLT-4: 18.0;SK-BR-3: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA022853, HPA023043, HPA023048" Approved Enhanced Mitochondria Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950" "unprognostic (2.36e-3)" "unprognostic (1.17e-1)" "unprognostic (2.87e-1)" "unprognostic (3.83e-1)" 2.4 3.6 2.3 2.3 3.0 1.5 6.3 2.7 5.7 2.3 4.6 0.8 2.7 13.8 3.4 1.5 4.6 2.3 2.7 16.3 2.4 2.3 4.9 16.6 3.0 4.2 2.5 1.5 2.3 9.9 3.6 2.3 3.4 2.2 2.4 1.5 1.1 3.1 2.4 15.5 2.4 5.9 1.6 2.3 3.3 2.6 2.6 0.6 3.0 2.4 12.6 3.0 2.3 2.3 0.0 0.4 0.0 0.1 0.8 0.6 0.1 1.2 0.6 1.8 4.6 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.3 0.3 0.9 0.3 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.0 0.6 0.3 0.0 6.4 0.0 0.8 18.0 0.7 1.0 0.0 3.2 0.3 1.1 0.0 0.0 3.2 1.5 0.0 6.8 1.8 2.9 1.5 0.0 0.5 1.1 1.0 1.7 0.6 0.0 0.7 1.1 0.5 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 2.3 3.0 2.7 3.7 2.4 2.3 2.5 1.5 2.2 0.6 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782167-49813960 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 245.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria 3200000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavourable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favourable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 22.7 12.9 9.4 6.9 10.7 4.4 13.0 3.6 7.0 4.1 27.2 8.0 7.8 25.9 5.1 5.1 7.1 4.1 9.2 38.9 6.8 7.0 60.3 245.7 7.9 7.5 10.7 6.1 6.4 13.6 6.3 7.1 7.5 6.7 7.9 18.4 9.5 3.3 6.2 22.9 4.2 37.0 11.3 9.7 6.9 6.0 6.5 7.5 8.4 15.7 8.8 5.0 8.1 4.9 13.0 31.8 27.5 33.0 35.5 40.9 28.6 0.7 13.9 23.2 21.2 30.7 16.2 11.8 7.1 11.6 12.0 9.3 29.5 12.0 12.4 15.2 26.1 0.9 38.6 4.5 11.9 37.9 9.1 8.8 18.1 34.9 14.5 0.1 16.6 21.4 1.5 19.4 6.1 19.6 7.6 11.7 33.2 16.0 0.5 19.1 21.0 5.6 30.4 49.6 45.4 40.5 0.6 33.3 26.4 0.5 16.3 1.1 9.2 12.8 9.3 10.2 12.9 15.4 7.7 23.8 27.4 31.6 7.3 17.9 9.3 13.1 25.9 27.5 32.1 33.0 40.9 13.0 19.2 28.6 31.8 9.7 16.4 24.3 2.5 35.5 31.1 14.9 22.6 28.6 9.4 10.7 3.6 7.0 6.8 7.0 10.7 6.1 6.7 7.5 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128916067 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavourable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favourable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 18.1 20.6 14.0 13.1 15.4 8.0 15.4 14.7 17.9 13.6 13.4 15.9 21.1 11.3 16.9 13.1 21.6 15.6 16.4 21.6 10.7 13.2 15.8 24.0 11.6 10.4 13.6 17.8 13.1 21.1 30.6 14.2 13.8 13.6 13.0 12.4 16.0 19.0 16.0 30.8 45.0 10.1 13.8 10.2 12.1 14.6 19.5 10.8 13.9 14.8 18.2 14.9 12.6 14.0 7.2 14.0 4.1 18.1 5.0 7.5 8.9 25.0 13.1 10.6 7.8 16.4 11.5 11.3 12.5 13.8 24.0 20.6 18.5 15.3 18.6 11.7 15.7 21.0 18.4 24.4 15.9 12.3 12.6 16.9 26.6 13.0 12.0 13.3 7.9 12.5 9.6 13.9 15.8 19.3 8.0 9.0 15.9 25.3 19.5 11.0 6.4 18.8 15.2 9.9 18.9 16.8 16.0 12.3 7.9 19.4 18.3 12.1 24.1 28.7 11.5 10.1 8.7 10.1 11.8 9.0 4.3 16.2 16.0 12.4 12.6 3.1 12.0 4.1 7.5 14.7 7.2 7.2 6.8 6.4 14.0 4.9 5.7 7.3 1.0 5.0 18.1 7.9 6.5 8.9 14.0 15.4 14.7 17.9 10.7 13.2 13.6 17.8 13.6 10.8 ACADM "ACAD1, MCAD, MCADH" ENSG00000117054 "Acyl-CoA dehydrogenase medium chain" P11310 1 75724347-75787575 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7;skeletal muscle: 82.8" "Cell line enhanced" "Detected in all" "Daudi: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006198, HPA026542" Enhanced Enhanced Mitochondria 1200000 Mitochondria "HPA006198: AB_1078087, HPA026542: AB_1844469" "unprognostic (9.04e-3)" "unprognostic (2.36e-1)" "prognostic favourable (7.30e-4)" "unprognostic (5.09e-3)" "unprognostic (1.61e-3)" "unprognostic (5.68e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (4.95e-2)" "unprognostic (9.40e-3)" "unprognostic (3.35e-1)" "prognostic favourable (3.83e-8)" "unprognostic (1.27e-1)" "unprognostic (4.09e-2)" "unprognostic (3.56e-2)" "unprognostic (1.24e-1)" 18.1 25.0 12.3 11.3 13.0 3.9 18.0 12.0 10.8 8.4 21.6 8.3 10.1 25.1 6.7 8.6 21.9 7.6 6.7 49.7 10.5 11.2 71.1 89.7 6.3 9.4 13.0 9.2 10.5 10.3 8.1 12.0 4.2 14.3 9.2 12.1 8.0 9.0 11.7 82.8 5.6 25.1 9.8 10.7 12.3 12.0 8.5 11.0 11.0 12.2 42.1 10.0 9.5 8.1 29.7 16.7 14.1 13.8 16.8 20.0 13.2 6.9 5.5 17.4 7.6 15.0 12.3 4.9 13.0 10.6 12.8 10.8 10.3 11.1 75.9 11.5 9.3 6.4 14.7 11.0 15.9 29.3 7.2 24.9 16.9 15.8 10.5 21.2 6.9 14.2 6.4 11.1 6.7 10.0 25.3 17.2 13.7 2.6 24.9 10.0 14.0 13.3 32.5 22.9 7.9 21.2 18.3 9.4 11.9 10.5 31.4 27.1 9.3 26.9 5.4 8.7 8.6 7.4 21.3 11.2 16.0 33.7 7.4 17.3 9.9 10.7 9.6 14.1 13.2 13.8 20.0 29.7 13.8 15.9 14.3 18.0 15.8 17.6 0.8 16.8 12.7 16.7 13.8 13.2 12.3 13.0 12.0 10.8 10.5 11.2 13.0 9.2 14.3 11.0 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell line enhanced" "Detected in many" "HMC-1: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Mitochondria 15000 Mitochondria Nucleoplasm "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favourable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favourable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.3 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 3.3 4.3 1.3 0.5 10.5 5.3 5.2 2.2 12.0 6.2 0.4 23.7 10.3 2.0 1.7 0.1 4.0 4.2 0.0 1.7 4.2 7.2 12.0 1.3 3.0 5.4 2.7 1.4 7.3 11.6 0.7 4.0 6.2 0.0 9.9 5.0 8.2 4.4 0.1 3.1 3.0 0.6 10.1 5.7 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058311 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 28.9;liver: 114.2" "Cell line enhanced" "Detected in all" "Hep G2: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041458 Enhanced Supported Mitochondria 63000 Mitochondria "HPA041458: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favourable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favourable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 4.6 9.4 6.7 2.4 9.0 1.4 8.3 10.3 8.3 3.9 5.3 5.5 6.4 16.8 4.1 3.3 4.4 4.1 3.1 13.7 8.5 4.8 28.9 114.2 4.3 2.7 5.1 8.2 5.0 5.3 8.0 4.9 1.9 7.5 7.9 5.8 4.9 5.6 6.0 12.7 4.7 5.5 5.2 4.8 2.7 4.8 2.9 5.4 3.6 4.3 7.9 3.9 5.0 4.1 6.3 6.8 13.5 5.0 9.0 11.7 6.0 9.5 6.8 5.1 9.3 7.0 8.7 4.5 5.9 12.0 5.9 6.0 6.0 3.1 10.0 4.1 5.0 4.0 7.9 4.1 9.9 6.5 8.2 5.2 2.1 34.6 4.9 7.3 5.0 6.4 4.2 3.7 3.4 5.7 5.0 7.4 7.4 4.4 7.0 6.1 3.1 4.3 8.3 10.7 3.1 8.5 10.6 1.0 5.9 9.1 2.7 9.3 8.3 3.6 6.0 3.2 2.9 7.4 7.1 8.3 9.4 5.3 5.0 7.0 2.4 13.5 5.0 12.3 10.0 5.0 11.7 5.9 9.4 8.6 6.8 6.3 8.9 9.9 3.2 9.0 3.0 4.1 7.6 6.0 6.7 9.0 10.3 8.3 8.5 4.8 5.1 8.2 7.5 5.4 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol 19000000 "Nucleoli, Mitochondria" "Nucleoplasm, Cytosol" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favourable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.2 31.9 13.1 18.0 56.6 20.8 24.8 24.5 34.1 28.0 17.4 12.9 30.2 17.8 20.5 51.4 25.7 8.8 26.8 24.8 56.5 9.0 9.5 22.7 19.6 27.2 9.0 24.8 23.2 24.6 23.4 36.9 25.1 12.2 21.8 44.9 12.6 9.4 10.9 6.2 12.6 13.1 14.5 42.4 62.2 30.4 3.5 8.6 34.6 44.0 20.1 20.2 13.9 25.0 24.8 18.6 12.5 23.9 20.4 9.5 0.9 45.6 16.0 18.0 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108121516-108147776 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 267.1" "Cell line enhanced" "Detected in all" "RPMI-8226: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria 870000 Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favourable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 18.8 28.5 8.9 6.9 9.5 5.4 16.9 5.6 11.6 8.5 16.8 8.5 9.4 15.5 8.8 8.9 8.8 7.6 5.1 53.8 7.4 7.4 88.8 267.1 7.3 6.0 9.9 9.9 10.3 27.3 14.3 6.3 3.8 22.4 7.6 13.1 10.6 27.1 15.9 65.0 8.2 10.9 16.4 8.1 7.7 13.9 14.2 7.2 1.7 10.1 32.1 5.2 12.3 6.9 18.8 20.2 2.3 14.7 7.7 20.7 11.6 15.8 13.0 10.3 29.6 33.3 29.5 5.7 15.2 16.3 16.5 19.3 35.8 16.4 8.8 26.2 17.0 16.8 29.8 14.4 18.0 17.5 24.4 25.3 14.8 32.5 23.0 23.9 15.0 26.7 16.0 14.4 27.0 17.5 35.1 13.1 26.3 9.1 14.1 22.3 10.1 29.1 19.7 20.3 85.2 22.6 10.4 16.5 19.6 24.8 32.2 16.6 27.5 19.6 19.5 17.8 10.4 16.2 18.3 4.4 12.9 16.5 7.9 47.9 12.6 0.8 9.8 2.3 15.6 14.7 17.7 18.8 17.6 17.5 20.2 10.2 15.5 14.3 1.0 7.7 14.4 7.0 20.7 11.6 8.9 9.5 5.6 11.6 7.4 7.4 9.9 9.9 22.4 7.2 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Cell line enhanced" "Detected in many" "ASC diff: 147.8;ASC TERT1: 35.9;HSkMC: 78.5;RPTEC TERT1: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favourable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 5.9 1.8 1.1 3.1 147.8 35.9 1.0 3.3 1.6 2.0 1.4 0.4 1.7 2.5 0.3 3.9 3.7 5.3 2.1 1.6 12.1 1.9 1.8 1.6 4.9 23.8 4.8 4.5 78.5 18.2 1.6 8.5 2.6 0.8 7.6 9.6 3.1 0.3 6.7 0.2 2.6 0.9 1.0 3.1 46.8 17.1 4.5 4.2 3.0 9.1 10.2 3.4 4.9 2.8 1.7 2.0 4.2 1.0 2.9 1.5 1.1 5.7 6.7 2.7 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: , HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.4 0.2 0.2 0.0 0.8 0.1 1.0 0.3 2.2 0.0 0.1 10.4 42.4 14.0 2.6 0.5 0.1 0.0 0.0 0.2 11.6 0.0 10.9 0.4 18.1 2.8 16.9 18.5 1.9 0.0 0.2 0.0 0.8 0.0 6.3 0.0 0.0 0.0 7.8 0.0 0.4 3.8 0.0 8.5 1.1 43.4 0.0 0.2 16.9 6.5 0.0 0.0 9.5 12.3 0.1 0.1 0.7 0.7 4.6 0.0 6.8 0.3 21.2 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 AFG3L2 "SCA28, SPAX5" ENSG00000141385 "AFG3 like matrix AAA peptidase subunit 2" Q9Y4W6 18 12328944-12377314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004479, HPA004480" Enhanced Supported Mitochondria Mitochondria "HPA004479: AB_1078109, HPA004480: AB_1078108" "unprognostic (1.11e-1)" "unprognostic (7.49e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (1.31e-1)" "unprognostic (5.06e-3)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (5.35e-2)" "unprognostic (1.54e-2)" "unprognostic (4.05e-2)" "unprognostic (3.00e-2)" "prognostic favourable (6.05e-14)" "unprognostic (5.90e-2)" "unprognostic (9.41e-2)" "unprognostic (5.74e-3)" "unprognostic (2.22e-1)" 11.5 15.8 11.8 14.3 14.0 11.7 19.9 17.2 30.3 11.2 25.7 9.5 12.7 33.1 11.4 10.1 18.3 10.4 11.2 77.4 13.2 13.1 27.2 22.9 16.3 23.7 12.0 13.2 12.0 23.1 34.3 12.6 9.9 16.9 10.8 23.5 12.2 14.9 14.8 61.0 17.5 35.0 15.1 14.0 9.9 16.0 8.9 7.1 10.7 16.9 22.4 13.2 14.0 11.6 10.1 15.8 8.5 12.3 19.9 15.2 8.4 16.9 17.4 12.4 14.0 14.4 15.7 16.6 19.0 19.0 27.3 20.0 26.9 10.5 48.9 21.0 17.3 17.1 31.4 21.9 22.3 11.4 13.4 14.6 19.0 25.1 19.7 55.1 22.0 17.4 24.0 25.8 34.2 19.8 32.9 29.0 13.3 26.9 19.7 16.9 17.3 12.8 22.2 39.3 40.8 23.4 37.8 23.2 16.2 29.9 32.4 26.7 14.9 25.0 15.0 32.5 28.0 30.9 24.8 20.4 23.5 31.4 17.8 21.7 14.9 2.6 11.5 8.5 8.7 12.3 10.7 10.1 10.4 13.7 15.8 7.7 13.3 15.2 0.8 19.9 10.8 8.1 6.4 8.4 11.8 14.0 17.2 30.3 13.2 13.1 12.0 13.2 16.9 7.1 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551189-141655244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 37.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: " "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 8.7 12.0 11.9 8.0 19.0 5.9 10.6 21.3 23.7 8.8 8.9 10.2 8.8 6.4 16.8 17.1 9.5 11.9 6.8 24.5 16.1 12.3 16.0 10.5 8.4 10.0 11.8 18.8 10.8 8.0 15.7 13.3 9.9 14.2 10.1 13.4 10.6 13.5 10.7 8.4 6.8 8.8 15.0 13.9 12.2 9.0 12.9 9.0 7.8 9.8 8.4 15.6 8.4 8.5 4.6 6.4 0.4 5.5 37.9 10.3 5.7 12.2 13.3 13.2 10.9 10.5 13.0 9.0 13.0 12.7 20.9 20.9 10.3 9.5 13.8 11.7 12.4 9.1 18.4 15.1 22.5 16.2 16.4 12.8 6.3 10.2 15.6 8.8 6.9 14.4 13.3 18.3 18.0 16.0 19.0 19.7 10.1 12.3 23.9 4.1 14.0 15.0 15.5 2.3 41.2 13.3 10.4 11.6 15.9 13.5 16.3 13.4 8.7 9.7 8.9 9.7 7.6 12.9 18.7 15.0 14.8 6.6 15.9 4.1 26.6 0.0 2.6 0.4 9.1 5.5 6.5 4.6 7.4 10.3 6.4 2.5 5.5 9.6 0.2 37.9 3.2 2.5 7.2 5.7 11.9 19.0 21.3 23.7 16.1 12.3 11.8 18.8 14.2 9.0 AGPAT5 "FLJ11210, LPAAT-e, LPAAT-epsilon" ENSG00000155189 "1-acylglycerol-3-phosphate O-acyltransferase 5" Q9NUQ2 8 6708357-6759666 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010644, HPA010950, HPA011646" Approved Supported Mitochondria Mitochondria "HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: " "unprognostic (1.05e-3)" "unprognostic (4.69e-1)" "prognostic favourable (8.82e-4)" "unprognostic (2.05e-2)" "unprognostic (2.99e-1)" "unprognostic (1.44e-2)" "prognostic unfavourable (4.57e-4)" "unprognostic (4.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.98e-2)" "unprognostic (6.33e-2)" "unprognostic (2.91e-1)" "unprognostic (6.62e-2)" "unprognostic (2.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (5.09e-3)" 5.9 12.5 20.0 8.5 20.7 5.1 9.8 10.0 21.2 6.0 12.2 16.5 6.8 9.3 9.3 19.1 8.4 9.7 5.9 4.0 19.3 16.9 14.2 14.3 5.1 16.8 18.7 9.5 6.4 16.2 11.4 18.5 16.3 14.2 11.0 12.3 3.3 5.4 16.0 10.2 5.1 8.4 8.6 30.6 8.6 11.0 30.8 12.7 14.3 7.3 6.8 10.4 7.3 5.7 11.0 8.4 3.0 4.8 5.3 3.9 2.9 9.2 7.4 11.7 6.9 3.1 5.0 10.4 4.9 5.1 7.4 7.1 4.6 7.3 20.2 3.3 3.2 11.0 8.9 9.9 12.9 4.4 6.1 24.9 5.8 10.4 7.8 10.4 10.9 6.6 8.4 7.2 9.6 12.8 18.4 10.9 12.1 6.0 18.8 12.8 20.4 5.8 13.6 14.1 7.9 6.7 13.1 23.9 12.5 4.7 8.7 9.3 3.9 13.7 5.3 12.0 5.7 4.6 13.6 4.1 12.6 11.0 7.1 12.6 14.3 3.0 4.1 2.6 1.9 4.8 3.9 8.7 3.0 3.3 2.7 11.0 2.3 2.7 0.4 5.3 4.2 8.4 2.7 2.9 20.0 20.7 10.0 14.6 19.3 16.9 18.7 9.5 14.2 12.7 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Cell line enhanced" "Detected in some" "Daudi: 31.1;HDLM-2: 43.3;Karpas-707: 17.2;U-266/70: 14.5;U-266/84: 10.9;U-87 MG: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: " "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.2 0.0 0.3 0.0 0.0 4.3 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.3 43.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 2.8 0.0 2.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 14.5 10.9 0.2 13.4 1.1 2.2 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 AK3 "AK3L1, AK6, AKL3L1" ENSG00000147853 "Adenylate kinase 3" Q9UIJ7 9 4709559-4742043 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 85.0;HEL: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063324 Enhanced Supported Mitochondria 68000 Mitochondria "HPA063324: " "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-3)" "unprognostic (6.44e-2)" "unprognostic (2.81e-2)" "unprognostic (9.81e-3)" "unprognostic (1.90e-1)" "unprognostic (2.76e-2)" "prognostic favourable (6.07e-9)" "unprognostic (1.24e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.55e-3)" 24.6 25.1 20.9 9.8 22.4 6.8 24.0 14.6 17.5 17.7 23.7 15.3 16.0 24.4 18.9 17.5 28.3 14.0 16.1 90.0 22.4 16.4 37.7 75.1 16.4 13.1 25.2 15.2 22.4 15.7 16.9 14.1 13.0 22.9 19.0 23.0 17.4 14.5 19.1 72.0 18.1 22.0 21.2 24.1 12.1 22.5 9.3 24.9 15.2 20.8 32.8 14.9 20.1 17.1 7.0 14.4 17.0 5.6 14.7 17.1 10.2 8.7 7.3 12.5 5.1 17.5 12.9 0.9 11.0 26.0 6.9 10.4 1.2 9.7 8.1 3.8 14.0 5.6 9.1 10.6 11.8 85.0 6.9 54.4 13.0 22.0 13.8 5.7 2.8 20.4 9.5 5.9 8.2 20.3 4.1 11.1 20.7 5.2 5.5 16.5 11.2 2.7 7.4 4.5 4.0 20.2 12.2 20.7 13.0 12.9 4.2 7.4 5.8 11.4 12.6 5.8 5.9 15.2 8.6 2.8 1.8 10.0 10.6 4.3 4.1 6.8 5.6 17.0 16.2 4.4 14.7 7.0 12.5 14.8 10.5 6.9 16.6 17.1 1.9 14.7 3.4 14.4 16.7 10.2 20.9 22.4 14.6 17.5 22.4 16.4 25.2 15.2 22.9 24.9 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.7;liver: 50.7" "Cell line enhanced" "Detected in many" "Hep G2: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;myeloid DC: 5.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" 18000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavourable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavourable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavourable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavourable (4.36e-4)" "prognostic unfavourable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 12.4 1.6 11.7 3.7 11.2 2.7 13.4 12.0 9.9 4.0 9.5 4.0 4.7 2.7 3.9 4.4 12.3 4.2 8.6 26.0 9.3 7.1 89.7 50.7 1.6 1.4 6.3 9.1 5.8 1.8 8.2 2.6 4.5 7.2 8.9 7.7 4.4 9.4 7.3 2.2 14.0 3.5 13.6 8.1 1.2 7.8 6.0 5.0 0.4 1.9 5.7 3.2 12.4 7.4 0.5 5.3 1.6 6.1 0.6 0.5 1.4 20.2 1.4 1.6 6.9 15.3 14.6 3.5 3.4 4.3 7.4 20.8 30.4 2.4 10.9 9.0 5.3 13.1 5.4 25.6 30.0 9.1 6.2 10.6 6.8 58.2 0.7 8.2 1.3 8.1 14.4 7.3 21.4 0.2 13.1 0.1 11.3 8.7 0.3 0.3 7.1 12.2 0.0 11.9 1.9 11.0 0.9 5.9 4.5 6.1 0.4 4.8 8.5 3.6 1.2 12.4 10.7 0.9 5.8 11.5 5.1 0.6 20.1 3.0 0.7 1.6 6.1 0.0 0.2 1.4 0.4 0.5 0.2 0.5 5.3 0.4 0.2 0.2 1.0 0.6 0.2 0.8 0.1 1.4 11.7 11.2 12.0 9.9 9.3 7.1 6.3 9.1 7.2 5.0 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria Mitochondria "CAB019286: , HPA008620: , HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favourable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.5 20.7 28.8 9.4 7.5 4.9 17.3 6.9 6.7 9.1 6.5 22.1 14.9 26.6 19.7 5.3 26.3 16.1 15.2 9.2 14.5 23.4 22.6 18.3 42.0 7.0 21.2 8.7 4.3 15.1 10.1 14.2 9.2 15.0 10.3 5.2 14.1 26.7 8.1 10.5 22.3 20.6 12.2 21.7 6.1 19.6 22.1 14.5 5.5 16.1 9.0 11.0 21.9 6.8 8.0 9.0 10.3 15.6 10.2 12.7 20.0 5.1 16.6 7.1 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favourable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favourable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.4 16.2 11.5 10.6 18.0 13.4 31.4 15.4 14.3 20.6 20.0 21.6 19.8 9.8 3.9 10.7 6.2 16.5 12.6 16.9 19.0 6.4 12.6 12.8 16.4 25.5 20.4 25.3 16.7 11.9 32.7 10.9 18.8 7.4 8.1 18.7 8.5 9.6 31.0 9.9 28.2 5.8 7.2 15.5 18.1 63.4 6.1 4.0 24.9 12.3 13.9 7.0 29.0 13.5 11.5 11.4 23.7 22.2 12.0 20.8 14.8 12.9 22.1 18.3 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605929-95656706 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 68.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Supported Mitochondria 23000 Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favourable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 6.3 10.4 7.1 10.4 7.9 5.2 7.7 7.3 9.3 13.7 20.1 7.2 20.5 33.8 9.3 12.3 12.8 8.5 15.2 7.2 6.2 7.1 13.0 28.9 6.6 7.4 6.7 5.3 14.5 40.7 12.7 17.4 14.3 7.7 9.6 19.4 7.9 68.8 20.5 3.5 9.6 45.4 10.0 5.4 8.6 15.2 8.4 5.4 12.7 25.9 9.7 15.9 8.6 8.2 13.1 5.2 0.3 4.0 13.0 16.3 8.0 18.2 17.3 16.6 43.6 22.4 21.7 17.9 21.3 32.1 21.7 27.3 34.6 14.6 62.1 20.0 33.5 24.2 33.3 21.9 24.7 17.6 26.2 19.7 12.3 49.1 14.7 34.3 22.0 22.7 13.5 17.7 34.7 22.7 18.3 13.1 16.2 26.2 31.0 22.1 19.6 17.3 29.2 19.1 21.3 25.3 13.9 16.6 16.5 16.9 13.5 15.7 20.1 16.0 18.8 9.0 14.4 23.2 24.4 15.1 11.2 38.0 17.6 39.8 11.5 0.0 1.4 0.1 15.5 2.7 16.3 13.1 14.2 16.0 5.2 9.0 12.1 13.4 0.3 13.0 4.0 3.1 13.3 8.0 7.1 7.9 7.3 9.3 6.2 7.1 6.7 5.3 7.7 5.4 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021037 Approved Supported Nucleoplasm,Vesicles,Mitochondria 210000 Mitochondria "Nucleoplasm, Vesicles" "HPA021037: AB_1844724" "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favourable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 23.9 22.3 6.9 11.0 9.8 11.7 5.5 11.5 5.8 9.7 10.0 14.9 4.7 15.1 6.9 16.1 3.4 22.7 24.3 9.7 16.9 9.8 7.5 16.4 44.2 7.1 11.9 8.5 13.9 5.3 7.9 6.9 9.2 21.6 14.8 14.7 9.1 0.0 4.8 20.5 10.0 4.9 41.8 11.5 8.7 10.8 15.1 7.0 8.7 5.8 6.7 5.5 9.3 6.2 11.2 18.6 9.3 14.3 2.2 4.3 6.0 5.8 12.2 7.6 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 ALDH1L2 "FLJ38508, mtFDH" ENSG00000136010 "Aldehyde dehydrogenase 1 family member L2" Q3SY69 12 105019784-105084577 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "pancreas: 48.9;salivary gland: 31.6" "Cell line enhanced" "Detected in many" "ASC diff: 22.6;ASC TERT1: 30.9;fHDF/TERT166: 35.1;HHSteC: 19.9;HSkMC: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039481, HPA059282" Approved Enhanced Mitochondria Mitochondria "HPA039481: AB_10795465, HPA059282: " "unprognostic (5.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.76e-1)" "unprognostic (8.86e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-1)" "unprognostic (5.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-8)" "unprognostic (3.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.53e-3)" "unprognostic (2.52e-5)" 4.2 1.2 3.2 2.7 1.9 0.7 2.7 5.3 2.7 5.5 2.2 0.9 3.3 2.4 2.9 3.2 1.5 2.6 2.7 2.9 1.6 2.0 0.7 0.4 2.7 2.0 2.0 2.1 1.0 48.9 0.7 2.8 1.1 2.5 3.6 2.3 4.8 31.6 4.5 1.0 1.5 1.3 5.4 5.3 1.2 3.7 0.8 1.3 0.0 2.2 1.4 3.0 3.9 2.2 0.2 1.3 0.0 0.1 0.0 0.1 0.1 4.3 0.4 0.2 9.4 22.6 30.9 0.5 14.0 9.0 1.8 4.8 0.5 0.0 0.0 0.5 35.1 0.0 0.0 0.3 2.3 0.0 0.1 0.2 0.0 1.1 19.9 1.7 0.0 25.0 1.1 4.7 8.9 1.0 0.7 12.6 3.6 0.0 0.0 0.1 0.5 0.1 0.0 0.0 1.3 0.0 0.0 3.3 1.6 0.0 2.9 7.1 2.0 14.9 0.1 1.4 1.3 0.0 0.7 15.7 4.1 0.0 5.7 6.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.1 3.2 1.9 5.3 2.4 1.6 2.0 2.0 2.1 2.5 1.3 ALDH5A1 "SSADH, SSDH" ENSG00000112294 "Aldehyde dehydrogenase 5 family member A1" P51649 6 24494852-24537207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell line enhanced" "Detected in many" "Daudi: 40.3;U-698: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029715, HPA029716" Enhanced Supported Mitochondria 44000 Mitochondria "HPA029715: AB_10599994, HPA029716: AB_10601876" "unprognostic (7.43e-2)" "unprognostic (1.12e-3)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "prognostic favourable (7.61e-6)" "unprognostic (2.38e-2)" "unprognostic (2.17e-2)" "prognostic favourable (6.20e-4)" "unprognostic (1.43e-2)" "unprognostic (1.21e-1)" "prognostic favourable (3.68e-4)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.00e-2)" "unprognostic (1.08e-2)" 5.8 4.8 23.7 8.3 27.4 3.1 4.1 13.5 21.5 4.1 6.0 9.5 1.2 7.7 3.9 3.1 5.6 13.5 4.4 9.8 17.3 21.0 18.4 62.6 5.0 8.9 16.0 14.7 5.8 6.6 11.4 4.5 2.2 13.0 6.2 5.7 4.1 3.9 4.3 31.1 6.9 5.4 2.8 10.9 4.8 5.2 3.7 8.8 21.4 12.1 4.9 8.8 6.3 5.5 3.9 3.8 0.4 0.2 1.6 6.8 1.2 3.2 2.9 2.1 3.1 0.0 0.0 3.5 0.3 0.6 0.8 0.5 11.5 0.8 40.3 6.1 0.3 0.0 3.4 0.4 0.5 4.1 5.6 6.3 1.9 13.1 0.5 9.7 0.8 0.3 1.6 0.1 0.0 0.0 3.1 0.0 0.6 7.5 11.8 5.8 0.8 1.5 13.6 0.6 0.3 2.4 6.4 3.6 3.2 3.8 0.4 3.9 5.7 5.3 0.0 0.4 2.0 0.1 2.0 5.7 8.5 50.3 0.0 3.1 0.4 0.4 0.1 0.2 1.7 0.0 3.3 3.7 2.4 2.8 0.2 3.9 6.8 5.7 0.4 1.6 0.2 3.8 1.6 1.2 23.7 27.4 13.5 21.5 17.3 21.0 16.0 14.7 13.0 8.8 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell line enhanced" "Detected in all" "T-47d: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favourable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favourable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.8 10.2 9.2 3.2 6.1 3.5 6.0 9.0 5.2 5.4 7.2 6.9 2.7 12.9 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.7 1.3 1.2 15.0 6.5 4.5 11.4 6.1 4.0 7.5 2.4 17.7 3.7 2.0 4.5 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 29.6 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.1 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023296 Enhanced Supported Mitochondria,Cytosol 140000 Mitochondria Cytosol "HPA023296: AB_1844738" "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favourable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 14.8 9.8 27.8 46.0 23.2 13.8 35.5 17.8 22.0 20.7 26.8 27.6 14.3 0.0 18.2 13.9 11.1 8.6 60.2 19.1 0.0 10.4 2.8 14.7 23.4 11.3 0.0 0.0 16.9 14.2 16.1 11.6 16.5 0.0 0.0 18.2 9.7 0.6 0.0 18.8 8.3 8.9 31.6 0.0 19.7 11.3 9.5 11.3 0.0 9.8 10.3 17.7 0.6 20.0 6.0 18.6 6.9 12.2 0.0 0.0 0.0 3.2 0.0 9.6 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 ALKBH7 "MGC10974, SPATA11" ENSG00000125652 "AlkB homolog 7" Q9BT30 19 6372433-6375251 "Predicted intracellular proteins" Necrosis "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008539, HPA039571, HPA039872" Approved Supported Mitochondria Mitochondria "HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710" "unprognostic (5.38e-2)" "unprognostic (3.58e-2)" "unprognostic (2.20e-1)" "unprognostic (1.15e-2)" "unprognostic (7.79e-2)" "unprognostic (3.56e-3)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (3.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.72e-3)" "unprognostic (1.54e-1)" "prognostic favourable (7.83e-6)" "unprognostic (7.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" 10.8 14.7 13.7 14.1 15.2 12.7 13.6 16.3 15.8 12.3 25.0 11.1 28.4 30.9 12.4 18.8 17.2 15.4 18.7 49.3 12.6 11.9 17.1 32.7 20.2 26.3 14.2 11.9 19.0 65.0 10.2 14.0 7.9 15.8 15.5 9.8 16.0 29.7 21.5 62.9 11.9 29.6 15.8 15.9 9.9 14.2 96.5 7.3 29.9 19.4 29.5 16.2 12.6 13.6 34.3 43.8 19.7 32.8 18.4 45.9 28.4 9.7 8.4 7.5 13.0 4.2 11.9 9.2 5.8 6.3 6.4 6.8 14.8 6.3 12.5 22.0 9.0 7.5 3.3 5.9 1.2 12.7 11.8 6.7 6.2 13.8 12.4 4.1 10.2 13.6 11.9 5.5 4.4 7.9 7.6 28.2 4.8 19.7 19.8 13.9 10.3 35.4 14.0 3.8 26.4 7.1 7.6 10.0 14.8 3.9 12.7 24.5 14.4 15.3 5.2 6.4 8.3 23.5 6.7 40.6 29.4 8.3 12.1 13.2 5.5 9.9 32.8 4.9 17.1 26.5 23.5 34.3 29.8 23.3 38.8 31.6 45.9 36.0 19.7 18.4 20.4 43.8 25.3 28.4 13.7 15.2 16.3 15.8 12.6 11.9 14.2 11.9 15.8 7.3 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.2;Hep G2: 29.5;NTERA-2: 5.3;SH-SY5Y: 7.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favourable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.2 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.2 0.1 0.4 0.1 0.2 0.1 0.0 0.3 29.5 1.1 0.0 0.1 0.3 0.7 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.2 0.2 5.3 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.8 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619798-67651720 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 53.7;thyroid gland: 75.4" "Cell line enhanced" "Detected in many" "HAP1: 25.0" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 1.5 3.9 2.4 1.7 6.4 0.6 2.7 8.3 5.3 9.3 5.4 0.5 2.0 2.1 3.7 2.3 7.3 0.8 4.9 2.1 3.3 5.5 41.4 2.0 1.7 0.6 3.2 1.7 8.8 2.6 32.1 22.5 4.4 4.6 53.7 1.1 3.4 26.6 3.8 17.2 0.8 10.4 2.2 3.9 0.7 1.4 1.9 2.1 0.1 75.4 13.6 2.2 5.3 4.1 2.5 1.7 2.0 1.4 0.3 2.9 3.4 3.5 0.5 6.2 4.0 0.9 0.0 8.4 2.8 7.5 9.1 15.4 15.3 1.8 6.0 0.7 1.8 0.8 25.0 11.3 11.0 0.2 6.2 2.7 1.1 17.5 2.7 0.6 16.4 0.4 14.8 4.4 21.6 15.3 7.9 0.0 0.6 1.7 0.9 0.6 11.8 0.2 0.2 0.8 6.9 7.4 6.0 13.8 5.2 1.7 1.7 2.6 6.4 0.2 3.1 2.7 6.9 0.2 2.0 0.5 0.9 2.0 5.5 3.1 4.6 0.3 1.4 2.0 1.1 0.5 0.5 0.7 0.3 0.9 1.7 2.5 0.6 0.6 1.7 0.3 1.2 0.1 2.9 3.4 2.4 6.4 8.3 5.3 3.3 5.5 3.2 1.7 4.6 2.1 ARMC1 "Arcp, FLJ10511" ENSG00000104442 "Armadillo repeat containing 1" Q9NVT9 8 65602456-65634217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026085 Approved Supported Mitochondria Mitochondria "HPA026085: AB_1845031" "prognostic unfavourable (4.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (8.18e-2)" "unprognostic (1.45e-2)" "prognostic unfavourable (7.73e-4)" "unprognostic (4.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.19e-2)" "prognostic unfavourable (9.15e-4)" "unprognostic (1.81e-1)" "unprognostic (3.30e-3)" "unprognostic (1.08e-1)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (1.66e-1)" 16.2 16.5 25.5 13.1 25.6 11.5 19.2 30.4 32.3 17.1 19.0 22.6 10.2 15.8 19.7 17.8 17.7 14.1 12.3 21.6 26.9 24.0 22.9 23.5 12.6 18.1 24.5 18.7 20.4 15.2 18.4 18.9 16.7 27.1 19.2 17.6 13.1 15.1 18.8 22.2 11.6 15.3 22.5 27.5 15.0 14.5 10.0 18.9 20.7 15.4 10.4 20.0 20.4 14.0 8.8 6.1 20.7 7.9 9.6 10.5 5.8 22.6 16.2 15.8 14.7 15.7 14.4 11.5 20.4 15.2 21.7 16.1 11.9 18.4 35.3 5.2 18.4 15.2 28.3 16.4 29.5 20.0 14.7 27.3 10.3 17.3 21.0 10.3 14.9 13.1 19.0 17.8 24.6 22.2 28.2 25.2 23.2 14.5 37.9 13.6 16.4 18.0 22.1 19.7 12.4 17.2 10.7 11.8 12.8 12.9 16.3 19.2 26.2 12.1 13.1 20.6 15.1 15.6 19.0 18.7 19.7 23.9 19.4 19.2 19.9 20.7 4.8 6.1 7.6 7.9 10.5 8.8 9.1 9.1 6.1 6.8 9.4 9.3 0.6 9.6 7.2 5.3 9.5 5.8 25.5 25.6 30.4 32.3 26.9 24.0 24.5 18.7 27.1 18.9 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099764 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavourable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavourable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 21.6 21.7 28.0 12.6 25.0 9.1 24.5 11.4 28.0 24.4 18.6 24.7 20.8 14.0 20.4 24.2 22.2 23.2 20.0 16.7 26.2 26.2 27.4 30.2 15.0 15.7 26.3 24.2 26.5 28.7 26.0 12.0 15.4 19.7 22.2 18.8 17.6 15.7 23.4 15.8 21.6 12.8 20.3 25.5 14.4 19.8 14.1 19.6 21.5 30.7 15.6 15.7 22.3 20.5 5.1 6.8 6.6 5.4 3.9 4.7 2.2 12.5 10.7 6.4 12.3 13.3 12.7 6.4 8.8 9.6 6.4 7.8 5.8 14.9 22.6 19.1 7.7 11.3 8.9 9.8 9.1 8.4 10.2 8.0 4.6 2.7 13.4 21.8 9.6 8.2 17.4 8.0 13.2 14.5 19.4 14.0 11.3 23.2 16.0 16.9 14.2 11.6 9.7 6.6 29.3 16.1 8.8 7.2 9.8 12.0 18.2 13.3 7.3 10.9 9.6 9.9 9.5 23.2 13.2 21.5 33.7 18.2 11.2 20.4 12.4 0.0 4.4 6.6 2.6 5.4 4.5 4.0 4.1 4.4 6.8 5.1 4.6 4.7 0.9 3.9 2.8 5.3 4.2 2.2 28.0 25.0 11.4 28.0 26.2 26.2 26.3 24.2 19.7 19.6 ATAD3A FLJ10709 ENSG00000197785 "ATPase family, AAA domain containing 3A" Q9NVI7 1 1512151-1534687 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA058968, HPA064867, HPA065305" Approved Supported Mitochondria Mitochondria "HPA058968: , HPA064867: , HPA065305: " "unprognostic (8.42e-2)" "unprognostic (1.67e-1)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.50e-1)" "unprognostic (8.74e-2)" "prognostic unfavourable (5.90e-5)" "unprognostic (6.62e-2)" "unprognostic (9.53e-2)" "unprognostic (5.81e-2)" "unprognostic (4.09e-2)" "unprognostic (7.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (3.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.87e-3)" 10.8 13.9 11.2 16.3 11.3 25.0 9.3 9.3 14.8 9.2 11.0 11.1 12.5 16.4 10.4 7.6 16.8 9.3 11.9 15.9 9.2 8.2 12.9 26.7 9.7 13.9 10.5 13.3 8.5 20.4 8.1 16.6 11.3 8.3 10.7 6.2 9.6 19.5 9.5 31.1 13.3 12.2 8.9 8.5 12.4 13.0 12.7 9.1 14.0 12.4 21.1 14.3 9.3 9.4 3.3 4.7 1.3 6.2 5.1 4.0 2.1 21.0 11.9 5.2 13.4 2.6 3.2 12.5 17.4 5.2 15.4 9.3 30.4 14.5 11.6 12.0 6.8 18.0 7.4 10.3 2.6 11.2 31.8 20.3 29.2 20.3 5.0 29.1 13.0 3.6 3.3 12.4 5.2 6.6 31.7 9.0 5.5 14.8 21.9 26.7 10.7 25.5 23.8 9.9 24.1 4.2 8.8 26.6 10.5 10.8 16.4 13.7 7.2 14.4 9.0 15.7 12.3 24.0 21.2 13.4 13.2 46.8 15.4 43.8 7.0 0.2 4.0 1.3 3.3 2.9 2.5 3.3 3.8 4.0 4.7 3.0 3.4 1.5 0.1 5.1 6.2 4.4 2.8 2.1 11.2 11.3 9.3 14.8 9.2 8.2 10.5 13.3 8.3 9.1 ATAD3B "KIAA1273, TOB3" ENSG00000160072 "ATPase family, AAA domain containing 3B" Q5T9A4 1 1471769-1497848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 3.7" "Low lineage specificity" "Detected in many" "HPA058968, HPA064867, HPA065305" Approved Supported Mitochondria Mitochondria "HPA058968: , HPA064867: , HPA065305: " "unprognostic (6.05e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (1.30e-1)" "unprognostic (1.97e-2)" "unprognostic (3.68e-1)" "prognostic unfavourable (1.81e-5)" "unprognostic (1.51e-1)" "unprognostic (2.27e-2)" "unprognostic (2.17e-2)" "unprognostic (8.24e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (5.48e-9)" "unprognostic (2.38e-2)" "unprognostic (2.80e-1)" "unprognostic (3.00e-2)" "unprognostic (1.68e-1)" 13.7 7.6 7.5 18.9 9.5 24.3 10.4 11.6 10.8 7.4 9.6 8.7 8.2 12.1 10.0 7.0 11.3 8.1 8.4 6.4 7.5 6.5 9.9 14.5 9.8 17.3 9.5 8.1 10.1 16.5 3.2 13.6 10.3 7.6 11.0 3.8 8.8 16.3 16.5 9.9 15.8 12.3 8.8 6.8 14.5 15.4 9.3 8.2 7.9 9.3 6.6 13.1 5.9 10.0 0.3 0.8 1.4 3.7 0.2 2.0 0.5 6.8 0.0 2.1 11.5 0.6 0.9 15.7 11.1 2.6 10.9 8.3 25.5 20.3 9.7 3.5 4.3 12.7 14.0 7.0 2.3 8.3 13.2 6.7 16.7 15.5 2.6 11.2 8.0 2.5 0.4 17.9 1.1 3.7 20.0 2.1 3.9 3.5 13.3 13.1 22.4 25.5 10.7 3.3 7.1 3.1 4.5 8.9 7.1 8.2 10.6 9.4 1.6 4.0 4.7 2.9 6.4 17.2 11.7 6.4 8.8 23.6 9.4 18.7 3.3 0.0 0.7 1.4 1.6 3.7 2.0 0.3 1.0 1.4 0.8 0.0 0.3 0.1 0.0 0.2 1.9 0.5 0.0 0.5 7.5 9.5 11.6 10.8 7.5 6.5 9.5 8.1 7.6 8.2 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA067683: " "unprognostic (2.85e-1)" "prognostic favourable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favourable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favourable (2.39e-7)" "prognostic favourable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 6.4 10.8 5.1 9.2 7.8 35.0 6.3 15.6 14.9 6.2 18.4 9.8 8.1 26.0 6.1 7.2 18.4 5.5 7.6 15.4 4.6 4.9 14.5 8.8 7.3 9.8 9.6 6.4 7.0 16.1 8.2 12.1 6.9 7.3 9.7 7.3 7.8 11.5 8.5 31.5 17.7 27.3 4.0 4.5 12.0 10.5 29.0 8.8 19.9 9.8 16.4 10.5 7.5 9.6 2.0 7.6 5.7 1.6 2.2 3.6 1.4 6.9 4.7 6.5 8.8 1.2 1.0 5.1 4.3 4.3 6.1 6.8 7.8 2.3 4.5 8.2 0.5 11.0 4.0 3.7 0.8 4.4 10.6 11.9 11.4 4.3 4.1 4.7 12.2 1.0 7.7 5.3 1.9 1.8 8.8 10.9 1.9 11.2 14.0 29.1 9.9 12.8 10.3 4.0 8.0 3.5 9.4 24.6 9.5 6.3 12.4 4.9 7.6 11.7 3.4 9.4 5.9 18.9 9.5 9.7 6.6 5.3 8.0 9.3 10.6 3.0 1.6 5.7 2.1 1.5 3.1 2.0 2.5 2.3 1.1 1.0 2.5 3.4 0.5 2.2 0.7 7.6 3.6 1.4 5.1 7.8 15.6 14.9 4.6 4.9 9.6 6.4 7.3 8.8 ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria 51000000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favourable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 30.1 60.0 34.7 30.3 45.8 22.4 33.9 52.6 65.0 27.0 52.1 20.5 39.3 55.6 25.2 30.5 44.4 30.0 27.9 196.2 31.4 36.1 94.0 64.8 25.2 40.2 42.3 31.8 28.6 49.0 73.2 35.9 25.7 41.5 28.3 54.9 37.6 42.6 42.8 182.2 34.0 50.4 36.6 22.6 32.1 46.7 24.0 19.9 45.6 35.1 99.7 41.1 31.5 26.4 58.7 110.9 17.9 64.5 44.2 63.6 124.8 42.5 43.4 57.8 54.2 70.4 78.2 64.1 49.3 69.9 76.0 66.7 64.9 33.7 100.9 30.3 59.7 79.4 99.5 75.7 71.0 44.9 55.9 66.7 56.0 80.4 46.1 141.1 63.4 72.1 53.2 54.8 57.1 78.3 53.8 59.7 64.9 44.3 72.5 69.4 54.1 45.8 71.8 67.2 136.5 103.0 104.2 58.8 54.9 36.1 45.2 60.5 58.2 82.4 45.5 41.9 36.2 21.9 42.9 68.6 58.7 65.0 41.7 84.9 44.5 11.8 64.5 17.9 43.5 58.2 55.8 58.7 52.4 47.5 110.9 44.0 63.6 52.8 6.7 44.2 52.2 54.0 58.9 124.8 34.7 45.8 52.6 65.0 31.4 36.1 42.3 31.8 41.5 19.9 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56646068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria 100000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavourable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favourable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 41.3 66.2 32.4 34.1 53.4 39.3 33.1 55.4 92.6 26.1 73.0 34.4 36.1 68.1 27.9 28.5 58.6 28.5 36.9 225.0 33.2 34.9 95.2 85.7 28.3 39.2 40.5 35.5 25.1 42.7 85.2 30.1 31.3 69.6 29.0 78.5 42.8 64.7 38.1 236.2 42.3 74.6 35.5 24.9 33.5 51.0 31.4 18.3 47.5 38.4 123.6 45.8 36.6 32.8 41.2 91.7 40.2 90.1 36.3 46.6 105.6 65.7 80.0 63.6 98.1 57.4 61.4 112.4 66.9 62.5 115.7 65.9 129.9 73.4 117.0 72.5 82.4 88.2 134.0 81.1 104.8 54.8 92.8 128.3 74.7 79.6 71.1 143.5 90.9 75.2 81.9 90.4 116.8 95.0 115.5 134.9 97.0 61.0 106.3 84.4 107.0 154.1 102.4 71.2 149.1 126.0 117.2 72.8 64.7 102.2 146.4 113.7 137.4 108.5 64.4 45.6 50.8 66.5 72.2 65.1 80.9 121.0 68.6 96.0 69.8 40.2 64.6 34.6 40.2 80.6 44.9 41.2 38.0 42.7 91.7 31.7 31.1 36.7 17.8 36.3 90.1 46.3 46.6 105.6 32.4 53.4 55.4 92.6 33.2 34.9 40.5 35.5 69.6 18.3 ATP5IF1 "ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898" ENSG00000130770 "ATP synthase inhibitory factor subunit 1" Q9UII2 1 28236109-28246906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027999 Supported Enhanced Mitochondria 1800000 Mitochondria "HPA027999: AB_10600984" "unprognostic (2.80e-2)" "unprognostic (3.72e-2)" "unprognostic (2.95e-1)" "prognostic favourable (6.38e-8)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (6.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.40e-2)" "prognostic favourable (8.20e-4)" "unprognostic (5.94e-2)" "unprognostic (3.52e-1)" "unprognostic (6.15e-3)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (2.79e-1)" "unprognostic (1.48e-3)" 17.1 35.1 65.9 32.1 64.0 58.5 20.9 41.8 71.7 24.6 54.5 15.7 33.8 78.2 18.6 24.1 26.4 31.9 38.4 135.2 51.8 60.7 60.2 55.4 20.1 28.7 46.8 58.7 20.5 33.8 20.7 37.6 19.4 53.0 30.4 30.5 24.8 34.5 34.4 135.2 26.3 58.7 15.4 31.0 25.9 45.0 72.4 26.2 24.3 25.0 44.6 23.5 17.9 18.6 56.5 64.2 35.7 35.2 39.1 64.8 55.2 45.1 23.4 13.8 13.0 10.4 11.4 16.4 20.3 10.0 17.4 17.1 22.5 33.1 31.9 30.5 12.3 27.5 15.7 20.2 13.8 23.8 53.0 27.3 101.5 30.3 11.3 20.8 27.7 13.1 33.5 15.5 12.5 16.6 48.2 29.2 12.4 30.0 30.9 38.5 45.8 29.0 29.6 15.3 45.1 33.8 30.0 27.9 20.0 25.1 26.2 25.8 38.9 23.1 17.1 5.6 15.5 22.0 23.9 75.6 45.5 44.1 26.7 57.1 6.5 30.3 35.2 35.7 46.5 31.7 46.2 56.5 49.6 49.1 42.3 43.7 46.7 45.0 30.9 39.1 28.3 64.2 64.8 55.2 65.9 64.0 41.8 71.7 51.8 60.7 46.8 58.7 53.0 26.2 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria Mitochondria "HPA044798: " "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.2 64.1 60.6 72.3 67.8 85.2 39.7 58.0 73.2 59.3 66.4 103.1 67.3 34.7 33.7 65.6 61.8 56.7 59.1 81.9 45.5 101.9 36.0 82.5 115.2 65.9 73.4 55.9 68.7 92.8 53.3 84.3 76.4 47.1 57.9 99.1 93.5 59.5 126.4 45.0 108.5 38.7 37.0 54.0 141.0 98.3 23.0 53.2 30.6 47.0 83.4 41.8 68.2 43.2 29.4 45.1 44.5 75.9 61.1 99.8 57.8 62.1 75.3 22.2 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.1 46.5 67.0 54.6 56.5 52.5 37.4 47.9 38.4 36.4 32.3 44.7 48.7 25.5 46.1 50.6 31.5 54.0 75.5 20.0 22.5 99.7 75.0 86.2 111.5 58.7 95.4 33.0 65.1 44.4 41.7 42.2 44.5 62.0 27.9 41.3 70.8 82.2 125.0 78.8 121.8 50.1 49.0 55.5 69.5 85.8 65.1 51.1 34.8 46.9 53.2 53.6 65.8 51.5 32.7 31.1 28.8 66.8 65.3 107.7 80.6 48.1 65.8 35.8 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported Mitochondria 1400000 Mitochondria "HPA067267: , HPA070412: " "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 87.2 77.0 65.0 104.9 51.2 52.0 41.1 58.0 45.1 62.3 67.5 81.8 80.6 81.8 61.1 35.9 53.8 71.8 66.3 66.6 58.9 92.2 55.4 123.2 105.4 38.7 94.4 63.5 59.3 64.1 54.1 57.4 59.2 112.3 90.3 65.2 205.0 141.2 163.9 92.4 90.8 63.3 54.2 139.9 131.2 97.0 62.5 68.9 75.9 187.7 54.8 47.3 122.6 50.2 54.9 87.7 90.6 84.5 51.7 118.8 170.7 63.4 92.4 84.1 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044629 Approved Supported Mitochondria 590000 Mitochondria "HPA044629: " "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favourable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.5 11.2 29.5 28.5 25.5 28.6 23.6 22.1 25.2 20.3 21.6 28.2 35.0 42.8 46.2 24.0 27.6 29.6 30.9 22.6 34.1 19.5 67.6 10.5 17.0 26.2 38.4 32.4 30.4 29.3 25.0 23.9 27.3 30.9 35.9 28.3 38.7 53.6 48.0 18.7 31.2 36.9 24.7 47.0 52.8 18.6 23.4 17.7 33.3 54.1 16.3 39.3 35.9 26.8 16.8 18.8 14.3 25.2 16.4 22.4 43.5 12.5 44.8 20.9 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell line enhanced" "Detected in some" "RT4: 2.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA044629 Uncertain Supported Mitochondria Mitochondria "HPA044629: " "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.6 0.3 1.0 0.2 0.6 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 0.9 0.5 0.8 0.0 1.3 0.0 0.5 0.8 1.7 1.5 0.0 0.2 0.0 0.6 0.0 2.4 0.2 0.1 0.0 0.7 0.2 0.2 0.0 0.0 1.2 0.8 0.8 0.6 0.6 1.1 0.1 0.3 0.7 0.9 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: , HPA060520: " "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favourable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 38.3 44.4 38.5 36.6 46.1 47.9 38.0 30.1 34.2 37.8 33.1 38.3 27.3 40.3 31.8 30.8 32.8 49.5 36.3 51.2 33.3 50.0 44.9 37.6 58.9 30.4 54.3 31.3 50.2 49.4 25.6 27.4 42.4 27.3 43.3 41.5 114.1 52.4 77.5 30.0 84.9 33.7 33.6 36.6 57.6 54.7 33.3 39.8 25.2 47.3 56.7 58.6 64.6 22.8 14.9 23.3 40.1 24.6 33.2 56.4 56.4 34.9 31.0 25.0 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favourable (3.26e-9)" "prognostic favourable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.1 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.8 6.2 7.8 21.0 15.9 11.2 16.0 19.0 21.0 15.9 16.6 7.4 21.0 4.9 4.2 6.2 26.4 21.2 6.6 9.0 19.5 18.3 14.1 18.4 9.3 10.1 7.1 45.0 6.2 9.9 24.1 11.6 40.7 8.2 14.0 5.2 9.6 3.0 13.3 19.0 14.0 15.2 9.5 13.6 8.3 14.8 16.2 16.8 12.8 12.1 49.9 20.2 20.1 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria 1600000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 38.8 38.5 54.3 28.6 48.6 25.6 37.8 34.5 50.4 30.0 52.9 19.6 33.2 46.6 25.8 47.4 58.9 25.7 31.0 143.6 47.7 44.8 78.8 86.2 24.8 29.2 45.7 39.2 28.5 43.3 38.5 29.8 35.4 40.3 33.1 53.1 35.4 56.8 36.3 184.2 35.5 59.9 39.1 32.8 32.7 40.4 15.7 21.3 30.3 48.7 88.5 33.7 45.8 29.0 72.5 100.7 90.9 103.8 54.9 100.0 86.2 66.4 58.4 44.7 58.3 72.9 89.3 60.2 57.2 75.5 64.2 61.3 45.6 52.3 45.1 38.1 71.5 60.6 53.8 74.9 86.1 21.9 45.7 46.0 48.6 89.8 71.8 58.6 30.3 75.8 59.7 52.2 74.7 85.4 47.9 61.5 78.9 64.5 58.0 65.9 34.1 83.0 41.1 129.6 83.5 132.7 65.1 45.1 49.5 67.5 107.7 91.1 106.7 59.8 44.0 80.0 55.9 69.4 66.7 49.4 39.0 46.1 71.6 58.9 51.5 67.2 90.5 90.9 58.3 103.8 67.4 72.5 100.0 71.6 100.7 57.6 90.9 83.5 50.7 54.9 83.1 89.8 94.6 86.2 54.3 48.6 34.5 50.4 47.7 44.8 45.7 39.2 40.3 21.3 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria 720000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favourable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 39.8 46.8 49.0 20.3 43.6 23.0 32.6 30.8 46.6 25.9 48.6 26.1 22.4 43.0 24.0 57.4 45.2 21.6 19.2 148.9 41.1 37.1 72.8 111.0 18.7 22.2 47.0 27.0 23.9 37.4 31.2 37.5 33.9 45.7 32.6 47.9 33.9 47.1 37.5 164.7 18.7 57.9 46.9 32.8 25.0 37.6 21.0 25.8 31.4 32.1 69.9 29.9 42.0 23.1 87.8 102.4 80.9 91.5 69.1 95.2 112.2 41.6 30.0 38.3 43.0 41.2 38.0 47.5 36.9 42.9 36.1 35.3 68.9 32.9 51.4 24.5 36.4 22.9 51.2 44.2 39.8 44.9 54.4 107.1 61.0 68.4 46.6 78.2 35.1 37.1 54.6 34.5 31.0 41.9 66.8 63.2 52.6 46.6 54.1 79.2 68.8 54.5 42.3 74.4 97.0 77.0 57.0 43.7 48.6 62.0 62.7 56.8 45.3 70.4 31.6 27.6 33.1 25.7 31.7 63.1 103.1 65.0 42.4 81.8 34.5 69.2 88.8 80.9 60.3 91.5 64.0 87.8 80.2 74.6 102.4 71.6 79.6 78.0 56.9 69.1 89.7 96.4 95.2 112.2 49.0 43.6 30.8 46.6 41.1 37.1 47.0 27.0 45.7 25.8 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915980 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Enhanced Mitochondria 4000000 Mitochondria "CAB016209: AB_631361, HPA041394: " "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favourable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 32.6 26.8 49.3 27.7 43.5 34.9 37.8 35.0 44.8 28.7 45.0 21.6 24.2 48.2 25.1 34.3 44.2 28.9 30.3 139.4 40.8 36.7 61.3 57.5 20.6 31.5 45.6 38.4 38.0 40.1 29.5 19.2 25.1 46.4 32.5 52.4 27.2 38.8 28.6 130.6 28.7 57.5 34.8 29.3 27.3 43.2 25.4 20.1 42.7 37.4 98.0 36.2 39.4 26.5 71.9 94.0 48.5 71.5 46.8 73.3 112.2 41.9 19.7 54.9 53.8 37.7 48.4 61.1 24.0 42.2 40.4 39.7 57.7 40.7 56.2 20.7 36.4 23.8 59.1 82.0 47.9 41.9 58.9 84.3 31.5 57.3 43.5 63.8 29.2 49.2 50.2 39.1 64.3 55.6 67.6 73.0 51.9 43.2 48.7 62.7 62.6 58.3 50.3 54.2 106.1 110.7 37.3 44.4 25.7 41.2 61.7 54.6 62.2 70.5 31.3 26.6 31.7 47.4 27.2 48.2 52.6 58.9 49.1 109.6 38.3 33.4 69.9 48.5 44.5 71.5 53.0 71.9 58.8 52.9 94.0 59.0 73.3 61.5 17.2 46.8 62.6 55.9 70.1 112.2 49.3 43.5 35.0 44.8 40.8 36.7 45.6 38.4 46.4 20.1 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favourable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 26.6 29.3 30.3 19.6 30.5 20.9 16.3 17.8 40.5 14.1 27.9 18.7 18.3 33.5 14.3 18.3 25.0 14.5 22.9 55.2 25.3 23.4 35.0 59.1 14.4 17.6 29.0 23.0 14.8 41.2 16.8 18.7 23.6 21.9 17.2 13.6 20.0 35.8 20.4 115.9 20.2 29.5 15.9 18.5 16.9 24.7 73.8 12.6 16.0 27.1 41.4 20.7 18.2 15.2 53.4 81.9 82.5 67.5 36.1 61.6 59.2 38.7 23.6 12.9 23.2 11.5 14.5 23.9 23.6 15.7 37.4 26.6 41.3 36.0 20.5 35.2 15.9 28.7 17.7 31.2 10.8 24.5 50.1 16.5 30.9 38.1 22.6 21.3 22.5 19.0 14.1 26.2 10.6 20.2 32.5 28.4 21.7 29.6 26.1 76.1 24.4 67.2 30.5 15.9 44.0 29.5 10.3 41.5 31.1 16.9 59.1 56.0 25.6 49.9 15.2 23.2 29.8 27.6 34.7 37.1 33.8 43.0 32.3 31.5 15.6 60.8 67.5 70.6 51.1 53.6 48.4 53.1 53.9 53.7 58.0 53.4 50.7 49.3 82.5 36.1 46.0 81.9 61.6 59.2 30.3 30.5 17.8 40.5 25.3 23.4 29.0 23.0 21.9 12.6 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: " "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 23.1 23.2 35.3 12.6 30.7 17.7 20.6 15.9 43.9 21.2 25.7 22.7 20.1 24.0 18.3 19.7 18.8 23.2 22.5 30.3 32.7 23.8 21.4 22.3 17.7 14.3 29.6 20.2 18.8 26.9 19.4 15.2 24.9 18.4 22.9 13.6 23.1 39.9 27.0 23.9 20.4 21.1 17.2 22.9 14.9 37.8 18.6 14.8 19.3 29.2 15.8 14.1 18.2 14.4 26.5 42.0 43.5 32.3 24.0 30.7 23.1 31.9 30.1 8.8 13.2 10.7 13.1 12.9 13.6 15.9 21.0 16.7 18.3 18.4 6.9 24.5 12.7 17.0 5.7 21.4 4.2 26.7 21.0 8.5 27.2 8.7 16.5 7.4 16.0 12.6 18.5 16.1 9.9 13.2 3.2 14.9 9.1 31.8 16.5 16.7 3.4 38.5 15.7 5.2 19.3 12.7 15.1 18.2 24.4 13.7 16.3 16.6 24.5 11.1 10.9 25.7 17.4 39.8 14.9 28.3 21.0 7.0 21.0 5.3 14.0 32.5 32.3 43.5 25.3 24.0 25.8 26.0 26.9 24.6 22.5 26.5 19.4 20.0 41.7 24.0 22.6 42.0 30.7 23.1 35.3 30.7 15.9 43.9 32.7 23.8 29.6 20.2 18.4 14.8 BCAT2 "BCAM, BCT2" ENSG00000105552 "Branched chain amino acid transaminase 2" O15382 19 48795062-48811029 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054091 Enhanced Supported Mitochondria 3400000 Mitochondria "HPA054091: " "unprognostic (2.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.16e-1)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.97e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (2.98e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (1.06e-1)" "prognostic favourable (3.68e-5)" "unprognostic (1.87e-3)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (7.50e-3)" 11.8 34.1 6.7 10.9 7.7 3.8 15.0 15.0 10.7 11.9 16.7 11.3 15.8 10.2 12.9 9.8 24.6 11.9 15.2 25.1 6.8 6.9 22.6 8.0 19.9 16.3 9.8 7.8 22.3 42.6 9.0 12.3 27.5 22.0 16.8 12.1 6.3 24.7 17.2 23.3 9.8 10.3 17.5 7.6 10.9 22.8 15.9 10.7 12.5 19.1 23.3 16.7 29.2 12.2 15.0 18.2 1.8 9.8 8.8 15.4 7.1 17.4 21.0 5.6 11.8 23.3 7.9 9.9 7.7 3.9 9.5 9.3 21.0 10.7 20.5 8.9 6.9 8.3 8.6 13.5 4.8 12.8 21.7 7.5 9.4 1.3 22.6 10.1 7.1 11.4 8.6 7.1 10.3 13.2 9.6 12.7 3.4 20.8 13.8 10.8 4.9 10.2 21.1 9.6 22.6 9.0 72.2 30.1 8.6 11.8 19.4 5.7 12.3 5.0 7.3 9.3 9.0 10.9 9.6 11.9 15.8 9.8 5.0 15.8 6.0 0.0 8.7 1.8 9.7 9.8 13.6 15.0 11.7 12.4 16.1 12.8 10.8 9.6 0.4 8.8 3.7 18.2 15.4 7.1 6.7 7.7 15.0 10.7 6.8 6.9 9.8 7.8 22.0 10.7 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favourable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 6.9 2.6 9.9 13.2 10.0 8.8 7.9 4.9 10.3 8.1 11.2 4.2 9.6 19.7 5.3 11.8 7.0 5.5 6.5 11.5 24.5 8.1 9.7 6.8 5.7 11.2 13.9 4.4 8.4 6.8 5.6 7.0 9.7 8.2 17.7 18.2 3.8 5.0 8.1 7.3 3.4 12.8 30.7 16.8 22.6 10.6 6.6 9.3 8.4 7.0 4.9 9.0 10.7 4.1 4.9 3.4 4.5 6.6 12.6 12.3 6.5 6.0 10.4 7.3 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 BCKDK ENSG00000103507 "Branched chain ketoacid dehydrogenase kinase" O14874 16 31106107-31112791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017995, HPA056067" Supported Supported Mitochondria Mitochondria "HPA017995: AB_1845309, HPA056067: " "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (6.94e-2)" "unprognostic (5.20e-2)" "unprognostic (5.39e-2)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (5.47e-2)" "unprognostic (1.60e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.24e-2)" "unprognostic (2.66e-3)" "unprognostic (4.85e-2)" "unprognostic (3.93e-2)" "unprognostic (1.00e-1)" "unprognostic (4.97e-2)" 15.4 29.7 11.9 13.1 15.0 9.4 18.3 18.8 21.3 11.7 14.1 9.6 19.9 11.2 14.8 14.9 14.9 13.8 15.1 39.2 14.2 10.3 21.3 46.5 18.2 32.5 10.7 17.3 15.1 52.4 17.4 8.9 11.4 13.2 14.9 9.9 10.4 33.9 25.7 67.7 21.5 12.2 19.9 15.6 16.0 19.9 11.2 9.3 8.0 11.7 25.9 10.6 15.3 12.0 6.9 26.8 26.6 33.0 6.3 6.8 13.6 18.1 20.4 11.5 17.3 14.2 14.3 12.5 15.8 19.5 24.6 24.1 13.3 12.1 17.0 23.0 19.7 12.6 8.1 27.5 15.9 13.7 25.3 18.4 13.9 24.2 25.1 9.5 16.9 21.0 11.1 21.1 17.6 26.2 9.3 16.1 36.8 30.9 8.8 12.6 9.8 16.5 17.8 16.8 31.3 18.8 12.5 17.8 16.3 12.3 30.3 9.8 18.2 9.2 16.8 18.8 10.9 19.2 13.1 16.8 6.0 6.0 21.3 13.8 17.6 12.2 33.0 23.1 5.7 27.4 5.6 6.9 5.2 4.2 26.8 5.4 4.4 5.0 26.6 6.3 19.3 5.8 6.8 13.6 11.9 15.0 18.8 21.3 14.2 10.3 10.7 17.3 13.2 9.3 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: " "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favourable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 15.3 17.4 13.3 7.6 14.2 10.9 17.3 13.0 17.4 9.2 11.9 14.8 8.8 8.3 10.5 10.7 14.5 11.7 10.0 18.9 12.7 12.2 18.9 20.9 10.6 9.3 14.4 13.4 10.4 22.0 25.8 12.3 14.1 12.2 11.1 14.1 15.2 12.4 9.5 61.2 15.5 12.4 11.7 13.0 8.3 11.2 22.9 11.5 12.1 13.5 14.5 12.3 14.6 10.2 6.5 11.3 4.7 17.3 10.4 8.3 9.5 14.0 6.3 10.1 9.6 16.8 16.2 13.4 10.1 17.7 15.0 17.1 7.1 9.4 12.2 7.3 14.4 19.3 11.6 15.5 15.7 11.7 8.8 11.5 5.7 3.7 21.0 16.0 10.0 13.1 18.2 12.8 34.7 13.1 28.5 11.5 16.3 9.5 8.1 5.1 8.0 7.9 8.6 15.6 4.5 15.6 9.7 14.3 9.0 13.3 13.5 24.1 9.2 15.8 13.0 8.9 4.6 12.7 9.6 9.9 8.9 10.5 13.3 12.3 15.2 3.8 17.3 4.7 4.6 15.6 5.7 6.5 6.2 5.7 11.3 5.4 5.5 4.5 4.4 10.4 11.0 5.7 8.3 9.5 13.3 14.2 13.0 17.4 12.7 12.2 14.4 13.4 12.2 11.5 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 156.0" "Cell line enhanced" "Detected in many" "U-937: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030947, HPA058709" Enhanced Enhanced Mitochondria Mitochondria "HPA030947: AB_10669548, HPA058709: " "unprognostic (2.72e-2)" "prognostic favourable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favourable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favourable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 3.5 2.8 6.6 5.2 11.2 4.7 4.6 18.1 13.8 4.0 13.9 4.6 6.3 9.6 2.1 3.6 12.9 5.5 6.1 19.6 6.3 5.8 6.0 156.0 2.0 4.2 5.9 9.1 3.0 2.8 5.8 3.6 1.4 7.7 4.5 11.1 6.2 8.6 4.4 7.3 8.0 13.7 2.4 3.5 2.3 4.7 1.8 3.6 5.4 5.2 11.3 7.4 3.6 3.6 6.1 4.6 2.9 1.6 4.7 9.9 4.0 10.5 1.4 0.6 5.4 0.9 0.0 0.0 1.2 1.0 5.5 3.1 9.5 3.5 0.0 15.7 0.3 4.9 4.8 2.5 2.1 0.1 0.0 5.6 3.6 3.2 4.0 12.4 5.9 1.6 3.0 2.1 4.6 1.3 0.0 4.2 0.1 18.8 9.5 8.4 4.1 1.9 9.1 2.0 14.4 5.8 4.8 10.0 4.3 3.8 0.5 2.0 12.7 10.4 0.1 0.3 1.8 0.0 9.9 4.9 9.2 0.1 0.3 35.3 0.7 2.9 1.6 0.6 5.9 0.2 8.2 6.1 6.5 5.3 4.2 5.5 9.9 5.9 0.0 4.7 0.3 4.6 4.2 4.0 6.6 11.2 18.1 13.8 6.3 5.8 5.9 9.1 7.7 3.6 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell line enhanced" "Detected in many" "BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" 19244000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: , HPA056104: " "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.6 0.2 0.0 2.3 1.9 0.0 22.4 4.3 17.2 13.1 0.0 2.6 0.0 2.1 8.1 1.0 0.1 0.2 16.5 0.1 0.1 0.0 2.2 0.0 10.0 0.1 0.1 5.8 2.2 3.8 2.2 0.7 0.0 0.0 2.7 0.0 0.0 0.0 2.1 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 0.1 0.0 7.4 24.1 4.0 9.3 5.0 0.3 0.0 0.0 9.3 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavourable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 18.1 6.9 16.6 11.2 46.3 29.2 14.0 18.4 54.1 17.3 38.3 3.1 8.8 5.6 17.4 34.6 9.3 8.2 23.6 57.6 3.6 4.5 23.2 7.2 5.4 25.8 2.0 40.3 35.0 18.6 19.6 11.8 22.1 10.4 13.6 36.2 7.9 14.3 7.6 5.3 7.6 7.7 21.1 11.0 17.9 11.8 17.7 15.8 8.9 1.8 13.9 9.1 4.4 28.9 32.5 14.1 20.3 4.1 20.0 9.0 7.5 49.4 4.2 7.3 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135398-74147994 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: " "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavourable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 18.5 16.1 23.2 11.7 26.0 18.0 20.4 15.6 29.8 11.0 24.0 7.5 12.1 18.4 10.0 13.8 12.6 11.2 12.5 56.8 18.9 21.0 22.0 15.7 14.1 14.7 24.1 18.1 6.9 27.8 12.8 12.3 7.7 17.6 11.5 19.7 11.9 21.5 14.2 57.2 5.9 15.3 14.4 15.8 8.8 16.8 8.2 10.6 7.7 12.1 27.9 11.1 8.9 9.1 14.3 20.7 3.4 9.7 15.2 32.0 13.9 23.5 30.7 11.2 11.0 20.7 19.6 27.6 22.0 13.0 24.5 16.8 39.9 11.0 15.6 20.2 19.0 12.5 25.6 31.4 22.0 30.5 42.2 19.8 21.3 60.8 18.5 38.8 9.7 15.6 24.1 23.8 29.6 18.2 41.4 18.5 26.5 36.3 32.4 29.0 16.4 47.1 21.3 29.1 32.0 32.4 23.9 16.9 10.1 15.6 25.7 27.1 14.7 24.7 10.0 20.3 34.7 22.7 43.6 17.0 29.9 21.4 21.4 31.2 18.2 3.4 4.8 1.1 23.2 9.1 25.3 14.3 32.0 24.5 12.1 12.4 28.0 24.1 0.9 15.2 9.7 20.7 27.8 13.9 23.2 26.0 15.6 29.8 18.9 21.0 24.1 18.1 17.6 10.6 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23094765-23100462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavourable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favourable (3.30e-5)" "unprognostic (1.63e-1)" 28.2 35.0 16.3 22.0 18.5 9.2 38.9 11.6 17.3 30.4 28.4 17.0 23.9 22.6 29.9 30.3 32.0 23.5 22.4 29.6 16.3 19.9 36.3 24.6 30.4 37.3 22.4 15.1 25.2 39.4 16.7 28.1 32.2 23.1 27.9 35.8 27.1 28.0 28.1 21.2 20.7 27.4 33.5 20.1 33.8 28.2 33.0 16.7 27.2 40.0 26.3 33.1 25.8 24.0 34.6 37.4 72.7 40.2 30.2 45.0 43.7 13.6 13.6 20.5 12.4 45.3 39.5 16.5 23.0 34.1 30.4 36.2 10.7 21.3 10.4 12.0 37.3 23.5 19.5 30.6 42.3 16.6 9.5 15.7 11.3 45.8 35.7 23.5 24.6 48.0 27.6 25.6 18.9 33.2 10.4 11.7 33.3 19.7 11.0 18.2 12.8 20.8 9.8 15.3 12.0 34.5 22.1 9.9 9.0 19.2 18.1 19.9 12.2 13.7 26.7 14.5 12.7 21.7 10.3 11.0 12.9 12.8 13.3 14.9 12.9 63.7 40.2 72.7 32.6 25.7 37.1 34.6 37.2 36.2 37.4 28.5 39.1 38.3 23.8 30.2 17.3 25.2 45.0 43.7 16.3 18.5 11.6 17.3 16.3 19.9 22.4 15.1 23.1 16.7 C19orf70 "MIC13, P117, QIL1" ENSG00000174917 "Chromosome 19 open reading frame 70" Q5XKP0 19 5678421-5680896 "Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favourable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 20.2 23.6 32.9 14.5 28.4 13.2 16.0 11.0 29.8 13.0 22.2 13.5 17.8 25.4 12.2 26.8 22.7 16.7 24.0 70.2 27.2 26.5 30.5 38.4 12.7 21.1 32.1 21.1 13.5 24.2 13.2 15.6 12.4 16.9 16.6 11.7 13.6 28.7 22.7 79.1 17.6 20.7 14.7 20.9 14.1 18.2 33.4 12.3 11.6 20.3 45.0 12.6 15.4 11.8 43.6 48.2 11.6 42.2 27.4 39.5 40.7 23.9 19.9 6.9 13.2 16.3 16.9 9.0 15.9 15.1 18.4 15.2 15.8 12.5 10.4 25.9 13.9 17.9 3.6 22.5 5.3 17.2 37.9 10.2 13.8 17.5 23.0 13.9 12.8 19.8 20.4 9.9 13.8 13.1 15.7 32.7 13.8 21.7 21.0 16.6 7.3 63.6 11.5 8.3 38.2 20.0 15.1 16.2 20.7 4.9 31.4 22.2 19.2 17.1 13.4 18.1 7.7 33.0 22.5 49.4 32.6 8.3 26.9 22.3 18.3 8.9 35.5 11.6 33.6 42.2 39.5 43.6 38.6 37.2 41.2 35.6 38.1 35.9 5.6 27.4 35.6 48.2 30.9 40.7 32.9 28.4 11.0 29.8 27.2 26.5 32.1 21.1 16.9 12.3 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favourable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favourable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 7.8 3.3 3.2 4.1 2.1 1.4 12.6 4.1 2.4 1.6 0.9 6.0 2.4 5.7 8.2 1.4 3.8 0.6 0.7 0.4 8.6 8.2 5.9 2.6 7.0 2.8 6.3 6.4 1.9 1.4 0.7 1.4 1.0 7.2 9.8 1.0 9.8 6.9 15.6 8.0 5.1 17.8 4.1 12.7 1.9 11.6 8.4 7.8 5.7 1.3 6.8 6.1 14.0 4.6 3.6 4.6 3.8 3.0 16.1 8.4 3.9 8.8 12.8 6.4 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 CA5B ENSG00000169239 "Carbonic anhydrase 5B" Q9Y2D0 X 15688830-15788409 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.4;fHDF/TERT166: 17.5;hTERT-HME1: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012618 Uncertain Supported Mitochondria Mitochondria "HPA012618: AB_1846000" "unprognostic (1.62e-2)" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-2)" "unprognostic (4.59e-5)" "unprognostic (2.50e-1)" "unprognostic (6.89e-4)" "unprognostic (4.11e-1)" "unprognostic (3.89e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favourable (6.66e-6)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (8.94e-2)" "unprognostic (3.08e-1)" 9.3 4.6 10.6 4.9 11.1 4.1 10.2 3.1 7.8 28.7 3.6 11.5 1.4 2.2 9.8 3.7 8.1 9.5 9.1 6.5 9.9 8.2 10.3 7.8 7.3 8.8 12.2 6.7 15.2 4.4 16.8 4.4 3.9 13.1 6.2 4.7 29.5 8.3 6.2 2.0 7.5 4.1 9.4 7.1 5.3 5.4 23.0 8.1 2.3 8.9 10.9 11.6 6.3 9.4 4.3 3.5 2.7 3.6 7.9 13.3 7.0 2.7 1.6 1.9 3.1 5.8 15.4 1.1 2.9 3.7 2.1 3.1 0.8 1.8 0.8 3.0 17.5 3.0 6.8 3.3 3.8 0.7 3.2 1.5 2.1 0.7 5.7 1.9 3.3 3.6 3.5 2.8 23.0 3.1 0.7 2.0 10.1 1.5 1.5 1.5 0.7 12.2 0.9 1.4 1.4 3.3 2.0 1.7 3.6 4.0 1.4 2.6 2.0 1.9 4.2 2.5 1.7 13.6 1.6 1.5 1.5 0.8 2.8 3.8 4.7 2.7 3.0 0.3 13.1 3.6 11.4 3.6 13.3 12.3 3.5 4.3 9.8 8.3 1.7 7.9 2.3 0.5 10.0 7.0 10.6 11.1 3.1 7.8 9.9 8.2 12.2 6.7 13.1 8.1 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096218-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria Mitochondria "HPA010921: AB_10670295, HPA010990: , HPA038297: " "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavourable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 15.1 17.8 9.9 8.1 10.6 6.8 19.6 19.8 15.0 13.5 18.1 13.9 6.4 13.7 13.8 14.2 12.9 12.3 13.0 14.5 9.7 7.5 18.1 12.2 12.0 7.8 14.8 10.7 9.6 9.1 6.1 8.1 7.6 13.7 10.2 7.6 9.9 12.1 10.7 15.5 14.6 12.2 12.5 12.5 12.5 15.7 19.9 10.3 5.3 10.0 13.4 7.1 15.5 12.6 5.6 17.3 23.0 21.7 9.2 11.5 12.3 11.9 11.7 1.4 3.5 1.9 3.7 4.9 9.9 4.9 7.0 3.1 2.8 4.0 2.6 7.0 3.5 20.8 1.2 8.0 0.6 49.1 4.6 4.5 2.5 6.5 7.9 4.0 4.3 9.2 2.5 5.0 2.0 8.1 2.0 4.8 4.7 23.6 4.3 10.9 1.4 26.6 2.9 7.8 10.4 8.5 4.5 3.6 6.6 5.3 2.6 10.8 5.9 4.3 8.0 3.5 7.1 6.6 3.0 3.9 3.5 0.5 14.6 4.1 12.2 14.1 21.7 12.8 6.1 16.0 6.2 5.6 6.0 6.5 17.3 3.3 5.5 5.5 23.0 9.2 9.1 6.2 11.5 12.3 9.9 10.6 19.8 15.0 9.7 7.5 14.8 10.7 13.7 10.3 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.7" "Cell line enhanced" "Detected in all" "Karpas-707: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 76.7;eosinophil: 62.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Supported Nucleoplasm,Mitochondria 310000 "Nucleoplasm, Mitochondria" "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favourable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 20.7 11.6 10.8 16.9 10.5 16.7 10.0 22.3 9.2 10.4 25.4 12.8 12.5 32.3 13.9 11.5 22.8 8.9 12.0 8.8 10.0 8.8 10.6 18.7 12.4 23.6 10.2 8.5 8.3 10.0 4.6 13.6 29.4 9.7 8.8 20.9 8.2 13.0 10.0 12.6 9.5 49.7 9.3 12.6 26.5 18.7 6.4 10.9 44.7 7.8 13.5 24.3 16.2 11.0 4.2 5.2 76.7 10.6 9.2 9.9 7.0 8.2 4.6 18.3 8.7 11.4 15.2 10.6 24.8 18.8 17.4 10.1 8.3 6.9 11.5 3.9 12.1 7.0 14.5 8.8 19.9 29.4 7.9 18.3 3.6 19.3 13.6 14.9 17.5 20.7 10.8 11.0 9.0 21.5 15.1 72.7 17.9 3.5 23.5 13.9 18.1 5.8 17.0 8.6 11.0 15.0 13.5 10.5 11.4 10.7 9.8 13.9 5.3 9.7 14.6 8.0 7.3 5.9 11.4 33.8 31.7 7.9 9.7 10.4 11.3 76.7 4.2 62.8 5.5 6.8 5.7 4.2 5.1 7.8 5.2 3.1 3.9 5.8 5.8 9.2 10.6 4.1 9.9 7.0 10.8 10.5 22.3 9.2 10.0 8.8 10.2 8.5 9.7 10.9 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.6 11.8 7.1 8.3 10.5 11.1 19.5 6.4 5.9 12.9 10.6 18.6 16.2 21.0 9.2 5.1 14.1 17.4 21.0 7.9 9.8 11.4 17.9 18.7 13.9 16.2 8.7 8.2 8.4 47.7 16.0 17.5 7.3 9.9 6.1 12.2 9.2 10.1 11.3 15.5 19.1 7.0 8.3 16.2 17.5 12.1 5.9 12.3 10.6 11.6 17.2 12.5 13.5 5.5 7.5 10.2 18.6 12.3 9.9 14.5 10.9 10.0 18.9 7.0 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 15.8 32.0 25.0 11.1 23.3 11.6 18.0 14.3 17.9 15.4 14.5 14.6 17.2 12.1 12.6 29.3 14.3 13.5 15.2 18.2 22.3 25.6 16.4 31.3 11.0 15.0 29.9 14.9 19.4 16.6 15.2 29.5 18.3 24.5 16.3 14.9 8.4 14.5 14.8 12.2 11.6 18.2 14.9 43.9 17.1 13.6 42.2 28.3 15.5 21.6 12.3 13.5 14.8 13.0 18.5 12.7 32.6 19.0 22.5 21.1 12.4 7.3 10.9 18.6 6.0 25.3 19.1 11.4 15.0 12.9 9.5 10.2 12.7 25.5 17.9 19.7 22.2 9.4 8.2 19.2 12.7 12.5 6.5 11.0 7.4 10.6 21.3 11.1 9.6 21.3 26.0 12.2 35.1 21.5 16.3 15.3 34.4 13.0 11.2 14.3 15.4 13.6 13.0 16.7 15.4 19.6 10.9 9.1 21.0 10.5 8.5 9.8 22.0 10.4 20.6 18.6 11.7 34.8 10.1 14.9 19.5 18.2 7.5 9.0 18.3 30.8 8.9 32.6 12.3 19.0 15.6 18.5 17.9 17.0 12.7 16.9 15.5 15.5 4.5 22.5 19.0 9.3 21.1 12.4 25.0 23.3 14.3 17.9 22.3 25.6 29.9 14.9 24.5 28.3 CCM2 "C7orf22, MGC4607, OSM" ENSG00000136280 "CCM2 scaffolding protein" Q9BSQ5 7 44999475-45076469 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020273, HPA021669, HPA065815" Supported Enhanced Mitochondria Mitochondria "HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: " "unprognostic (4.30e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (3.17e-1)" "prognostic unfavourable (2.45e-4)" "unprognostic (4.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.37e-3)" "unprognostic (3.92e-1)" "unprognostic (2.65e-1)" "prognostic favourable (1.16e-4)" "unprognostic (3.03e-1)" "prognostic unfavourable (5.06e-7)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (2.81e-2)" "unprognostic (2.48e-1)" 16.7 18.3 31.6 20.7 52.0 11.2 8.6 21.3 36.1 9.7 12.5 13.9 8.6 10.5 7.2 7.0 10.6 8.4 9.1 13.7 29.8 23.1 7.9 31.6 12.4 30.7 29.0 14.2 8.2 17.9 16.5 11.2 11.5 17.8 7.7 8.8 6.9 13.6 12.6 27.0 13.4 10.6 13.3 14.7 20.8 11.2 10.5 11.5 37.5 7.4 8.2 23.4 15.4 12.6 14.8 7.3 32.4 13.8 17.6 50.6 11.1 14.0 15.5 9.3 18.5 17.6 15.5 6.9 17.0 14.0 12.2 16.5 11.2 14.6 19.8 13.2 21.5 18.3 5.7 22.0 8.1 22.0 11.1 8.8 12.4 7.9 15.6 3.6 23.7 17.5 14.5 21.4 9.2 22.2 10.0 16.1 24.4 21.1 17.3 48.0 10.7 17.3 9.3 5.3 16.1 12.5 13.6 18.0 14.0 13.9 11.0 7.5 12.6 16.5 16.8 16.7 14.1 16.6 16.3 28.9 22.6 40.0 16.3 13.1 20.0 27.1 10.5 31.2 17.3 12.1 11.6 13.6 20.5 18.7 7.2 14.8 19.9 14.7 32.4 17.6 13.8 7.3 50.6 11.1 31.6 52.0 21.3 36.1 29.8 23.1 29.0 14.2 17.8 11.5 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favourable (5.42e-4)" 16.4 33.6 22.6 21.7 21.5 16.5 32.0 21.3 29.4 16.4 24.7 9.2 25.9 28.0 16.8 38.6 29.5 17.8 25.3 36.1 19.3 18.4 32.9 37.8 28.9 23.8 19.4 20.9 15.6 47.2 16.3 19.7 25.3 21.2 21.5 20.8 12.7 31.9 28.7 45.1 16.6 24.3 22.0 15.3 24.8 23.4 24.8 15.6 21.0 29.5 31.6 20.6 17.0 18.1 30.7 38.2 22.2 27.3 17.9 32.1 18.2 22.0 16.8 14.1 20.0 11.7 11.5 14.3 11.5 13.5 11.6 15.7 15.1 20.1 11.0 12.8 10.2 15.6 13.8 14.9 9.7 16.7 26.3 8.4 14.1 23.1 13.8 12.8 13.5 10.6 18.7 9.9 6.7 16.1 12.8 12.5 15.3 22.3 15.7 28.3 13.5 111.5 15.1 11.0 14.2 19.0 12.4 7.0 13.8 7.2 50.3 23.6 28.2 17.9 9.5 7.4 16.2 12.2 19.8 12.5 13.0 17.3 17.3 26.0 5.7 22.2 27.0 15.9 19.7 27.3 23.7 30.7 24.2 23.5 26.6 26.1 20.3 20.5 11.1 17.9 21.5 38.2 32.1 18.2 22.6 21.5 21.3 29.4 19.3 18.4 19.4 20.9 21.2 15.6 CHCHD10 "C22orf16, N27C7-4" ENSG00000250479 "Coiled-coil-helix-coiled-coil-helix domain containing 10" Q8WYQ3 22 23765834-23768443 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 127.0;skeletal muscle: 226.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003440 Enhanced Supported Mitochondria Mitochondria "HPA003440: AB_1078348" "unprognostic (3.88e-2)" "unprognostic (2.36e-3)" "unprognostic (8.90e-2)" "unprognostic (9.80e-2)" "unprognostic (7.68e-2)" "unprognostic (5.97e-3)" "unprognostic (1.59e-1)" "unprognostic (1.85e-1)" "unprognostic (2.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" "prognostic favourable (2.15e-7)" "unprognostic (5.19e-3)" "unprognostic (2.06e-1)" "unprognostic (5.68e-3)" "unprognostic (2.62e-3)" 23.1 14.9 25.8 16.4 33.9 5.7 20.0 11.8 31.0 17.3 39.4 9.6 18.3 30.6 6.1 15.5 20.2 7.6 11.3 127.0 23.7 23.5 40.4 86.1 8.3 16.9 25.8 18.4 4.8 24.3 36.4 12.7 11.7 14.5 11.7 31.6 24.3 33.7 22.2 226.6 7.2 30.2 12.8 12.2 13.0 17.3 4.1 9.6 3.0 27.8 73.1 15.8 13.8 9.3 9.4 7.3 7.6 7.8 0.8 5.0 1.0 6.0 16.4 5.1 21.2 11.2 7.1 8.2 2.1 5.8 6.0 7.0 30.6 8.2 18.5 5.7 10.4 19.5 27.8 8.7 5.5 6.0 30.3 4.7 13.0 28.9 19.1 13.6 22.0 13.8 23.1 9.1 2.4 7.3 8.4 11.9 5.4 30.5 4.3 8.6 3.7 41.6 16.0 0.8 42.6 28.4 13.7 9.0 4.8 2.9 36.5 28.0 13.0 10.7 3.2 0.2 0.2 3.7 0.0 4.7 2.0 12.8 5.0 11.4 2.7 0.2 3.9 7.6 2.8 7.8 1.9 9.4 3.2 4.0 1.7 7.8 5.0 3.6 0.1 0.8 6.9 7.3 3.7 1.0 25.8 33.9 11.8 31.0 23.7 23.5 25.8 18.4 14.5 9.6 CHCHD2 C7orf17 ENSG00000106153 "Coiled-coil-helix-coiled-coil-helix domain containing 2" Q9Y6H1 7 56101569-56106576 "Disease related genes, Predicted intracellular proteins" Transcription Activator "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 220.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027407, HPA052510" Uncertain Enhanced Mitochondria Mitochondria "HPA027407: AB_10959659, HPA052510: AB_2681856" "unprognostic (8.68e-3)" "unprognostic (2.79e-1)" "unprognostic (8.48e-2)" "unprognostic (2.32e-1)" "unprognostic (3.90e-2)" "prognostic unfavourable (1.90e-5)" "prognostic unfavourable (9.41e-5)" "unprognostic (4.38e-2)" "unprognostic (3.61e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (2.60e-2)" "unprognostic (4.01e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (2.40e-2)" 41.5 112.8 57.2 33.0 59.5 73.0 46.0 39.3 56.9 38.0 46.6 33.2 45.5 51.9 34.2 53.8 50.1 39.2 44.3 75.3 46.8 50.2 56.2 66.9 34.2 62.6 58.3 49.0 43.8 77.8 28.4 42.8 38.4 42.3 41.3 40.1 45.3 56.5 70.0 147.2 33.0 49.3 45.7 42.6 34.1 44.2 27.1 28.1 48.9 62.1 65.9 38.8 38.5 30.9 63.2 107.7 52.6 69.1 51.5 72.8 121.3 220.2 38.6 25.4 52.5 20.1 27.8 18.8 32.4 30.8 41.8 40.5 35.3 36.9 64.6 42.9 19.8 37.5 32.2 35.5 33.7 41.9 58.5 38.1 32.5 50.2 37.5 51.3 61.6 24.7 40.6 31.3 38.5 31.2 79.9 39.3 34.0 30.5 69.0 158.9 55.0 61.5 46.6 24.8 106.0 37.4 28.8 48.5 60.4 25.5 63.0 40.7 72.0 73.4 24.9 25.8 60.5 106.8 47.6 36.3 51.7 115.2 40.6 55.4 32.0 40.5 69.1 52.6 53.1 61.0 54.8 63.2 57.2 56.3 79.5 57.8 51.6 52.8 37.0 51.5 59.5 107.7 72.8 121.3 57.2 59.5 39.3 56.9 46.8 50.2 58.3 49.0 42.3 28.1 CHCHD3 "FLJ20420, Mic19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784868-133082088 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 109.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria 110000 Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavourable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favourable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 15.2 15.8 9.9 13.4 11.6 15.4 13.7 10.1 14.2 10.5 17.3 9.8 7.9 19.9 13.2 9.7 10.5 9.7 10.4 42.6 9.5 8.9 23.2 17.9 11.7 10.6 10.4 8.0 11.6 9.8 13.9 17.0 10.7 10.9 10.5 18.3 11.5 10.6 11.1 109.1 9.0 20.5 13.9 9.7 12.2 13.9 6.4 10.8 19.7 14.6 30.1 13.2 12.9 13.6 19.0 28.2 15.4 29.9 21.2 19.9 15.3 23.8 24.5 25.0 34.4 18.1 16.6 14.8 23.5 22.3 26.7 29.7 28.8 26.6 19.9 9.3 14.8 16.8 28.9 20.2 37.8 25.9 27.3 20.5 25.3 16.7 35.8 45.9 15.3 15.0 13.9 36.6 38.4 18.7 43.6 18.3 24.8 31.5 66.8 40.4 40.9 28.4 33.3 36.5 28.4 26.1 19.9 31.8 39.8 19.5 15.3 44.3 12.9 27.5 15.4 25.7 11.0 40.2 42.0 17.6 22.5 50.1 40.4 39.4 35.9 14.9 21.8 15.4 16.1 29.9 15.3 19.0 14.7 15.5 28.2 11.7 13.0 14.5 3.1 21.2 24.1 24.6 19.9 15.3 9.9 11.6 10.1 14.2 9.5 8.9 10.4 8.0 10.9 10.8 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria Mitochondria "HPA034688: AB_10696361, HPA063727: " "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favourable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 11.4 13.3 15.0 8.8 16.4 3.3 12.8 11.6 17.7 9.2 15.8 12.6 9.5 15.7 8.7 11.7 12.1 10.9 9.8 27.3 13.7 13.5 22.3 20.1 7.8 8.9 17.0 10.7 11.5 18.8 21.7 9.3 9.2 13.5 12.7 17.2 9.6 10.7 13.8 32.2 8.9 12.7 15.3 11.1 9.6 11.9 9.4 14.3 7.2 13.4 12.4 13.2 14.0 16.4 14.1 19.8 7.9 18.1 16.6 14.3 8.6 8.0 16.7 8.7 8.6 7.6 8.6 25.4 8.7 8.1 10.8 9.5 9.8 6.6 17.4 8.6 6.6 6.6 18.0 18.0 13.3 10.8 18.0 20.3 12.4 13.0 12.7 13.6 8.8 7.5 19.2 17.6 28.3 12.0 21.0 15.6 11.4 17.0 17.0 8.2 13.4 22.6 12.3 8.8 37.0 12.1 8.8 7.2 8.9 9.8 31.6 12.6 15.1 13.9 4.3 9.9 7.2 12.2 15.8 8.7 23.0 17.3 9.8 21.1 7.2 5.7 12.5 7.9 6.6 18.1 11.4 11.2 11.0 9.9 19.8 14.1 14.3 9.7 5.4 16.6 17.5 8.1 12.2 8.6 15.0 16.4 11.6 17.7 13.7 13.5 17.0 10.7 13.5 14.3 CHCHD5 "C2orf9, MGC11104, MIC14, MIX14" ENSG00000125611 "Coiled-coil-helix-coiled-coil-helix domain containing 5" Q9BSY4 2 112584240-112589275 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038263 Approved Supported Mitochondria Mitochondria "HPA038263: AB_10671525" "unprognostic (3.56e-2)" "unprognostic (3.41e-2)" "unprognostic (3.36e-2)" "unprognostic (4.57e-2)" "unprognostic (1.85e-1)" "unprognostic (7.75e-2)" "unprognostic (2.72e-1)" "unprognostic (7.18e-3)" "unprognostic (8.04e-2)" "unprognostic (4.96e-2)" "unprognostic (2.07e-1)" "unprognostic (4.95e-2)" "unprognostic (1.39e-2)" "unprognostic (3.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" 12.7 17.8 15.1 11.4 15.0 15.7 15.6 9.0 13.4 10.5 12.4 11.7 19.8 17.5 11.4 17.5 16.2 20.0 16.7 20.3 12.0 12.1 20.3 36.6 12.9 17.6 16.7 11.4 10.7 36.8 10.2 20.0 11.9 10.1 13.4 6.5 11.0 12.6 37.7 33.3 12.9 16.1 11.8 12.1 11.7 15.2 50.0 12.9 20.7 20.2 23.4 8.6 13.0 12.1 27.9 40.2 32.1 35.4 28.6 37.1 28.6 13.4 22.5 10.1 0.0 4.1 8.8 9.6 5.9 7.8 12.3 8.8 24.4 16.6 10.3 23.7 8.2 9.9 3.8 13.2 1.6 11.1 18.4 13.9 7.3 19.2 18.2 11.8 9.8 11.7 11.3 16.2 10.0 6.7 14.4 15.7 7.7 33.4 10.5 18.6 11.2 11.1 0.3 8.4 20.2 16.1 12.3 12.9 14.5 7.5 11.4 13.2 14.6 10.5 9.3 12.3 17.5 7.4 8.5 28.3 26.6 11.9 17.1 3.2 14.5 11.1 35.4 32.1 26.3 31.6 22.3 24.0 25.1 24.9 31.8 27.9 26.1 26.9 19.2 28.6 28.7 40.2 37.1 28.6 15.1 15.0 9.0 13.2 12.0 12.1 16.7 11.4 10.1 12.9 CHCHD6 "CHCM1, MGC13016, Mic25, PPP1R23" ENSG00000159685 "Coiled-coil-helix-coiled-coil-helix domain containing 6" Q9BRQ6 3 126704220-126960406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047673, HPA051975" Approved Supported Mitochondria Mitochondria "HPA047673: AB_10961761, HPA051975: " "unprognostic (3.94e-2)" "prognostic favourable (7.46e-4)" "unprognostic (6.20e-2)" "unprognostic (1.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (6.83e-3)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.79e-2)" "unprognostic (2.08e-1)" "prognostic favourable (6.76e-4)" "unprognostic (6.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.11e-3)" 5.5 13.8 23.2 5.8 20.8 3.8 8.7 8.9 27.0 7.4 5.3 8.7 4.9 4.1 6.7 5.6 7.2 14.6 5.6 11.6 31.1 17.0 7.5 6.1 8.3 3.7 15.3 18.8 14.5 15.1 6.7 7.7 4.4 11.4 7.0 3.4 7.6 14.2 8.9 4.0 8.1 4.6 5.8 9.9 4.8 7.4 34.0 7.6 3.3 12.3 5.9 4.3 5.0 7.4 10.5 6.3 1.8 3.5 6.3 11.1 4.3 18.6 10.9 9.7 23.4 3.4 5.3 5.6 7.2 4.9 8.5 8.2 15.0 8.2 8.2 16.8 4.3 11.0 7.2 19.8 4.2 2.2 19.7 6.7 8.0 14.6 10.3 14.7 4.5 5.3 12.1 4.1 8.7 5.5 6.1 4.9 7.4 14.0 21.4 14.6 11.6 12.4 11.5 14.8 19.7 7.4 8.1 17.8 11.1 7.4 12.7 23.0 7.4 5.5 4.9 9.5 11.9 12.8 7.4 6.3 2.9 10.1 10.7 4.8 8.8 0.0 2.3 1.8 6.9 3.5 8.7 7.8 9.8 8.1 6.3 10.5 9.5 11.1 0.0 6.3 3.3 4.4 8.9 4.3 23.2 20.8 8.9 25.6 31.1 17.0 15.3 18.8 11.4 7.6 CIAPIN1 Anamorsin ENSG00000005194 "Cytokine induced apoptosis inhibitor 1" Q6FI81 16 57428169-57447528 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041350, HPA042182" Enhanced Supported Mitochondria 6400 Mitochondria "HPA041350: AB_10796665, HPA042182: AB_10794646" "unprognostic (1.78e-2)" "unprognostic (9.62e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (1.41e-3)" "unprognostic (8.15e-3)" "unprognostic (1.99e-1)" "unprognostic (2.48e-2)" "unprognostic (4.70e-3)" "unprognostic (1.62e-1)" "prognostic favourable (4.42e-4)" "unprognostic (5.61e-2)" "unprognostic (3.86e-2)" "unprognostic (8.90e-3)" "unprognostic (1.16e-1)" 13.5 21.0 12.8 12.6 19.1 11.5 12.2 18.3 29.3 10.6 19.3 14.8 8.7 14.5 11.9 10.7 18.9 10.8 15.9 23.9 12.8 16.5 20.7 19.7 13.1 14.1 15.6 17.6 10.5 17.2 18.9 11.9 21.8 21.0 11.7 17.3 14.2 15.0 11.3 35.3 17.5 15.0 14.2 10.6 14.4 13.7 44.0 10.7 19.2 15.8 18.0 20.9 13.1 12.1 22.7 32.4 17.3 27.5 27.5 48.8 45.5 15.9 23.8 25.6 19.8 14.7 10.1 22.2 18.8 15.9 32.6 15.3 26.7 13.0 17.1 27.1 14.1 30.8 34.2 25.0 28.2 10.0 20.9 22.0 20.9 28.0 24.1 26.7 22.9 16.0 27.6 23.4 29.9 31.7 30.8 10.6 18.6 15.8 26.4 21.4 34.8 35.0 49.4 30.8 35.8 21.7 18.1 22.6 28.3 40.1 28.7 18.1 21.0 23.4 20.3 14.3 18.7 14.4 20.8 28.2 35.9 57.3 17.4 25.7 22.5 13.9 27.5 17.3 26.9 25.7 24.8 22.7 22.7 28.3 32.4 22.3 48.8 43.0 6.7 27.5 20.8 27.7 24.3 45.5 12.8 19.1 18.3 29.3 12.8 16.5 15.6 17.6 21.0 10.7 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Mitochondria Mitochondria "HPA074383: " "prognostic unfavourable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavourable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 11.9 6.1 4.9 8.9 6.6 7.4 2.9 10.2 11.7 10.2 14.1 14.4 11.3 21.4 8.6 10.5 7.9 13.2 9.1 9.2 9.6 17.9 5.6 10.2 11.5 7.5 9.9 4.4 9.2 7.5 9.7 14.9 11.9 12.4 10.0 7.1 4.0 8.4 10.7 5.2 19.2 6.5 18.1 11.2 13.7 4.2 15.5 5.5 7.8 20.9 7.2 13.9 5.3 11.7 4.4 7.9 12.6 12.0 10.2 16.7 16.1 11.8 9.9 4.2 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 CLPP ENSG00000125656 "Caseinolytic mitochondrial matrix peptidase proteolytic subunit" Q16740 19 6361452-6368910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010649 Supported Supported Mitochondria Mitochondria "HPA010649: AB_1078538" "unprognostic (2.28e-1)" "unprognostic (7.14e-2)" "unprognostic (2.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.17e-2)" "unprognostic (1.15e-2)" "unprognostic (6.17e-3)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "prognostic favourable (6.50e-4)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (6.97e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.86e-3)" 22.1 27.3 18.4 22.5 18.8 20.1 19.9 16.6 20.9 16.1 23.2 17.9 22.2 25.4 16.9 15.1 26.6 15.3 19.2 28.9 17.4 16.7 28.5 64.7 15.5 35.5 19.0 15.2 23.7 32.7 11.6 18.5 18.4 13.6 19.1 14.1 18.6 26.3 23.4 73.1 17.8 26.0 14.8 16.7 21.2 21.3 21.1 11.4 54.8 27.0 25.1 25.3 20.7 23.2 29.7 37.5 14.9 20.0 27.6 46.3 32.9 31.6 21.1 15.4 28.1 9.7 13.5 16.0 18.8 13.8 26.8 24.0 16.9 11.6 31.9 29.3 15.0 19.8 15.2 23.7 10.1 33.1 47.9 23.5 18.6 25.0 26.3 21.2 31.1 17.1 17.4 18.6 20.8 26.0 23.2 43.2 17.5 37.0 36.3 22.2 22.2 49.4 25.6 18.6 48.3 19.9 17.7 25.5 24.4 11.9 29.1 27.6 15.0 30.4 18.1 17.7 16.4 41.6 35.4 55.6 46.4 30.7 24.3 29.9 28.1 5.5 20.0 10.5 28.0 17.7 33.2 28.3 39.9 34.5 24.1 29.7 35.2 34.1 14.9 27.6 12.1 37.5 46.3 32.9 18.4 18.8 16.6 20.9 17.4 16.7 19.0 15.2 13.6 11.4 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: " "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favourable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.2 9.0 7.8 9.9 8.4 10.8 8.5 6.0 6.8 6.6 7.0 8.9 7.4 16.3 5.1 8.1 11.3 28.7 8.0 7.1 6.4 5.2 12.2 8.7 11.3 12.0 15.6 7.1 12.8 11.0 6.1 11.7 8.4 11.2 5.8 7.7 6.6 7.3 13.8 8.8 4.0 14.5 9.4 16.8 12.5 12.2 6.8 5.5 8.1 13.1 8.8 5.9 13.2 7.4 6.7 5.9 5.4 5.6 6.2 9.4 8.6 6.6 19.8 5.2 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 CMC2 "C16orf61, DC13, MGC45036" ENSG00000103121 "C-X9-C motif containing 2" Q9NRP2 16 80966448-81020270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006871, CAB026396" Approved Supported Mitochondria Mitochondria "CAB026396: , HPA006871: AB_1845581" "unprognostic (2.43e-1)" "unprognostic (3.63e-2)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "unprognostic (1.50e-1)" "unprognostic (3.01e-3)" "unprognostic (2.48e-2)" "unprognostic (6.36e-2)" "unprognostic (9.20e-2)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (4.57e-3)" "prognostic favourable (2.64e-5)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (2.68e-1)" 8.2 17.0 31.5 8.9 30.9 25.5 15.0 18.7 28.7 7.2 11.8 22.2 8.7 12.8 6.4 11.9 12.5 5.5 11.5 42.3 28.3 27.9 24.7 29.1 9.5 13.3 30.7 16.0 5.7 19.7 19.2 11.1 11.0 23.9 15.2 11.8 7.0 10.3 9.3 32.0 6.2 13.5 10.6 27.8 9.5 13.5 28.1 20.3 9.8 10.3 13.0 11.0 11.8 7.0 21.9 25.3 20.1 17.9 24.7 34.6 10.3 21.8 31.2 23.4 14.0 7.8 7.9 13.8 22.2 10.1 19.8 10.2 21.3 15.0 10.1 16.6 10.6 15.8 15.9 12.9 26.3 14.8 19.1 15.4 22.3 22.7 12.8 12.6 26.4 6.8 7.3 23.9 13.5 17.5 36.4 13.6 19.2 41.7 19.7 41.0 13.8 18.8 24.8 12.7 12.9 15.3 11.0 19.7 11.4 33.8 12.0 25.4 23.9 11.7 10.1 18.0 25.3 17.3 22.3 14.0 30.4 56.2 13.7 16.4 20.9 14.9 16.6 20.1 17.4 16.0 16.3 21.9 22.1 17.9 17.8 18.9 15.7 17.8 7.1 24.7 17.9 25.3 34.6 10.3 31.5 30.9 18.7 28.7 28.3 27.9 30.7 16.0 23.9 20.3 CMC4 "MTCP1, MTCP1NB, p8, P8MTCP1" ENSG00000182712 "C-X9-C motif containing 4" P56277 X 155061622-155071362 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045866 Approved Supported Mitochondria Mitochondria "HPA045866: AB_10964642" "unprognostic (4.54e-3)" "unprognostic (7.31e-2)" 11.5 9.2 13.4 9.2 12.6 6.2 26.7 7.1 8.9 11.0 11.3 6.7 13.2 9.7 9.9 13.6 12.5 8.9 8.3 49.6 10.9 10.0 12.0 21.8 15.0 26.2 13.7 5.7 11.9 34.6 7.1 11.4 6.8 11.6 10.5 6.0 7.6 14.5 12.6 21.2 8.2 11.4 15.2 15.8 8.3 8.5 7.3 7.4 5.4 14.5 10.0 7.7 12.4 8.7 11.3 10.8 11.8 7.5 12.0 9.0 4.6 19.6 5.0 3.0 6.6 8.4 8.1 4.7 3.9 5.6 5.6 9.5 3.7 3.8 13.5 10.3 4.3 6.5 4.0 5.2 4.0 14.3 10.1 2.2 3.4 4.5 8.6 4.2 3.1 7.7 8.5 5.8 7.6 4.7 2.2 5.0 5.8 7.4 5.6 7.9 1.8 14.3 4.3 7.0 8.8 6.3 1.2 6.2 5.1 5.2 5.8 6.8 4.3 2.4 5.5 8.6 5.3 5.5 5.2 20.3 20.4 36.0 8.1 9.7 5.6 1.1 7.5 11.8 9.0 4.2 8.7 11.0 7.1 8.3 10.8 11.3 2.2 5.9 0.8 12.0 1.5 2.1 8.2 4.6 13.4 12.6 7.1 8.9 10.9 10.0 13.7 5.7 11.6 7.4 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA011944 Approved Supported Mitochondria Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavourable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 13.8 16.2 22.4 14.4 21.7 17.6 14.5 13.8 24.0 11.8 10.9 14.4 17.4 11.4 14.8 14.3 15.1 9.6 10.9 47.8 19.7 18.5 23.4 14.4 11.9 24.2 23.0 13.2 11.1 23.9 9.4 22.1 11.3 17.4 10.9 14.7 17.9 17.5 17.7 55.5 7.0 12.6 9.7 19.9 16.2 14.5 11.8 14.3 16.2 15.8 22.4 28.3 14.8 8.8 21.0 17.9 24.2 17.2 18.6 21.0 14.4 10.6 28.7 23.8 23.5 7.0 7.9 15.9 15.0 25.7 20.3 21.2 21.9 24.5 20.3 25.3 9.1 15.6 27.5 23.0 25.8 18.2 25.2 25.2 17.0 20.1 11.6 19.6 11.2 6.5 14.8 14.8 22.0 18.5 42.7 17.7 16.6 14.6 28.8 49.3 14.9 20.8 17.5 21.8 37.5 24.9 12.0 14.7 26.3 15.0 27.9 9.6 20.9 13.2 13.7 10.1 22.1 9.9 21.1 42.6 34.4 36.4 28.8 25.3 26.9 1.3 15.3 16.0 12.9 17.2 9.5 19.7 12.0 13.2 17.9 21.0 16.9 21.0 24.2 18.6 14.6 16.0 11.5 14.4 22.4 21.7 13.8 24.0 19.7 18.5 23.0 13.2 17.4 14.3 COA3 "CCDC56, COX25, HSPC009, MITRAC12" ENSG00000183978 "Cytochrome c oxidase assembly factor 3" Q9Y2R0 17 42795147-42798704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031966 Approved Supported Mitochondria Mitochondria "HPA031966: AB_10602115" "unprognostic (1.20e-1)" "prognostic favourable (3.40e-4)" "unprognostic (5.65e-2)" "prognostic favourable (8.93e-4)" "unprognostic (7.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.78e-2)" "unprognostic (1.16e-2)" "unprognostic (1.48e-1)" "unprognostic (2.25e-2)" "unprognostic (8.44e-3)" "unprognostic (1.52e-1)" "prognostic favourable (6.62e-4)" "unprognostic (1.64e-1)" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" "unprognostic (3.01e-2)" 13.4 17.8 34.5 11.1 26.7 4.6 20.6 19.5 31.8 18.7 33.7 18.0 18.2 35.9 14.0 62.6 30.2 26.2 20.0 26.3 29.3 26.0 57.2 44.1 13.7 14.1 31.2 22.2 17.0 97.0 16.2 15.0 17.8 26.1 22.0 31.6 14.9 30.3 25.1 28.7 12.6 33.5 14.5 21.6 12.2 27.1 9.5 17.1 13.1 22.8 28.6 19.8 14.1 18.1 56.1 49.2 46.0 59.1 46.2 50.5 59.7 16.0 54.5 25.1 13.7 23.2 19.8 15.5 12.6 19.3 30.3 27.5 21.5 20.4 0.9 35.9 15.4 15.7 19.3 30.9 28.7 15.7 50.7 10.8 25.7 67.9 16.5 14.6 13.2 20.0 23.3 28.5 16.4 24.0 17.3 14.0 26.8 26.4 4.8 32.1 11.4 19.7 19.2 36.7 27.6 30.7 22.2 18.7 15.7 12.9 13.7 21.9 42.7 19.2 14.6 33.2 17.3 14.0 16.7 16.5 17.8 8.6 24.9 14.6 22.4 46.0 59.1 36.8 39.8 54.9 41.6 56.1 41.4 40.2 49.2 51.2 38.4 38.2 6.3 46.2 45.5 32.9 50.5 59.7 34.5 26.7 19.5 31.8 29.3 26.0 31.2 22.2 26.1 17.1 COA5 "C2orf64, FLJ27524, MGC52110, Pet191" ENSG00000183513 "Cytochrome c oxidase assembly factor 5" Q86WW8 2 98599310-98608515 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057768 Uncertain Supported Mitochondria Mitochondria "HPA057768: " "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (1.67e-3)" "unprognostic (2.61e-2)" "unprognostic (7.11e-2)" "unprognostic (4.69e-2)" "prognostic favourable (2.65e-4)" "unprognostic (1.32e-3)" "unprognostic (3.71e-3)" "unprognostic (8.00e-3)" "unprognostic (3.08e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.93e-2)" "unprognostic (2.50e-1)" "prognostic favourable (1.00e-5)" 13.7 21.4 30.9 12.2 29.3 9.1 20.6 31.3 28.2 18.6 15.0 20.3 18.5 15.4 20.2 33.5 11.1 20.5 13.4 19.3 28.3 26.5 28.1 23.4 13.9 15.8 30.7 29.0 23.6 16.8 21.0 19.1 14.2 23.4 19.8 15.9 13.7 16.2 20.3 30.7 18.0 13.5 14.7 32.7 15.6 16.0 15.6 21.5 15.3 24.5 10.1 16.1 13.9 15.0 24.7 30.3 28.1 25.5 18.1 30.0 22.0 12.7 5.4 16.9 12.3 19.9 16.5 14.1 7.4 5.9 8.0 8.4 11.0 11.0 6.5 13.5 5.9 9.0 14.7 7.8 9.7 16.8 13.7 9.0 11.1 18.0 14.5 8.5 8.4 15.9 17.0 5.6 7.4 8.6 12.6 7.6 8.8 10.7 11.4 15.2 11.7 12.0 7.0 12.6 14.2 17.5 6.9 12.9 16.3 6.3 7.8 18.5 9.7 18.0 7.5 12.3 11.0 7.3 6.1 12.4 17.4 8.2 14.8 19.0 10.0 18.2 25.5 28.0 25.2 22.7 21.9 23.5 23.0 24.1 24.1 24.7 28.1 27.9 28.1 18.1 23.7 30.3 30.0 22.0 30.9 29.3 31.3 25.9 28.3 26.5 30.7 29.0 23.4 21.5 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234384049 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favourable (7.12e-4)" 11.0 17.8 26.4 14.4 33.9 9.4 16.6 14.3 27.5 9.7 17.7 5.7 12.9 26.4 8.4 20.3 15.5 9.4 14.2 19.1 19.3 15.7 21.4 21.4 13.6 16.2 16.3 16.1 9.1 16.7 7.6 9.5 8.7 13.4 13.3 15.6 6.0 13.6 11.6 52.7 8.7 19.7 10.6 11.4 12.5 14.4 5.8 13.3 13.1 13.6 20.2 12.0 11.6 14.6 27.5 33.3 19.7 31.3 18.3 36.6 20.2 17.8 22.9 8.3 9.4 8.8 17.3 26.5 13.1 8.0 13.8 13.0 17.6 23.9 17.9 24.4 7.5 22.8 12.9 16.2 11.0 22.1 55.2 8.0 26.1 46.6 33.7 19.7 15.6 11.4 21.8 18.1 14.0 17.0 38.9 16.1 15.0 9.5 18.6 38.1 20.4 10.9 11.1 10.0 35.1 17.2 17.0 14.8 10.8 12.8 22.6 40.4 20.1 34.0 12.8 16.4 13.6 22.0 39.2 19.2 37.2 21.8 12.5 31.2 29.2 19.7 31.3 9.7 18.5 28.5 18.2 27.5 29.9 23.0 33.3 18.0 31.3 23.1 8.1 18.3 23.8 22.5 36.6 20.2 26.4 33.9 14.3 27.5 19.3 15.7 16.3 16.1 13.4 13.3 COQ4 CGI-92 ENSG00000167113 "Coenzyme Q4" Q9Y3A0 9 128322536-128334072 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021406, HPA042945" Supported Supported Mitochondria Mitochondria "HPA021406: , HPA042945: AB_10961047" "unprognostic (9.15e-2)" "prognostic favourable (2.97e-5)" "unprognostic (2.29e-1)" "prognostic favourable (4.93e-6)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (2.11e-1)" "unprognostic (1.31e-3)" "unprognostic (2.89e-2)" "prognostic favourable (5.76e-6)" "unprognostic (6.21e-3)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.14e-3)" 15.5 29.4 22.6 21.4 29.9 12.2 25.4 20.7 33.8 19.8 23.0 15.7 34.8 53.8 14.8 30.5 32.8 37.7 24.0 23.9 22.6 21.7 31.8 33.4 28.9 28.6 18.9 31.4 18.1 43.8 24.7 30.7 13.1 27.7 22.2 18.0 15.2 32.9 50.7 29.6 31.6 37.3 20.1 25.7 15.9 23.1 17.5 14.3 13.6 34.5 25.0 16.7 18.5 17.9 18.3 28.2 8.0 15.5 14.1 21.1 13.2 11.0 16.7 10.1 11.1 7.4 10.5 18.3 9.8 6.4 12.8 9.1 14.3 13.9 14.9 8.7 7.5 31.7 8.6 11.6 4.8 7.2 17.2 5.4 36.0 15.9 12.2 15.5 8.3 12.2 13.6 10.6 11.6 10.1 36.2 10.2 8.1 30.7 18.9 11.9 11.2 19.6 18.5 14.0 28.3 15.7 10.9 18.9 13.5 19.1 22.8 11.9 29.3 5.3 13.8 12.2 11.4 17.6 13.1 17.4 14.3 12.2 15.5 7.5 8.4 7.8 14.2 8.0 21.1 15.5 19.1 18.3 19.2 20.9 17.7 16.0 15.5 18.9 1.8 14.1 15.2 28.2 15.2 13.2 22.6 29.9 20.7 33.8 22.6 21.7 18.9 31.4 27.7 14.3 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503274-120534434 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria Nucleoli Mitochondria "HPA049487: " "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 14.6 21.7 15.8 16.1 16.7 7.0 29.5 15.6 21.3 12.5 16.4 13.5 21.8 15.7 12.6 16.4 14.0 15.5 13.5 31.9 14.8 13.1 26.0 39.8 17.6 19.1 17.5 15.4 15.1 28.6 14.2 13.4 18.6 19.4 12.7 17.1 11.6 17.9 17.8 58.4 11.1 13.2 14.0 18.5 14.6 12.4 16.9 15.0 17.2 17.7 30.4 15.2 10.1 17.0 21.3 27.4 9.7 19.6 25.1 28.2 22.4 16.3 26.2 23.7 6.8 31.2 24.1 16.3 20.0 13.1 20.5 13.0 10.5 13.8 16.5 23.7 20.9 17.7 21.0 22.2 21.1 20.6 12.4 22.0 16.1 17.3 25.6 23.9 13.8 23.0 24.1 19.1 22.5 18.0 21.5 12.1 23.6 21.5 13.8 27.5 20.8 20.4 25.6 24.0 23.9 26.4 12.5 17.9 14.4 14.5 7.4 27.2 37.2 19.7 17.9 14.2 16.3 10.5 13.2 26.2 22.0 18.8 16.2 22.7 17.0 9.4 19.6 9.7 18.8 19.2 18.2 21.1 20.4 19.9 27.4 21.3 28.2 22.3 2.1 25.1 17.9 18.0 24.4 22.4 15.8 16.7 15.6 21.3 14.8 13.1 17.5 15.4 19.4 15.0 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226897536-226987545 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 216.5" "Cell line enhanced" "Detected in many" "HEK 293: 33.0;RPMI-8226: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria Mitochondria "HPA061662: " "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 13.3 25.4 2.8 2.7 4.5 5.3 8.5 14.5 3.9 3.2 7.3 4.1 4.2 6.9 3.6 5.5 7.3 5.0 6.1 41.0 2.7 1.8 3.8 17.7 2.7 4.1 5.0 2.4 7.2 20.3 1.6 1.6 2.0 3.8 6.5 2.0 1.9 7.2 5.0 216.5 4.4 4.4 7.8 2.9 3.5 8.8 3.0 4.7 2.7 4.6 50.2 5.8 10.2 3.5 15.2 9.3 32.3 11.5 9.9 11.8 11.6 3.2 5.8 1.5 4.5 4.7 3.1 23.6 1.5 1.3 2.2 2.9 9.2 5.2 9.5 7.3 1.0 3.7 2.9 3.3 0.5 9.9 33.0 6.6 4.8 15.1 1.0 10.0 4.1 5.9 5.1 1.7 2.3 1.0 11.4 7.8 0.3 4.3 5.8 14.7 6.4 12.0 5.7 7.1 30.2 0.7 2.4 24.3 9.9 3.0 11.8 8.5 6.2 13.6 1.2 2.5 2.3 3.5 5.5 17.6 15.4 5.0 2.3 11.4 2.4 19.7 11.5 32.3 8.7 8.6 8.3 12.1 8.5 7.7 9.3 15.2 11.8 9.0 21.9 9.9 6.5 4.1 10.6 11.6 2.8 4.5 14.5 3.9 2.7 1.8 5.0 2.4 3.8 4.7 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691529-40718207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 13.6 17.8 21.1 13.1 16.4 11.5 10.0 24.1 19.2 13.6 13.6 18.6 14.8 17.9 15.0 13.2 16.6 26.5 16.7 14.7 15.7 10.7 11.8 15.6 12.1 12.2 15.5 12.1 16.3 19.4 12.6 32.7 7.9 13.2 15.1 5.7 12.3 16.8 17.6 10.3 12.9 18.6 16.2 15.6 12.1 17.5 12.5 16.7 16.8 15.5 6.9 13.2 14.8 11.8 12.9 15.0 17.7 15.6 9.7 13.1 10.5 8.2 33.7 6.9 13.3 6.2 6.0 6.4 7.7 8.3 5.8 6.2 10.5 15.0 11.0 14.9 4.4 7.1 4.8 8.6 2.1 13.2 10.0 10.6 20.5 5.8 10.7 3.6 16.5 7.9 9.2 4.2 5.1 6.5 5.6 6.0 4.0 5.0 4.7 4.4 5.3 3.5 7.9 9.7 8.3 10.1 13.9 12.4 10.1 10.3 15.8 16.7 14.2 13.8 6.1 5.0 17.0 3.6 4.5 6.7 5.4 5.6 18.9 4.2 6.9 15.8 15.6 14.6 11.6 15.4 13.1 12.9 9.0 12.4 15.0 11.7 8.9 9.1 17.7 9.7 13.7 8.7 8.8 10.5 21.1 16.4 24.1 19.2 15.7 10.7 15.5 12.1 13.2 16.7 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;HDLM-2: 2.4;THP-1: 1.8;TIME: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: , HPA062721: " "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.6 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.5 0.0 1.3 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.5 0.1 0.6 1.1 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favourable (4.32e-6)" "prognostic favourable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 8.6 16.6 6.9 9.9 6.9 6.3 15.7 10.5 7.4 19.2 13.3 14.5 6.4 20.4 8.3 10.5 16.7 14.1 13.5 15.5 11.0 14.1 12.1 13.4 16.0 12.2 12.5 11.4 9.1 17.0 12.0 15.3 10.1 16.4 7.0 8.4 10.7 10.6 8.2 10.5 8.6 8.9 23.4 14.4 12.1 16.2 5.2 8.8 10.8 14.4 13.0 8.1 7.1 8.3 8.4 7.0 8.5 13.2 8.5 11.9 9.2 12.6 13.0 10.3 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 COX14 "C12orf62, MGC14288" ENSG00000178449 "COX14, cytochrome c oxidase assembly factor" Q96I36 12 50111979-50120457 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria Mitochondria "HPA044618: AB_10960419, HPA062014: " "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavourable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 33.1 30.2 25.9 16.7 33.7 17.5 27.8 46.4 28.9 18.5 24.0 16.7 29.7 28.1 13.9 34.0 17.6 17.1 22.1 60.1 23.4 24.9 39.5 40.4 18.2 18.6 29.6 28.7 16.6 19.6 19.5 26.1 15.0 27.8 18.5 22.0 25.1 26.4 30.5 75.4 13.1 27.1 20.5 24.8 19.0 20.9 8.4 26.6 8.7 25.4 38.5 16.7 19.3 21.8 56.8 65.7 56.4 52.2 38.7 58.6 52.5 16.4 31.6 7.0 15.9 31.1 19.1 14.0 12.7 16.4 18.7 16.2 30.1 21.3 15.5 36.6 15.4 16.0 11.8 17.9 16.2 17.0 44.5 30.4 28.0 24.3 13.0 23.7 27.1 24.0 24.8 14.0 16.3 17.1 14.7 30.2 19.0 36.0 19.2 33.7 11.5 42.5 15.8 12.3 35.5 27.1 27.3 18.7 11.1 19.4 35.1 36.9 23.4 20.1 14.9 11.6 12.7 18.9 11.1 22.1 31.6 18.8 17.0 20.6 6.3 56.4 52.2 46.0 43.2 48.9 45.4 56.8 54.5 47.6 49.5 47.1 52.0 50.9 18.8 38.7 44.3 65.7 58.6 52.5 25.9 33.7 46.4 28.9 23.4 24.9 29.6 28.7 27.8 26.6 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: " "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favourable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.5 31.5 13.4 29.2 19.3 15.1 10.9 11.2 14.3 16.9 16.0 23.5 20.9 27.2 18.4 9.7 21.5 28.6 15.7 18.4 12.5 14.0 15.6 16.0 24.3 20.3 21.0 14.9 16.4 14.6 17.8 28.9 17.6 17.7 21.1 15.4 15.4 15.1 15.5 14.8 14.9 18.7 19.5 17.5 15.6 10.5 11.0 18.2 20.1 11.0 19.0 42.1 8.7 13.9 8.8 12.6 13.1 16.6 17.2 22.3 18.3 15.6 34.1 7.4 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 COX16 "C14orf112, HSPC203" ENSG00000133983 "COX16, cytochrome c oxidase assembly homolog" Q9P0S2 14 70325081-70359731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria Mitochondria "HPA062659: " "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favourable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.3 25.2 23.6 15.4 20.4 10.9 23.5 14.8 23.3 16.2 19.6 16.8 16.8 21.8 12.4 29.6 19.9 18.3 18.5 24.0 19.4 20.1 30.6 40.6 15.3 16.0 20.9 16.2 16.9 32.3 12.3 18.3 19.1 20.3 19.7 21.2 13.4 28.9 16.7 39.7 17.0 24.6 11.3 20.6 23.5 24.4 11.7 15.3 19.9 25.9 29.2 18.4 14.2 14.2 22.3 22.9 11.1 17.2 20.4 19.4 18.0 31.4 14.8 18.8 18.1 11.9 18.4 14.5 16.3 14.4 15.2 15.9 10.7 29.4 10.5 12.2 15.1 13.0 13.8 17.1 19.9 9.2 14.8 11.8 11.9 10.7 6.9 13.7 14.7 16.3 12.8 9.5 9.3 16.4 8.4 16.6 18.7 25.2 20.5 14.2 18.9 22.5 15.0 18.8 17.2 20.2 14.7 20.7 18.1 15.5 30.7 11.0 23.0 20.2 15.5 14.1 25.7 14.7 15.5 14.8 12.6 9.6 24.9 5.1 16.6 11.1 16.7 3.9 13.3 17.1 15.5 22.3 17.2 15.2 17.6 17.9 17.3 17.6 1.3 20.4 17.2 22.9 19.4 18.0 23.6 20.4 14.8 23.3 19.4 20.1 20.9 16.2 20.3 15.3 COX17 ENSG00000138495 "COX17, cytochrome c oxidase copper chaperone" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria 1000000 Mitochondria "HPA042226: , HPA048158: " "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 16.6 42.9 20.0 18.2 19.4 21.2 30.4 21.1 20.4 10.2 16.8 9.2 43.5 22.0 11.9 22.9 11.7 11.0 13.6 53.5 17.2 23.0 27.6 37.0 17.8 20.3 23.2 15.2 7.9 39.9 21.1 45.7 18.2 33.7 17.2 16.2 19.4 25.6 33.3 80.4 8.7 21.0 15.4 20.8 15.3 22.3 13.4 16.7 11.1 16.6 37.1 17.2 13.7 20.1 35.6 53.5 52.8 46.9 19.8 33.9 22.0 27.2 28.5 15.6 3.8 6.0 5.6 5.6 15.2 9.2 14.1 14.7 25.1 19.8 19.7 18.5 7.2 10.3 15.4 15.5 8.5 24.8 18.5 17.1 22.6 19.8 6.9 24.9 32.0 6.4 15.0 8.8 12.1 9.1 13.9 47.5 16.3 44.4 25.0 35.9 17.5 47.6 11.1 10.5 32.6 21.9 16.1 26.0 11.4 18.8 18.1 22.8 22.7 39.7 7.2 12.1 19.0 7.6 20.9 33.8 33.7 41.8 17.2 19.1 20.8 50.1 22.4 52.8 21.8 33.2 23.0 35.6 27.2 24.7 22.9 27.2 21.7 22.6 17.7 19.8 46.9 53.5 33.9 22.0 20.0 19.4 21.1 20.4 17.2 23.0 23.2 15.2 33.7 16.7 COX20 "FAM36A, FLJ43269" ENSG00000203667 "COX20, cytochrome c oxidase assembly factor" Q5RI15 1 244835322-244845057 "Disease related genes, Predicted membrane proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043617, HPA045490" Approved Enhanced Mitochondria Mitochondria "HPA043617: AB_10965694, HPA045490: AB_10962869" "unprognostic (5.84e-3)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (2.86e-1)" "unprognostic (3.62e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "prognostic favourable (3.13e-4)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (2.54e-2)" "unprognostic (3.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.02e-3)" 13.1 37.9 30.2 17.5 28.9 12.5 14.9 22.0 25.8 11.8 20.5 11.8 9.3 18.2 17.5 16.9 20.6 11.4 16.2 35.4 22.8 27.7 36.7 23.6 11.1 13.4 32.1 18.3 26.7 15.1 14.3 15.1 15.0 19.2 20.2 11.8 27.9 11.3 15.5 33.3 8.1 19.4 42.5 22.0 10.1 17.9 21.1 17.0 10.4 17.5 20.2 10.7 23.0 16.5 18.2 16.3 11.6 18.4 12.2 22.5 10.5 36.2 9.1 9.2 28.7 6.3 4.8 21.6 15.3 10.2 8.7 7.9 25.9 25.4 5.5 19.4 10.3 9.5 4.8 12.3 11.9 15.4 3.3 10.6 13.4 23.8 8.4 26.1 16.4 4.3 5.9 12.9 9.0 10.0 21.9 23.0 18.0 9.0 14.0 11.6 24.3 18.9 10.3 11.4 33.6 16.3 8.6 5.4 14.7 19.1 10.1 19.8 18.7 7.5 19.4 19.5 25.7 17.0 32.8 36.5 50.1 11.7 24.9 29.1 18.6 5.7 8.8 11.6 15.4 18.4 15.1 18.2 18.3 16.8 15.0 16.0 11.0 16.9 1.7 12.2 17.8 16.3 22.5 10.5 30.2 28.9 22.0 25.8 22.8 27.7 32.1 18.3 19.2 17.0 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favourable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.1 72.0 48.9 65.3 90.7 85.1 84.5 40.3 82.5 76.4 38.2 121.7 66.9 72.4 49.6 64.2 88.9 69.6 81.0 68.0 24.6 71.9 40.4 60.9 118.2 81.8 36.6 30.1 98.6 125.8 62.5 85.4 79.7 67.9 29.7 64.7 159.1 73.4 113.6 65.7 84.8 83.3 30.8 63.3 113.3 87.6 58.2 47.3 85.4 54.3 65.3 79.6 102.4 56.0 38.3 44.4 35.2 43.1 60.0 57.0 166.4 58.5 72.7 43.0 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favourable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.5 22.9 14.1 23.4 16.7 15.2 61.0 25.2 14.1 16.7 18.7 63.1 20.5 33.0 54.2 16.1 29.9 16.3 25.3 7.6 25.7 69.2 44.4 25.3 75.3 32.1 42.2 32.6 28.1 22.4 16.1 12.6 14.3 32.6 14.6 12.9 48.4 26.6 61.1 27.8 120.1 26.1 24.3 49.4 22.5 30.1 28.1 30.0 24.5 29.6 47.3 15.7 44.1 26.0 15.3 26.1 24.5 16.2 38.1 36.0 25.2 27.8 36.2 15.8 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria Mitochondria "HPA062394: " "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favourable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 46.7 100.0 57.0 59.5 43.9 37.4 69.8 29.8 39.8 52.9 45.2 120.9 47.7 98.5 89.1 42.0 78.2 55.5 65.3 34.4 59.0 119.6 52.8 57.2 88.6 40.6 57.9 38.0 45.0 80.7 48.3 57.3 44.5 51.8 30.8 43.9 130.8 83.4 146.6 51.9 146.8 57.1 38.2 92.2 83.5 112.7 75.2 65.4 54.6 53.6 70.0 96.1 66.1 33.5 33.0 40.8 34.0 41.4 47.9 65.8 76.2 51.8 56.8 43.9 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648223-35658861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria 1200000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favourable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 37.2 32.2 62.1 32.1 58.7 46.2 42.8 31.1 57.6 34.1 65.0 25.2 41.2 52.7 27.1 70.2 52.4 36.3 39.8 132.5 51.5 52.2 61.1 68.9 24.7 40.4 57.4 60.2 29.2 41.1 41.4 28.8 30.2 39.2 30.2 77.1 31.8 54.9 44.2 168.4 35.1 63.2 37.6 38.7 30.7 42.0 21.0 29.0 42.7 37.6 110.6 52.7 33.8 31.6 110.6 115.5 111.1 116.1 61.2 107.9 167.5 42.8 102.5 44.5 59.3 58.5 59.9 41.3 34.9 53.0 57.7 58.4 83.6 43.2 48.4 61.9 55.0 31.5 71.3 59.3 56.8 56.2 48.9 82.8 54.8 81.9 46.2 74.4 43.2 70.3 74.4 53.9 31.3 56.0 51.6 72.5 58.0 83.0 52.2 54.9 33.0 69.1 45.3 48.9 80.0 131.6 85.7 39.1 44.7 56.2 96.9 34.5 38.4 80.8 33.4 33.4 38.3 35.4 54.3 43.5 52.2 65.7 44.1 57.7 42.9 87.7 108.6 94.7 65.5 116.1 62.4 110.6 90.5 76.1 111.8 92.7 89.6 79.4 111.1 61.2 107.8 115.5 107.9 167.5 62.1 58.7 31.1 57.6 51.5 52.2 57.4 60.2 39.2 29.0 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Enhanced Mitochondria 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: " "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 16.7 6.7 7.9 32.2 18.0 13.1 13.2 5.5 5.2 3.8 4.3 6.8 35.9 40.7 41.6 8.5 22.3 4.5 45.6 6.3 7.3 11.4 84.4 8.1 19.8 11.7 38.9 26.1 12.1 60.7 3.1 7.0 5.6 5.9 73.1 6.3 16.0 40.4 35.8 15.1 15.6 46.9 2.6 39.8 57.2 89.2 24.5 14.9 3.8 83.6 40.8 58.9 24.9 4.8 28.6 37.2 30.2 7.8 18.2 14.6 24.1 40.2 15.8 25.3 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria Mitochondria Nucleoli "CAB073545: , HPA059124: " "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 37.5 24.1 26.8 29.0 46.0 65.6 32.0 31.2 45.6 28.5 36.4 26.4 27.2 33.3 31.3 35.7 16.9 31.9 33.0 41.8 51.2 24.5 22.5 17.3 46.8 54.2 33.8 25.1 64.3 66.6 27.9 67.4 40.1 32.8 57.2 44.1 30.6 40.3 56.3 26.2 25.1 22.0 46.5 28.3 40.8 30.5 31.8 36.4 13.1 32.9 89.4 23.6 39.5 30.2 25.9 33.9 31.3 30.4 47.0 52.5 25.0 36.6 36.8 21.9 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in all" "HEL: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: " "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.3 7.9 7.0 12.4 13.2 9.8 20.3 10.5 7.6 10.9 12.4 13.1 5.1 1.7 11.9 5.5 11.9 8.7 11.4 18.6 5.2 7.6 56.9 4.5 16.9 6.7 12.0 13.5 7.7 9.6 10.3 4.3 10.3 10.9 7.4 10.2 5.0 12.1 10.3 8.3 14.5 8.6 16.0 7.5 9.2 6.8 4.6 4.6 11.1 3.8 31.6 5.9 7.7 8.6 16.2 15.9 9.2 7.7 11.3 8.9 9.1 16.1 13.2 11.8 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria 790000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavourable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favourable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 18.0 18.3 9.9 9.9 12.1 15.8 24.4 7.0 10.3 12.8 31.9 8.2 14.1 33.7 17.0 7.2 11.2 12.8 14.7 14.6 12.0 6.6 30.6 62.0 13.1 10.1 10.5 8.6 17.0 24.4 16.9 13.8 8.7 10.8 15.6 22.0 19.7 12.9 11.4 6.9 10.3 33.4 16.9 8.7 18.9 16.8 10.4 9.0 17.9 13.2 7.5 7.6 11.3 30.2 2.5 11.9 10.6 8.6 5.7 8.8 2.5 8.3 14.8 2.1 14.5 9.5 8.6 0.6 6.7 5.5 5.3 1.1 0.5 28.3 0.0 24.8 17.6 27.5 18.8 4.0 1.6 13.4 1.8 20.5 16.2 6.8 14.2 11.9 24.9 8.9 1.9 10.6 6.4 18.8 2.1 16.9 4.8 24.0 9.7 21.1 0.2 15.8 27.1 0.3 36.5 12.5 20.9 0.3 9.5 18.5 35.7 5.9 31.9 11.6 18.8 11.6 0.2 23.2 9.6 13.2 16.8 8.5 12.2 8.8 12.6 9.2 7.8 10.6 8.8 8.6 5.1 2.3 5.5 5.3 5.0 2.5 3.4 7.0 3.8 5.7 7.2 11.9 2.9 2.5 9.9 12.1 7.0 10.3 12.0 6.6 10.5 8.6 10.8 9.0 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favourable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favourable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.8 3.3 7.7 7.5 6.6 3.9 8.8 4.9 5.0 7.1 6.6 1.6 6.7 13.5 7.5 2.3 7.9 14.3 11.3 6.0 7.4 8.4 7.7 4.5 1.3 9.8 7.3 7.4 8.4 9.7 5.1 4.4 4.8 9.8 4.8 4.4 4.6 5.7 6.0 14.4 8.8 6.6 7.3 14.3 8.8 7.4 11.5 7.7 9.8 12.5 18.5 14.5 15.6 4.7 4.0 3.2 7.0 4.0 14.9 9.1 8.3 5.1 8.4 5.8 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria 4400000 Mitochondria "CAB075750: , CAB075751: , CAB075752: , CAB075753: , CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favourable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.4 38.4 31.3 40.7 41.7 38.8 20.4 29.6 29.1 52.1 36.5 54.1 34.9 69.4 29.1 37.3 38.5 86.6 44.5 49.9 24.1 44.0 47.7 27.9 39.0 23.4 58.3 34.3 42.7 42.6 40.9 49.6 58.6 49.3 41.7 45.5 28.5 48.2 18.0 24.9 55.5 47.0 36.8 52.4 32.3 36.1 41.2 27.0 38.3 45.6 30.0 63.5 34.0 38.8 26.3 36.9 37.1 31.2 27.5 41.9 45.2 24.3 42.9 24.7 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 CTU2 "C16orf84, NCS2" ENSG00000174177 "Cytosolic thiouridylase subunit 2" Q2VPK5 16 88706463-88715386 "Predicted intracellular proteins" "tRNA processing" "Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041135, HPA041894" Uncertain Supported Mitochondria Mitochondria "HPA041135: AB_10794543, HPA041894: AB_10796463" "unprognostic (4.19e-1)" "unprognostic (3.62e-2)" "unprognostic (5.19e-2)" "unprognostic (5.77e-2)" "unprognostic (3.00e-2)" "unprognostic (5.96e-2)" "prognostic unfavourable (5.68e-4)" "unprognostic (4.83e-2)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (1.19e-3)" "unprognostic (2.90e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" 10.9 10.5 13.0 10.9 12.8 12.0 7.8 11.6 17.4 9.0 8.8 11.7 4.6 9.5 11.4 6.7 8.1 8.8 8.5 11.0 12.8 10.2 6.5 11.4 7.7 12.2 12.9 15.3 12.5 15.7 7.0 10.9 7.5 9.9 8.3 4.4 5.8 15.6 9.6 25.4 11.5 7.8 14.7 8.7 9.1 9.5 22.8 11.2 9.3 9.7 11.1 7.9 8.3 7.2 7.5 7.7 1.4 8.0 8.1 9.3 4.6 6.9 10.9 4.3 9.2 3.7 3.8 10.6 7.3 5.6 8.1 4.0 12.8 6.6 10.2 9.8 4.6 6.9 7.1 7.1 2.2 3.1 21.4 7.1 4.5 12.8 6.2 6.9 5.4 4.2 5.2 6.4 6.9 6.8 26.1 2.9 3.0 18.6 18.9 15.7 6.4 17.7 15.3 3.3 10.7 2.8 2.7 14.2 6.9 11.9 2.2 4.5 6.5 7.6 7.6 8.5 10.9 9.6 7.9 9.6 4.8 29.0 7.1 15.0 9.2 1.4 6.4 0.0 9.3 8.0 7.8 6.9 8.4 9.0 7.7 7.5 8.9 7.1 0.5 8.1 6.5 7.6 4.7 4.6 13.0 12.8 11.6 17.4 12.8 10.2 12.9 15.3 9.9 11.2 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell line enhanced" "Detected in all" "PC-3: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favourable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.4 13.4 28.0 11.1 12.3 25.8 12.8 15.6 32.7 21.5 35.2 27.8 31.5 28.9 17.1 33.0 29.2 25.4 12.3 19.3 38.7 33.8 42.5 32.2 19.9 19.9 22.1 17.9 31.8 20.8 41.3 18.9 30.7 28.2 17.0 79.8 37.3 18.5 15.5 151.2 33.0 17.9 55.2 26.8 35.8 36.0 15.9 35.7 49.4 26.2 40.6 30.6 14.4 20.8 44.4 23.0 38.9 31.3 22.7 23.4 26.5 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 CYCS "CYC, HCS" ENSG00000172115 "Cytochrome c, somatic" P99999 7 25120091-25125361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Respiratory chain, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 109.6;skeletal muscle: 103.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004222, CAB005126, CAB018597" Enhanced Supported Mitochondria 190000000 Mitochondria "CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383" "unprognostic (3.06e-2)" "unprognostic (3.39e-1)" "unprognostic (3.32e-2)" "unprognostic (4.11e-3)" "unprognostic (1.15e-1)" "prognostic unfavourable (2.81e-4)" "unprognostic (4.44e-2)" "unprognostic (7.04e-3)" "unprognostic (5.67e-2)" "unprognostic (6.22e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "prognostic favourable (1.30e-5)" "unprognostic (1.18e-1)" "unprognostic (4.94e-2)" "unprognostic (8.75e-3)" "unprognostic (7.04e-2)" 20.3 29.3 29.8 20.0 44.8 17.1 14.7 25.1 41.1 12.1 62.1 13.3 9.6 35.4 11.4 10.7 26.6 11.0 13.1 109.6 30.2 26.4 39.8 37.0 13.4 13.8 30.7 34.7 12.2 9.3 24.8 18.6 10.3 29.9 13.7 58.5 13.5 14.9 15.7 103.7 11.3 30.2 21.8 28.0 15.6 24.3 23.5 18.1 17.3 18.3 41.2 20.0 15.9 14.3 35.5 38.0 17.1 38.3 25.2 31.0 25.2 43.0 24.1 26.1 36.3 15.0 11.6 26.9 41.5 17.1 31.1 36.2 39.9 29.5 49.6 20.4 18.1 51.2 53.0 39.1 55.0 14.7 23.8 41.3 28.6 28.3 23.6 94.3 36.8 15.4 35.0 31.1 67.5 27.8 75.6 52.6 33.0 19.9 51.5 36.7 48.9 45.7 36.3 31.4 47.4 48.4 42.3 53.0 25.2 21.6 92.4 33.4 47.9 56.5 20.1 28.6 52.1 44.1 76.6 54.4 63.0 110.8 38.1 68.7 79.2 17.1 20.0 14.0 25.3 38.3 31.0 35.5 23.4 26.8 38.0 26.0 22.4 26.8 3.0 25.2 33.6 27.8 29.5 25.2 29.8 44.8 25.1 41.1 30.2 26.4 30.7 34.7 29.9 18.1 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Group enriched" "Detected in some" 16 "A549: 92.9;Hep G2: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: " "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 92.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 CYP27A1 "CP27, CTX, CYP27" ENSG00000135929 "Cytochrome P450 family 27 subfamily A member 1" Q02318 2 218781749-218815293 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 149.0" "Cell line enhanced" "Detected in some" "Hep G2: 72.6;HSkMC: 13.9;RPTEC TERT1: 18.5;SK-MEL-30: 29.8;WM-115: 11.6" "Cancer enhanced" "Detected in all" "liver cancer: 176.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 38.2;neutrophil: 30.6" "Group enriched" "Detected in many" 20 "granulocytes: 30.6;monocytes: 38.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059155 Enhanced Supported Mitochondria Mitochondria "HPA059155: " "prognostic favourable (1.05e-4)" "unprognostic (4.21e-2)" "unprognostic (2.34e-1)" "unprognostic (1.83e-3)" "unprognostic (3.71e-3)" "unprognostic (1.31e-2)" "prognostic favourable (8.62e-6)" "unprognostic (6.04e-2)" "unprognostic (1.73e-1)" "unprognostic (4.04e-1)" "unprognostic (1.25e-3)" "unprognostic (8.76e-3)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (7.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 14.4 12.3 6.3 4.7 13.4 0.7 5.5 2.4 7.5 6.5 21.9 16.9 24.9 21.0 5.0 5.4 3.5 9.2 5.1 6.9 8.3 6.2 12.6 149.0 22.4 5.6 19.9 5.7 9.5 2.4 6.3 7.1 2.0 12.1 11.6 6.0 15.1 10.0 21.5 10.0 3.9 36.8 5.0 18.8 3.1 3.5 3.7 15.7 3.7 3.1 4.0 7.6 5.5 5.7 0.1 1.7 30.6 38.2 0.0 0.1 10.0 0.0 0.0 0.7 0.0 1.3 0.8 0.1 0.8 3.0 1.0 2.1 3.6 0.1 0.0 1.5 2.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.1 72.6 4.2 0.1 0.0 13.9 0.1 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.1 0.0 0.7 0.1 18.5 0.0 0.0 0.0 0.0 0.0 29.8 0.5 0.7 1.6 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.6 0.0 38.2 0.1 0.0 4.3 0.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 30.6 0.0 0.3 0.2 0.0 10.0 6.3 13.4 2.4 7.5 8.3 6.2 19.9 5.7 12.1 15.7 D2HGDH "D2HGD, FLJ42195, MGC25181" ENSG00000180902 "D-2-hydroxyglutarate dehydrogenase" Q8N465 2 241734579-241768816 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056216, HPA060548" Uncertain Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA056216: , HPA060548: " "unprognostic (2.85e-1)" "unprognostic (3.35e-2)" "unprognostic (6.98e-3)" "unprognostic (7.88e-2)" "unprognostic (2.42e-1)" "prognostic favourable (9.11e-4)" "unprognostic (2.49e-3)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (7.82e-3)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (9.60e-2)" "unprognostic (3.05e-2)" 7.3 17.0 10.9 13.3 10.7 11.5 7.7 9.8 9.5 12.2 15.9 11.7 32.4 7.8 14.6 30.6 12.0 11.7 22.6 8.7 11.3 7.9 13.8 18.7 8.7 7.7 12.2 8.5 10.6 17.1 18.7 26.4 7.4 13.0 12.3 10.1 13.1 13.8 22.2 24.3 27.1 10.5 11.8 7.0 10.0 9.9 4.3 11.3 6.1 15.2 14.0 12.5 11.3 9.5 5.0 1.1 0.0 0.6 0.0 2.8 0.3 6.5 7.0 4.1 6.6 10.0 5.4 14.4 6.0 8.0 6.4 5.1 7.6 14.4 5.4 2.9 6.2 15.1 3.9 5.0 2.8 5.9 3.8 10.0 6.3 13.1 5.6 11.9 8.0 9.6 9.1 5.0 5.0 6.2 12.9 3.4 5.6 11.0 9.9 12.2 1.9 13.5 12.4 4.6 10.2 11.7 23.7 13.5 4.5 6.1 15.8 4.1 9.6 4.2 2.5 9.9 3.8 5.1 3.7 6.4 1.2 8.3 6.9 13.2 6.5 0.0 0.5 0.0 0.8 0.6 1.2 5.0 0.3 2.8 1.1 0.6 1.6 0.6 0.0 0.0 0.6 0.3 1.9 0.3 10.9 10.7 9.8 9.5 11.3 7.9 12.2 8.5 13.0 11.3 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 27.8 36.5 22.9 26.3 25.9 28.9 34.2 19.5 23.6 23.5 33.4 19.5 22.8 29.4 28.7 28.1 31.3 21.8 23.2 56.3 27.0 26.4 32.8 52.2 23.9 49.0 24.9 23.0 23.3 38.5 20.7 27.1 20.5 23.0 27.9 32.1 24.5 28.0 27.1 64.0 30.9 26.5 36.0 23.2 30.8 30.3 31.6 21.1 44.4 27.6 28.4 38.0 38.0 24.1 39.0 41.1 15.9 35.2 34.0 56.5 39.6 32.3 21.0 17.2 27.2 25.4 32.1 42.3 27.3 28.9 28.1 24.6 38.7 39.8 46.2 55.7 22.2 33.1 25.5 23.8 30.7 28.9 18.6 28.1 18.8 35.1 34.8 38.4 25.1 26.9 34.2 35.8 47.4 27.6 60.7 32.9 29.2 43.0 33.7 45.0 30.4 34.4 27.9 21.6 49.0 33.4 31.0 20.0 35.5 26.2 77.4 47.1 48.0 63.3 23.6 23.9 25.2 29.5 45.8 36.0 53.7 53.2 23.8 34.5 30.7 13.9 30.1 15.9 31.3 35.2 51.4 39.0 45.1 38.0 41.1 32.2 56.5 48.4 13.0 34.0 31.9 26.8 45.0 39.6 22.9 25.9 19.5 23.6 27.0 26.4 24.9 23.0 23.0 21.1 DARS2 FLJ10514 ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824503-173858546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favourable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 17.0 22.2 6.3 10.1 8.1 5.4 9.0 7.5 8.6 7.8 15.1 6.7 8.3 11.7 10.4 6.1 13.4 6.4 5.9 11.2 5.5 6.0 21.9 14.8 8.2 11.0 6.4 4.2 9.5 14.9 18.1 15.3 10.9 10.0 8.5 16.6 10.2 10.2 6.2 10.6 6.0 16.1 6.2 9.0 11.4 11.3 8.4 6.9 26.1 12.2 6.3 12.5 9.7 8.1 9.3 9.0 4.8 10.7 5.0 9.3 5.2 29.2 19.6 12.2 7.6 9.3 13.3 15.6 12.9 10.7 18.7 14.3 18.3 26.4 15.9 17.7 10.3 30.1 33.7 21.8 25.6 18.1 16.5 13.7 9.8 12.8 9.1 11.6 12.5 9.6 10.0 18.9 19.3 18.6 27.7 12.5 15.5 8.1 14.7 6.5 23.6 17.6 17.4 15.6 29.2 17.0 9.8 16.0 14.7 14.2 31.6 20.3 33.1 15.3 8.2 9.6 15.2 13.2 20.6 9.8 24.8 18.4 5.6 12.9 20.7 4.4 7.0 4.8 6.6 10.7 9.3 9.3 7.2 5.8 9.0 7.3 7.7 4.8 0.7 5.0 7.4 3.7 5.1 5.2 6.3 8.1 7.5 8.6 5.5 6.0 6.4 4.2 10.0 6.9 DBT ENSG00000137992 "Dihydrolipoamide branched chain transacylase E2" P11182 1 100186919-100249834 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026481, HPA026485, HPA026533" Enhanced Supported Mitochondria Mitochondria "HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" "unprognostic (3.67e-2)" "unprognostic (5.29e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "unprognostic (3.88e-2)" "unprognostic (1.65e-2)" "unprognostic (6.01e-2)" "unprognostic (1.21e-1)" "unprognostic (2.37e-2)" "unprognostic (2.90e-1)" "prognostic favourable (8.79e-12)" "unprognostic (1.63e-1)" "unprognostic (3.77e-1)" "unprognostic (9.67e-2)" "unprognostic (9.92e-2)" 8.6 14.1 8.3 5.0 13.6 3.9 8.7 8.0 11.8 8.5 7.8 7.9 13.6 6.6 9.8 6.6 13.6 8.6 5.2 18.1 8.6 7.3 22.2 29.1 8.0 5.3 10.2 8.2 9.1 13.7 10.2 12.3 7.3 9.4 12.0 7.6 5.2 11.3 8.3 15.7 8.1 5.8 11.2 8.6 6.0 12.6 5.7 8.2 9.6 13.0 8.7 6.3 12.8 7.7 4.4 2.6 3.3 3.1 4.0 5.0 2.1 11.5 5.7 5.2 10.6 11.6 10.1 12.2 7.9 6.4 7.1 8.6 11.8 4.4 10.5 11.6 4.7 10.4 11.6 8.4 8.9 11.1 6.7 7.6 10.9 5.8 9.9 10.0 3.6 9.8 9.3 5.8 9.1 6.6 12.2 11.5 5.6 2.6 8.3 3.2 11.0 11.4 8.1 19.2 7.9 7.8 10.5 9.2 5.7 17.5 15.6 13.2 12.3 6.2 7.6 7.0 4.7 8.9 7.1 8.1 8.2 5.4 8.3 6.2 3.1 3.3 2.2 1.8 4.9 3.1 5.0 4.4 4.4 4.2 2.2 4.1 4.5 4.2 2.1 4.0 2.7 2.6 3.4 2.1 8.3 13.6 8.0 11.8 8.6 7.3 10.2 8.2 9.4 8.2 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: " "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favourable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.1 4.5 5.4 6.3 3.5 10.5 4.2 6.2 10.6 7.6 8.8 9.8 23.0 6.5 5.2 11.1 6.4 10.2 6.3 3.1 10.5 8.3 4.8 9.1 8.5 13.0 9.0 6.8 11.1 8.7 8.0 5.9 14.8 3.6 4.7 13.7 13.6 18.3 11.0 6.8 13.4 4.2 24.6 7.4 7.1 9.4 6.3 17.1 4.9 9.3 9.4 14.3 4.2 4.7 4.0 6.7 6.9 8.1 9.8 22.1 5.8 10.1 6.3 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavourable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favourable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favourable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.3 5.9 17.4 19.7 12.2 19.9 3.7 9.1 15.7 5.9 9.3 2.3 10.3 7.9 7.2 10.9 7.8 6.4 9.2 9.9 11.9 0.7 19.0 5.3 9.4 15.3 4.1 3.9 15.7 7.1 4.7 8.0 17.7 19.7 15.7 28.5 11.9 11.8 6.1 1.1 17.8 10.0 4.6 14.1 29.2 26.0 0.7 6.6 13.8 129.9 10.9 16.6 10.7 15.9 10.1 4.8 13.3 5.4 7.9 6.0 9.3 9.6 9.4 12.8 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria Mitochondria "HPA076422: " "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavourable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.8 10.5 13.9 10.2 60.2 38.9 10.7 41.5 46.7 29.2 35.0 9.6 11.4 11.8 54.0 37.5 15.7 16.1 14.1 32.4 17.2 28.7 8.5 11.5 5.8 36.6 17.0 18.4 38.7 31.6 26.8 15.1 28.7 12.5 13.0 37.3 5.4 8.6 9.2 17.2 15.5 7.9 19.6 7.6 37.0 4.0 9.0 14.5 22.1 34.8 21.9 11.8 24.8 26.1 28.0 8.9 32.2 40.4 9.3 11.0 10.8 30.2 8.5 31.4 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1, autophagy regulator" Q9NTK1 10 44970981-44978810 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 204.9;breast: 227.9" "Cell line enhanced" "Detected in many" "ASC diff: 34.4;HDLM-2: 23.9;HHSteC: 62.2;HSkMC: 48.4;HUVEC TERT2: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: " "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavourable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 204.9 14.6 8.7 14.1 16.8 2.4 227.9 10.8 19.7 14.1 36.5 2.9 10.0 7.4 25.0 14.9 23.5 25.5 28.0 37.0 8.5 6.0 13.0 48.2 70.7 20.6 9.4 3.3 51.2 107.1 4.7 12.2 33.4 21.6 25.8 5.7 12.1 16.2 13.0 81.0 19.6 9.9 30.2 39.0 9.5 12.7 31.9 11.0 0.8 33.3 13.4 19.1 52.1 27.6 0.0 3.7 1.2 0.3 0.0 0.7 1.4 6.7 0.0 0.1 0.0 34.4 16.8 1.7 0.0 2.3 0.1 0.4 0.2 2.5 0.0 0.3 3.0 0.2 0.2 2.0 0.1 23.9 0.9 0.0 0.0 2.4 62.2 0.0 0.0 48.4 0.1 0.0 0.3 38.3 0.0 14.7 0.1 0.0 0.0 0.3 0.0 0.2 1.1 0.4 5.6 0.1 2.4 1.3 0.0 0.0 0.3 1.3 0.0 1.6 0.3 1.8 1.3 0.1 1.6 0.4 0.6 0.0 10.4 0.6 0.9 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.5 0.0 0.1 3.7 0.0 1.4 8.7 16.8 10.8 19.7 8.5 6.0 9.4 3.3 21.6 11.0 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 67.6;skeletal muscle: 65.0" "Cell line enhanced" "Detected in many" "Daudi: 29.8;RPMI-8226: 53.0;RPTEC TERT1: 43.9;U-698: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "myeloid DC: 17.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 17.1" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 8.1 30.2 6.4 5.2 11.0 1.1 9.7 5.1 9.2 18.9 12.7 17.8 5.7 7.8 16.0 5.7 7.2 12.7 6.1 4.3 7.3 6.3 22.7 7.5 2.7 8.5 9.5 6.1 12.5 5.6 13.3 13.6 4.4 7.5 6.4 4.8 0.7 67.6 7.9 65.0 4.3 7.4 7.7 8.2 5.3 20.0 2.1 11.5 0.7 45.0 20.7 2.7 4.8 5.7 0.1 17.1 0.3 1.5 0.3 0.8 0.8 0.0 1.0 0.1 0.3 6.3 1.9 0.1 0.0 0.1 0.1 0.1 0.7 0.1 29.8 0.7 0.3 0.1 1.6 0.0 0.1 0.6 0.8 4.0 0.2 0.1 3.8 0.8 6.9 1.7 2.8 0.2 0.1 0.0 0.0 4.9 0.1 2.0 0.0 0.7 0.4 1.0 0.1 1.4 53.0 43.9 1.2 0.9 0.2 0.5 3.2 0.9 2.8 0.1 0.0 0.1 0.2 6.3 0.1 13.2 3.1 15.6 1.9 1.1 0.2 0.0 0.8 0.0 0.2 1.5 0.7 0.1 0.3 0.6 17.1 0.1 0.8 0.5 0.3 0.3 0.1 0.8 0.3 0.8 6.4 11.0 5.1 9.2 7.3 6.3 9.5 6.1 7.5 11.5 DHFR ENSG00000228716 "Dihydrofolate reductase" P00374 5 80626228-80654983 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Methotrexate resistance, One-carbon metabolism" "Oxidoreductase, RNA-binding" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB037129, HPA051465" Uncertain Supported Mitochondria Mitochondria "CAB037129: AB_439683, HPA051465: " "unprognostic (1.44e-2)" "unprognostic (1.03e-2)" "unprognostic (2.24e-3)" "unprognostic (2.91e-3)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (2.83e-2)" "unprognostic (2.35e-2)" "unprognostic (2.02e-2)" "unprognostic (4.19e-3)" "unprognostic (1.83e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (1.82e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" 17.7 6.1 16.0 11.6 13.9 28.3 10.9 10.2 14.0 7.5 12.6 18.1 11.7 14.5 5.9 9.0 9.8 4.7 6.9 9.7 17.3 14.4 13.1 35.5 8.6 23.2 18.9 9.4 7.5 4.9 9.6 7.2 8.5 13.0 5.9 15.5 8.6 8.0 8.4 10.4 5.9 14.5 7.3 25.3 9.1 7.4 10.5 11.5 13.4 9.2 2.3 22.8 7.9 6.1 2.4 3.3 3.5 2.6 2.1 4.0 2.1 19.6 13.6 34.6 25.6 6.6 6.9 12.7 15.7 12.1 27.4 31.7 12.9 23.7 39.8 6.9 9.1 13.8 44.4 20.3 44.4 17.6 27.4 19.1 22.6 12.0 1.4 22.2 8.5 4.8 2.1 24.5 2.7 13.2 21.4 30.6 27.7 19.7 54.7 9.0 17.4 8.0 35.5 67.9 39.4 15.7 12.5 28.3 19.8 22.2 10.4 11.2 20.5 22.0 7.9 8.7 13.2 24.3 30.0 14.4 28.8 43.1 19.4 45.2 22.3 0.8 1.2 1.1 2.3 2.6 1.1 2.1 2.7 3.2 1.9 2.4 2.1 2.7 3.5 2.1 1.7 3.3 4.0 2.1 16.0 13.9 10.2 14.0 17.3 14.4 18.9 9.4 13.0 11.5 DHFR2 "DHFRL1, DHFRP4, FLJ16119" ENSG00000178700 "Dihydrofolate reductase 2" Q86XF0 3 94047836-94063389 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051465 Uncertain Supported Mitochondria Mitochondria "HPA051465: " "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-2)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (1.38e-1)" "unprognostic (5.92e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (4.62e-2)" "unprognostic (2.95e-1)" "unprognostic (1.52e-1)" "prognostic favourable (2.30e-6)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-2)" 6.6 8.0 9.7 5.2 10.9 2.2 7.7 5.2 13.2 9.8 6.3 15.2 2.8 5.8 11.7 9.9 5.3 9.4 7.6 5.1 9.8 8.1 10.6 9.3 7.1 7.3 10.2 6.9 15.3 10.8 15.4 13.1 4.5 12.2 9.5 6.7 6.2 6.6 8.9 2.8 5.8 10.1 9.0 12.6 9.4 6.6 8.2 8.6 16.9 10.3 4.8 6.4 7.3 6.2 5.0 4.1 3.8 3.3 2.8 7.3 2.5 4.2 6.6 5.1 5.1 7.0 8.9 2.0 6.6 7.2 3.3 3.8 1.3 7.0 2.8 4.5 3.5 5.9 3.8 4.6 5.2 9.4 2.1 3.5 3.1 3.7 7.2 2.3 4.1 9.0 6.3 3.9 5.1 3.4 1.8 6.5 4.3 5.1 12.0 1.4 4.1 8.1 3.1 6.6 4.6 4.6 2.2 6.3 6.4 9.5 2.5 10.7 6.5 3.5 5.3 5.3 8.9 2.1 2.4 4.8 4.8 4.0 5.2 6.1 7.1 3.6 2.2 3.8 3.8 3.2 7.3 3.8 5.1 6.1 1.4 5.0 6.9 6.2 3.5 2.8 3.3 4.1 6.1 2.5 9.7 10.9 5.2 13.2 9.8 8.1 10.2 6.9 12.2 8.6 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.3 15.4 4.5 7.4 2.4 3.2 8.5 6.3 2.5 9.6 7.4 12.1 6.8 16.6 8.6 3.4 7.8 8.8 6.8 11.3 3.7 8.3 9.1 7.5 11.8 6.8 12.6 6.7 3.1 7.0 11.6 12.2 6.9 13.9 3.0 5.8 19.6 11.9 12.1 10.1 6.0 15.1 5.9 17.5 5.8 4.9 5.3 6.3 8.5 9.1 4.1 8.1 6.4 3.0 8.8 5.5 8.3 9.2 5.8 10.8 28.1 4.6 13.8 8.0 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell line enhanced" "Detected in some" "Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053915: , HPA069551: " "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavourable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favourable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 19.7 1.5 0.1 0.0 48.8 0.0 0.2 1.7 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 2.2 0.1 0.4 0.1 0.0 58.4 0.2 0.3 0.4 285.8 0.3 0.2 0.0 0.0 0.1 93.6 0.5 0.2 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068972-12123225 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.5" "Cell line enhanced" "Detected in all" "T-47d: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Approved Supported Mitochondria Mitochondria "HPA037949: , HPA037950: AB_10673650, HPA066098: " "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favourable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 5.7 6.3 6.5 4.7 6.6 2.2 5.0 5.7 7.2 5.5 5.7 9.8 5.0 4.5 4.7 5.0 5.1 4.2 4.5 7.7 5.3 4.8 23.8 69.5 4.2 6.9 7.5 5.2 7.1 16.6 5.4 4.1 4.7 6.2 7.6 6.3 7.2 9.7 7.1 10.5 3.6 4.3 3.5 6.1 5.1 6.1 4.4 6.6 10.1 6.8 6.7 8.0 5.2 4.1 9.5 12.5 16.8 11.0 10.2 4.1 3.3 11.2 8.7 13.0 10.3 8.1 4.8 15.7 5.7 3.7 10.2 9.1 5.5 6.7 8.1 1.9 3.5 16.1 13.6 4.4 11.7 4.5 6.1 4.4 3.4 4.2 7.9 1.7 1.7 5.9 3.5 5.9 2.4 5.5 6.9 6.6 2.7 21.8 5.9 3.2 7.2 2.0 10.1 4.2 6.8 6.6 2.7 3.4 15.3 11.2 20.1 6.7 44.2 6.4 2.4 3.3 2.4 6.9 4.1 5.9 4.1 5.2 4.3 3.1 5.5 16.8 4.8 10.7 3.2 6.8 3.4 9.5 2.5 2.1 8.6 7.8 2.5 3.3 14.0 10.2 11.0 12.5 4.1 3.3 6.5 6.6 5.7 7.2 5.3 4.8 7.5 5.2 6.2 6.6 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favourable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 18.4 18.7 22.1 18.5 31.1 23.6 18.3 31.2 43.5 22.3 17.8 26.9 15.5 17.3 23.3 14.8 21.0 24.8 17.9 21.3 19.1 19.8 18.6 19.3 16.7 22.0 20.4 28.0 27.1 21.2 37.3 24.8 20.6 23.6 20.4 13.0 22.0 20.4 23.6 27.1 26.2 16.1 18.8 15.3 21.2 18.7 54.4 18.4 23.8 20.1 15.2 16.9 18.6 17.6 9.9 13.0 9.8 10.5 8.2 16.1 11.6 8.1 20.7 20.5 21.1 9.5 7.9 14.0 15.4 13.2 26.6 19.2 23.8 17.4 26.5 12.1 15.0 12.5 30.3 21.5 9.5 18.0 36.3 23.1 30.5 23.2 16.5 21.5 24.0 13.8 13.7 28.1 19.8 17.3 32.5 17.1 12.4 22.0 27.3 23.6 22.8 35.4 18.2 11.0 23.5 13.3 20.7 16.9 22.5 15.0 21.4 11.1 15.0 22.6 12.0 16.1 20.9 18.1 28.2 20.7 25.8 24.1 16.7 18.8 19.9 9.8 10.1 7.2 15.0 10.3 13.0 9.9 12.7 16.1 13.0 9.3 12.1 13.0 1.5 8.2 10.5 7.8 14.3 11.6 22.1 31.1 31.2 43.5 19.1 19.8 20.4 28.0 23.6 18.4 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.0 37.8 26.7 18.1 19.2 18.8 20.5 19.8 19.5 23.3 21.0 32.6 10.0 23.3 18.7 17.9 19.0 29.0 23.7 27.7 20.1 22.7 25.5 15.6 29.9 27.4 27.4 10.6 26.0 16.9 27.5 41.3 26.9 29.2 9.9 22.6 28.4 22.4 40.3 21.5 35.5 20.4 26.6 25.6 26.3 29.7 25.3 25.8 26.5 10.6 21.5 35.8 19.3 18.3 18.0 22.2 20.4 17.8 21.6 36.1 33.4 23.0 21.1 23.6 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 DLAT "DLTA, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112024814-112064390 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 55.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Enhanced Mitochondria Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favourable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavourable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favourable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 14.1 10.7 10.6 8.8 11.9 4.8 10.9 10.5 14.2 6.7 13.3 6.3 7.8 12.4 6.3 8.1 12.2 7.2 6.4 55.4 10.4 13.5 19.1 12.0 6.6 8.7 11.2 9.7 7.9 6.0 15.8 7.8 8.3 13.0 8.3 13.5 7.6 10.4 9.9 41.0 7.2 13.0 6.6 7.3 6.9 8.1 7.3 4.2 12.7 10.7 22.1 8.8 7.5 6.7 9.2 9.1 7.9 8.9 7.2 10.3 8.0 6.0 6.1 8.1 10.8 11.4 8.5 9.7 8.3 4.8 9.2 10.4 19.3 17.8 24.8 16.3 7.6 13.0 16.9 8.9 10.5 8.9 10.5 15.7 6.5 11.9 8.2 19.9 9.0 10.3 9.8 9.2 9.3 8.4 25.7 11.9 10.8 4.7 9.0 23.9 9.5 11.8 14.0 11.0 27.9 16.9 6.4 15.6 9.5 10.0 28.3 6.3 21.0 12.4 5.6 9.2 10.0 9.2 10.6 3.9 6.2 37.6 2.6 21.8 7.2 7.9 6.6 4.7 8.3 8.9 9.5 9.2 8.2 8.9 9.1 7.5 10.3 8.3 0.5 7.2 8.9 7.4 8.8 8.0 10.6 11.9 10.5 14.2 10.4 13.5 11.2 9.7 13.0 4.2 DLD "DLDH, GCSL, LAD" ENSG00000091140 "Dihydrolipoamide dehydrogenase" P09622 7 107890970-107931730 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044849 Supported Supported Mitochondria 16000000 Mitochondria "HPA044849: " "unprognostic (2.01e-3)" "unprognostic (2.26e-1)" "unprognostic (1.27e-2)" "unprognostic (9.27e-2)" "unprognostic (5.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.48e-1)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (9.43e-2)" "unprognostic (7.35e-2)" "prognostic favourable (7.58e-9)" "unprognostic (4.08e-2)" "unprognostic (1.88e-1)" "unprognostic (4.45e-3)" "unprognostic (1.18e-1)" 25.7 37.9 14.5 12.7 25.4 12.0 15.2 16.6 27.2 13.2 28.0 10.6 12.2 20.9 13.6 9.6 25.6 11.6 12.7 69.1 16.4 14.4 40.7 37.9 11.0 13.0 16.7 20.1 15.1 14.8 24.6 22.4 15.4 29.3 14.7 26.8 12.8 19.4 14.4 71.5 13.8 29.5 23.7 10.6 17.4 23.0 10.6 10.7 18.7 17.0 31.8 16.9 20.1 11.7 13.5 30.4 45.8 37.8 22.9 19.4 20.2 39.9 32.4 18.0 31.0 25.9 22.9 20.4 23.0 19.4 26.8 20.8 37.9 22.4 39.1 39.7 24.4 26.6 36.2 32.4 40.5 26.1 21.5 27.5 43.0 27.0 19.9 45.2 28.4 26.1 23.6 28.4 15.5 32.1 68.6 29.2 29.0 44.9 36.9 32.8 21.4 23.5 26.6 28.8 53.0 36.6 59.8 22.4 23.7 37.7 63.7 33.8 24.2 38.7 20.3 29.6 24.3 57.6 34.9 22.1 42.1 26.3 27.9 48.3 30.6 36.5 22.3 45.8 17.5 28.2 18.5 13.5 17.7 17.3 30.4 12.3 18.7 19.4 14.0 22.9 37.8 10.5 16.8 20.2 14.5 25.4 16.6 27.2 16.4 14.4 16.7 20.1 29.3 10.7 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997606-79236038 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 50.2;liver: 81.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria 440000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: " "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favourable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favourable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 2.8 2.2 0.8 0.8 1.3 0.0 1.5 0.4 0.6 0.5 0.5 0.7 1.9 0.1 0.9 5.9 0.4 0.4 0.6 1.3 0.8 0.8 50.2 81.8 0.1 0.1 0.8 0.3 1.0 0.5 0.3 2.1 0.0 1.1 0.9 0.1 2.7 0.4 1.1 0.6 0.2 0.3 2.0 1.7 0.0 0.4 1.2 0.2 0.0 1.5 0.8 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 1.4 0.4 0.3 5.6 1.3 2.3 0.0 0.1 0.0 0.4 1.7 0.0 0.1 0.0 1.8 0.3 0.0 0.0 0.0 11.3 3.1 0.0 0.0 2.7 3.3 3.5 2.5 0.0 0.0 3.6 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.3 0.4 0.6 0.8 0.8 0.8 0.3 1.1 0.2 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 49.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.5" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria Mitochondria "HPA037487: AB_10672493, HPA057526: " "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.6 1.2 2.0 13.7 2.4 7.0 3.0 6.2 3.8 1.6 4.5 1.1 0.8 3.5 3.0 1.8 3.2 1.0 2.4 2.0 2.5 2.2 3.4 6.2 3.3 8.4 2.9 5.0 1.9 2.4 1.1 2.3 4.0 1.7 3.0 5.0 0.9 2.3 0.8 2.3 2.9 5.2 1.9 3.0 5.2 2.6 7.0 1.4 49.1 1.5 5.1 10.8 2.3 2.0 0.4 0.1 0.9 0.1 5.5 0.6 0.1 13.7 7.1 16.3 11.5 1.8 1.3 11.5 6.8 5.7 9.8 12.1 17.0 9.0 14.1 2.6 2.1 8.5 9.3 3.6 11.8 8.7 7.0 8.6 4.4 6.5 0.5 14.7 9.3 1.0 1.4 7.0 2.0 4.4 12.5 12.8 5.6 4.8 22.7 10.7 11.5 13.4 17.8 11.3 4.5 4.2 6.4 7.4 8.9 9.4 11.9 2.2 9.2 6.3 1.8 3.8 11.7 4.8 12.9 6.5 7.3 21.1 3.2 14.1 4.9 0.0 0.0 0.9 0.2 0.0 0.2 0.4 0.2 0.6 0.1 0.4 0.3 0.3 0.1 5.5 0.1 0.0 0.4 0.1 2.0 2.4 6.2 3.8 2.5 2.2 2.9 5.0 1.7 1.4 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Enhanced Vesicles,Mitochondria Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: , HPA044229: " "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favourable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 8.9 17.9 6.3 11.8 7.9 6.9 11.7 11.8 8.9 16.5 13.6 14.9 12.6 17.6 11.0 7.6 13.6 20.4 14.0 9.6 12.1 17.6 9.0 15.5 14.3 19.5 15.6 8.6 8.4 16.8 14.5 24.3 7.9 23.1 14.6 9.3 20.4 14.6 11.3 13.7 16.6 18.2 10.0 32.9 12.3 9.6 15.5 6.7 12.9 29.6 19.5 16.9 13.1 7.4 12.3 8.4 29.6 14.7 15.1 20.2 24.0 6.6 15.1 14.4 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363789 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA062738: " "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.6 11.3 13.8 13.0 11.9 13.4 10.4 8.1 13.9 9.7 8.9 9.2 4.0 12.8 10.0 6.2 13.4 7.4 7.1 29.9 11.2 9.1 13.7 14.0 8.0 14.9 11.4 3.5 13.6 25.3 5.0 6.5 7.1 8.5 11.2 2.8 6.2 9.2 7.0 29.6 7.0 7.2 9.9 8.0 13.7 8.3 6.3 6.8 11.6 11.2 7.4 8.9 8.0 9.2 8.6 4.2 8.0 3.1 0.9 6.9 1.2 4.1 7.5 2.6 7.6 1.3 2.7 6.7 6.8 3.7 5.5 2.4 9.0 4.4 9.7 25.0 4.9 9.0 1.6 3.9 0.6 39.6 9.9 3.5 3.7 3.7 5.1 7.8 6.6 3.4 4.0 4.0 2.5 2.9 5.6 7.0 3.5 31.1 9.2 13.0 11.4 19.8 28.2 3.7 11.2 6.7 4.3 11.5 16.7 6.9 6.4 6.1 7.9 7.2 6.3 9.2 8.4 6.4 10.3 6.1 8.7 8.6 6.8 3.8 8.5 8.0 1.8 0.3 3.8 3.1 4.8 8.6 5.3 5.6 2.4 5.7 5.4 4.5 1.4 0.9 1.7 4.2 6.9 1.2 13.8 11.9 8.1 11.7 11.2 9.1 11.4 3.5 8.5 6.8 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell line enriched" "Detected in some" 4 "MCF7: 27.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA059449: , HPA062780: " "prognostic favourable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favourable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favourable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 1.0 0.0 3.4 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.3 27.1 0.0 1.1 0.2 0.1 0.0 5.3 0.2 1.8 2.3 0.4 0.1 2.2 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Supported Mitochondria Mitochondria "HPA039015: , HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favourable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.1 5.7 2.7 7.9 17.9 0.3 3.2 5.2 5.3 5.8 1.2 1.1 0.0 4.4 6.2 4.3 4.4 5.9 4.3 0.0 4.0 0.8 3.7 0.1 7.6 1.7 1.0 11.1 2.3 12.0 13.8 2.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 6.0 0.0 4.7 0.1 5.7 0.7 4.1 2.9 5.0 1.4 2.3 5.3 1.1 5.0 6.4 2.6 6.0 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 EARS2 "KIAA1970, MSE1" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23522014-23557731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavourable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favourable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 8.4 19.0 11.0 8.5 19.0 2.7 13.6 13.4 16.8 11.1 10.0 10.8 12.7 6.4 11.4 10.2 10.5 13.1 7.8 14.9 10.9 11.9 14.5 18.3 7.3 8.1 9.9 14.0 12.0 18.9 32.7 10.9 12.4 10.3 11.3 11.0 8.8 16.4 11.7 17.3 11.1 6.9 8.3 9.3 7.6 9.2 12.6 10.4 6.3 14.5 9.0 11.0 8.6 16.9 3.0 6.2 0.5 5.5 10.6 7.9 3.3 8.1 16.4 7.7 12.4 5.4 7.8 9.4 9.0 6.9 11.2 9.4 11.9 8.2 11.3 9.3 8.3 9.1 29.1 16.6 10.7 4.5 14.1 6.5 10.1 20.2 8.7 7.2 8.2 8.3 9.9 10.0 14.2 5.0 20.3 6.0 7.9 17.1 7.2 5.2 20.4 5.7 12.9 8.9 21.7 14.1 7.0 13.8 10.1 7.1 13.4 7.2 18.1 8.2 4.0 8.8 7.8 9.7 11.4 11.0 10.4 9.1 9.0 10.1 13.0 0.0 2.8 0.3 4.2 3.6 7.9 3.0 4.7 4.3 6.2 3.0 4.6 4.5 0.5 10.6 5.5 4.5 3.4 3.3 11.0 19.0 13.4 16.8 10.9 11.9 9.9 14.0 10.3 10.4 ECH1 HPXEL ENSG00000104823 "Enoyl-CoA hydratase 1" Q13011 19 38815422-38832005 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA005835" Supported Supported Enhanced Mitochondria 5700000 Mitochondria "HPA002907: AB_1847964, HPA005835: AB_1847965" "unprognostic (1.91e-1)" "unprognostic (3.03e-2)" "unprognostic (3.64e-2)" "unprognostic (6.43e-2)" "unprognostic (5.73e-3)" "unprognostic (6.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (5.86e-2)" "unprognostic (2.24e-1)" "unprognostic (3.37e-1)" "unprognostic (7.01e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (3.54e-1)" "unprognostic (3.52e-1)" "unprognostic (1.74e-2)" 33.0 52.0 17.6 21.7 20.9 14.7 29.6 11.4 19.8 14.8 34.1 19.5 19.8 25.8 16.8 15.4 30.2 18.9 30.6 130.6 18.6 15.5 40.0 105.8 16.9 19.6 22.2 17.2 16.0 36.5 11.5 11.3 32.8 17.5 20.9 27.1 20.8 27.4 15.2 130.9 18.7 24.4 27.0 13.3 28.1 24.8 26.2 20.6 15.9 24.5 43.5 21.5 21.3 19.3 68.7 60.7 49.9 61.1 61.4 72.6 83.3 12.8 56.5 8.8 14.5 34.2 17.8 12.8 6.3 11.1 5.6 5.7 36.2 25.5 20.1 24.9 15.0 6.1 14.6 15.1 4.4 69.6 8.1 24.3 17.2 29.2 34.8 25.8 24.7 23.6 39.2 7.3 12.7 13.2 11.5 33.6 12.3 24.1 17.9 14.9 5.8 13.7 20.4 26.4 40.0 35.3 29.3 11.0 14.1 33.2 16.5 17.5 22.2 58.0 11.1 9.9 8.5 9.7 5.9 25.5 29.5 19.2 15.0 33.3 18.9 49.1 61.1 49.9 51.9 46.8 48.9 68.7 50.9 51.2 60.7 62.2 45.7 51.4 8.1 61.4 38.3 41.4 72.6 83.3 17.6 20.9 11.4 19.8 18.6 15.5 22.2 17.2 17.5 20.6 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362480-133373689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria 1500000 Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favourable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 36.5 18.7 16.6 9.1 16.6 5.0 15.2 8.2 18.3 8.8 21.8 13.0 34.7 22.8 9.5 14.1 16.5 12.2 17.4 29.8 14.6 11.5 62.1 148.2 6.3 7.8 14.8 10.3 11.6 16.3 9.2 11.0 12.8 11.1 13.9 14.0 11.0 40.2 38.4 35.7 8.8 32.1 9.9 11.9 7.3 11.0 10.2 10.2 3.9 16.2 17.5 13.0 11.2 7.8 39.4 53.7 18.3 45.7 33.5 32.1 44.5 28.7 36.1 19.7 49.1 28.6 18.4 18.0 21.2 28.0 29.6 25.1 79.2 28.0 21.7 18.4 23.8 27.0 25.5 21.5 21.4 16.6 44.8 21.6 21.8 56.3 24.0 28.0 15.4 20.5 18.6 19.6 25.1 26.2 19.5 19.1 28.8 68.2 13.9 54.7 13.7 43.4 24.0 23.9 11.6 36.5 36.9 12.7 20.2 21.9 36.4 27.5 28.3 27.0 21.0 13.4 19.4 27.7 27.9 14.4 8.8 24.6 31.7 15.3 11.0 17.0 41.7 18.3 24.9 45.7 32.1 39.4 28.1 27.1 53.7 32.2 28.9 27.9 4.4 33.5 34.3 23.2 26.0 44.5 16.6 16.6 8.2 18.3 14.6 11.5 14.8 10.3 11.1 10.2 ECI1 DCI ENSG00000167969 "Enoyl-CoA delta isomerase 1" P42126 16 2239395-2252300 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041746, HPA043227" Enhanced Enhanced Mitochondria 11000000 Mitochondria "HPA041746: AB_10960693, HPA043227: AB_10960273" "unprognostic (4.99e-2)" "prognostic favourable (3.04e-5)" "unprognostic (3.75e-1)" "unprognostic (2.92e-3)" "unprognostic (8.90e-2)" "unprognostic (2.85e-2)" "prognostic favourable (1.07e-4)" "unprognostic (1.98e-1)" "unprognostic (2.17e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-2)" "unprognostic (2.66e-2)" "prognostic favourable (8.99e-8)" "unprognostic (2.61e-2)" "unprognostic (3.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.08e-3)" 15.7 12.5 12.5 9.8 10.8 9.1 16.8 12.8 11.3 10.9 27.6 9.7 20.3 30.9 10.6 16.7 15.5 13.4 17.3 56.4 10.1 10.3 36.5 57.4 10.3 10.7 12.4 8.8 10.8 30.4 11.1 11.9 10.6 13.0 13.4 8.4 16.3 40.9 19.1 90.3 10.4 31.2 14.1 10.1 8.0 17.2 8.4 9.6 10.4 38.7 25.4 10.5 14.4 11.5 7.6 6.5 3.9 7.1 5.8 6.7 1.7 7.3 17.5 6.7 27.6 2.6 3.6 25.3 7.4 5.1 6.1 9.0 30.9 22.5 10.6 18.6 4.6 18.1 7.9 7.0 0.8 18.4 40.4 3.2 16.4 38.1 23.6 9.5 1.5 6.8 16.7 5.0 11.0 6.1 17.6 22.6 2.0 30.2 0.9 14.3 15.6 17.8 33.4 7.3 51.1 11.6 8.3 23.2 14.7 17.9 33.9 22.4 21.8 17.0 5.0 4.8 18.0 5.1 8.2 25.0 14.7 17.3 6.3 8.9 6.7 3.2 6.8 2.7 3.8 7.1 6.0 7.6 5.5 2.9 5.5 7.4 6.7 5.6 3.9 5.8 4.2 6.5 6.7 1.7 12.5 10.8 12.8 11.3 10.1 10.3 12.4 8.8 13.0 9.6 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115689-4135597 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favourable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 17.9 29.2 13.2 7.3 17.4 4.5 17.0 8.9 9.5 15.7 18.0 10.7 14.9 16.2 15.2 26.2 10.6 12.7 12.4 32.1 10.3 11.1 56.8 102.3 7.4 8.9 13.3 7.2 19.0 59.2 8.9 17.2 11.1 10.3 14.6 14.0 13.3 9.0 10.5 45.7 5.6 22.7 10.3 11.9 10.1 23.2 11.9 9.3 13.3 17.7 26.6 7.5 12.6 8.9 20.6 25.1 7.0 16.2 25.5 27.7 16.7 17.8 9.7 16.3 35.4 20.5 30.5 2.0 25.3 26.0 27.7 24.8 7.3 2.7 0.7 31.9 27.5 9.4 18.5 14.7 40.3 6.7 21.2 9.4 13.8 39.3 11.9 8.5 4.7 21.0 9.1 23.5 13.2 57.6 30.8 6.9 26.2 7.1 24.0 21.2 11.0 34.9 23.3 20.2 0.3 14.9 3.6 0.3 7.6 1.5 10.6 22.4 24.5 4.0 58.1 20.9 11.5 18.4 15.0 10.6 18.8 1.8 10.7 7.5 16.1 6.9 15.5 7.0 18.9 11.5 25.9 19.9 22.3 26.4 25.1 20.6 27.7 27.1 0.4 25.5 16.2 19.2 23.6 16.7 13.2 17.4 8.9 9.5 10.3 11.1 13.3 7.2 10.3 9.3 EFEMP1 "DHRD, FBLN3, FBNL, MTLV, S1-5" ENSG00000115380 "EGF containing fibulin extracellular matrix protein 1" Q12805 2 55865967-55924139 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 64.8;HUVEC TERT2: 263.9;TIME: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016368, HPA049806, HPA070841, HPA071588" Supported Supported Mitochondria "Secreted to extracellular matrix" 1800000000 Mitochondria "CAB016368: AB_2277777, HPA049806: , HPA070841: , HPA071588: " "unprognostic (8.21e-2)" "unprognostic (7.68e-2)" "unprognostic (9.01e-3)" "prognostic unfavourable (4.72e-4)" "unprognostic (3.43e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-1)" "unprognostic (9.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.89e-8)" "unprognostic (3.15e-3)" "unprognostic (4.94e-2)" "unprognostic (3.09e-1)" "prognostic unfavourable (6.68e-5)" 63.1 14.1 13.6 14.1 35.1 0.1 45.5 8.0 12.8 14.8 20.4 22.0 16.6 6.2 20.1 31.9 22.0 38.6 37.1 55.4 8.2 9.7 16.3 3.5 38.5 24.5 12.5 15.5 52.9 10.9 3.3 6.6 84.5 25.8 47.5 22.9 116.9 26.8 40.5 15.6 13.8 12.0 29.9 8.6 10.1 12.6 9.3 13.5 0.9 57.4 18.1 7.3 45.5 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.2 0.4 0.0 20.1 13.0 0.0 12.5 13.4 1.5 1.1 0.0 1.2 0.0 8.1 15.1 21.0 0.0 15.0 0.5 0.0 0.0 0.0 5.3 0.0 55.1 0.0 0.0 64.8 6.9 1.5 17.3 263.9 0.0 0.0 5.6 2.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 17.4 6.5 0.0 20.2 0.0 233.7 0.1 7.0 25.9 8.0 0.7 0.0 0.0 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 35.1 8.0 8.8 8.2 9.7 12.5 15.5 25.8 13.5 EIF4E2 "4EHP, EIF4EL3, IF4e" ENSG00000135930 "Eukaryotic translation initiation factor 4E family member 2" O60573 2 232550052-232583644 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019253, HPA077074" Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA019253: AB_1848092, HPA077074: " "unprognostic (3.44e-2)" "unprognostic (2.70e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-2)" "unprognostic (1.63e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.38e-4)" "unprognostic (1.42e-1)" "unprognostic (5.62e-3)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" "unprognostic (1.21e-2)" "unprognostic (1.36e-2)" "unprognostic (7.74e-2)" "unprognostic (3.34e-3)" "unprognostic (1.88e-1)" "unprognostic (9.38e-2)" 19.0 22.9 27.9 24.0 24.4 25.4 19.4 27.1 38.1 17.6 30.7 18.4 17.0 24.4 26.2 18.2 32.1 18.5 20.0 21.3 25.8 14.8 29.8 43.2 20.4 21.0 18.6 27.2 22.0 26.2 16.3 25.0 26.8 26.3 19.9 35.7 16.1 27.3 15.9 77.6 23.8 25.2 25.3 27.0 25.4 26.7 25.2 21.5 18.1 19.1 24.8 27.1 20.0 21.2 13.5 38.9 49.6 46.8 14.1 24.1 29.7 27.6 22.9 28.1 20.7 20.6 28.2 43.3 37.2 20.2 25.6 26.3 25.2 26.1 27.1 10.6 36.2 23.5 31.6 32.3 32.3 24.2 26.0 37.0 24.7 33.5 25.1 51.6 35.0 24.2 24.3 26.9 19.5 41.6 34.7 9.2 28.9 44.5 21.0 43.9 44.7 19.1 18.2 62.4 17.7 51.4 32.9 27.3 37.4 19.8 23.0 23.7 21.9 36.3 38.0 24.0 31.7 25.1 27.4 17.3 16.3 35.6 26.9 28.5 20.8 49.6 45.1 40.7 14.8 46.8 11.8 13.5 15.1 15.4 38.9 12.2 12.9 13.1 29.5 14.1 41.7 15.2 24.1 29.7 27.9 24.4 27.1 38.1 25.8 14.8 18.6 27.2 26.3 21.5 ERAL1 HERA-B ENSG00000132591 "Era like 12S mitochondrial rRNA chaperone 1" O75616 17 28854938-28861067 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021425, HPA024423" Supported Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA021425: AB_1848228, HPA024423: AB_1848229" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (5.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.55e-1)" "unprognostic (8.37e-3)" "prognostic unfavourable (3.59e-4)" "unprognostic (8.20e-2)" "unprognostic (7.04e-2)" "unprognostic (2.70e-1)" "unprognostic (8.57e-3)" "unprognostic (5.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.49e-1)" "unprognostic (2.62e-1)" "unprognostic (5.79e-2)" 16.2 24.8 24.1 13.3 31.6 12.7 19.4 25.1 47.9 18.4 20.9 27.1 15.8 18.0 21.5 19.2 20.6 22.2 17.2 24.5 23.0 22.0 24.9 33.7 14.8 16.0 21.3 20.2 22.0 18.1 29.3 15.4 24.7 27.6 18.0 23.4 17.3 28.2 21.2 34.1 18.3 19.7 21.8 18.4 17.0 18.2 17.3 15.5 20.4 20.3 21.5 23.8 16.1 14.8 20.1 29.0 11.1 23.1 20.8 18.2 14.9 15.9 31.1 18.2 20.6 20.1 13.8 17.8 12.8 18.3 38.9 32.0 30.3 10.3 20.6 15.6 22.0 17.8 33.3 29.2 32.5 20.3 39.0 16.5 20.7 30.6 25.8 19.6 15.1 18.0 26.0 31.5 29.9 31.7 32.8 13.0 21.6 25.1 20.4 30.4 16.8 14.9 18.9 28.9 26.6 23.5 18.2 19.4 15.6 20.9 51.5 16.5 36.2 23.1 12.7 15.9 17.9 17.5 26.9 10.5 19.0 22.0 17.2 17.2 16.1 11.1 17.9 7.1 17.8 23.1 13.4 20.1 15.2 13.0 29.0 18.6 17.6 18.2 1.4 20.8 15.6 15.0 16.3 14.9 24.1 31.6 25.1 47.9 23.0 22.0 21.3 20.2 27.6 15.5 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein alpha subunit" P13804 15 76215355-76311472 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria 6300000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favourable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 18.8 39.9 12.8 16.4 13.6 10.7 26.1 7.6 13.4 8.6 26.4 7.3 9.6 27.5 10.1 11.1 18.9 7.7 12.6 84.4 13.3 8.5 36.4 78.3 9.8 15.7 11.9 12.9 7.8 28.1 7.6 11.0 24.0 11.8 11.2 26.0 9.4 15.8 10.8 84.0 12.3 29.2 17.3 11.8 11.7 18.5 9.7 10.8 10.8 11.9 37.9 12.8 14.8 11.5 24.6 50.7 25.2 38.8 36.0 29.3 39.4 21.7 35.9 23.8 24.9 26.8 28.6 37.5 26.3 30.5 34.2 30.7 31.7 40.7 36.5 26.5 26.1 55.9 92.3 36.6 39.9 43.8 18.0 39.7 26.1 36.6 21.9 37.9 29.7 21.4 34.7 17.3 28.9 34.5 37.5 38.0 35.0 34.3 7.8 31.7 18.5 10.8 34.3 29.6 48.8 37.6 70.1 24.9 12.6 39.9 91.2 36.1 46.8 40.2 20.2 33.4 22.7 29.2 31.7 18.5 38.0 45.0 24.0 50.5 23.6 11.2 38.8 25.2 22.1 34.5 20.8 24.6 20.8 22.7 50.7 20.2 17.0 21.1 9.9 36.0 28.4 20.3 29.3 39.4 12.8 13.6 7.6 13.4 13.3 8.5 11.9 12.9 11.8 10.8 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell line enriched" "Detected in all" 4 "Hep G2: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favourable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favourable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.2 34.2 4.7 13.0 15.2 17.8 7.5 9.0 6.9 7.3 7.3 28.7 21.8 13.2 9.2 14.5 11.7 9.4 19.2 2.2 19.7 36.6 10.4 20.9 185.6 16.7 9.9 7.8 27.6 5.7 9.9 10.2 6.2 15.6 14.9 9.4 26.8 10.3 9.4 3.0 42.3 11.5 12.8 24.7 10.0 15.2 10.6 5.1 19.9 5.7 10.3 14.9 9.6 8.7 7.6 8.0 8.2 8.2 22.9 13.9 11.8 39.0 14.8 19.6 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 ETHE1 "HSCO, YF13H12" ENSG00000105755 "ETHE1, persulfide dioxygenase" O95571 19 43506719-43527244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028360, HPA029028, HPA029029" Enhanced Enhanced Mitochondria 13000 Mitochondria "HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998" "unprognostic (8.04e-2)" "unprognostic (3.33e-1)" "unprognostic (1.50e-2)" "unprognostic (2.45e-1)" "unprognostic (8.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "prognostic unfavourable (9.58e-4)" "unprognostic (7.75e-2)" "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" "unprognostic (2.73e-2)" 7.7 10.5 5.2 28.3 6.3 13.1 8.8 4.5 6.7 10.9 80.7 4.6 9.6 27.4 7.1 12.2 28.2 7.1 18.4 8.9 4.4 4.1 19.0 21.3 11.4 15.5 5.6 4.9 7.4 12.7 3.0 7.2 16.7 5.1 12.0 72.1 5.6 18.5 6.7 9.4 9.1 40.3 11.8 4.5 11.0 13.2 3.3 4.7 12.0 26.2 23.3 24.4 10.9 13.3 7.9 35.8 7.4 24.3 9.9 20.2 15.1 13.4 17.7 3.6 12.6 19.8 13.5 1.4 20.9 57.0 18.0 18.5 5.3 13.8 0.0 15.7 20.0 11.0 5.2 31.5 4.8 6.7 1.7 3.4 7.7 14.7 9.0 5.0 4.7 13.8 24.8 6.9 19.5 13.3 2.2 22.6 8.8 9.1 5.8 4.6 0.9 8.6 6.6 1.6 3.0 39.1 28.0 0.0 4.5 5.3 19.2 12.5 5.8 8.4 11.2 2.9 12.4 3.5 3.8 6.4 5.0 0.3 12.6 20.8 15.0 7.4 24.3 0.6 17.2 12.7 20.0 7.9 20.2 16.3 35.8 3.4 15.6 14.8 0.7 9.9 8.5 7.1 19.4 15.1 5.2 6.3 4.5 6.7 4.4 4.1 5.6 4.9 5.1 4.7 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA012531: , HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favourable (1.92e-5)" "prognostic unfavourable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 7.4 9.9 14.1 12.8 14.2 8.1 6.6 18.5 14.1 8.2 8.0 10.5 6.6 5.4 9.7 8.9 5.2 7.4 9.0 22.8 11.7 9.1 7.2 5.8 7.2 12.9 11.1 11.0 8.0 7.4 7.6 16.8 7.3 8.7 9.4 8.2 6.8 5.9 9.3 9.5 4.8 8.1 11.2 8.0 10.8 6.6 9.7 11.2 11.5 8.7 4.0 11.0 9.0 6.4 24.5 6.8 2.1 5.2 12.0 13.6 2.6 3.7 6.6 7.6 6.6 5.2 7.6 3.1 11.9 7.7 10.4 11.8 6.0 3.7 12.9 3.2 4.8 3.8 9.6 4.2 8.8 14.4 8.6 9.7 10.0 6.3 6.3 10.5 8.1 5.9 4.6 9.3 4.9 14.0 4.4 8.6 16.5 2.4 7.3 3.5 7.3 8.5 4.8 4.2 5.7 5.4 5.0 3.5 1.8 7.4 1.8 3.2 2.6 5.0 11.7 8.7 6.1 9.2 9.6 4.8 8.2 11.8 6.5 9.1 6.2 0.4 5.0 2.1 13.6 4.4 11.9 24.5 13.0 13.0 3.4 22.4 13.1 13.0 0.2 12.0 5.2 6.8 5.8 2.6 14.1 14.2 18.5 14.1 11.7 9.1 11.1 11.0 8.7 11.2 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favourable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favourable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 10.4 17.0 10.4 6.7 9.9 6.5 9.2 8.6 12.7 6.8 21.7 9.3 8.2 26.7 9.8 10.9 14.8 5.8 10.2 15.8 10.9 11.4 46.8 43.6 5.6 5.2 10.1 9.4 7.9 17.4 9.0 11.1 10.4 9.9 8.1 11.1 8.5 9.1 9.8 20.2 12.4 24.8 6.9 8.8 6.3 14.9 6.9 9.5 4.7 12.5 19.0 5.7 9.9 7.9 18.5 23.1 8.6 27.5 19.6 16.0 13.7 8.3 18.8 9.0 15.8 12.0 8.7 5.6 13.7 6.8 9.2 10.1 12.0 8.7 5.3 11.6 8.5 17.2 7.0 11.0 8.3 8.0 16.6 4.8 16.2 27.6 11.7 8.2 9.2 11.4 14.5 8.4 5.6 11.9 4.9 5.6 11.5 38.2 4.4 12.5 5.3 14.1 10.2 12.2 15.0 32.9 10.5 17.6 14.6 17.9 14.4 21.5 21.2 5.6 17.4 15.1 10.8 8.8 7.4 8.1 17.0 6.3 9.6 6.0 6.4 6.5 23.5 8.6 14.4 27.5 13.0 18.5 14.5 15.7 23.1 16.9 16.0 14.9 2.0 19.6 19.1 17.9 14.7 13.7 10.4 9.9 8.6 12.7 10.9 11.4 10.1 9.4 9.9 9.5 FAM110B "C8orf72, MGC39325" ENSG00000169122 "Family with sequence similarity 110 member B" Q8TC76 8 57994509-58204279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.0;RPTEC TERT1: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4" "Group enriched" "Detected in many" 11 "granulocytes: 13.1;monocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008318, HPA011781" Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA008318: AB_1853892, HPA011781: AB_1853891" "unprognostic (2.07e-1)" "unprognostic (6.91e-2)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.88e-8)" "unprognostic (4.09e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "unprognostic (8.72e-2)" "prognostic favourable (1.44e-4)" "unprognostic (1.06e-2)" "prognostic favourable (4.31e-8)" "unprognostic (2.23e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.15e-4)" 6.5 3.1 15.7 4.1 12.2 4.1 9.9 23.7 18.4 8.8 6.1 5.0 24.3 2.3 8.9 6.8 3.0 9.1 7.9 21.7 10.3 14.4 6.6 6.0 4.1 2.0 8.0 5.9 8.2 3.0 16.7 4.1 5.0 7.9 10.0 3.2 9.5 8.5 19.8 17.1 3.0 3.3 10.4 11.5 30.8 5.5 14.7 4.9 0.0 8.6 3.4 2.1 7.9 9.4 0.3 0.9 13.1 6.4 0.0 0.2 0.5 0.0 1.1 4.1 0.1 1.8 0.7 1.6 7.7 9.0 5.4 2.5 0.0 0.1 0.0 1.5 5.5 0.0 3.6 0.0 4.2 0.0 3.8 0.7 1.2 4.5 6.2 1.0 0.2 6.6 1.5 0.2 3.4 0.0 0.0 0.1 4.1 0.1 0.0 2.7 3.9 1.7 0.0 4.6 0.0 13.4 0.8 3.9 4.3 0.0 0.5 0.2 3.6 0.4 0.0 3.8 2.5 0.0 2.6 1.7 0.0 0.0 1.8 0.0 4.4 0.0 1.4 13.1 0.0 3.6 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.0 6.4 0.0 0.1 0.5 15.7 12.2 23.7 11.8 10.3 14.4 8.0 5.9 7.9 4.9 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favourable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 30.4 6.5 9.7 18.1 17.9 16.6 5.0 12.5 11.2 11.9 30.5 16.3 14.0 33.2 21.8 4.3 21.4 17.6 30.4 31.9 17.1 13.2 26.9 11.3 29.1 11.8 26.2 9.6 19.2 16.0 11.3 24.0 15.8 18.1 13.3 17.0 11.9 26.7 31.9 14.3 34.7 16.1 13.9 43.2 34.5 74.4 14.6 11.7 9.3 22.2 25.5 13.9 13.0 11.1 11.8 8.5 6.9 12.9 26.5 9.0 33.7 35.1 25.7 5.4 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 FASTKD2 KIAA0971 ENSG00000118246 "FAST kinase domains 2" Q9NYY8 2 206765357-206792509 "Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067191 Supported Mitochondria Mitochondria "HPA067191: " "unprognostic (1.19e-1)" "unprognostic (2.45e-1)" "unprognostic (3.50e-3)" "unprognostic (1.36e-3)" "unprognostic (7.40e-2)" "unprognostic (2.69e-3)" "prognostic unfavourable (8.29e-4)" "unprognostic (1.69e-2)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.32e-2)" "unprognostic (4.87e-2)" "unprognostic (7.18e-2)" "unprognostic (1.03e-3)" "unprognostic (3.57e-2)" 17.2 20.0 12.8 11.2 24.2 9.4 17.1 18.7 23.9 15.5 15.0 9.0 13.1 14.1 19.7 12.7 20.9 15.5 11.2 23.9 12.1 8.4 19.0 27.4 12.8 12.4 10.4 18.1 16.9 15.1 16.6 29.4 12.3 21.2 13.5 17.0 10.3 15.5 11.5 42.0 17.1 14.5 15.6 11.0 14.0 16.3 10.8 11.8 14.2 17.7 19.4 16.0 16.7 14.2 13.4 19.6 5.1 13.9 19.2 19.5 12.8 14.9 13.7 12.8 14.5 14.6 17.5 24.0 17.5 14.9 30.1 17.2 24.3 16.4 18.9 19.7 18.2 20.5 15.9 24.7 26.7 5.8 10.3 14.7 14.1 23.4 17.8 31.8 13.8 18.8 25.3 22.8 25.1 20.2 27.8 9.6 22.1 12.8 13.5 13.6 22.9 26.3 11.8 19.9 19.4 20.8 25.1 18.7 12.0 13.5 23.0 20.8 10.8 16.7 15.7 18.4 16.5 12.6 18.2 9.7 15.9 24.4 21.4 14.8 15.1 5.1 13.9 3.2 13.1 13.5 14.4 13.4 14.6 13.7 19.6 10.8 19.5 17.5 0.8 19.2 9.8 9.4 11.3 12.8 12.8 24.2 18.7 23.9 12.1 8.4 10.4 18.1 21.2 11.8 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA068525: , HPA074462: " "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavourable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favourable (8.53e-4)" 7.1 15.5 8.6 9.7 13.3 7.6 12.3 9.1 15.0 8.3 10.7 8.6 7.9 10.4 8.8 10.2 8.9 7.5 6.5 7.2 8.7 7.3 17.8 14.5 8.3 10.0 9.2 13.7 9.3 8.4 13.0 10.8 6.4 8.0 8.6 13.5 8.1 11.1 15.8 10.2 9.0 12.1 7.8 8.8 12.0 9.1 6.0 7.4 12.2 8.9 7.4 12.2 9.1 7.0 9.6 6.7 7.4 7.3 4.8 10.3 4.7 7.0 6.2 6.1 7.9 3.8 4.9 12.0 6.0 5.1 9.3 7.2 9.3 7.6 24.6 12.0 6.2 7.5 14.9 8.3 13.3 6.7 7.7 8.5 20.3 7.3 5.2 14.0 7.1 5.5 3.6 8.7 5.4 5.1 11.6 4.3 7.0 5.1 9.4 8.2 5.6 8.8 11.0 7.5 5.6 7.6 7.6 4.3 4.0 17.8 7.9 8.7 7.1 6.5 3.5 9.3 9.4 9.6 9.7 5.0 4.7 15.7 6.2 13.0 7.5 3.8 5.4 7.4 6.1 7.3 8.2 9.6 9.4 6.5 6.7 6.8 10.3 9.7 0.2 4.8 5.7 3.8 10.2 4.7 8.6 13.3 9.1 15.0 8.7 7.3 9.2 13.7 8.0 7.4 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429883-110464881 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.9;seminal vesicle: 55.6" "Cell line enhanced" "Detected in all" "U-698: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favourable (3.58e-7)" "prognostic favourable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 5.5 113.9 3.9 4.7 4.5 3.9 5.6 2.7 4.0 3.2 7.5 5.2 33.7 7.9 3.2 3.9 5.1 3.0 5.6 9.6 3.6 4.3 10.7 22.8 7.8 4.7 4.5 2.5 3.5 8.6 3.5 3.7 48.4 3.1 4.8 4.2 4.2 4.1 55.6 7.3 3.3 12.3 3.6 3.4 3.9 5.0 5.3 2.6 5.2 8.7 5.0 3.5 5.6 5.4 10.7 6.9 3.4 5.8 4.4 8.7 2.9 5.2 3.7 5.7 6.2 5.6 10.0 12.8 4.9 6.0 4.3 7.4 12.6 8.9 12.4 14.4 6.3 6.3 6.6 7.4 5.9 11.8 8.4 6.2 6.5 7.7 9.8 6.5 10.2 17.3 6.1 3.9 9.3 8.8 6.2 18.5 9.2 5.8 9.2 14.6 5.1 7.0 13.7 5.4 11.4 9.4 9.5 7.8 4.0 9.3 10.6 6.2 6.2 4.5 5.2 4.4 5.4 5.3 5.2 4.2 3.2 37.2 3.3 13.4 5.6 1.8 5.7 3.4 5.3 4.2 5.8 10.7 7.3 7.4 6.9 7.5 8.6 6.1 0.7 4.4 5.8 5.3 8.7 2.9 3.9 4.5 2.7 4.0 3.6 4.3 4.5 2.5 3.1 2.6 FDXR ADXR ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 93.9" "Cell line enhanced" "Detected in many" "BEWO: 29.5;Hep G2: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favourable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 1.7 93.9 2.6 2.1 3.1 1.3 1.8 8.4 2.7 2.1 4.6 3.2 6.4 2.6 2.6 23.8 8.7 6.6 6.1 1.9 3.4 1.7 2.7 4.1 4.4 1.7 2.9 3.5 7.1 3.9 2.3 1.5 2.6 3.6 3.3 2.1 0.9 5.3 4.2 7.9 5.6 2.5 2.0 4.4 9.7 2.2 32.1 3.0 3.9 2.0 7.7 3.7 3.0 3.0 5.4 7.4 4.8 6.4 10.0 15.2 5.6 3.9 21.1 3.1 3.5 2.3 3.0 29.5 4.7 5.2 2.8 5.7 5.9 3.5 9.4 0.8 2.0 8.1 2.3 5.9 0.8 8.9 4.9 7.1 3.5 54.0 6.4 1.5 25.0 9.9 6.7 2.9 1.0 14.4 11.3 1.5 4.3 16.7 6.1 3.3 1.7 4.6 3.3 5.3 5.0 2.3 6.7 1.7 4.0 3.2 7.1 3.4 15.4 1.5 6.7 1.9 17.6 3.1 2.3 4.4 0.7 2.0 5.3 2.4 6.6 1.8 6.4 4.8 6.2 4.3 5.3 5.4 5.6 7.3 7.4 2.8 4.9 6.1 2.1 10.0 3.2 1.4 15.2 5.6 2.6 3.1 8.4 2.7 3.4 1.7 2.9 3.5 3.6 3.0 FH fumarase ENSG00000091483 "Fumarate hydratase" P07954 1 241497603-241519761 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Tricarboxylic acid cycle" Lyase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017785, HPA025770, HPA025948, HPA027341" Enhanced Supported Enhanced Mitochondria 2800000 Mitochondria "CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222" "unprognostic (1.03e-2)" "unprognostic (3.82e-2)" "unprognostic (9.46e-3)" "unprognostic (2.18e-1)" "unprognostic (2.10e-1)" "unprognostic (2.07e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-1)" "unprognostic (5.14e-2)" "unprognostic (1.85e-2)" "unprognostic (1.27e-2)" "unprognostic (1.09e-1)" "prognostic favourable (2.76e-7)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (4.41e-2)" "unprognostic (1.24e-2)" 14.3 28.1 15.7 10.4 20.2 9.3 13.3 15.7 24.4 10.5 22.7 9.9 16.7 23.2 13.7 10.7 17.7 10.3 9.5 59.0 22.9 13.9 35.0 93.4 9.9 13.3 15.2 19.4 9.4 13.9 25.2 11.4 14.3 18.4 12.3 24.4 10.2 18.4 20.6 65.1 13.4 21.4 14.7 14.4 11.1 17.5 14.0 11.7 13.8 12.3 45.2 13.4 13.4 11.2 16.0 26.4 4.5 18.8 10.4 13.9 8.9 29.2 24.5 23.3 21.0 22.9 27.0 36.9 36.3 28.5 41.0 25.8 35.1 18.3 18.6 24.1 27.8 41.7 35.6 27.0 35.8 21.2 11.5 17.4 26.0 29.9 20.5 40.7 15.9 19.5 16.8 23.0 26.0 25.2 53.0 24.1 29.8 14.6 35.1 27.2 24.7 52.7 29.0 25.5 83.5 39.5 24.9 30.0 25.9 30.6 36.3 23.2 27.6 27.7 24.7 18.4 23.8 32.5 60.5 21.6 23.1 22.6 20.6 46.8 26.4 4.5 12.8 2.7 9.7 18.8 12.6 16.0 11.4 9.0 26.4 14.1 13.9 12.7 0.7 10.4 15.7 13.2 13.2 8.9 15.7 20.2 15.7 24.4 22.9 13.9 15.2 19.4 18.4 11.7 FIS1 "CGI-135, Fis1, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017430 Approved Supported Mitochondria 590000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favourable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 35.1 46.8 53.4 22.3 49.9 32.7 35.8 26.0 60.0 30.3 34.4 57.9 38.0 30.0 31.1 42.7 35.6 47.0 39.4 78.6 52.6 44.8 39.6 58.3 27.8 23.6 65.3 37.8 41.2 56.6 39.5 37.1 34.0 45.1 29.3 26.3 28.8 45.2 43.8 120.5 29.7 29.2 32.4 87.9 28.1 31.1 30.4 44.1 21.3 47.1 48.8 22.6 30.5 29.3 73.0 73.4 63.6 67.4 55.6 72.8 87.9 24.7 29.2 21.9 31.4 25.3 33.9 15.0 26.9 32.8 24.6 21.2 20.1 40.8 24.3 36.0 36.9 14.6 15.3 43.5 13.8 18.8 22.2 11.0 42.5 26.6 30.2 20.5 17.1 32.2 41.0 17.2 26.4 44.5 23.1 33.4 37.0 113.9 31.9 37.0 24.3 28.4 15.6 12.3 53.2 37.2 28.7 28.4 33.3 12.8 61.9 18.2 20.6 23.3 36.4 28.9 18.6 29.9 28.6 28.3 21.6 14.0 26.8 23.3 37.7 58.9 67.4 63.6 63.2 65.5 65.1 72.2 61.0 59.7 73.4 73.0 60.7 63.5 51.4 55.6 59.0 61.4 72.8 87.9 53.4 49.9 26.0 60.0 52.6 44.8 65.3 37.8 45.1 44.1 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: " "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favourable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.6 26.3 20.6 39.1 21.3 33.5 51.7 29.7 31.6 22.7 31.5 24.9 50.0 21.0 48.3 36.4 19.9 12.7 41.3 6.4 25.6 60.3 19.6 34.3 29.9 36.7 19.4 43.2 43.7 39.9 20.4 13.0 23.3 41.1 50.0 19.7 61.0 35.2 58.1 42.1 38.2 37.0 17.1 71.8 30.5 24.0 22.9 41.7 20.8 17.2 37.0 20.2 56.7 27.1 28.4 26.0 55.4 22.5 38.3 21.9 24.4 64.3 31.2 25.2 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 FOXRED1 H17 ENSG00000110074 "FAD dependent oxidoreductase domain containing 1" Q96CU9 11 126269055-126278131 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039620, HPA046192" Uncertain Supported Mitochondria Mitochondria "HPA039620: , HPA046192: " "prognostic unfavourable (7.36e-4)" "unprognostic (4.62e-2)" "unprognostic (2.71e-1)" "unprognostic (3.47e-3)" "unprognostic (1.76e-1)" "unprognostic (1.84e-1)" "unprognostic (9.59e-2)" "unprognostic (1.43e-1)" "unprognostic (8.14e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-2)" "unprognostic (1.59e-1)" "prognostic favourable (2.01e-6)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" 7.2 12.3 14.6 8.5 14.9 10.4 7.8 12.6 19.2 6.1 11.7 9.2 6.4 10.3 6.8 6.9 7.7 7.7 7.5 20.1 11.1 11.7 14.6 36.2 5.1 9.2 12.9 18.2 4.3 7.5 9.2 7.7 7.1 13.6 5.8 13.0 8.0 7.5 11.9 15.0 6.1 8.2 8.0 8.7 9.5 8.8 6.8 11.7 8.3 6.2 9.8 10.0 8.0 4.9 7.5 16.5 5.3 12.4 8.5 8.9 7.7 9.5 11.0 8.1 10.1 6.1 2.8 11.2 5.0 6.2 9.4 9.4 16.3 9.8 15.6 13.9 4.0 16.0 21.6 13.0 5.9 8.3 5.9 32.5 7.2 19.2 8.0 8.0 7.0 2.6 5.0 6.2 11.2 10.3 18.6 8.5 7.9 13.1 9.1 14.0 6.7 19.0 14.9 14.4 18.4 8.5 4.9 10.5 9.0 9.9 15.0 5.4 36.2 13.4 3.7 5.6 4.6 10.1 8.0 5.2 7.4 12.8 6.9 27.3 7.7 1.6 9.7 5.3 6.9 12.4 7.1 7.5 5.5 8.9 11.8 6.2 7.9 6.9 1.9 8.5 8.9 16.5 7.6 7.7 14.6 14.9 12.6 19.2 11.1 11.7 12.9 18.2 13.6 11.7 FXN "CyaY, FA, FARR, FRDA, X25" ENSG00000165060 Frataxin Q16595 9 69035259-69120427 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022164, HPA068304" Supported Supported Mitochondria,Cytosol Mitochondria Cytosol "CAB022164: , HPA068304: " "unprognostic (3.38e-2)" "unprognostic (1.54e-1)" "unprognostic (7.47e-2)" "unprognostic (2.37e-3)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.71e-3)" "unprognostic (1.10e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-1)" "unprognostic (4.74e-2)" 8.7 19.9 10.8 9.1 9.8 21.9 11.8 13.9 11.0 8.3 9.3 12.3 11.6 6.6 12.4 11.7 9.2 9.6 7.2 20.2 8.7 10.1 10.2 40.2 9.5 12.8 11.7 8.5 16.8 25.9 18.8 8.6 8.4 10.5 9.9 11.6 12.1 11.9 13.6 25.1 5.2 7.2 16.6 8.9 12.9 9.2 13.3 9.7 3.7 11.1 9.5 9.6 10.5 7.9 15.8 17.7 2.0 18.5 24.2 28.3 19.1 11.2 9.6 15.7 7.5 7.2 10.7 15.2 8.2 7.2 12.5 9.7 5.1 7.3 20.2 6.3 8.5 12.4 18.5 18.7 15.8 23.6 21.1 28.5 6.3 37.5 12.3 20.8 12.4 11.8 15.1 12.5 13.6 16.7 21.3 19.8 11.6 11.0 5.9 9.1 21.2 19.1 14.0 10.8 13.8 14.4 9.4 12.1 5.4 8.4 5.5 8.5 6.2 6.4 9.9 8.2 14.3 10.7 11.8 5.6 4.8 12.0 3.8 17.2 8.2 2.0 16.7 0.1 21.5 18.5 16.3 15.8 22.0 21.2 17.7 10.3 28.3 27.1 0.8 24.2 14.1 15.0 17.0 19.1 10.8 9.8 13.9 11.0 8.7 10.1 11.7 8.5 10.5 9.7 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957236 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Enhanced Mitochondria Mitochondria "HPA055205: , HPA065048: , HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 23.9 31.8 32.7 22.3 29.1 28.1 19.3 17.2 31.4 16.9 18.9 11.2 17.9 21.1 19.2 20.0 22.3 17.5 25.0 41.9 26.4 27.6 24.3 31.5 15.3 21.0 26.0 23.6 20.7 29.6 10.1 18.5 21.3 17.7 18.7 9.7 13.1 36.2 21.7 85.5 18.4 19.2 19.5 19.3 19.8 20.0 17.2 17.1 14.8 27.0 37.9 14.8 17.5 21.5 34.2 17.7 4.8 14.1 16.1 23.6 10.6 19.8 17.0 7.1 10.0 5.0 6.5 10.0 14.7 7.4 14.7 12.1 23.4 8.1 14.4 24.6 8.8 14.0 8.7 14.4 3.8 9.3 42.7 10.2 22.9 26.2 12.2 16.9 15.6 7.7 11.7 10.2 8.4 8.5 15.4 5.6 9.1 29.3 26.7 35.6 19.7 53.7 19.8 7.2 23.0 11.3 11.8 22.0 20.1 11.0 14.8 16.6 11.6 16.0 13.8 28.6 10.0 24.8 27.0 22.4 15.6 14.9 19.8 21.3 16.4 4.1 14.1 4.8 14.4 13.4 14.5 34.2 22.1 22.8 17.7 28.0 23.6 17.4 0.9 16.1 11.3 16.9 17.5 10.6 32.7 29.1 17.2 29.1 26.4 27.6 26.0 23.6 17.7 17.1 GATB "PET112, PET112L" ENSG00000059691 "Glutamyl-tRNA amidotransferase subunit B" O75879 4 151670504-151761023 "Predicted intracellular proteins" "Protein biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042610 Uncertain Supported Mitochondria Mitochondria "HPA042610: AB_10797502" "unprognostic (2.52e-1)" "unprognostic (3.33e-1)" "unprognostic (1.01e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (2.06e-1)" "unprognostic (6.76e-2)" "unprognostic (1.37e-1)" "unprognostic (8.17e-2)" "prognostic favourable (1.20e-10)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-1)" 11.2 17.0 12.3 10.5 13.6 8.2 9.2 10.7 19.8 7.3 9.7 11.2 6.4 5.8 5.9 8.9 10.1 9.1 7.0 31.3 10.7 10.8 21.4 21.8 5.3 6.8 15.8 11.1 12.1 6.8 14.6 8.4 9.9 10.6 5.9 9.9 7.8 7.7 7.1 22.7 8.5 6.3 8.1 22.6 6.9 7.4 7.8 10.4 10.5 7.7 18.9 9.3 8.0 5.8 9.1 17.0 1.5 13.2 6.8 6.8 8.3 8.6 6.8 9.8 9.4 14.3 13.7 8.5 11.5 15.1 20.5 16.0 11.4 14.3 11.8 3.0 12.0 8.1 20.9 22.0 22.0 6.6 12.8 5.4 9.5 23.6 14.0 11.1 5.4 14.2 14.2 19.7 6.9 15.2 21.1 10.4 15.7 9.6 13.9 12.1 10.0 12.8 11.8 9.3 9.3 18.5 7.3 10.1 11.3 9.2 12.8 13.5 10.8 8.1 8.3 10.3 5.6 7.1 7.9 12.4 16.1 9.8 14.5 9.9 7.5 0.7 9.4 1.5 4.0 13.2 6.3 9.1 5.3 5.6 17.0 8.2 6.8 6.4 0.9 6.8 9.4 6.7 5.4 8.3 12.3 13.6 10.7 19.8 10.7 10.8 15.8 11.1 10.6 10.4 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in some" 4 "RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favourable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.7 8.8 0.3 0.0 0.6 4.4 0.1 0.1 0.4 0.0 0.7 0.0 0.0 0.2 5.1 0.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.6 0.1 3.1 0.0 0.1 55.9 0.4 0.9 14.7 6.5 1.1 1.8 0.1 0.3 0.7 5.8 0.0 0.0 0.1 0.0 1.7 34.5 43.6 0.2 0.4 0.1 0.3 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020460 Uncertain Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548" "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.7 2.3 5.9 33.6 12.2 9.9 4.1 12.6 13.3 9.6 8.2 5.1 1.0 2.7 5.9 5.6 5.1 5.9 8.9 2.2 1.2 10.7 6.1 7.3 20.1 19.9 10.8 8.0 11.6 5.4 6.3 14.0 7.8 15.6 3.2 4.5 7.7 11.3 20.0 2.5 9.4 11.9 1.2 16.1 12.1 6.9 12.2 8.3 9.8 15.9 6.7 12.8 5.3 5.9 9.7 5.3 6.4 4.3 10.7 5.2 5.7 6.7 10.1 10.1 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 GCDH ACAD5 ENSG00000105607 "Glutaryl-CoA dehydrogenase" Q92947 19 12891026-12914207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043252, HPA048492" Enhanced Supported Mitochondria Mitochondria "HPA043252: AB_2678390, HPA048492: AB_2680418" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" "unprognostic (6.79e-3)" "unprognostic (8.07e-3)" "unprognostic (8.20e-3)" "unprognostic (3.14e-2)" "prognostic favourable (7.28e-5)" "prognostic favourable (3.35e-4)" "unprognostic (1.62e-1)" "unprognostic (3.03e-2)" "unprognostic (7.50e-3)" "unprognostic (7.46e-2)" "prognostic favourable (6.79e-8)" "unprognostic (7.09e-3)" "unprognostic (3.42e-1)" "unprognostic (5.32e-2)" "unprognostic (1.59e-1)" 12.5 12.1 11.4 8.6 13.3 8.2 9.5 11.5 14.0 9.5 10.5 15.5 8.6 9.1 11.7 7.3 9.1 10.5 7.5 19.8 9.3 8.0 20.2 62.6 6.3 12.1 15.5 14.1 13.7 12.3 7.9 8.7 4.9 9.7 10.4 6.9 9.6 14.7 9.7 17.5 6.6 8.1 8.2 8.7 8.6 11.3 4.9 11.8 13.0 10.9 13.7 9.0 12.0 6.6 10.9 14.5 7.2 8.1 21.7 20.6 12.3 11.2 6.2 6.7 12.4 9.9 4.9 6.2 8.4 5.0 9.8 7.4 11.5 4.8 16.3 15.8 4.6 7.1 9.3 7.2 4.9 14.0 9.9 10.4 10.9 14.1 11.3 19.6 8.3 6.3 9.0 6.9 7.5 8.4 25.3 5.1 4.8 12.3 23.0 17.2 7.6 16.2 22.0 6.9 31.6 5.7 5.1 14.9 9.0 11.8 10.3 7.2 8.0 13.0 5.9 8.0 6.0 14.8 8.0 27.3 13.8 17.1 5.6 22.5 6.9 7.2 8.1 4.6 11.7 7.1 11.6 10.7 15.0 13.7 14.5 10.9 20.6 15.5 2.0 21.7 5.3 8.6 12.5 12.3 11.4 13.3 11.5 14.0 9.3 8.0 15.5 14.1 9.7 11.8 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favourable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavourable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 11.9 2.7 1.0 0.9 1.1 1.0 5.6 6.0 6.9 4.0 2.7 9.1 1.4 1.3 3.9 6.4 3.9 11.8 7.9 2.0 4.8 4.3 7.8 1.3 3.9 9.8 2.8 1.3 2.9 6.1 0.7 2.3 0.1 3.6 2.9 7.9 0.6 13.7 10.5 4.0 5.6 1.7 2.0 7.2 11.7 28.7 7.0 2.6 5.9 11.8 1.3 0.1 8.8 4.1 2.0 2.8 6.0 5.6 4.4 4.0 0.2 9.2 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984207-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: " "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favourable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 9.7 12.2 9.7 15.2 9.9 10.7 14.8 15.2 12.5 8.1 24.8 10.8 15.2 29.6 10.1 10.2 11.0 10.2 16.1 17.8 9.8 9.7 13.7 33.5 17.1 18.1 10.7 9.7 9.4 43.8 19.2 10.9 18.0 8.0 11.9 18.0 10.5 22.5 12.5 27.5 8.3 33.2 9.2 9.6 15.2 12.8 20.0 7.8 7.7 15.1 15.0 11.4 12.4 17.1 16.1 9.1 9.8 12.7 7.8 17.7 7.7 11.3 18.1 14.9 12.1 6.3 12.6 19.3 13.2 12.9 18.6 15.2 26.0 19.0 6.4 18.0 9.8 17.1 11.3 17.4 11.8 19.7 23.1 8.8 17.8 29.5 11.4 12.7 16.6 8.1 13.5 16.2 14.6 8.7 13.7 21.4 13.5 26.7 14.5 13.8 23.8 18.1 31.8 11.4 20.7 18.9 8.9 13.1 12.5 17.8 38.0 14.1 18.1 13.6 8.1 18.1 20.2 10.1 22.6 36.3 19.6 18.3 6.0 8.7 15.2 3.1 12.6 9.8 9.2 10.5 9.9 16.1 12.6 15.6 9.1 13.4 11.5 7.9 1.1 7.8 12.7 4.0 17.7 7.7 9.7 9.9 15.2 12.5 9.8 9.7 10.7 9.7 8.0 7.8 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139440-84153245 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria Mitochondria "HPA016464: AB_1849656, HPA061664: " "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favourable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 28.7 50.7 46.0 21.9 53.3 25.3 26.0 30.9 62.7 21.4 45.5 20.2 23.9 43.3 21.2 24.5 30.0 19.9 21.8 94.9 40.8 42.8 80.5 71.6 19.2 23.2 45.2 42.4 20.7 25.1 29.9 24.0 20.9 62.8 22.6 46.0 24.3 26.0 24.5 87.6 19.9 35.6 28.9 24.6 20.1 30.1 41.7 17.5 21.5 29.3 47.6 26.6 26.1 19.1 46.8 63.7 60.6 67.5 44.4 51.6 106.0 41.2 43.0 18.4 42.1 31.6 28.2 32.7 28.5 50.3 37.1 34.7 52.2 34.4 32.7 32.1 37.7 37.3 39.0 37.3 35.9 32.6 29.6 23.2 44.9 51.3 59.9 72.2 38.1 31.7 73.4 38.2 111.5 32.0 53.8 61.2 34.0 36.0 25.5 57.8 18.5 38.3 23.3 16.9 49.1 51.4 33.3 15.1 17.6 28.8 25.3 57.6 51.6 46.4 27.0 18.0 24.3 26.2 45.8 43.3 47.1 36.7 47.4 67.0 12.5 52.6 64.3 60.6 42.2 67.5 47.1 46.8 44.2 44.9 63.7 37.2 41.5 44.4 51.3 44.4 59.6 33.0 51.6 106.0 46.0 53.3 30.9 62.7 40.8 42.8 45.2 42.4 62.8 17.5 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell line enhanced" "Detected in some" "BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: " "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavourable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favourable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.5 7.0 0.0 0.1 65.3 0.0 0.0 0.0 0.0 15.5 0.1 0.1 1.5 0.0 0.1 0.0 0.1 0.0 0.3 3.7 0.0 0.0 10.3 0.0 0.0 14.2 0.0 0.0 0.5 0.0 2.7 0.0 0.1 0.3 0.3 0.2 0.0 7.6 1.2 0.3 0.0 0.1 27.0 0.3 6.2 3.2 0.0 6.0 0.0 1.4 0.0 0.9 0.1 0.2 0.7 0.3 0.3 8.9 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria Mitochondria "HPA042465: AB_10794048, HPA063716: " "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favourable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favourable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 13.7 24.1 19.3 11.2 16.9 54.8 9.7 10.5 17.3 7.4 16.6 7.7 8.1 17.6 9.1 10.8 10.7 8.4 12.6 45.3 16.1 14.5 22.5 43.3 7.7 8.4 15.5 9.5 15.8 19.1 8.3 9.4 27.3 10.4 9.9 9.9 13.3 11.6 11.0 68.8 7.9 15.7 12.6 8.3 9.1 12.8 24.2 7.1 19.9 14.8 25.6 9.7 10.0 10.8 6.0 9.9 5.5 4.5 4.8 8.7 3.0 13.9 18.7 8.6 11.4 8.5 6.2 39.0 10.3 6.7 8.9 8.5 24.4 15.3 20.1 15.3 5.2 14.1 12.8 10.3 7.5 13.2 19.3 17.2 12.0 36.5 9.7 27.5 18.5 7.6 8.6 6.4 9.0 8.9 20.4 15.8 6.3 39.2 21.6 27.9 14.7 20.9 39.5 30.6 12.0 9.9 16.8 22.9 14.3 9.9 12.5 14.1 19.2 11.8 10.6 5.7 12.6 13.8 14.5 8.6 10.2 15.3 12.4 16.6 13.1 1.0 3.5 5.5 5.2 4.5 6.1 6.0 6.4 7.7 5.4 5.8 5.9 5.8 2.2 4.8 2.7 9.9 8.7 3.0 19.3 16.9 10.5 17.3 16.1 14.5 15.5 9.5 10.4 7.1 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880827-190965552 "Enzymes, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 127.9" "Cell line enhanced" "Detected in all" "EFO-21: 138.9;RPTEC TERT1: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" 25000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 16.5 37.3 37.8 20.4 24.7 10.7 34.3 43.8 47.3 11.9 13.1 5.8 8.9 36.9 14.6 11.9 7.6 11.0 17.7 15.7 23.3 22.8 127.9 5.3 22.6 25.4 20.6 36.8 14.1 17.0 26.4 10.1 14.8 35.1 9.4 13.1 10.8 9.0 13.9 7.4 13.0 40.9 15.5 11.7 19.3 8.7 6.9 12.1 15.0 17.7 8.0 22.9 14.1 16.1 5.2 5.0 6.0 2.1 3.9 9.4 1.5 6.2 7.0 4.9 6.4 15.4 10.7 12.7 18.8 14.3 13.7 15.8 8.5 6.2 12.9 138.9 39.7 8.2 8.6 7.4 20.1 31.8 5.6 21.4 10.3 10.5 14.1 12.5 10.1 9.7 7.7 10.8 7.4 17.8 9.9 26.4 30.5 3.3 8.4 12.1 13.1 11.5 10.7 12.7 11.2 63.8 11.6 6.8 7.1 25.7 5.7 23.9 2.2 7.7 12.6 19.9 14.6 9.9 22.8 8.5 19.4 17.8 7.1 10.3 15.7 6.0 1.5 2.5 5.5 2.1 9.4 4.8 6.5 7.0 2.2 5.2 6.8 8.1 3.0 3.9 1.4 5.0 5.6 1.5 37.8 24.7 43.8 47.3 23.3 22.8 20.6 36.8 35.1 12.1 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050486-87094866 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 182.4" "Cell line enhanced" "Detected in all" "Hep G2: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" 26000000 Mitochondria "HPA042492: , HPA044839: , HPA061369: " "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavourable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favourable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 15.5 21.5 57.8 9.9 54.5 5.9 23.2 13.4 37.9 12.1 14.5 19.9 5.5 18.4 10.9 7.5 17.0 11.5 12.6 16.7 44.1 35.3 56.2 182.4 13.1 11.5 40.6 30.8 17.5 15.2 8.7 6.6 13.5 31.1 26.5 14.6 8.1 10.0 13.3 9.2 15.3 19.8 14.0 22.7 10.2 12.2 6.4 33.2 12.6 16.1 8.7 13.1 14.0 9.5 9.2 15.8 9.2 14.6 13.7 11.9 5.9 24.0 19.5 15.3 25.9 29.1 35.9 16.7 19.0 33.0 18.5 20.3 44.9 23.6 27.1 15.6 27.7 38.0 19.9 19.2 19.8 19.5 15.7 13.1 11.7 106.0 65.0 30.7 19.1 24.7 36.2 20.5 61.4 22.0 13.2 24.5 19.9 17.5 27.6 27.6 17.4 15.7 21.0 19.5 17.6 53.1 19.7 7.9 14.8 17.1 13.6 24.3 18.6 21.6 21.8 9.6 8.5 19.4 19.3 14.7 15.1 32.4 23.2 35.2 5.7 5.5 13.8 9.2 8.7 11.1 10.9 9.2 11.8 10.6 15.8 8.8 10.6 8.5 1.3 13.7 14.6 5.9 11.9 5.9 57.8 54.5 13.4 37.9 44.1 35.3 40.6 30.8 31.1 33.2 GLUD2 GLUDP1 ENSG00000182890 "Glutamate dehydrogenase 2" P49448 X 121047588-121050080 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.3;testis: 31.9" "Cell line enhanced" "Detected in some" "HAP1: 7.8;K-562: 8.6;SK-MEL-30: 11.1;THP-1: 5.5;WM-115: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA042492, HPA044839, HPA061369" Uncertain Supported Mitochondria Mitochondria "HPA042492: , HPA044839: , HPA061369: " "unprognostic (1.44e-1)" "unprognostic (5.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.42e-1)" "unprognostic (2.61e-1)" "unprognostic (2.35e-1)" "prognostic favourable (1.98e-4)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (4.77e-3)" "unprognostic (5.96e-2)" 3.1 2.5 4.8 0.8 7.3 0.5 1.6 2.2 3.5 1.1 0.7 2.0 0.6 0.6 1.0 5.2 0.7 1.0 1.6 1.5 5.7 1.8 4.7 11.3 0.9 0.9 2.7 6.2 0.7 1.5 0.7 0.7 2.7 4.3 0.8 0.6 0.2 0.9 3.1 0.7 0.8 1.0 1.0 1.5 0.5 0.9 31.9 4.1 0.0 1.4 0.0 0.8 0.8 0.6 0.8 1.2 0.7 1.1 1.2 0.7 0.4 0.0 2.1 0.5 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.3 0.0 1.1 0.0 0.8 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 2.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 1.7 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 11.1 2.7 5.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.5 0.6 0.8 0.7 0.4 1.1 0.7 0.8 0.7 0.7 1.2 0.4 0.7 0.5 0.0 1.2 1.1 0.2 0.7 0.4 4.8 7.3 2.2 3.5 5.7 1.8 2.7 6.2 4.3 4.1 GLUL GLNS ENSG00000135821 "Glutamate-ammonia ligase" P15104 1 182381704-182392206 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 138.5;ASC TERT1: 97.9;HSkMC: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 92.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 92.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007316, HPA007571, CAB008636" Approved Supported Mitochondria,Cytosol 28000 "Mitochondria, Cytosol" "CAB008636: AB_1616669, HPA007316: AB_1078981, HPA007571: AB_1078980" "prognostic favourable (4.81e-4)" "unprognostic (1.52e-3)" "unprognostic (3.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.25e-1)" "unprognostic (9.52e-2)" "unprognostic (7.58e-2)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (8.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.38e-2)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" "unprognostic (5.55e-2)" "unprognostic (4.53e-3)" 173.3 19.2 83.7 37.2 91.0 47.6 63.1 48.5 80.7 41.9 20.4 49.9 9.4 6.2 20.5 29.7 54.0 31.6 26.2 23.5 74.0 48.7 15.6 64.9 39.5 36.9 71.0 48.8 66.2 49.0 7.4 8.9 41.8 70.6 17.4 23.3 39.3 30.4 25.5 159.8 27.9 16.4 30.5 51.3 36.1 71.4 24.0 55.2 8.6 63.9 15.5 24.2 34.7 32.2 2.5 11.0 92.2 21.1 3.4 6.3 18.6 2.9 1.2 13.7 0.0 138.5 97.9 10.1 5.0 16.2 3.0 2.7 7.2 3.0 2.5 5.4 9.7 6.8 5.9 35.6 2.5 6.8 16.6 33.5 5.7 14.0 7.3 14.7 26.8 84.6 42.8 3.8 45.4 6.1 28.2 1.5 10.7 1.6 22.9 14.1 10.1 6.4 8.3 3.6 4.3 5.3 13.0 9.4 6.2 1.4 18.3 1.9 17.8 18.7 4.5 0.1 0.2 0.0 1.1 0.5 0.3 0.0 2.6 8.4 0.5 43.6 21.1 54.9 6.3 20.5 2.6 1.6 4.5 5.2 11.0 2.5 2.3 3.9 92.2 3.4 17.1 6.1 1.7 18.6 83.7 91.0 48.5 80.7 74.0 48.7 71.0 48.8 70.6 55.2 GPX4 "MCSP, PHGPx" ENSG00000167468 "Glutathione peroxidase 4" P36969 19 1103926-1106791 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Oxidoreductase, Peroxidase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008630, HPA047224, HPA058546" Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" 220000 "Nucleoplasm, Mitochondria" "CAB008630: AB_1616685, HPA047224: , HPA058546: " "unprognostic (8.42e-3)" "prognostic favourable (7.18e-4)" "unprognostic (8.14e-3)" "prognostic favourable (1.84e-5)" "unprognostic (1.00e-1)" "unprognostic (8.72e-2)" "unprognostic (2.53e-3)" "unprognostic (8.49e-2)" "unprognostic (2.69e-2)" "unprognostic (1.47e-1)" "prognostic favourable (7.72e-4)" "unprognostic (1.29e-1)" "prognostic favourable (8.61e-4)" "unprognostic (1.61e-2)" "unprognostic (2.20e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 163.0 76.4 63.3 27.1 73.7 33.3 102.3 33.5 83.7 53.3 49.1 42.4 33.8 56.9 27.2 74.7 35.6 38.4 46.9 64.4 54.2 60.2 75.3 119.0 44.7 41.7 74.6 47.3 47.1 35.1 33.1 54.7 46.4 49.3 44.7 25.5 82.3 61.6 46.9 98.2 36.3 58.5 43.6 46.5 32.4 27.7 170.4 36.5 29.9 52.8 49.8 39.2 51.2 47.0 56.7 64.0 85.2 85.2 28.4 58.5 110.5 28.3 32.3 46.7 98.7 141.7 84.0 52.0 22.5 81.3 42.9 43.8 65.9 38.5 10.3 24.6 45.5 32.0 27.3 32.6 21.0 57.6 49.3 19.4 29.0 92.9 82.4 22.7 31.1 83.3 49.7 21.7 36.6 60.0 27.1 25.9 35.4 72.9 38.4 39.0 44.2 52.1 53.3 6.3 29.7 46.6 70.6 40.3 25.5 44.1 41.9 45.8 40.9 55.6 50.8 45.7 30.4 78.3 28.2 91.1 61.7 24.0 43.0 45.6 26.2 75.6 85.2 85.2 37.0 62.0 43.0 56.7 54.3 38.6 64.0 47.8 58.5 41.7 42.4 28.4 68.3 44.1 46.8 110.5 63.3 73.7 33.5 83.7 54.2 60.2 74.6 47.3 49.3 36.5 GRPEL1 "FLJ25609, GrpE, hMGE" ENSG00000109519 "GrpE like 1, mitochondrial" Q9HAV7 4 7058906-7068197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036647 Supported Supported Mitochondria 1900000 Mitochondria "HPA036647: AB_10672359" "unprognostic (6.13e-3)" "unprognostic (3.66e-2)" "unprognostic (1.92e-2)" "unprognostic (6.31e-2)" "unprognostic (9.77e-2)" "unprognostic (2.12e-3)" "unprognostic (2.17e-1)" "unprognostic (2.21e-3)" "unprognostic (1.51e-1)" "unprognostic (5.53e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-2)" "prognostic favourable (2.00e-6)" "unprognostic (9.61e-2)" "unprognostic (7.18e-2)" "unprognostic (2.81e-1)" "unprognostic (7.30e-2)" 14.7 35.8 11.5 7.3 10.8 20.7 11.4 10.6 15.2 7.9 9.9 9.3 8.5 8.9 7.8 8.8 11.4 8.7 7.6 22.8 10.9 11.6 22.6 46.8 8.1 9.0 12.5 10.9 10.9 12.9 9.6 7.7 11.0 14.8 8.3 9.9 7.2 9.1 8.5 38.0 10.2 10.4 8.4 11.4 17.2 10.7 14.2 11.7 8.1 9.4 15.8 10.7 11.2 8.3 17.6 22.9 24.8 16.8 15.8 21.5 15.8 9.9 9.4 5.4 10.7 10.6 8.9 6.7 13.2 10.6 15.0 11.1 16.6 13.1 21.6 8.9 10.1 10.2 21.5 15.1 17.6 5.2 13.5 23.1 8.6 17.9 12.3 23.3 11.8 8.8 20.1 13.2 16.0 13.1 13.5 9.1 17.5 10.1 18.3 28.9 8.1 31.5 12.4 20.4 9.0 14.9 10.5 15.4 7.5 10.4 10.3 11.2 9.2 13.6 11.2 10.0 6.2 14.2 22.9 9.8 14.0 14.6 13.6 15.2 7.9 6.3 16.0 24.8 15.3 16.8 21.5 17.6 16.7 17.3 22.9 12.8 21.4 16.4 5.5 15.8 13.4 13.9 16.3 15.8 11.5 10.8 10.6 15.2 10.9 11.6 12.5 10.9 14.8 11.7 GRPEL2 "DKFZp451C205, FLJ23713, Mt-GrpE#2" ENSG00000164284 "GrpE like 2, mitochondrial" Q8TAA5 5 149345430-149354583 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018173, HPA023211" Uncertain Enhanced Mitochondria Mitochondria "HPA018173: AB_1850358, HPA023211: AB_1850360" "unprognostic (3.13e-2)" "unprognostic (1.69e-1)" "prognostic favourable (3.87e-5)" "prognostic unfavourable (2.21e-4)" "unprognostic (3.22e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (6.16e-8)" "unprognostic (1.34e-1)" "unprognostic (8.16e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.20e-4)" "unprognostic (3.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.20e-1)" "unprognostic (2.26e-1)" 7.4 5.1 5.4 6.5 6.4 5.3 9.8 10.9 8.9 13.3 4.8 3.7 3.9 6.0 5.4 5.8 43.1 5.1 4.3 6.3 5.5 5.6 7.5 5.7 10.2 8.1 5.1 5.2 7.5 6.8 7.2 6.5 8.5 8.4 5.1 4.8 3.7 7.2 6.7 7.8 5.4 5.8 4.3 4.4 5.9 6.1 4.9 5.1 7.4 7.9 14.4 12.8 6.1 11.5 3.5 3.8 8.2 2.5 3.7 13.5 4.6 9.0 4.9 7.1 25.5 4.5 4.7 14.3 8.0 6.8 7.8 11.0 12.0 6.1 9.4 8.5 4.2 7.0 11.3 11.7 10.0 5.0 9.5 11.9 9.4 6.8 13.6 11.1 6.0 6.9 14.4 9.7 15.2 4.7 10.3 23.2 5.8 6.4 7.2 9.5 9.4 17.9 9.1 9.9 12.4 5.0 8.4 14.7 12.2 8.1 15.0 23.9 13.1 13.3 5.3 8.5 9.4 6.1 11.8 8.6 11.4 9.1 8.6 16.2 7.7 8.2 2.5 3.3 5.1 2.4 6.2 3.5 7.7 5.7 3.8 1.9 10.3 7.7 1.9 3.7 2.5 1.0 13.5 4.6 5.4 6.4 10.9 8.9 5.5 5.6 5.1 5.2 8.4 5.1 GRSF1 ENSG00000132463 "G-rich RNA sequence binding factor 1" Q12849 4 70815782-70839945 "Predicted intracellular proteins" "mRNA processing, tRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036984, HPA036985" Enhanced Enhanced Mitochondria Mitochondria "HPA036984: AB_2675415, HPA036985: AB_10672785" "unprognostic (1.45e-3)" "unprognostic (1.82e-2)" "prognostic favourable (1.47e-5)" "unprognostic (8.63e-2)" "unprognostic (6.73e-2)" "unprognostic (4.15e-3)" "prognostic unfavourable (8.29e-5)" "unprognostic (1.94e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (7.68e-2)" "unprognostic (8.05e-2)" "prognostic favourable (2.72e-9)" "unprognostic (6.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-1)" "unprognostic (9.65e-3)" 17.9 33.4 21.3 22.3 19.9 8.8 29.0 19.1 42.5 16.8 22.7 19.7 15.0 18.1 17.2 18.2 21.7 18.9 22.9 33.3 22.9 22.6 23.9 23.6 23.7 24.6 24.8 20.2 17.3 26.9 19.6 13.7 18.3 23.6 17.7 27.1 12.0 32.1 20.9 101.8 18.7 17.2 18.1 24.1 17.3 22.5 13.6 19.1 37.0 19.7 31.1 21.7 21.1 15.4 5.7 20.0 7.6 11.6 14.3 11.7 5.6 31.9 21.8 25.7 26.7 27.3 31.9 36.9 38.8 24.6 29.3 24.1 22.2 32.9 46.2 29.7 39.9 12.2 45.4 30.3 39.3 25.1 14.9 24.3 22.4 30.7 33.7 35.5 14.0 26.8 29.2 29.6 20.6 30.1 27.8 26.9 40.7 34.2 58.3 25.0 27.4 23.1 24.1 40.0 19.6 36.2 40.0 26.8 24.2 18.3 52.2 64.0 22.6 17.4 27.5 27.4 29.0 22.6 24.4 22.4 17.8 29.7 22.7 23.1 26.7 7.6 11.6 5.2 7.6 8.8 9.5 5.7 11.2 11.7 20.0 4.9 11.2 9.5 1.6 14.3 10.5 19.3 9.3 5.6 21.3 19.9 19.1 42.5 22.9 22.6 24.8 20.2 23.6 19.1 GSDMC MLZE ENSG00000147697 "Gasdermin C" Q9BYG8 8 129748196-129786888 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2" "Cell line enhanced" "Detected in some" "A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5" "Group enriched" "Detected in many" 6 "cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "HPA023670, HPA024767, HPA026317" Supported Enhanced Mitochondria Mitochondria "HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008" "unprognostic (6.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.61e-3)" "unprognostic (4.23e-2)" "unprognostic (2.11e-2)" "unprognostic (4.22e-3)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (8.28e-2)" "unprognostic (7.51e-2)" "unprognostic (4.92e-3)" "unprognostic (5.71e-2)" "unprognostic (2.93e-3)" "unprognostic (1.87e-2)" "unprognostic (1.88e-1)" "unprognostic (8.66e-2)" "unprognostic (1.90e-1)" 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.2 25.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.4 0.0 0.0 14.1 0.0 0.0 0.2 25.0 0.0 0.0 0.0 0.1 0.1 19.2 17.5 1.4 5.9 0.3 0.3 1.2 0.1 0.4 0.3 0.0 8.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.3 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.1 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583595-67586656 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 298.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol 120000000 "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 24.2 25.3 20.2 23.8 21.7 46.2 39.5 15.5 19.8 51.8 51.9 23.5 125.4 35.2 43.5 41.9 181.6 60.8 51.1 45.3 18.3 23.5 44.2 5.9 61.0 39.4 25.5 19.9 33.4 60.7 44.1 33.8 57.9 46.0 37.0 17.9 59.9 50.2 110.8 33.7 58.5 34.0 30.1 22.8 25.1 48.5 15.4 15.4 29.8 91.6 131.5 75.6 40.8 79.5 25.3 191.4 12.4 168.2 70.1 40.7 167.2 68.1 93.0 45.3 70.5 35.1 39.6 41.9 29.8 40.0 45.6 35.5 170.8 71.7 0.1 68.4 47.1 99.7 122.4 131.2 12.9 47.5 44.5 3.3 67.7 0.0 52.1 22.4 39.9 49.1 298.4 36.3 35.1 68.3 73.9 19.0 35.6 0.2 51.3 62.5 86.7 39.9 47.9 7.6 0.2 72.5 0.2 15.4 44.0 41.8 13.6 135.0 0.2 37.7 36.8 21.0 53.4 44.0 21.6 11.8 73.8 25.0 23.9 37.1 43.6 2.3 168.2 12.4 40.7 125.7 15.0 25.3 18.4 33.3 191.4 24.3 15.3 27.3 7.0 70.1 79.4 76.2 18.3 167.2 20.2 21.7 15.5 19.8 18.3 23.5 25.5 19.9 46.0 15.4 GTPBP3 "FLJ14700, GTPBG3, MSS1, MTGP1, THDF1" ENSG00000130299 "GTP binding protein 3, mitochondrial" Q969Y2 19 17334920-17342735 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042158 Approved Supported Mitochondria Mitochondria "HPA042158: AB_10964400" "unprognostic (1.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (3.08e-3)" "unprognostic (1.34e-1)" "unprognostic (2.18e-2)" "prognostic unfavourable (1.86e-4)" "unprognostic (6.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavourable (2.81e-4)" "prognostic unfavourable (1.64e-4)" "unprognostic (4.94e-3)" "unprognostic (1.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.79e-1)" 8.0 13.8 8.1 12.0 14.7 10.0 9.3 11.7 12.6 9.6 8.2 7.4 9.8 12.5 10.2 6.9 13.0 9.8 12.4 7.9 11.3 10.7 9.2 13.7 7.5 13.4 7.8 11.6 11.3 12.3 14.8 11.0 8.0 11.4 10.6 7.2 10.3 13.2 15.6 14.3 22.9 10.6 8.6 6.7 13.2 11.0 3.5 6.3 16.7 9.2 10.9 16.2 8.5 10.0 6.6 9.3 1.3 4.4 6.3 7.3 3.7 9.1 5.5 5.1 6.6 1.7 1.6 25.0 4.3 1.8 4.0 3.9 7.6 7.4 13.9 11.1 1.6 8.2 6.5 3.7 3.2 11.5 30.2 8.4 8.0 9.9 2.2 8.9 5.5 1.7 5.4 3.7 4.8 3.1 15.8 6.3 2.0 7.2 10.6 7.9 10.8 24.8 12.7 4.0 13.1 3.6 4.2 12.0 10.7 4.6 7.2 5.9 6.3 3.7 3.4 6.2 5.5 13.6 7.6 10.7 16.6 16.8 4.8 11.7 4.7 0.5 3.1 0.6 7.1 4.4 5.8 4.5 6.5 6.1 4.8 6.6 7.3 6.8 1.3 6.3 2.4 9.3 4.4 3.7 8.1 14.7 11.7 12.6 11.3 10.7 7.8 11.6 11.4 6.3 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990918-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria Mitochondria "HPA034831: AB_10671506, HPA058631: " "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favourable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 7.5 9.3 7.4 7.3 7.8 9.5 7.3 8.5 10.1 7.1 11.9 9.2 8.3 8.0 8.3 5.2 12.2 6.4 7.4 20.0 7.6 7.6 12.2 8.2 6.2 13.2 7.6 8.3 10.4 12.1 13.0 12.1 9.3 9.5 8.2 9.3 6.6 9.6 5.2 25.3 6.5 11.8 7.4 11.7 9.3 9.1 22.7 8.9 25.4 13.4 14.3 10.2 9.6 8.0 6.7 12.2 6.7 7.0 11.9 15.8 7.8 19.2 8.8 11.7 13.1 7.1 12.4 9.3 13.3 11.6 13.7 17.1 15.4 8.3 12.6 7.9 7.3 13.2 15.5 12.9 15.8 5.6 10.8 34.5 8.9 8.0 6.8 22.0 8.5 9.8 9.3 7.5 5.4 12.6 12.2 15.0 13.2 7.6 14.0 10.8 24.0 16.7 12.0 10.7 8.0 9.6 12.2 13.5 13.7 10.8 8.5 17.7 9.6 15.0 7.5 10.0 14.8 3.6 12.4 9.8 12.8 17.7 10.0 18.3 11.0 6.7 7.0 4.5 10.4 4.6 9.1 6.7 11.9 10.0 12.2 5.9 15.8 10.3 1.0 11.9 3.9 5.8 8.2 7.8 7.4 7.8 8.5 10.1 7.6 7.6 7.6 8.3 9.5 8.9 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Supported Supported Mitochondria 8700000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 36.6 19.5 8.5 15.6 9.2 6.1 41.7 5.4 9.7 15.2 29.7 10.6 9.4 23.3 18.3 13.3 20.5 15.7 12.4 98.3 7.8 8.1 37.2 60.3 10.6 8.8 10.0 7.0 17.1 17.8 9.8 6.8 5.1 9.2 15.6 25.0 11.6 20.4 12.5 64.6 9.0 37.1 19.6 10.2 8.0 19.1 12.6 7.2 40.9 16.1 38.0 13.1 14.2 10.6 18.6 22.6 5.6 10.7 20.2 13.0 8.9 8.8 8.3 18.0 13.1 43.3 13.9 8.7 13.0 19.4 14.2 14.0 5.9 16.7 50.4 7.0 10.7 11.9 23.9 18.1 15.7 15.4 12.5 11.7 15.9 13.2 6.9 24.7 5.5 14.5 9.7 10.0 9.2 9.5 14.5 26.8 16.0 16.1 41.9 9.9 8.5 11.1 32.0 25.2 25.2 15.3 36.1 21.7 12.5 12.6 45.1 12.8 21.5 19.6 5.3 10.0 5.7 14.1 7.1 15.2 17.6 21.9 13.6 16.8 7.7 0.0 6.1 5.6 10.1 7.8 12.5 18.6 11.4 12.1 19.7 15.5 13.0 13.0 0.7 20.2 10.7 22.6 10.0 8.9 8.5 9.2 5.4 9.7 7.8 8.1 10.0 7.0 9.2 7.2 HADHA "GBP, LCEH, LCHAD, MTPA" ENSG00000084754 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" P40939 2 26190635-26244726 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015536, HPA056070" Approved Enhanced Mitochondria 2700000 Mitochondria "HPA015536: AB_1850473, HPA056070: " "unprognostic (2.02e-1)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (3.43e-1)" "unprognostic (2.67e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.16e-2)" "unprognostic (3.45e-1)" "unprognostic (3.81e-1)" "unprognostic (1.16e-1)" "prognostic favourable (3.68e-5)" "unprognostic (7.97e-2)" "unprognostic (1.71e-1)" "unprognostic (2.87e-3)" "unprognostic (2.64e-2)" 41.6 35.3 18.1 13.1 19.5 17.0 23.9 17.4 16.9 20.2 44.9 26.5 15.7 48.1 21.1 15.3 30.8 20.5 15.1 80.0 15.6 15.5 41.3 71.7 17.7 19.3 21.6 13.1 27.3 37.5 29.8 23.5 21.3 24.8 21.9 32.2 23.6 21.1 16.6 117.5 23.3 66.4 25.1 27.8 24.0 24.1 18.7 19.0 25.2 25.1 41.3 24.6 26.9 18.8 15.3 28.9 12.4 32.2 13.5 17.6 26.0 23.3 20.8 13.7 22.4 54.5 34.1 11.7 18.3 19.8 18.9 16.4 26.3 22.7 15.4 12.0 32.1 14.9 24.0 35.5 17.1 34.5 29.4 23.1 22.1 43.8 18.8 29.1 17.0 34.8 23.3 26.8 26.9 31.6 31.4 31.3 24.3 28.6 12.7 32.6 11.7 40.2 11.7 29.6 33.1 21.6 28.2 9.7 19.3 21.5 22.4 24.8 11.9 28.2 28.9 11.0 16.3 16.4 13.4 10.3 20.3 27.4 17.1 34.5 13.2 8.1 27.7 12.4 12.3 32.2 14.8 15.3 14.2 15.0 28.9 11.2 16.7 15.3 7.4 13.5 28.0 11.0 17.6 26.0 18.1 19.5 17.4 16.9 15.6 15.5 21.6 13.1 24.8 19.0 HADHB MTPB ENSG00000138029 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta" P55084 2 26243170-26290468 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.0;skeletal muscle: 155.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037539, HPA037540, HPA066099" Enhanced Supported Mitochondria 1100000 Mitochondria "HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618" "unprognostic (5.15e-2)" "unprognostic (8.72e-2)" "unprognostic (8.21e-2)" "unprognostic (8.67e-2)" "unprognostic (7.70e-2)" "unprognostic (2.59e-2)" "unprognostic (7.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (2.03e-1)" "unprognostic (8.94e-2)" "prognostic favourable (1.37e-9)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (2.88e-1)" "unprognostic (9.68e-2)" 23.3 45.5 24.8 11.0 24.7 9.9 16.6 16.6 17.4 13.8 21.4 31.1 19.3 43.6 17.1 16.2 20.6 13.9 12.6 126.0 18.0 20.0 45.8 62.4 12.8 16.1 34.8 18.3 16.2 23.7 19.9 13.1 12.6 27.8 15.8 22.8 19.9 27.2 15.9 155.6 13.2 35.0 20.3 29.5 15.3 19.5 15.8 23.8 10.6 22.4 44.9 14.5 18.5 12.8 20.2 45.2 21.5 49.1 23.8 26.8 33.9 22.7 18.0 12.6 22.5 77.7 43.0 12.7 19.2 29.4 19.8 19.4 21.5 22.2 11.4 13.5 31.4 18.0 20.9 27.1 24.3 25.7 18.2 26.2 10.7 42.0 33.3 21.1 20.1 41.6 44.8 20.5 33.5 36.6 21.9 18.5 41.2 16.7 11.8 40.8 8.7 19.6 13.1 41.6 21.7 40.7 32.4 6.0 20.7 32.9 37.5 50.4 23.2 37.8 25.3 18.7 19.5 17.5 13.8 13.9 20.9 20.1 21.5 33.8 18.5 21.0 49.1 18.9 14.2 43.4 18.1 20.2 19.3 17.6 45.2 14.8 18.0 16.3 21.5 23.8 33.2 15.3 26.8 33.9 24.8 24.7 16.6 17.4 18.0 20.0 34.8 18.3 27.8 23.8 HAX1 "HCLSBP1, HS1BP1" ENSG00000143575 "HCLS1 associated protein X-1" O00165 1 154272511-154275875 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055141, HPA075289" Approved Supported Mitochondria Mitochondria "HPA055141: , HPA075289: " "unprognostic (1.32e-1)" "unprognostic (2.68e-1)" "unprognostic (9.50e-2)" "unprognostic (6.93e-2)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (2.20e-1)" "unprognostic (9.09e-3)" "unprognostic (3.09e-2)" "unprognostic (8.91e-2)" "prognostic unfavourable (1.34e-5)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.96e-1)" 24.0 25.4 28.6 16.0 33.9 12.2 29.2 15.1 36.6 24.9 24.8 21.9 22.9 18.6 20.2 42.7 27.7 24.5 20.2 59.5 24.7 26.3 32.1 61.7 17.3 20.3 25.8 20.3 29.3 47.8 21.0 35.2 18.4 23.5 26.1 25.0 26.6 52.0 26.3 90.4 17.8 27.8 25.1 22.6 23.2 23.9 31.3 17.0 23.8 32.4 45.8 27.7 27.0 18.6 39.1 34.9 59.1 39.6 30.9 51.8 42.8 20.4 17.5 14.9 32.5 18.4 20.6 24.1 19.5 32.0 41.4 38.5 23.2 23.0 29.8 28.3 33.0 17.7 34.0 27.0 32.0 30.5 25.5 14.5 14.4 20.0 41.0 30.2 31.5 19.1 49.9 31.1 37.3 23.0 28.3 44.6 26.6 49.3 30.2 25.0 16.4 38.4 21.5 10.9 57.3 21.8 11.5 22.8 22.8 17.4 42.3 58.9 34.9 83.4 11.4 17.2 23.2 18.0 26.8 52.0 54.2 55.9 26.2 27.9 28.4 58.3 28.4 59.1 34.2 33.5 39.1 39.1 43.1 38.7 34.0 38.2 51.8 41.2 17.2 30.9 39.6 34.9 50.8 42.8 28.6 33.9 15.1 36.6 24.7 26.3 25.8 20.3 23.5 17.0 HCCS "CCHL, MLS" ENSG00000004961 "Holocytochrome c synthase" P53701 X 11111301-11123078 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002946 Approved Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA002946: AB_1079041" "prognostic unfavourable (8.69e-5)" "unprognostic (6.89e-3)" "unprognostic (8.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.34e-1)" "unprognostic (5.44e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (9.18e-2)" "unprognostic (2.73e-1)" "unprognostic (2.52e-2)" "unprognostic (2.10e-2)" "unprognostic (1.60e-1)" "prognostic favourable (6.17e-8)" "unprognostic (2.66e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.93e-2)" 10.6 14.2 8.8 9.0 12.7 11.8 9.6 11.0 17.7 6.7 15.5 7.4 8.0 17.2 8.5 5.5 15.8 6.9 9.8 36.9 8.4 8.3 15.9 19.0 9.5 10.1 8.2 11.1 10.0 11.4 11.5 10.0 12.8 10.6 7.8 15.2 9.3 12.8 8.0 41.6 13.8 14.4 10.4 6.3 12.3 12.2 10.5 6.0 10.3 10.8 16.4 11.8 11.4 17.3 18.1 28.4 13.3 29.7 8.4 11.1 8.7 23.2 26.8 12.5 12.0 11.8 11.4 13.3 23.5 17.9 29.7 25.5 31.1 17.0 14.5 12.1 18.8 21.6 25.9 22.4 29.0 13.5 20.3 14.5 34.4 15.5 20.9 15.8 17.7 11.1 17.5 28.2 19.3 21.0 26.8 16.8 19.9 31.5 11.4 12.8 22.7 29.0 11.2 25.2 28.4 20.0 18.3 9.1 10.7 23.4 25.5 15.0 19.7 11.4 20.6 19.3 10.4 49.2 20.0 12.4 12.6 19.2 15.5 12.7 18.4 10.1 22.5 13.3 9.9 29.7 9.5 18.1 9.7 8.9 28.4 15.5 8.5 11.1 6.2 8.4 24.8 25.9 10.4 8.7 8.8 12.7 11.0 17.7 8.4 8.3 8.2 11.1 10.6 6.0 HCFC1 "CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF" ENSG00000172534 "Host cell factor C1" P51610 X 153947553-153971807 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018312 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA018312: AB_1850522" "unprognostic (2.05e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (2.64e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (4.31e-6)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "prognostic favourable (9.62e-5)" "unprognostic (1.45e-1)" "unprognostic (1.29e-3)" "unprognostic (1.99e-2)" "unprognostic (2.12e-1)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" 16.0 19.2 18.2 23.7 18.5 48.3 14.2 24.4 23.3 13.9 20.0 17.3 14.1 16.8 26.3 13.6 18.2 18.8 20.8 14.7 17.0 12.7 15.6 17.2 19.0 24.9 14.6 16.1 20.4 15.6 21.9 26.4 13.8 15.8 17.7 11.2 13.8 21.5 20.6 27.8 18.2 18.3 19.7 20.0 25.2 18.0 15.3 17.9 52.3 16.4 15.6 17.6 17.4 18.3 4.8 8.0 1.7 5.6 2.8 6.7 3.5 15.2 19.9 13.5 17.1 5.7 4.1 19.9 6.3 4.9 7.5 6.8 21.0 10.3 27.8 16.2 8.1 12.6 14.6 10.3 3.9 14.7 17.2 16.6 15.9 16.5 3.9 20.4 27.6 6.3 6.7 13.0 5.7 7.9 23.1 17.6 5.2 21.4 28.2 26.4 17.6 12.2 33.0 11.1 16.8 5.6 14.2 15.1 16.4 11.6 12.1 6.4 11.1 18.5 10.4 14.3 17.6 12.3 20.2 28.1 38.3 34.8 11.6 19.9 13.4 1.7 4.0 1.7 6.0 5.6 4.3 4.8 4.8 4.6 4.5 4.4 4.9 6.7 0.8 2.8 4.0 8.0 3.2 3.5 18.2 18.5 24.4 23.3 17.0 12.7 14.6 16.1 15.8 17.9 HEATR1 "BAP28, FLJ10359, UTP10" ENSG00000119285 "HEAT repeat containing 1" Q9H583 1 236549005-236604504 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046917, HPA062200" Approved Enhanced "Nucleoli fibrillar center,Mitochondria" 120000 "Nucleoli fibrillar center" Mitochondria "HPA046917: , HPA062200: " "unprognostic (2.61e-1)" "unprognostic (1.44e-3)" "unprognostic (6.26e-2)" "unprognostic (1.34e-3)" "unprognostic (7.18e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (5.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.80e-1)" "unprognostic (4.67e-3)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (8.08e-2)" "unprognostic (3.38e-1)" "unprognostic (3.27e-2)" "unprognostic (4.00e-2)" 14.1 11.0 9.2 14.7 11.3 15.2 13.8 15.0 13.9 10.7 10.6 8.6 8.3 7.6 15.9 9.4 14.7 12.5 8.1 9.4 10.0 5.8 9.9 13.2 10.6 16.5 12.9 6.9 15.8 17.2 13.5 12.8 10.5 11.6 11.1 10.8 8.2 12.6 9.5 12.7 14.5 11.6 13.1 6.6 16.1 11.5 20.3 13.2 18.3 12.0 12.8 17.9 12.7 12.8 9.9 5.9 1.8 4.5 6.4 10.0 2.4 14.5 17.5 9.2 13.8 12.9 14.5 20.6 11.7 7.6 13.5 12.1 17.5 12.4 23.9 13.3 10.8 17.7 20.8 12.6 18.4 12.0 24.0 16.9 12.4 14.9 11.6 30.2 11.0 11.8 11.4 20.5 17.7 15.5 38.3 8.1 13.4 7.8 14.3 8.3 36.6 7.2 16.0 13.3 22.4 8.7 14.7 8.6 19.2 14.2 10.2 12.1 12.1 11.4 14.7 13.6 12.9 17.5 29.0 15.4 19.1 28.3 12.2 17.0 20.3 1.8 3.6 1.1 7.3 4.5 6.6 9.9 7.2 7.9 4.3 8.1 10.0 9.4 0.5 6.4 4.3 5.9 5.9 2.4 9.2 11.3 15.0 13.9 10.0 5.8 12.9 6.9 11.6 13.2 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42784298-42804531 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 89.9" "Low lineage specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favourable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favourable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 27.7 30.4 50.1 15.5 43.4 9.6 20.4 20.3 56.4 18.3 63.8 25.2 10.8 35.2 15.7 24.8 36.7 13.5 18.8 68.6 43.2 43.3 45.9 78.4 15.3 16.0 54.4 35.9 12.8 12.8 14.7 29.2 17.2 50.9 24.4 67.3 21.8 16.6 26.8 34.9 15.0 28.4 22.8 58.8 13.0 31.6 14.7 20.7 8.9 28.1 30.6 16.9 20.1 25.0 11.9 89.9 25.9 26.6 12.3 18.8 30.1 26.9 15.2 33.7 27.6 86.3 51.6 32.8 36.4 29.9 35.7 32.8 26.7 27.5 16.5 21.9 31.8 16.3 27.0 40.2 44.7 23.7 29.8 51.0 27.2 49.4 39.4 29.2 24.0 53.5 44.2 27.4 38.2 31.3 50.3 17.7 49.8 11.0 16.1 10.7 28.2 36.9 13.2 23.9 11.7 88.2 67.0 14.2 18.5 32.0 24.2 34.4 24.3 22.1 27.4 21.1 19.2 59.1 37.6 16.5 34.0 34.1 27.8 31.2 16.3 16.9 14.7 25.9 15.4 22.7 13.7 11.9 15.1 15.1 16.3 8.5 12.9 15.3 14.9 12.3 26.6 89.9 18.8 30.1 50.1 43.4 20.3 56.4 43.2 43.3 54.4 35.9 50.9 20.7 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388747-176389771 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA042715: " "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavourable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 37.2 38.5 31.4 33.5 36.0 34.9 37.5 21.4 33.2 26.8 43.8 22.5 29.7 36.7 25.7 31.1 47.0 31.5 39.4 80.0 28.5 26.6 46.3 56.1 30.1 54.1 30.3 20.0 33.2 42.6 36.6 28.8 26.4 21.0 41.2 30.9 31.2 64.0 32.6 115.9 27.8 38.1 43.3 25.9 37.3 31.6 28.8 15.0 63.1 42.3 53.8 34.3 42.1 28.7 70.4 104.6 25.5 107.7 31.1 67.6 88.9 17.6 31.2 18.6 31.6 19.6 37.4 48.9 11.1 21.2 32.4 40.8 32.5 37.3 32.1 27.1 20.2 22.7 28.2 49.8 13.0 75.2 44.3 15.8 32.1 44.5 27.5 24.6 43.1 47.4 41.4 18.2 22.2 27.2 17.5 64.7 23.7 58.2 28.0 31.4 22.0 34.2 27.2 13.9 58.1 50.6 29.4 19.6 26.2 12.7 53.6 54.5 32.0 41.6 17.0 22.1 22.9 20.3 23.1 30.1 35.9 26.1 28.6 44.2 13.8 25.5 84.5 23.8 46.3 106.5 45.8 70.4 64.9 53.5 104.6 52.2 59.6 55.6 14.4 31.1 107.7 68.6 67.6 88.9 31.4 36.0 21.4 33.2 28.5 26.6 30.3 20.0 21.0 15.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: " "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.8 0.7 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 HINT2 ENSG00000137133 "Histidine triad nucleotide binding protein 2" Q9BX68 9 35812960-35815354 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020961, HPA059109" Supported Enhanced Mitochondria "Intracellular and membrane" 1100000 Mitochondria "HPA020961: AB_1850715, HPA059109: " "unprognostic (9.64e-3)" "unprognostic (1.53e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (3.97e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.66e-4)" "unprognostic (3.71e-3)" "unprognostic (2.87e-2)" "prognostic favourable (2.97e-9)" "unprognostic (4.29e-2)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (1.72e-1)" 18.4 27.2 16.0 14.5 15.5 10.3 15.6 9.5 16.5 10.0 16.4 11.0 26.1 15.3 8.9 24.1 12.6 14.4 21.7 33.7 13.3 13.3 34.8 68.7 15.2 14.2 15.3 13.6 6.8 30.8 21.0 14.1 12.8 12.5 10.8 16.4 12.2 20.2 31.0 30.9 10.3 15.8 17.0 12.3 11.3 16.7 10.3 8.2 16.8 14.9 29.8 11.8 10.4 7.5 24.6 62.0 7.8 20.3 15.1 25.5 18.5 9.7 26.8 16.7 16.1 10.7 9.0 11.0 9.2 13.8 15.1 16.7 17.6 10.9 12.7 10.7 8.8 9.8 7.6 14.4 16.0 27.7 13.8 13.9 23.4 15.8 24.8 7.8 14.0 10.0 13.2 14.4 23.5 11.7 8.1 41.5 12.0 20.8 19.5 9.8 7.4 46.2 19.7 11.1 17.5 21.6 7.6 13.3 15.9 12.0 14.9 16.0 16.1 15.1 5.3 8.1 12.8 10.5 11.6 36.1 40.1 18.3 18.0 10.8 12.7 7.8 20.3 1.1 18.5 14.3 16.7 24.6 19.9 18.5 28.6 23.8 15.4 15.9 1.9 15.1 13.0 62.0 25.5 18.5 16.0 15.5 9.5 16.5 13.3 13.3 15.3 13.6 12.5 8.2 HK1 ENSG00000156515 "Hexokinase 1" P19367 10 69269984-69401884 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycolysis, Immunity, Inflammatory response, Innate immunity" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007043, HPA007044, CAB010052, HPA011956" Supported Supported Mitochondria 16000000 Mitochondria "CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049, HPA011956: AB_1850758" "unprognostic (8.80e-2)" "unprognostic (1.78e-1)" "unprognostic (2.03e-1)" "unprognostic (2.00e-3)" "unprognostic (1.15e-2)" "prognostic unfavourable (3.39e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-3)" "unprognostic (1.12e-1)" "unprognostic (1.37e-3)" "unprognostic (7.25e-2)" "unprognostic (1.40e-2)" "unprognostic (2.00e-3)" "unprognostic (3.86e-2)" 17.5 10.5 21.1 19.9 30.4 23.5 15.8 40.0 48.6 16.6 16.9 10.1 7.6 6.3 13.5 9.4 44.8 15.2 12.6 61.6 19.8 23.3 10.8 4.4 17.2 14.3 19.8 31.3 9.0 4.6 12.5 14.7 22.6 31.3 25.5 15.4 21.2 21.5 26.8 62.1 30.7 8.6 25.6 9.7 13.3 20.3 28.9 10.6 18.9 33.6 32.6 23.0 25.8 23.1 11.4 25.5 17.8 39.3 8.9 23.0 29.6 17.4 9.9 13.3 12.7 14.9 11.2 8.5 17.4 45.8 23.3 25.2 2.9 1.9 1.2 13.8 29.1 15.3 12.4 38.9 22.3 11.6 9.7 43.4 10.6 0.2 17.0 0.8 32.9 16.9 22.7 33.3 74.5 24.1 72.3 9.2 31.9 28.9 5.0 2.2 20.4 44.3 7.7 8.1 0.1 16.1 20.6 13.7 16.1 19.9 38.7 11.5 21.1 2.8 24.7 34.8 15.9 19.1 24.2 11.0 7.2 3.0 45.1 22.8 10.0 17.8 27.3 13.4 14.0 39.3 23.0 11.4 16.2 15.8 25.5 6.8 14.5 11.5 6.6 8.9 39.3 2.9 17.8 29.6 21.1 30.4 40.0 48.6 19.8 23.3 19.8 31.3 31.3 10.6 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220303-69267559 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 77.4" "Cell line enhanced" "Detected in some" "A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.3;T-reg: 6.6" "Lineage enriched" "Detected in single" 29 "T-cells: 8.3" "Region enhanced" "Detected in some" "cerebral cortex: 12.2" "Low region specificity" "Detected in all" "HPA011956, HPA064198, HPA064230" Approved Enhanced Mitochondria Mitochondria "HPA011956: AB_1850758, HPA064198: , HPA064230: " "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.2 0.0 0.9 1.2 1.6 0.0 0.2 0.8 1.4 0.5 29.8 0.5 0.2 29.9 0.5 1.0 0.3 2.5 11.2 0.2 0.5 0.6 15.6 4.6 1.3 0.3 0.3 0.2 1.0 4.7 0.0 0.5 0.2 0.4 0.2 2.3 12.0 0.2 0.2 0.2 0.0 77.4 0.2 0.2 0.2 0.4 0.6 0.2 0.2 5.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 8.3 1.6 0.4 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.9 41.4 0.0 12.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.1 1.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.7 0.0 4.4 1.4 0.0 0.0 8.3 3.2 0.0 0.2 0.0 0.0 6.6 1.6 0.9 1.6 0.8 0.4 0.5 0.6 0.3 0.2 0.4 0.2 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119747996-119768905 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 257.0" "Cell line enriched" "Detected in some" 16 "RT4: 66.2" "Cancer enhanced" "Detected in many" "liver cancer: 441.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Supported Mitochondria 820000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favourable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favourable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favourable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 0.3 0.1 0.3 8.7 0.3 0.0 20.6 0.3 0.3 0.3 30.8 0.4 0.3 13.8 0.3 0.3 0.7 0.1 4.4 42.0 0.4 0.0 7.4 257.0 0.8 0.3 0.3 0.3 0.3 1.4 0.0 0.3 0.8 0.7 3.8 19.8 18.9 5.1 0.3 1.4 1.8 12.2 1.9 0.3 0.3 8.1 6.1 0.3 0.4 0.3 0.6 2.1 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 66.2 0.0 0.2 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.3 0.7 0.3 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell line enhanced" "Detected in some" "BEWO: 46.3;HL-60: 13.1;NB-4: 16.3;SK-BR-3: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Mitochondria Mitochondria "HPA031997: AB_10602909, HPA057346: " "prognostic favourable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favourable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 46.3 0.6 0.0 0.8 0.1 11.5 3.0 2.3 0.1 0.5 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.0 0.0 0.3 13.1 0.3 0.5 0.1 0.4 0.0 0.9 0.0 2.1 0.1 5.7 8.4 16.3 0.2 0.0 2.5 0.0 7.6 0.1 0.1 9.1 0.6 5.8 29.3 4.5 0.0 2.4 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.2 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: " "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favourable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favourable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.2 6.3 2.6 3.4 10.5 3.3 3.8 6.6 4.8 4.5 4.9 10.0 19.4 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 7.8 5.6 9.3 4.0 13.5 3.0 6.1 6.0 14.8 5.9 7.7 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 6.0 4.0 4.1 14.1 7.3 13.3 6.2 13.1 10.6 9.1 9.8 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Approved "Vesicles,Intermediate filaments,Mitochondria" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: " "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favourable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.5 30.2 10.3 11.0 7.9 7.6 7.3 6.8 9.1 4.8 7.3 9.7 11.6 13.0 6.4 3.9 16.3 6.3 14.5 2.4 10.0 5.6 4.3 16.5 11.5 8.6 10.1 6.1 10.6 12.7 8.3 10.8 11.5 14.6 17.9 13.9 18.7 8.6 15.3 6.8 18.4 10.6 4.3 8.7 6.2 14.2 10.8 18.0 2.9 19.7 18.0 5.1 9.2 10.3 12.4 7.4 5.7 23.3 18.4 18.9 12.0 6.3 9.3 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112379937-112472410 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favourable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favourable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 31.0 26.3 18.3 5.8 17.7 4.1 13.8 5.7 12.1 10.1 14.1 11.9 6.2 15.2 11.0 5.0 14.4 8.8 7.6 52.1 16.1 13.7 29.3 70.5 11.4 7.8 17.9 10.8 21.3 11.4 7.9 7.7 9.9 12.4 12.2 11.0 10.2 7.3 6.9 54.1 12.5 18.3 13.3 12.9 10.1 9.9 5.9 14.5 5.7 13.2 27.7 6.9 14.2 10.7 3.6 4.6 23.3 5.0 2.6 4.1 2.4 15.2 13.7 10.3 5.2 17.9 17.8 11.9 10.5 6.5 7.5 6.3 26.3 17.2 9.8 5.8 15.3 17.6 11.1 14.7 9.3 41.2 7.3 10.2 22.2 25.7 11.2 5.7 6.6 18.9 10.7 11.2 8.1 8.7 14.1 6.6 20.4 10.1 14.2 5.3 6.0 17.8 9.2 31.2 14.4 15.9 13.9 7.4 5.3 26.3 17.5 8.8 24.7 7.0 9.8 10.8 10.1 30.2 10.2 7.8 19.2 4.6 13.4 8.5 6.3 21.9 4.0 15.2 2.3 3.9 3.5 3.3 2.5 2.6 4.5 3.6 3.0 3.1 23.3 2.6 5.0 4.6 4.1 2.4 18.3 17.7 5.7 12.1 16.1 13.7 17.9 10.8 12.4 14.5 HSPA9 "GRP75, HSPA9B, mot-2, mthsp75, PBP74" ENSG00000113013 "Heat shock protein family A (Hsp70) member 9" P38646 5 138554882-138575444 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000898, CAB005219" Supported Supported Mitochondria 3100000 Mitochondria "CAB005219: AB_647720, HPA000898: AB_1079032" "prognostic unfavourable (2.93e-4)" "unprognostic (1.86e-1)" "prognostic favourable (4.53e-4)" "unprognostic (3.73e-2)" "unprognostic (2.33e-1)" "unprognostic (9.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (9.85e-2)" "unprognostic (2.53e-1)" "unprognostic (2.74e-1)" "unprognostic (1.31e-1)" "unprognostic (8.78e-3)" "unprognostic (1.02e-1)" "unprognostic (2.15e-1)" "unprognostic (3.27e-2)" "unprognostic (2.29e-1)" 26.4 76.4 30.9 22.1 33.2 39.8 27.7 24.3 39.5 20.0 28.7 30.4 24.0 27.8 23.1 29.7 28.5 19.1 19.3 55.0 28.2 32.5 59.9 117.7 20.5 22.8 35.5 31.3 28.9 31.9 56.7 25.5 24.6 43.7 25.3 32.7 20.6 26.0 26.4 84.2 24.0 25.7 24.0 29.3 24.6 27.7 18.6 32.0 21.1 41.0 32.8 29.1 23.7 33.1 19.3 24.1 6.6 20.9 20.5 28.3 23.3 32.7 41.5 23.7 45.4 24.9 16.3 48.8 34.8 30.9 39.1 42.6 79.1 35.0 62.8 47.8 25.8 27.8 63.1 46.6 54.3 31.5 30.9 34.6 37.3 52.7 67.3 34.8 38.5 27.7 70.8 43.1 97.4 18.5 43.2 54.1 30.8 40.2 36.5 30.0 34.7 34.5 41.0 34.3 48.6 43.9 47.3 28.5 21.7 40.3 64.2 131.7 36.9 40.9 17.7 38.4 24.3 32.0 55.1 66.8 47.8 63.2 47.3 61.5 38.2 6.6 16.9 6.5 24.0 20.9 28.3 19.3 20.6 23.0 24.1 14.1 23.0 22.8 3.9 20.5 20.6 14.1 18.2 23.3 30.9 33.2 24.3 39.5 28.2 32.5 35.5 31.3 43.7 32.0 HSPD1 "GroEL, HSP60, SPG13" ENSG00000144381 "Heat shock protein family D (Hsp60) member 1" P10809 2 197486581-197516737 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, Isomerase" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 162.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001523, CAB002775, HPA050025, CAB072816" Supported Enhanced Mitochondria 53000000 Mitochondria "CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995" "unprognostic (2.79e-2)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.59e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (2.25e-4)" "unprognostic (3.51e-2)" "unprognostic (9.91e-2)" "unprognostic (8.63e-3)" "unprognostic (3.47e-2)" "unprognostic (7.83e-3)" "unprognostic (5.64e-3)" "unprognostic (1.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (4.10e-2)" 28.5 125.2 28.7 23.4 31.8 21.0 55.9 18.2 24.3 17.4 30.3 17.8 23.3 28.9 17.5 18.5 27.2 25.3 16.3 24.0 24.2 27.8 67.1 147.5 22.4 25.3 35.5 16.1 30.2 50.6 32.5 25.9 27.1 33.6 25.9 37.2 11.9 17.6 21.0 36.4 13.7 32.0 23.6 32.4 22.7 25.2 10.9 35.8 22.7 38.7 29.4 30.3 33.3 162.6 25.6 30.3 6.2 29.3 23.1 33.5 22.2 40.4 49.8 41.8 37.5 28.7 30.0 60.8 42.2 22.3 50.8 37.3 167.0 24.4 123.1 55.1 22.0 41.4 163.6 46.5 72.1 30.2 65.6 87.4 80.6 193.3 27.0 96.8 27.5 33.9 54.0 45.0 79.4 39.8 107.6 48.3 37.3 51.8 60.1 98.0 82.6 104.2 72.3 51.6 88.9 53.4 42.3 54.8 31.0 42.3 45.8 54.1 31.7 57.5 17.7 31.6 43.8 40.6 66.6 27.1 59.6 102.2 37.1 58.5 33.9 4.5 19.7 5.3 15.5 29.3 28.8 25.6 25.0 21.8 30.3 21.0 33.5 29.0 6.2 23.1 25.8 20.2 19.7 22.2 28.7 31.8 18.2 24.3 24.2 27.8 35.5 16.1 33.6 35.8 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58318574 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066812 Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA066812: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.9 8.9 9.0 6.6 13.9 6.9 9.4 17.0 11.5 7.4 9.2 6.4 7.1 11.3 8.6 8.5 9.4 7.8 7.1 15.9 7.9 9.3 12.1 16.2 6.9 8.2 8.5 10.7 11.0 12.9 8.8 14.2 6.7 7.8 9.6 10.1 9.7 9.2 9.4 35.2 7.2 9.7 12.6 6.0 9.7 8.6 9.8 6.4 6.8 10.7 19.8 9.2 7.8 8.1 23.9 21.6 23.7 20.4 21.3 26.5 13.5 8.0 6.1 9.4 6.7 8.0 9.0 12.1 11.5 8.7 14.3 12.6 13.4 6.1 16.0 3.4 8.3 7.1 15.8 10.4 14.8 8.9 11.0 9.6 13.6 11.3 8.7 12.6 9.1 11.1 10.7 15.2 9.2 12.5 9.4 15.2 9.0 4.7 8.1 6.4 12.2 14.0 5.7 6.0 11.4 9.6 11.9 5.9 8.8 7.1 6.6 13.1 8.9 11.1 7.3 12.2 8.6 11.0 14.0 11.6 20.9 12.5 9.8 9.4 7.4 13.5 17.3 23.7 18.7 20.4 20.1 23.9 18.7 23.5 17.5 23.8 26.5 20.2 18.4 21.3 16.7 21.6 13.4 13.5 9.0 13.9 17.0 11.5 7.9 9.3 8.5 10.7 7.8 6.4 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529377-74533348 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria Mitochondria "CAB004004: AB_326421, HPA006602: , HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 16.4 12.7 10.6 14.9 11.3 18.9 12.9 10.7 17.7 12.3 12.8 12.6 9.7 12.6 12.9 6.9 10.7 10.6 9.0 12.9 11.6 8.7 13.1 11.4 11.3 13.2 10.8 11.9 18.7 12.9 10.5 9.0 10.4 13.5 11.6 5.5 10.2 13.1 9.2 17.6 9.0 12.6 11.8 9.1 17.3 11.8 13.9 12.6 12.2 16.8 12.6 9.3 10.4 15.2 12.9 9.4 5.9 8.1 5.5 7.8 7.0 7.9 4.9 5.7 4.9 7.9 3.2 15.2 6.9 3.6 4.2 2.4 9.1 3.5 7.2 5.4 3.9 9.0 6.7 7.9 1.1 16.2 13.4 14.4 4.7 8.0 7.4 6.7 10.6 3.8 5.3 7.9 6.7 5.2 18.9 10.7 3.1 5.2 12.4 14.2 4.7 14.2 8.5 16.1 7.9 3.4 3.2 6.6 7.9 3.7 8.5 13.2 3.9 6.6 3.7 7.3 9.0 14.7 15.4 13.1 4.3 4.7 6.3 10.7 5.8 5.9 8.1 4.8 7.3 6.2 7.8 12.9 7.3 6.2 9.4 11.6 6.3 6.4 3.2 5.5 4.7 6.6 7.4 7.0 10.6 11.3 10.7 17.7 11.6 8.7 10.8 11.9 13.5 12.6 IARS2 FLJ10326 ENSG00000067704 "Isoleucyl-tRNA synthetase 2, mitochondrial" Q9NSE4 1 220094102-220148041 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cataract, Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024212, HPA024594, HPA024596" Enhanced Enhanced Mitochondria 26000 Mitochondria "HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370" "unprognostic (2.15e-2)" "prognostic unfavourable (1.04e-4)" "unprognostic (2.42e-3)" "unprognostic (3.22e-2)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (1.78e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.24e-5)" "unprognostic (9.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.01e-1)" "unprognostic (2.16e-1)" "unprognostic (8.87e-2)" "unprognostic (6.27e-3)" 25.9 39.3 18.0 17.9 16.9 6.7 31.9 15.1 20.8 16.9 26.2 14.8 24.3 18.9 21.5 16.8 23.8 18.8 16.5 40.0 17.5 12.6 29.5 37.3 16.8 25.9 15.6 16.0 20.5 20.5 42.5 15.3 26.2 17.4 18.5 24.9 15.0 22.4 22.3 57.8 22.2 23.4 17.7 15.7 16.1 18.5 15.7 13.7 19.5 17.8 25.9 20.1 24.9 18.7 16.8 20.0 17.2 19.0 18.5 22.6 16.8 37.7 35.4 20.4 20.0 30.8 31.1 49.1 23.0 24.8 25.5 20.7 34.0 39.5 34.9 31.2 28.5 36.7 28.2 28.7 29.5 24.1 34.0 17.3 29.0 38.2 19.1 27.5 18.8 22.4 29.3 27.5 28.5 24.7 42.7 20.3 33.3 20.9 21.6 19.8 26.4 23.5 19.2 40.6 55.8 36.7 25.4 11.0 30.9 34.8 54.1 35.8 62.6 31.1 25.3 25.1 21.0 33.7 38.5 17.4 26.7 25.4 26.6 21.6 27.8 17.2 16.7 15.1 16.8 19.0 22.6 16.8 18.4 22.0 20.0 13.6 20.8 19.0 3.3 18.5 14.5 7.3 19.7 16.8 18.0 16.9 15.1 20.8 17.5 12.6 15.6 16.0 17.4 13.7 IBA57 "C1orf69, FLJ12734" ENSG00000181873 "IBA57, iron-sulfur cluster assembly" Q5T440 1 228165815-228182257 "Disease related genes, Predicted intracellular proteins" "Heme biosynthesis" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030555, HPA030556, HPA030557" Approved Supported Mitochondria Mitochondria "HPA030555: AB_2673522, HPA030556: , HPA030557: AB_10670433" "unprognostic (3.00e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-1)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "unprognostic (8.16e-3)" "unprognostic (1.03e-1)" "unprognostic (6.11e-2)" "unprognostic (7.01e-2)" "unprognostic (8.00e-3)" "unprognostic (2.87e-2)" "unprognostic (1.61e-1)" "prognostic favourable (1.71e-9)" "unprognostic (4.94e-2)" "unprognostic (5.02e-1)" "unprognostic (5.04e-3)" "unprognostic (7.14e-2)" 5.2 7.5 4.7 5.3 5.5 8.2 6.1 7.8 5.1 4.7 4.5 4.1 3.8 4.5 5.3 4.2 4.7 3.8 6.8 7.9 4.9 3.2 5.8 9.5 6.3 12.7 3.5 4.5 5.9 18.3 7.4 2.9 6.4 5.2 4.5 3.9 4.9 5.3 3.1 22.9 8.0 5.7 4.9 3.5 4.9 5.3 3.1 3.2 5.0 5.2 6.4 4.7 3.6 3.7 2.8 3.4 4.7 1.7 2.8 3.5 0.9 3.3 3.4 3.8 1.7 2.0 2.3 4.6 2.0 1.0 1.6 0.9 7.3 2.9 7.2 4.5 2.1 6.2 2.9 4.4 1.4 1.5 6.3 4.2 4.3 3.5 1.7 4.8 4.8 3.1 2.7 1.8 2.2 2.2 7.1 3.4 1.5 2.6 4.8 2.9 2.8 4.0 6.0 4.3 1.2 2.3 6.9 5.8 4.0 3.4 10.4 2.6 8.3 6.6 5.1 4.3 4.0 2.9 5.1 2.5 1.2 3.6 1.9 2.0 3.2 4.7 1.7 0.8 2.3 1.4 3.5 1.5 1.9 1.8 1.2 2.8 2.8 2.6 2.7 2.8 1.5 3.4 1.7 0.9 4.7 5.5 7.8 4.6 4.9 3.2 3.5 4.5 5.2 3.2 ICA1L "ALS2CR14, ALS2CR15" ENSG00000163596 "Islet cell autoantigen 1 like" Q8NDH6 2 202773150-202871985 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042507 Approved Supported Mitochondria Mitochondria "HPA042507: AB_10797016" "unprognostic (4.14e-3)" "unprognostic (3.60e-3)" "unprognostic (5.15e-2)" "unprognostic (5.63e-3)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (8.05e-4)" "unprognostic (1.66e-1)" "unprognostic (9.60e-2)" "unprognostic (4.50e-4)" "unprognostic (4.15e-1)" "unprognostic (8.15e-3)" "unprognostic (2.97e-2)" "unprognostic (1.74e-1)" "unprognostic (9.79e-2)" "unprognostic (1.58e-3)" 3.3 7.3 11.6 2.2 15.6 5.4 3.8 24.8 19.8 5.8 5.2 8.5 4.1 2.3 10.1 8.9 4.2 12.6 5.5 6.5 11.1 12.1 3.3 1.2 3.2 2.2 7.3 14.0 9.4 3.2 15.2 22.6 7.6 9.1 8.8 2.7 5.8 1.9 9.5 8.1 3.0 2.0 7.6 7.2 2.2 3.6 11.9 7.8 1.0 7.8 1.8 2.1 4.5 3.2 5.3 4.6 4.2 5.3 6.7 4.2 1.6 1.5 1.1 2.8 8.3 2.8 5.0 20.5 2.7 3.6 1.9 2.4 1.6 0.6 1.6 0.8 3.2 0.8 4.0 1.3 2.5 1.9 3.1 3.2 1.6 1.8 1.6 4.0 2.1 2.0 2.4 1.9 1.5 2.3 2.8 1.5 2.3 0.7 3.4 5.4 7.8 2.8 4.1 4.0 0.7 1.6 3.7 7.9 7.9 4.1 0.2 1.7 1.0 3.1 1.6 7.3 1.7 1.5 4.0 5.7 7.9 4.7 4.0 1.2 1.4 2.2 2.6 1.5 2.6 2.7 2.2 4.0 1.9 2.1 4.6 5.3 3.1 4.2 4.2 6.7 5.3 2.8 1.8 1.6 11.6 15.6 24.8 16.9 11.1 12.1 7.3 14.0 9.1 7.8 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial" P48735 15 90083045-90102504 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.2;skeletal muscle: 190.7" "Cell line enhanced" "Detected in all" "MOLT-4: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria 53000000 Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favourable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 5.4 2.0 14.9 10.1 16.6 22.6 8.8 4.9 19.1 6.4 16.2 13.8 12.4 16.1 5.9 15.3 23.7 6.0 9.4 126.2 10.2 9.3 25.0 93.2 6.9 15.8 14.4 12.0 3.0 25.1 8.4 3.3 15.1 11.9 13.3 14.5 6.0 28.0 21.9 190.7 11.0 13.9 15.8 11.0 7.5 27.9 1.2 7.6 28.2 3.4 69.0 13.6 11.0 8.6 16.8 32.8 17.2 56.3 22.2 29.5 31.2 10.2 5.8 30.2 30.0 4.2 5.2 25.7 12.8 19.5 12.1 13.0 2.7 8.9 12.2 3.6 10.6 3.5 4.4 3.9 5.8 23.9 2.9 20.8 2.2 20.3 5.1 14.2 21.1 10.8 2.2 2.9 2.3 24.8 3.1 10.5 9.3 29.8 68.3 22.1 9.0 2.4 57.9 21.7 36.3 18.7 12.3 43.6 22.1 15.9 63.6 5.1 51.3 43.9 5.9 21.7 3.1 2.8 5.9 17.3 3.2 1.4 6.9 30.0 12.5 9.0 26.4 17.2 26.1 48.0 12.4 16.8 18.7 29.5 32.8 9.8 10.2 18.2 5.1 22.2 56.3 17.8 15.9 31.2 14.9 16.6 4.9 19.1 10.2 9.3 14.4 12.0 11.9 7.6 IDH3A ENSG00000166411 "Isocitrate dehydrogenase 3 (NAD(+)) alpha" P50213 15 78131498-78171949 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 47.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041465, HPA062971" Supported Enhanced Mitochondria 2000000 Mitochondria "HPA041465: AB_10794377, HPA062971: AB_2684913" "unprognostic (2.33e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-3)" "unprognostic (2.26e-1)" "unprognostic (1.02e-1)" "unprognostic (4.01e-1)" "unprognostic (2.29e-1)" "unprognostic (6.47e-2)" "unprognostic (1.69e-2)" "unprognostic (2.30e-1)" "unprognostic (3.05e-1)" "unprognostic (1.42e-1)" "prognostic favourable (6.49e-8)" "unprognostic (1.40e-1)" "unprognostic (3.08e-2)" "unprognostic (4.49e-2)" "unprognostic (3.39e-2)" 14.6 18.1 18.0 13.0 25.3 6.5 7.7 16.1 29.5 9.9 17.6 11.9 6.1 24.5 11.2 5.9 12.0 8.4 6.5 41.5 16.6 16.8 15.2 10.4 8.8 11.0 20.6 18.1 8.0 9.2 18.5 12.4 8.4 29.0 10.1 18.8 10.4 11.2 11.9 47.7 11.1 23.8 11.9 18.1 10.1 8.9 11.5 13.8 16.2 8.1 26.5 16.4 11.1 10.3 10.1 47.2 6.1 17.0 5.5 6.0 7.4 15.9 21.9 4.0 13.9 10.0 10.2 8.7 19.0 9.3 15.5 11.8 15.5 9.7 34.0 14.1 11.1 24.1 36.9 14.7 14.4 14.9 12.2 13.1 23.7 7.0 8.5 25.4 18.8 7.7 9.1 15.1 15.9 9.7 16.8 14.0 9.8 15.2 18.6 6.8 4.9 8.2 10.8 17.0 10.6 12.9 21.7 15.9 6.1 21.8 31.2 17.6 12.4 13.8 10.0 18.3 17.0 24.1 30.6 16.0 35.6 18.1 12.9 24.3 14.3 4.2 9.4 2.7 5.3 17.0 5.7 9.2 5.2 4.8 14.2 10.1 5.6 6.0 6.1 5.5 16.6 47.2 5.6 7.4 18.0 25.3 16.1 29.5 16.6 16.8 20.6 18.1 29.0 13.8 IDH3B RP46 ENSG00000101365 "Isocitrate dehydrogenase 3 (NAD(+)) beta" O43837 20 2658395-2664219 "Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049387, HPA054180" Supported Enhanced Mitochondria Mitochondria "HPA049387: AB_2680740, HPA054180: AB_2682407" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.12e-1)" "unprognostic (2.43e-2)" "unprognostic (3.24e-2)" "unprognostic (6.83e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.76e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "unprognostic (1.39e-2)" "prognostic favourable (6.78e-8)" "unprognostic (8.89e-2)" "unprognostic (4.02e-2)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" 19.5 20.0 19.4 15.5 31.7 20.6 18.5 32.1 30.5 16.4 23.9 16.9 14.5 30.5 19.2 16.7 20.7 17.9 19.2 57.3 19.8 20.0 29.7 25.2 15.1 17.6 24.0 29.4 20.2 15.2 27.6 12.2 17.0 31.2 15.4 25.6 16.2 19.3 19.5 75.5 20.9 24.9 21.5 17.1 19.2 19.9 19.6 16.0 19.7 19.1 37.7 22.5 16.7 17.4 34.7 49.4 25.8 44.7 29.5 38.6 33.9 26.1 35.5 16.2 14.1 18.0 14.2 18.8 14.1 18.0 33.3 26.6 45.7 27.6 29.6 12.9 19.3 37.0 29.9 45.7 30.6 8.1 23.5 35.9 13.8 47.3 17.6 39.0 7.8 18.8 17.6 31.1 16.4 19.6 45.3 16.6 20.2 14.4 33.9 44.8 31.5 33.7 27.8 29.6 33.2 19.1 24.6 29.3 21.2 17.3 57.7 29.7 28.9 17.4 17.4 26.0 16.4 8.8 32.3 22.6 51.6 31.2 12.2 40.4 24.6 22.2 41.7 25.8 33.9 44.7 25.6 34.7 29.4 30.7 49.4 30.6 34.4 29.8 11.9 29.5 38.3 22.9 38.6 33.9 19.4 31.7 32.1 30.5 19.8 20.0 24.0 29.4 31.2 16.0 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favourable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 28.9 26.7 15.8 22.2 24.8 20.5 19.4 15.1 21.3 26.8 28.5 22.1 22.1 36.9 26.2 24.2 21.7 23.9 20.6 9.9 12.1 30.5 13.8 36.3 17.7 28.1 19.2 29.2 23.1 14.9 20.7 22.6 20.5 7.6 20.3 21.6 40.5 21.8 22.6 7.1 35.4 19.3 13.5 32.2 29.9 18.0 20.2 13.8 9.4 32.0 15.0 13.3 16.6 18.1 17.0 10.7 25.0 35.7 27.9 6.9 47.0 27.8 23.9 18.8 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327894-89340971 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 80.0" "Group enriched" "Detected in many" 4 "BJ hTERT+: 34.4;BJ hTERT+ SV40 Large T+: 80.5;BJ hTERT+ SV40 Large T+ RasG12V: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 80.0" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA059914: " "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavourable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 50.5 15.7 14.9 11.3 17.3 22.1 10.6 6.9 17.0 6.8 9.7 7.6 4.1 14.5 8.8 16.8 6.2 10.9 15.1 8.9 14.2 12.9 19.3 17.0 25.9 10.0 13.5 12.4 11.3 4.3 3.8 5.5 22.9 23.0 9.7 5.4 9.2 19.6 8.1 8.1 5.0 11.3 11.1 18.4 26.0 7.2 5.1 12.1 14.3 14.9 5.5 2.9 11.0 5.9 1.6 2.5 80.0 18.4 0.3 2.6 3.2 6.2 0.4 0.1 1.7 7.3 7.9 0.0 4.0 34.4 80.5 93.5 0.3 9.1 0.5 1.7 6.4 5.6 0.1 0.8 5.9 0.9 0.0 2.4 1.8 0.2 4.2 0.7 2.0 4.9 0.1 7.0 0.5 0.4 0.1 1.4 2.0 0.0 1.5 1.9 0.1 2.0 1.5 0.5 0.4 2.3 3.0 0.0 0.0 0.7 0.1 15.8 0.2 0.8 0.6 1.3 0.2 2.2 1.0 2.2 1.8 0.1 1.8 3.0 1.3 15.2 7.5 26.6 0.7 16.0 0.1 1.6 1.1 0.5 2.5 1.4 0.7 0.8 80.0 0.3 18.4 0.5 2.6 3.2 14.9 17.3 6.9 17.0 14.2 12.9 13.5 12.4 23.0 12.1 IMMT "HMP, Mic60, MINOS2, P87, P89" ENSG00000132305 "Inner membrane mitochondrial protein" Q16891 2 86143932-86195770 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022439, HPA036164, HPA036165" Supported Enhanced Mitochondria 240000 Mitochondria "CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980" "unprognostic (3.83e-3)" "unprognostic (1.56e-1)" "unprognostic (1.95e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (1.40e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (2.03e-4)" "unprognostic (5.66e-2)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (7.35e-2)" "unprognostic (2.21e-1)" "prognostic favourable (3.51e-6)" "unprognostic (2.06e-3)" "unprognostic (6.35e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" 20.0 36.9 15.6 17.0 23.5 15.3 15.4 17.5 27.1 13.6 24.8 16.0 15.4 25.1 16.5 13.6 19.1 13.9 12.3 67.3 15.1 18.0 37.5 35.1 14.3 17.7 18.4 18.8 13.3 23.1 31.4 17.6 21.6 32.2 12.8 26.3 17.3 16.7 21.2 78.6 15.4 25.6 17.9 12.1 20.0 22.0 28.3 15.0 29.1 16.2 38.3 19.9 18.0 14.1 10.9 21.5 7.6 21.6 13.2 16.1 14.4 34.0 33.7 30.5 14.0 29.8 27.5 31.2 24.5 25.7 33.2 30.2 48.4 27.1 52.3 24.6 25.9 25.4 39.1 35.4 40.7 21.1 31.9 41.3 21.3 57.2 30.3 39.8 28.4 31.4 25.8 31.2 37.4 37.4 40.2 29.8 32.0 29.3 39.6 41.6 36.4 26.9 26.5 65.4 47.0 37.8 38.7 37.2 27.6 25.1 38.2 37.4 21.7 28.3 28.0 23.9 26.3 34.5 30.4 23.7 29.9 35.9 27.2 47.6 28.9 7.5 18.6 7.6 16.1 21.6 14.6 10.9 14.4 13.3 21.5 8.8 13.1 15.5 2.5 13.2 19.9 11.1 14.9 14.4 15.6 23.5 17.5 27.1 15.1 18.0 18.4 18.8 32.2 15.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405795-40435947 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria 66000 Mitochondria Nucleoplasm "HPA041391: , HPA044250: " "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favourable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favourable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 12.3 32.0 15.4 13.2 20.6 6.7 24.3 14.4 18.0 12.7 13.7 20.5 23.3 12.3 11.8 16.6 8.9 17.2 22.7 30.4 13.8 16.1 28.9 71.9 14.2 10.4 16.1 15.9 19.4 18.9 19.5 23.9 7.4 16.3 21.0 13.0 14.4 11.8 31.9 30.6 3.5 9.8 13.7 14.7 11.0 14.4 11.2 15.7 8.6 55.7 12.2 9.0 11.2 7.9 11.6 34.1 14.3 29.8 14.7 13.5 8.6 8.7 5.3 9.6 17.3 15.4 13.5 0.4 13.5 13.1 17.3 10.7 19.7 7.6 0.3 25.7 16.9 10.3 18.4 19.8 10.6 12.5 14.8 22.6 15.4 18.9 27.0 9.2 22.5 20.5 6.9 9.6 20.1 17.0 1.0 1.1 15.4 13.7 11.4 14.2 8.1 16.8 16.7 13.3 10.4 20.4 23.6 16.5 9.2 18.5 40.4 8.1 34.7 40.6 14.5 14.3 9.4 10.1 10.7 21.8 14.9 0.3 13.5 9.1 14.1 5.8 10.2 14.3 13.5 16.1 12.6 11.6 7.5 11.4 22.3 9.9 8.4 11.7 1.3 14.7 29.8 34.1 9.7 8.6 15.4 20.6 14.4 18.0 13.8 16.1 16.1 15.9 16.3 15.7 KIAA0391 "MRPP3, PRORP" ENSG00000100890 KIAA0391 O15091 14 35121846-35277614 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA020459: " "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 13.9 26.1 18.8 17.6 20.1 12.5 17.5 23.1 21.9 17.4 22.4 20.6 15.6 16.6 13.0 19.4 26.1 14.7 13.2 16.7 17.6 16.3 31.1 29.5 20.9 29.5 20.2 17.7 10.8 16.5 29.8 27.4 13.4 19.2 14.1 24.9 15.8 18.0 21.8 22.2 23.0 16.5 15.0 23.0 18.7 15.8 17.1 20.9 31.2 18.9 21.3 24.8 18.2 16.0 10.0 9.7 10.9 5.4 12.1 25.5 12.4 22.7 18.1 12.6 16.7 13.9 16.4 11.1 15.3 13.8 19.6 17.0 17.2 14.1 25.0 19.9 14.5 17.6 23.2 26.5 22.1 19.6 7.2 11.2 14.0 36.7 14.3 13.8 12.3 17.5 20.4 18.5 17.1 28.4 18.1 7.3 23.9 25.7 20.9 15.2 13.5 18.0 20.0 21.0 14.5 27.5 23.3 11.8 13.3 19.8 22.0 12.7 32.0 11.4 21.5 15.1 13.6 11.7 13.1 7.9 18.5 26.2 7.7 15.0 15.8 10.9 5.4 3.4 15.4 5.2 22.4 10.0 23.8 16.6 7.2 7.0 21.2 15.6 6.3 12.1 4.3 9.7 25.5 12.4 18.8 20.1 23.1 21.9 17.6 16.3 20.2 17.7 19.2 20.9 L2HGDH "C14orf160, FLJ12618" ENSG00000087299 "L-2-hydroxyglutarate dehydrogenase" Q9H9P8 14 50237563-50312548 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065409, HPA069708" Approved Enhanced Mitochondria Mitochondria "HPA065409: , HPA069708: " "unprognostic (1.74e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-3)" "unprognostic (1.04e-2)" "unprognostic (4.33e-2)" "unprognostic (8.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (9.91e-2)" "unprognostic (2.84e-1)" "unprognostic (1.97e-1)" "prognostic favourable (9.75e-10)" "unprognostic (1.24e-2)" "unprognostic (5.88e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" 5.4 5.1 6.9 3.6 8.4 3.5 5.1 12.7 10.9 3.5 5.6 4.9 4.8 6.2 3.4 4.3 9.0 4.4 3.2 7.7 6.1 4.7 25.5 16.0 2.5 3.3 7.7 4.7 4.2 5.4 7.1 5.8 2.6 5.7 4.6 6.8 7.7 5.0 5.6 17.7 7.0 5.0 4.7 5.3 2.3 5.6 6.0 6.0 3.7 6.5 6.2 5.2 4.6 4.4 1.4 1.5 10.5 0.6 2.4 3.3 0.8 13.8 9.8 4.0 3.9 2.0 1.3 11.4 4.6 2.6 7.3 8.7 15.6 6.4 10.9 5.4 1.8 10.2 12.1 4.8 8.2 8.7 6.9 23.7 6.7 2.1 1.9 8.3 8.2 1.2 3.1 4.8 4.2 3.1 8.3 6.9 1.9 16.7 9.4 3.8 5.9 10.4 8.9 13.2 8.5 6.8 16.3 8.3 5.9 13.6 10.4 5.9 13.6 2.3 2.9 4.6 13.1 5.3 6.1 6.3 14.3 15.4 2.6 4.2 5.2 10.5 0.6 1.4 1.5 0.3 3.3 1.4 1.7 1.6 0.9 1.2 2.1 2.6 0.9 2.4 0.3 1.5 2.4 0.8 6.9 8.4 12.7 10.9 6.1 4.7 7.7 4.7 5.7 6.0 LACTB "FLJ14902, MRPL56" ENSG00000103642 "Lactamase beta" P83111 15 63121800-63142061 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protease" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036361, HPA036362" Supported Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA036361: AB_10672244, HPA036362: AB_10670798" "unprognostic (6.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.22e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.10e-2)" "unprognostic (8.08e-2)" "unprognostic (6.25e-2)" "unprognostic (8.98e-2)" "unprognostic (3.08e-1)" "unprognostic (6.22e-3)" "unprognostic (5.16e-3)" "unprognostic (6.28e-2)" "unprognostic (3.24e-1)" "unprognostic (8.64e-2)" "unprognostic (7.90e-2)" "unprognostic (3.88e-3)" 26.5 22.7 9.2 13.1 12.2 31.5 9.3 7.3 9.1 6.8 11.4 6.3 4.0 12.5 7.0 6.9 9.8 5.7 9.2 24.9 7.9 6.1 20.5 38.3 18.8 12.9 8.5 6.1 7.2 9.3 6.7 10.4 7.4 9.5 7.6 10.4 5.8 9.3 4.7 37.3 10.1 19.6 8.1 8.0 21.6 8.3 13.2 9.8 8.3 8.4 11.1 9.0 11.5 12.8 3.3 10.4 5.8 8.9 2.3 3.1 2.0 21.4 13.5 3.8 2.6 19.5 10.5 3.2 9.4 14.5 16.2 30.2 3.4 13.8 2.8 11.6 13.6 6.0 13.1 6.1 20.3 19.7 3.2 5.5 4.6 8.4 18.2 5.0 9.6 14.2 13.0 16.6 13.7 16.6 5.2 8.2 27.3 8.1 3.8 6.0 5.8 4.2 2.8 9.9 6.5 8.7 33.6 3.5 1.6 6.8 7.7 20.2 5.8 8.2 29.7 21.8 17.1 9.8 11.8 8.6 7.5 0.7 16.7 14.1 10.0 3.6 8.8 4.6 1.3 8.9 2.0 3.3 1.1 1.0 10.4 2.9 1.0 1.6 5.8 2.3 7.6 0.9 3.1 2.0 9.2 12.2 7.3 9.1 7.9 6.1 8.5 6.1 9.5 9.8 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388506-45549421 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: , HPA066085: " "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favourable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favourable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 9.6 14.3 18.8 9.6 21.8 6.7 8.1 11.9 17.9 9.2 14.8 13.1 8.3 9.6 9.8 8.9 10.4 11.2 8.4 14.2 14.6 13.6 18.9 17.2 7.0 10.3 15.7 9.5 10.2 8.2 20.0 14.0 10.6 12.3 10.8 15.3 10.0 8.7 9.8 14.1 7.8 8.8 11.0 8.8 10.0 8.9 7.3 11.8 16.1 10.5 8.3 12.8 11.3 7.8 5.1 5.9 2.4 3.3 8.4 6.0 3.7 6.2 7.9 9.2 8.7 8.4 9.5 9.9 9.8 10.1 18.3 13.7 14.0 8.8 13.0 8.4 11.4 6.8 34.2 20.5 13.9 11.4 8.6 14.1 12.8 13.5 8.8 20.4 5.2 12.3 12.7 17.5 9.2 11.4 21.9 7.4 11.4 6.9 14.6 7.5 23.0 14.6 8.3 9.2 14.5 16.3 15.2 7.3 9.1 15.6 8.8 8.1 14.0 12.0 10.0 11.2 8.3 9.3 11.7 5.8 10.6 13.9 13.2 13.9 9.9 0.6 2.8 2.4 6.0 3.3 5.8 5.1 4.4 5.4 5.9 4.0 4.8 5.4 1.2 8.4 3.0 4.5 3.9 3.7 18.8 21.8 11.9 17.9 14.6 13.6 15.7 9.5 12.3 11.8 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856247 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.77e-4)" "prognostic favourable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 16.9 15.3 11.9 11.2 13.1 9.9 16.8 17.3 19.9 6.7 23.7 10.0 7.5 20.3 8.5 6.9 22.0 8.1 15.0 18.9 10.2 10.2 16.2 20.4 9.4 10.7 10.6 10.5 9.5 19.7 13.0 8.7 7.6 10.7 8.2 16.3 9.2 9.7 7.2 17.2 18.5 19.4 8.0 7.7 10.6 15.6 12.6 9.0 50.7 10.9 19.9 16.6 8.0 9.7 5.0 14.7 3.8 5.6 6.7 7.1 2.1 12.1 20.6 6.4 19.9 9.9 7.0 11.5 12.0 5.9 12.1 9.5 19.0 13.5 20.0 8.6 12.6 12.3 16.4 17.0 7.5 13.3 17.1 20.5 16.8 13.6 12.9 20.7 16.9 11.3 12.2 13.8 12.3 10.4 26.9 12.6 8.3 13.3 29.9 23.7 16.8 23.8 17.2 9.0 11.7 9.5 16.9 16.4 14.5 13.7 17.4 7.2 16.3 10.9 15.6 13.9 8.3 11.7 20.0 11.0 16.9 16.0 12.3 18.1 11.1 3.8 4.5 2.1 7.1 5.6 7.0 5.0 6.0 6.1 4.7 4.6 4.0 5.9 0.7 6.7 5.3 14.7 4.6 2.1 11.9 13.1 17.3 19.9 10.2 10.2 10.6 10.5 10.7 9.0 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: " "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favourable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favourable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.5 5.1 7.7 12.8 8.2 9.2 16.2 15.4 19.7 9.6 8.3 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 8.2 14.7 14.3 11.1 11.6 8.9 12.3 3.4 18.3 7.6 6.1 10.7 10.2 11.4 15.1 6.9 5.8 13.1 17.6 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 29.0 20.6 15.4 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 12.7 42.3 57.8 7.3 15.3 18.0 21.7 28.3 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 11.1 45.7 9.0 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 LRPPRC "GP130, LRP130, LSFC" ENSG00000138095 "Leucine rich pentatricopeptide repeat containing" P42704 2 43886508-43996005 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033786, HPA036408, HPA036409" Enhanced Enhanced Mitochondria 16000 Mitochondria "CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-3)" "prognostic unfavourable (1.72e-5)" "unprognostic (1.68e-1)" "unprognostic (8.34e-3)" "prognostic unfavourable (2.31e-7)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.44e-3)" "unprognostic (7.68e-2)" "prognostic favourable (6.65e-6)" "unprognostic (9.07e-2)" "unprognostic (1.92e-1)" "unprognostic (1.12e-1)" "unprognostic (5.00e-2)" 20.6 25.5 20.2 27.7 24.8 26.7 37.2 34.3 51.8 16.4 31.7 15.1 15.9 21.8 21.5 19.2 22.5 18.6 15.2 36.6 24.3 21.9 41.7 31.6 26.3 38.0 21.9 22.9 23.6 28.0 33.3 19.7 17.6 29.2 18.9 32.5 13.6 17.8 22.8 63.2 22.4 19.1 32.6 17.9 18.0 20.7 20.7 16.0 25.4 20.5 30.5 19.9 20.4 17.8 15.8 15.5 5.5 11.7 13.2 18.1 12.4 30.1 24.7 15.6 19.8 15.4 20.5 26.8 20.1 14.6 21.9 17.0 39.6 16.0 43.3 19.4 12.4 25.6 29.1 21.5 29.4 26.1 18.4 39.2 19.5 52.4 22.7 56.3 17.8 20.3 18.9 20.3 32.9 17.6 57.7 17.6 19.3 16.7 29.5 65.2 26.0 17.6 33.1 34.9 35.2 24.0 27.7 27.6 26.8 22.7 30.5 36.5 22.4 34.2 15.1 15.8 21.7 16.7 21.4 17.9 20.2 37.8 15.2 35.0 13.6 5.5 10.7 1.8 9.5 10.8 18.0 15.2 12.8 12.6 15.5 15.8 18.1 15.4 0.8 13.2 11.7 6.2 10.5 12.4 20.2 24.8 34.3 51.8 24.3 21.9 21.9 22.9 29.2 16.0 MALSU1 "C7orf30, mtRsfA" ENSG00000156928 "Mitochondrial assembly of ribosomal large subunit 1" Q96EH3 7 23298739-23311729 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AN3-CA: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020487, HPA052210" Approved Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA020487: AB_1845757, HPA052210: " "unprognostic (3.62e-1)" "unprognostic (3.68e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-3)" "unprognostic (5.24e-3)" "prognostic unfavourable (9.71e-4)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (9.79e-2)" "unprognostic (1.83e-3)" "unprognostic (3.15e-2)" "unprognostic (7.15e-2)" "unprognostic (2.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.68e-1)" 7.9 11.3 9.5 6.9 9.4 7.6 11.0 8.6 11.1 7.9 8.4 8.3 5.8 5.1 9.2 10.2 12.3 10.1 7.6 29.8 8.8 9.1 12.5 21.2 8.2 10.2 8.9 7.2 10.3 10.1 8.0 7.8 12.6 12.7 7.9 7.8 17.2 10.6 10.3 20.1 6.7 7.0 8.9 8.1 6.9 7.5 13.7 5.6 8.5 14.8 14.9 8.0 9.2 7.5 6.1 4.8 3.5 5.4 4.2 7.3 5.1 5.0 6.3 4.6 27.2 4.6 3.2 4.7 3.9 2.8 3.6 3.3 10.6 4.2 5.1 4.2 2.4 5.2 4.5 2.4 4.4 2.5 8.2 3.0 8.6 16.3 3.0 6.6 1.8 2.7 3.8 3.0 3.4 3.3 9.0 1.3 4.5 3.5 4.6 20.8 8.5 17.0 3.9 3.9 6.7 3.5 4.5 4.2 5.1 3.2 5.1 8.0 2.6 3.9 5.7 2.9 2.6 5.5 6.8 2.0 5.0 8.8 11.0 8.2 9.0 3.4 5.4 3.5 4.4 4.0 5.0 6.1 6.1 4.9 4.7 5.7 7.3 4.9 3.4 4.2 3.3 4.8 5.7 5.1 9.5 9.4 8.6 11.1 8.8 9.1 8.9 7.2 12.7 5.6 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: , HPA059299: " "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.3 39.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.4 5.3 0.0 0.0 0.5 1.6 0.1 4.2 74.2 0.0 4.0 18.6 20.9 0.0 10.9 4.7 0.0 0.1 1.3 0.6 0.0 0.1 0.3 1.2 0.0 0.0 0.1 5.3 30.6 0.7 1.8 0.0 0.0 0.0 0.1 0.0 2.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 MARC1 "FLJ22390, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786759-220819657 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.3;breast: 81.3" "Cell line enhanced" "Detected in many" "BEWO: 51.0;HeLa: 21.7;Hep G2: 25.0;NTERA-2: 21.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5" "Group enriched" "Detected in many" 32 "granulocytes: 28.5;monocytes: 20.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028702 Approved Supported Mitochondria Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavourable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 71.3 3.0 4.6 7.5 6.1 7.3 81.3 3.1 4.0 3.4 7.8 2.1 18.7 3.3 1.4 5.5 3.4 2.8 6.4 6.7 3.7 4.6 3.4 33.6 4.3 4.3 4.0 3.3 2.5 4.0 4.0 3.3 9.7 4.3 14.9 6.8 4.4 27.8 10.5 4.2 1.4 3.8 2.6 2.6 4.3 3.2 0.6 1.4 0.1 22.0 2.7 1.4 3.9 7.5 0.2 0.7 28.5 20.6 0.0 0.1 4.9 5.6 3.1 2.0 0.0 0.4 0.1 51.0 0.5 0.4 0.3 0.5 16.8 0.3 0.0 2.1 0.5 0.0 10.6 1.0 0.7 0.0 10.7 0.0 21.7 25.0 1.3 0.1 0.1 2.0 0.6 0.0 0.0 0.3 1.6 0.1 0.3 5.5 0.0 10.7 21.5 9.4 0.0 0.0 0.1 2.4 6.3 6.0 14.0 3.0 3.7 0.0 14.2 12.8 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.0 20.6 8.1 0.1 1.5 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 28.5 0.0 0.4 0.2 0.0 4.9 4.6 6.1 3.1 4.0 3.7 4.6 4.0 3.3 4.3 1.4 MARCH1 "FLJ20668, MARCH-I, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;lymphoid tissue: 32.4" "Cell line enhanced" "Detected in many" "Daudi: 9.4;U-266/70: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 95 "classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014600 Uncertain Supported Mitochondria Mitochondria "HPA014600: AB_1853573" "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 7.7 4.2 11.6 20.5 19.7 3.9 4.0 3.1 14.5 3.7 3.9 8.5 0.1 4.4 3.9 4.6 3.6 4.2 5.9 2.6 12.6 10.1 3.0 4.5 8.3 28.5 17.3 6.3 4.2 4.1 1.5 4.1 10.2 13.5 3.5 5.1 2.4 4.6 1.8 1.6 4.9 9.0 6.5 24.4 32.4 4.1 2.3 17.9 2.6 3.2 1.4 24.6 9.0 4.2 18.5 18.1 9.9 17.2 0.1 0.0 6.6 0.8 0.7 2.9 1.7 0.0 0.0 1.8 1.2 0.1 0.0 0.0 1.6 3.3 9.4 3.5 0.0 1.4 0.0 0.0 0.0 1.0 1.0 6.7 3.7 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.2 0.0 2.5 4.9 3.3 1.0 2.3 2.6 3.6 1.3 2.6 0.5 0.7 0.1 1.5 1.5 1.3 0.9 1.4 0.5 4.0 0.7 3.1 1.1 2.0 0.7 2.3 9.7 3.2 2.6 1.3 2.1 1.5 0.0 16.8 9.9 0.0 17.0 0.0 18.5 0.0 0.0 18.1 15.7 0.0 0.0 0.1 0.1 17.2 6.8 0.0 6.6 11.6 19.7 3.1 12.5 12.6 10.1 17.3 6.3 13.5 17.9 MARCH5 "FLJ20445, MARCH-V, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291163-92353964 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria Mitochondria "HPA056596: " "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 18.2 21.7 17.5 17.7 18.3 20.7 27.1 16.8 25.7 15.5 15.4 12.7 20.7 15.8 19.3 18.8 28.0 14.8 15.4 18.4 15.8 15.1 21.7 27.6 16.5 16.6 16.3 17.9 20.9 16.7 16.3 12.3 16.3 14.8 22.2 14.8 14.5 19.4 19.3 42.6 13.7 16.0 18.1 14.0 12.1 14.4 20.1 13.5 25.0 24.5 21.5 17.3 14.7 21.0 7.3 9.4 16.8 10.2 6.5 8.7 6.6 16.4 8.9 17.6 20.2 12.1 12.6 9.1 14.7 16.2 18.4 18.9 5.9 11.8 9.6 10.2 14.4 13.6 12.3 12.3 26.5 7.2 14.5 7.7 8.4 13.9 14.6 12.3 7.7 12.8 16.7 12.1 25.5 16.1 8.4 12.0 14.7 10.4 10.8 14.1 4.1 13.5 11.8 18.1 5.7 18.8 10.7 8.2 15.2 12.8 9.5 15.6 16.5 9.6 15.6 8.6 9.5 9.4 20.1 12.2 9.3 8.5 7.9 17.0 5.7 5.2 8.3 9.0 7.6 10.2 7.6 7.3 8.4 8.0 9.4 6.7 8.7 8.3 16.8 6.5 8.5 6.2 7.8 6.6 17.5 18.3 16.8 25.7 15.8 15.1 16.3 17.9 14.8 13.5 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria 230000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favourable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favourable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 15.9 13.9 13.0 15.5 17.7 10.8 25.5 17.7 15.7 12.3 18.5 17.2 15.1 17.2 14.9 10.6 17.3 13.8 12.2 15.4 12.3 8.0 13.3 13.9 18.1 17.4 19.9 9.0 18.9 22.5 23.4 13.7 12.0 13.8 13.1 18.6 13.6 15.3 22.4 39.4 22.1 17.0 17.1 13.7 12.7 15.8 5.9 17.1 15.1 14.6 14.0 14.3 18.2 21.6 5.1 5.6 6.4 6.9 5.9 4.8 4.6 17.2 20.1 8.2 10.2 22.6 15.5 6.4 10.5 13.4 11.2 8.2 15.7 11.2 7.5 6.4 14.7 21.8 9.8 15.7 11.5 4.6 4.7 14.4 7.4 24.9 12.5 9.0 6.1 15.6 13.4 18.9 11.3 11.3 16.2 5.8 10.9 15.6 13.6 7.7 5.2 11.1 10.3 11.4 7.5 11.9 17.4 6.2 6.4 11.9 23.3 10.0 12.4 8.4 17.0 15.3 5.7 18.0 12.1 11.9 14.2 5.3 6.1 11.1 7.7 4.4 6.9 6.1 4.8 5.1 3.6 3.8 3.8 3.7 4.4 5.1 4.4 4.4 6.4 5.9 5.5 5.6 3.0 4.6 13.0 17.7 17.7 15.7 12.3 8.0 19.9 9.0 13.8 17.1 MCAT "fabD, FASN2C, MCT, MCT1, MT, NET62" ENSG00000100294 "Malonyl-CoA-acyl carrier protein transacylase" Q8IVS2 22 43132206-43143394 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003122, HPA035471" Approved Supported Mitochondria Mitochondria "HPA003122: , HPA035471: AB_10670590" "unprognostic (1.05e-1)" "unprognostic (1.57e-2)" "unprognostic (1.39e-2)" "prognostic favourable (5.53e-4)" "unprognostic (3.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-3)" "unprognostic (4.71e-2)" "unprognostic (5.13e-2)" "unprognostic (2.94e-1)" "unprognostic (1.32e-1)" "unprognostic (9.86e-2)" "prognostic favourable (2.18e-4)" "prognostic favourable (3.89e-4)" "unprognostic (3.67e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-1)" 10.4 18.2 13.3 8.2 17.2 11.0 12.8 10.4 24.6 10.6 11.9 9.4 10.7 9.5 11.0 17.2 12.3 20.7 21.4 12.9 14.4 14.2 25.6 24.3 8.6 7.1 12.0 12.0 14.4 16.2 20.3 14.3 9.2 15.1 12.8 10.6 9.9 14.5 10.2 17.7 11.7 9.7 8.6 6.0 7.6 12.1 19.6 5.2 18.4 20.1 14.0 9.9 8.5 8.1 10.2 13.9 2.5 9.5 11.6 10.3 5.6 7.1 9.4 6.7 11.7 5.6 6.0 6.8 8.0 7.1 10.8 10.1 9.4 7.3 12.0 8.3 5.9 12.0 12.6 10.6 8.1 4.1 37.3 4.5 10.8 10.4 9.0 21.3 5.4 4.5 10.3 10.5 8.4 7.7 10.5 4.9 5.2 13.2 9.9 23.2 6.4 16.7 13.2 6.6 19.0 13.5 6.2 8.8 4.7 8.6 16.8 12.1 8.7 13.8 4.6 4.7 9.3 10.2 11.2 8.8 9.0 8.6 10.1 8.1 5.6 0.0 9.5 0.7 7.7 9.1 10.3 8.3 8.6 10.1 13.9 10.2 10.1 7.1 2.5 11.6 5.5 13.7 5.5 5.6 13.3 17.2 10.4 24.6 14.4 14.2 12.0 12.0 15.1 5.2 MCCC1 MCCA ENSG00000078070 "Methylcrotonoyl-CoA carboxylase 1" Q96RQ3 3 183015218-183116075 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008310 Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA008310: AB_1853620" "unprognostic (4.01e-2)" "unprognostic (1.83e-3)" "unprognostic (2.05e-2)" "unprognostic (2.59e-3)" "unprognostic (3.46e-2)" "unprognostic (4.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-3)" "unprognostic (2.57e-3)" "unprognostic (9.82e-2)" "unprognostic (9.74e-2)" "unprognostic (7.65e-2)" "prognostic favourable (3.68e-4)" "unprognostic (4.73e-1)" "unprognostic (2.21e-1)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" 25.1 26.0 14.1 10.4 16.4 9.0 24.6 23.1 20.6 9.0 12.6 15.1 10.1 12.6 11.0 11.4 15.8 9.5 11.6 24.4 12.2 10.1 42.4 41.1 13.8 8.0 17.0 14.4 12.8 32.3 10.2 15.8 5.5 13.4 11.4 13.7 9.9 14.2 15.6 19.4 11.5 10.1 11.3 10.5 8.3 17.7 8.9 16.4 8.9 14.0 8.5 13.2 23.2 9.5 13.1 19.4 17.1 11.3 18.9 11.6 7.6 14.1 5.4 3.4 3.6 15.0 6.8 6.9 6.5 9.1 7.2 8.2 7.4 5.7 15.6 10.6 5.7 7.3 5.2 4.3 9.2 5.2 5.8 13.3 6.2 7.8 9.9 8.9 7.6 7.7 4.9 3.4 7.7 9.6 7.3 8.2 8.0 11.6 8.6 4.4 3.8 5.9 7.2 7.7 20.0 10.5 22.5 7.7 5.6 24.9 34.4 7.0 52.6 12.5 4.6 5.5 4.4 4.4 9.6 8.4 15.4 15.8 6.0 12.8 5.1 8.5 9.7 17.1 8.3 11.3 9.4 13.1 10.8 9.0 19.4 11.1 11.6 10.4 1.6 18.9 11.2 12.7 6.8 7.6 14.1 16.4 23.1 20.6 12.2 10.1 17.0 14.4 13.4 16.4 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 74.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favourable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favourable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 12.4 29.4 9.2 11.8 13.6 2.7 30.5 7.9 10.0 11.2 15.3 12.2 15.1 13.0 9.7 20.0 14.5 9.1 12.3 74.3 7.6 8.1 35.6 61.9 8.4 11.6 7.8 8.0 9.6 18.9 14.1 10.3 15.1 13.4 24.6 18.1 12.8 20.6 29.4 17.6 10.8 14.1 7.8 17.0 11.0 13.6 6.9 6.9 9.4 22.2 13.3 14.3 15.7 8.5 8.8 16.7 1.7 11.5 12.9 10.2 6.7 11.8 16.3 7.0 26.9 7.5 7.8 12.0 5.6 9.5 11.7 8.5 28.7 15.1 27.5 20.9 8.2 9.8 12.2 18.9 14.7 14.5 15.6 14.9 8.5 31.5 13.2 7.4 14.2 9.9 9.9 10.7 8.5 10.3 18.8 10.3 8.1 32.3 0.1 13.5 9.2 9.2 14.4 20.2 40.4 30.4 21.4 11.1 12.3 24.7 36.7 12.0 30.4 18.8 7.5 4.8 7.4 8.6 15.2 7.4 13.7 17.0 7.8 20.6 11.8 1.7 7.4 1.6 6.1 11.5 7.9 8.8 7.9 6.9 16.7 8.6 8.0 8.7 1.2 12.9 6.8 7.4 10.2 6.7 9.2 13.6 7.9 10.0 7.6 8.1 7.8 8.0 13.4 6.9 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 328.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Mitochondria "CAB002781: , CAB068195: , HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 9.8 5.0 9.4 5.6 19.1 20.2 12.9 12.1 12.4 12.7 10.3 6.3 8.1 12.5 7.1 8.6 13.2 7.1 14.4 12.8 10.3 4.9 5.1 8.1 7.2 15.1 8.6 11.6 11.0 16.6 12.4 24.2 13.9 11.4 18.2 16.6 10.8 4.2 6.6 17.4 8.9 6.5 7.6 6.5 14.0 7.1 7.3 9.9 8.6 11.7 15.5 7.4 13.3 17.1 8.1 8.5 5.1 15.1 23.3 27.3 328.0 13.9 6.8 10.6 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 41.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria 1400000 Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavourable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favourable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 8.2 6.5 6.3 9.4 6.1 12.3 9.8 41.0 6.8 7.0 19.8 4.1 8.5 19.1 10.9 7.4 13.4 7.8 11.5 6.9 4.8 4.3 11.1 7.2 10.1 7.4 3.4 4.1 5.8 12.1 8.2 5.5 8.8 5.5 4.6 21.9 5.1 9.5 5.8 41.4 9.0 23.0 11.0 3.8 4.9 29.4 4.7 3.5 4.9 5.4 14.9 7.3 10.1 15.0 3.4 5.4 16.6 7.6 1.9 4.6 3.6 19.7 32.0 8.3 6.0 12.7 14.3 8.5 12.2 17.4 12.2 13.0 19.0 18.9 8.4 9.8 14.8 18.0 10.9 14.5 16.3 9.2 10.2 10.5 12.0 10.5 9.9 26.3 8.9 14.5 12.3 10.9 23.4 14.6 6.5 6.3 11.3 11.4 7.1 5.7 9.1 6.7 7.4 17.8 2.2 16.5 10.8 8.9 3.9 15.0 16.8 3.6 3.3 6.9 11.8 5.9 10.2 12.7 8.1 4.7 5.9 5.9 7.9 13.2 4.5 1.7 6.1 16.6 2.9 6.7 3.1 3.4 3.0 3.5 5.4 1.7 2.3 2.6 8.2 1.9 7.6 1.9 4.6 3.6 6.3 6.1 41.0 6.8 4.8 4.3 3.4 4.1 5.5 3.5 MDH2 ENSG00000146701 "Malate dehydrogenase 2" P40926 7 76048051-76067508 "Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019714, HPA019716, HPA019848, HPA026720" Enhanced Enhanced Mitochondria 47000000 Mitochondria "HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685" "unprognostic (3.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-3)" "unprognostic (8.94e-2)" "unprognostic (6.45e-2)" "unprognostic (3.77e-2)" "unprognostic (3.60e-1)" "unprognostic (2.02e-2)" "unprognostic (1.40e-1)" "unprognostic (9.70e-2)" "prognostic favourable (1.49e-5)" "unprognostic (8.57e-2)" "unprognostic (9.64e-2)" "unprognostic (5.68e-2)" "unprognostic (2.66e-1)" 18.1 39.1 17.4 15.4 20.6 18.3 22.2 15.3 34.4 14.9 27.0 13.5 16.9 32.5 16.6 13.5 31.8 19.4 17.6 103.1 17.1 18.8 29.1 101.9 13.8 26.6 17.4 21.9 17.3 35.5 16.8 16.9 17.5 20.5 17.9 24.3 15.0 26.8 21.5 175.8 24.6 26.7 21.9 12.8 21.1 22.3 17.6 9.5 22.4 20.1 76.2 23.8 19.9 17.8 37.1 52.8 22.1 45.3 30.1 45.6 44.7 28.6 47.0 17.0 42.6 19.5 21.4 29.3 19.3 24.9 27.6 25.0 41.3 34.5 43.4 8.7 25.4 29.3 43.7 28.8 19.8 30.9 63.2 24.1 25.3 38.1 24.0 37.4 24.9 27.0 25.7 26.8 40.1 25.7 75.8 25.4 25.5 64.9 32.4 66.1 37.9 59.3 26.5 21.0 62.4 25.8 37.9 42.7 38.9 19.3 96.8 39.7 55.0 42.3 19.8 27.8 26.3 30.0 38.3 28.5 23.5 48.0 24.1 48.0 42.1 22.1 38.9 18.2 32.7 43.5 34.2 37.1 36.9 35.3 52.8 32.1 36.0 33.1 10.2 30.1 45.3 47.1 45.6 44.7 17.4 20.6 15.3 34.4 17.1 18.8 17.4 21.9 20.5 9.5 ME2 ENSG00000082212 "Malic enzyme 2" P23368 18 50878734-50954257 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008247, HPA008880" Enhanced Supported Mitochondria 3400000 Mitochondria "HPA008247: AB_1853704, HPA008880: AB_1853702" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (9.57e-3)" "unprognostic (2.22e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.29e-8)" "unprognostic (1.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-2)" "unprognostic (4.75e-2)" "unprognostic (1.43e-2)" "unprognostic (4.27e-3)" "unprognostic (2.30e-1)" "unprognostic (2.47e-1)" "unprognostic (4.09e-1)" 12.6 18.1 17.1 18.4 16.2 11.6 10.7 13.2 16.0 9.4 26.4 14.3 16.8 30.2 10.5 7.7 10.6 9.3 10.5 34.6 15.8 17.8 12.1 12.1 10.3 24.1 18.7 14.0 11.1 16.7 20.6 20.2 10.5 47.7 11.8 26.6 9.4 8.8 23.1 29.5 7.1 44.8 16.9 18.9 36.6 20.3 15.3 8.7 24.3 9.0 7.8 17.3 14.2 15.7 4.9 9.6 14.3 17.4 6.7 6.0 4.5 12.9 13.0 17.4 20.2 7.9 8.8 8.0 10.8 8.1 14.2 12.0 5.9 7.1 46.2 4.3 9.6 10.8 25.8 10.9 16.3 19.1 4.0 11.8 8.2 6.9 23.4 39.2 14.2 5.4 13.5 17.8 29.0 18.1 12.5 11.3 9.6 2.7 28.3 3.9 11.6 5.3 18.6 8.6 13.3 15.4 2.8 21.5 11.4 10.1 6.2 10.8 4.7 19.0 11.1 10.1 11.3 5.2 14.3 21.1 8.5 22.7 10.2 28.0 10.7 5.0 11.6 14.3 5.0 13.1 4.1 4.9 3.3 6.0 9.6 4.9 2.9 3.5 13.3 6.7 17.4 3.2 3.1 4.5 17.1 16.2 13.2 16.0 15.8 17.8 18.7 14.0 47.7 8.7 MECR "CGI-63, ETR1, FASN2B, NRBF1" ENSG00000116353 "Mitochondrial trans-2-enoyl-CoA reductase" Q9BV79 1 29192873-29230942 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022018, HPA022030, HPA028740" Enhanced Supported Mitochondria Mitochondria "HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133" "unprognostic (2.53e-1)" "unprognostic (1.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.06e-2)" "unprognostic (8.66e-2)" "prognostic favourable (5.81e-6)" "unprognostic (7.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "prognostic unfavourable (5.29e-4)" 16.4 11.9 16.0 6.6 17.0 6.0 12.3 7.8 17.7 13.0 9.7 8.6 7.1 7.8 10.5 8.4 9.4 10.9 8.5 24.8 15.7 11.5 11.0 13.7 8.3 10.0 14.7 16.3 11.7 14.3 8.1 10.0 10.8 12.8 7.5 8.9 10.8 12.6 10.0 45.5 11.3 5.9 10.2 10.7 5.4 8.1 8.2 10.5 4.4 8.3 12.8 7.6 8.0 7.2 8.3 14.7 0.3 11.5 11.6 13.1 6.5 10.3 9.9 4.8 22.5 4.9 8.8 17.8 7.8 8.9 10.3 10.0 7.5 21.2 13.6 15.8 7.7 12.9 6.1 16.0 6.4 9.3 12.6 11.8 6.3 9.5 15.4 13.0 6.0 8.7 14.2 5.4 20.1 11.3 10.1 14.1 12.8 11.6 11.0 7.2 13.0 12.7 6.8 8.2 24.0 10.9 6.0 7.4 11.4 11.6 16.5 14.5 6.1 12.6 11.4 7.5 8.1 11.7 11.6 13.5 5.6 10.2 20.2 17.4 14.1 0.1 7.0 0.0 8.3 11.5 13.1 8.3 7.8 6.7 14.7 7.4 8.4 8.5 0.3 11.6 7.0 8.6 6.3 6.5 16.0 17.0 7.8 17.7 15.7 11.5 14.7 16.3 12.8 10.5 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria Mitochondria "HPA010968: AB_1845714, HPA074625: " "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 20.2 23.9 31.6 18.0 27.6 22.3 21.3 25.7 38.4 19.6 22.5 26.5 14.7 22.1 21.9 20.9 21.5 18.0 17.1 40.5 27.8 28.4 33.7 24.4 16.6 27.1 30.2 20.2 25.7 27.6 25.0 19.3 17.7 28.0 20.6 22.5 25.6 20.6 27.6 37.4 16.7 18.6 22.9 33.4 16.9 18.8 97.0 20.6 25.9 19.8 22.2 23.3 20.7 17.8 40.2 34.9 59.9 33.8 29.3 44.1 33.1 22.8 19.6 24.2 33.3 31.3 30.2 32.1 22.8 30.9 27.9 29.8 21.4 16.4 13.1 27.3 24.9 19.0 39.8 29.0 37.9 27.7 31.9 27.6 50.8 53.5 41.4 26.7 24.8 27.0 38.3 26.4 28.3 24.0 24.0 39.4 24.6 23.1 28.2 41.1 32.8 20.8 25.6 30.6 25.3 40.7 21.6 25.7 24.1 50.1 23.3 33.3 14.9 26.5 16.2 27.2 23.0 40.1 25.3 32.1 21.8 26.3 35.9 23.8 36.9 42.4 32.9 59.9 32.8 33.8 35.3 40.2 34.5 32.0 34.5 38.2 36.6 31.0 31.0 29.3 30.6 34.9 44.1 33.1 31.6 27.6 25.7 38.4 27.8 28.4 30.2 20.2 28.0 20.6 MFN1 FLJ20693 ENSG00000171109 "Mitofusin 1" 3 179347692-179394931 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033437, HPA059230" Approved Supported Mitochondria Mitochondria "CAB033437: AB_2250540, HPA059230: " "unprognostic (2.94e-2)" "unprognostic (5.56e-2)" "unprognostic (5.44e-3)" "prognostic unfavourable (6.70e-4)" "prognostic favourable (6.11e-4)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.08e-5)" "unprognostic (6.37e-2)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "unprognostic (3.76e-3)" "unprognostic (7.91e-2)" "unprognostic (7.90e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (9.79e-2)" 13.7 16.5 12.2 12.1 17.2 9.9 15.4 24.3 22.4 18.4 16.5 15.9 19.4 12.0 19.6 21.3 19.6 18.5 13.4 31.1 12.0 11.4 17.9 14.9 12.3 16.0 16.9 14.5 16.6 29.9 18.2 22.3 12.4 21.5 17.7 14.6 12.8 17.4 17.4 21.7 19.6 16.6 15.7 16.0 18.2 17.8 11.8 17.0 16.9 14.5 20.1 19.6 17.6 15.1 10.5 4.1 8.9 4.5 4.1 7.3 2.1 16.7 5.0 9.7 15.7 13.9 13.0 12.9 10.4 10.8 11.0 13.2 12.4 6.9 5.7 11.0 15.4 9.9 13.6 10.3 19.4 8.9 10.5 9.3 11.6 6.8 11.4 4.9 8.9 9.0 9.1 11.9 8.4 14.0 6.8 7.6 15.4 8.9 7.2 3.7 11.5 9.3 5.1 15.3 21.1 10.5 17.7 9.2 13.1 9.8 26.3 14.2 36.0 3.6 11.7 9.7 10.8 15.0 15.2 10.2 11.0 9.5 10.8 8.3 10.4 5.5 3.8 8.5 4.3 4.5 7.3 7.8 4.9 4.4 3.4 10.5 4.6 5.1 8.9 4.1 3.6 4.1 4.4 2.1 12.2 17.2 24.3 22.4 12.0 11.4 16.9 14.5 21.5 17.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Cell line enhanced" "Detected in some" "BJ: 10.5;fHDF/TERT166: 15.6;HHSteC: 12.7;HUVEC TERT2: 31.7" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" HPA015994 Enhanced Supported Mitochondria Mitochondria "HPA015994: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.5 0.0 1.5 0.0 0.0 0.1 0.0 0.1 15.6 0.2 2.2 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.7 0.1 0.1 3.8 0.3 1.7 0.1 31.7 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.2 4.4 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 MGME1 "bA504H3.4, C20orf72, DDK1" ENSG00000125871 "Mitochondrial genome maintenance exonuclease 1" Q9BQP7 20 17968913-17991122 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040913 Approved Supported Mitochondria Mitochondria "HPA040913: AB_10962835" "unprognostic (5.81e-3)" "unprognostic (5.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-3)" "unprognostic (5.42e-2)" "unprognostic (1.44e-2)" "prognostic unfavourable (6.98e-8)" "unprognostic (5.31e-2)" "unprognostic (7.05e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (1.13e-7)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (8.70e-2)" "unprognostic (6.89e-2)" 8.7 14.2 6.4 12.0 7.6 10.9 14.9 7.0 6.7 8.4 10.5 11.7 8.2 10.2 7.3 8.6 14.3 5.4 6.5 10.5 7.3 4.8 10.5 11.3 6.5 13.9 11.5 7.2 5.8 9.6 7.1 14.1 19.9 8.4 8.5 10.7 10.4 11.0 7.8 17.8 26.9 10.9 5.2 9.8 19.5 7.6 12.9 8.3 31.8 15.5 7.6 16.9 10.6 9.6 13.2 10.9 24.1 8.5 8.8 9.2 4.5 16.9 19.7 16.2 15.2 6.7 11.8 21.8 14.3 10.6 13.8 18.9 24.3 17.3 20.2 8.1 6.3 25.4 16.7 21.3 21.1 7.4 13.8 13.1 11.0 36.6 4.9 8.5 22.5 7.1 15.0 20.5 10.8 11.0 17.8 13.2 27.7 12.7 15.2 11.7 14.2 17.5 11.6 36.3 19.1 12.0 12.5 12.5 10.4 10.1 24.7 21.6 23.6 6.0 8.8 24.0 19.4 11.8 15.4 9.9 22.0 17.3 6.1 6.6 17.4 24.0 8.5 24.1 4.9 8.1 6.4 11.4 6.3 6.4 6.8 13.2 4.5 4.3 8.2 8.8 7.5 10.9 9.2 4.5 6.4 7.6 7.0 6.7 7.3 4.8 11.5 7.2 8.4 8.3 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Uncertain Supported Mitochondria Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favourable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 16.8 36.4 22.9 14.4 25.3 17.0 15.4 56.3 30.7 18.2 16.9 18.9 11.6 20.9 29.7 14.3 13.3 20.5 18.6 24.0 23.3 21.7 58.9 64.7 16.7 11.2 20.9 22.7 25.0 11.6 21.1 23.4 16.3 25.2 14.9 19.2 15.1 15.5 13.8 36.9 16.3 21.5 22.2 17.5 18.1 24.1 11.8 15.0 15.1 13.8 14.6 11.9 20.0 15.2 6.5 9.5 39.0 21.7 5.6 6.5 11.5 15.8 28.0 17.9 20.9 28.9 27.2 8.1 17.5 39.8 26.2 36.2 16.4 30.1 21.5 14.9 24.5 19.0 22.4 15.8 31.0 19.1 18.3 14.5 15.7 23.7 22.9 19.9 16.0 27.1 14.3 28.7 26.8 22.5 22.3 25.4 30.4 14.4 17.4 18.9 7.5 6.8 19.1 24.1 14.1 32.1 11.8 13.8 19.8 20.7 25.9 16.1 15.4 19.3 13.8 13.0 20.2 25.7 14.5 13.5 22.4 15.1 26.0 26.6 8.8 7.3 21.7 39.0 6.5 18.3 5.7 5.8 5.8 6.0 9.5 6.5 5.7 4.8 18.3 5.6 18.4 6.1 5.5 11.5 22.9 25.3 56.3 30.7 23.3 21.7 20.9 22.7 25.2 15.0 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: " "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 12.0 6.9 16.6 10.5 14.8 19.9 14.3 20.6 16.8 22.0 15.3 10.1 19.6 18.9 13.3 19.6 16.2 16.3 17.2 30.3 19.1 16.9 32.6 7.6 11.6 17.9 24.4 19.0 17.2 17.1 12.3 8.7 14.6 11.5 8.5 35.8 10.5 16.2 23.3 11.3 11.0 17.9 42.3 12.6 43.2 9.9 13.4 10.3 14.0 16.5 13.3 16.1 23.1 18.0 9.6 8.6 19.5 16.9 6.4 8.3 13.8 9.4 20.5 23.7 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 11.7 11.0 12.2 6.9 23.7 8.1 19.2 18.1 25.4 10.5 8.2 20.3 7.2 9.7 12.0 7.5 8.7 9.1 10.3 8.6 15.7 16.1 20.2 11.2 8.3 6.6 19.2 19.7 12.7 8.9 28.0 13.9 10.1 26.4 13.3 8.0 7.6 12.1 9.6 15.7 7.6 10.6 10.1 29.9 7.5 9.8 7.6 18.8 5.9 21.8 5.1 5.9 10.5 8.1 6.2 3.7 7.3 6.8 5.8 6.7 3.2 8.5 5.5 3.5 4.4 8.6 11.2 9.2 12.4 5.9 7.3 7.5 6.1 5.9 3.7 13.8 8.5 5.9 4.7 7.3 13.9 5.4 4.8 4.3 6.8 2.8 8.8 4.0 3.4 8.0 8.0 14.9 10.9 7.3 2.4 5.1 11.0 1.3 3.9 2.3 3.0 6.9 2.1 8.5 1.9 8.8 9.3 7.0 5.7 5.7 8.7 15.8 3.3 2.6 11.7 10.5 4.9 15.8 12.9 3.0 4.3 2.3 9.3 3.5 4.5 7.3 5.5 6.6 5.9 6.8 6.2 4.6 4.7 4.7 3.7 6.2 6.7 5.9 3.5 5.8 4.3 3.0 4.3 3.2 12.2 23.7 18.1 25.4 15.7 16.1 19.2 19.7 26.4 18.8 MINOS1 "C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial inner membrane organizing system 1" Q5TGZ0 1 19596977-19629821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria Mitochondria "HPA059930: " "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favourable (8.11e-4)" 10.1 9.7 22.0 8.1 21.3 5.4 12.6 20.4 22.2 17.7 16.3 7.2 7.5 10.6 14.5 13.7 15.1 15.2 13.7 25.4 18.3 21.4 19.8 12.5 9.7 8.3 20.6 15.5 14.0 13.3 14.5 16.6 8.3 17.0 17.2 18.3 9.3 13.8 17.8 25.2 10.1 17.4 18.2 12.1 8.9 11.4 5.0 11.8 7.7 13.7 20.3 11.8 13.9 10.9 7.0 8.4 9.0 10.5 3.7 11.3 8.9 7.5 10.5 6.0 6.5 11.5 10.9 3.7 6.6 7.4 7.8 7.9 7.3 7.0 6.4 5.5 8.7 5.6 10.3 8.7 12.6 9.7 7.2 5.6 16.8 10.1 5.1 8.7 4.2 8.9 14.3 7.7 9.5 11.3 12.0 4.8 11.6 13.4 4.4 11.4 5.1 13.3 4.4 7.2 8.5 19.1 4.6 12.4 5.5 7.3 5.9 5.7 5.8 4.9 7.5 6.1 4.7 7.7 6.5 3.1 5.1 6.6 4.8 16.6 5.7 5.6 8.1 9.0 6.4 10.5 5.8 7.0 8.7 7.0 8.2 6.7 11.3 8.1 5.5 3.7 10.5 8.4 7.8 8.9 22.0 21.3 20.4 22.2 18.3 21.4 20.6 15.5 17.0 11.8 MIPEP MIP ENSG00000027001 "Mitochondrial intermediate peptidase" Q99797 13 23730189-23889419 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030676, HPA031669, HPA031670" Approved Enhanced Mitochondria Mitochondria "HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198" "unprognostic (2.05e-1)" "unprognostic (3.17e-2)" "unprognostic (3.75e-3)" "unprognostic (3.72e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-2)" "unprognostic (1.12e-1)" "unprognostic (7.54e-2)" "unprognostic (4.76e-1)" "prognostic favourable (7.66e-12)" "unprognostic (1.62e-2)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (6.90e-3)" 7.3 14.9 6.2 7.1 12.2 4.4 11.0 4.7 10.3 8.1 12.2 12.9 12.1 8.4 9.6 20.4 14.4 17.1 11.7 16.9 8.8 5.3 24.7 12.0 8.2 8.4 5.1 8.0 8.5 14.7 8.1 15.4 5.3 9.1 10.9 13.1 9.1 12.9 10.1 16.2 22.0 8.9 11.5 4.4 6.5 9.8 13.9 4.9 8.9 10.9 15.7 11.1 11.2 8.6 9.2 6.5 1.2 10.6 9.7 10.0 3.9 8.9 10.1 5.0 11.7 11.5 15.5 10.7 6.5 10.1 9.8 8.2 13.4 17.8 10.5 6.6 5.2 22.6 11.5 13.6 12.2 6.1 7.3 4.6 4.8 11.5 9.4 10.7 2.5 7.6 17.1 10.1 9.0 12.2 8.8 1.7 15.2 6.6 7.6 6.0 6.9 10.2 8.5 13.5 9.1 21.8 6.0 11.8 3.9 6.9 11.4 13.6 11.7 6.0 6.7 6.0 5.0 9.8 6.9 1.7 2.4 5.6 10.3 5.5 7.4 0.0 3.0 1.2 7.9 3.7 10.0 9.2 7.7 7.1 6.5 7.7 7.4 7.3 0.0 9.7 10.6 5.6 5.1 3.9 6.2 12.2 4.7 10.3 8.8 5.3 5.1 8.0 9.1 4.9 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria Mitochondria "HPA045119: AB_10960421, HPA055790: " "unprognostic (3.30e-2)" "prognostic favourable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favourable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favourable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 28.1 23.8 13.7 12.1 7.6 12.3 11.9 11.6 10.0 4.6 13.8 13.7 11.7 6.3 12.2 9.5 8.4 9.3 20.9 6.8 10.1 33.1 9.9 26.4 9.0 10.9 13.5 9.7 7.0 9.6 23.8 22.0 7.3 10.4 18.3 48.9 4.2 9.3 10.1 13.6 34.5 22.1 5.2 25.6 22.8 8.7 38.2 8.7 9.0 39.6 6.6 6.9 7.2 24.4 7.7 15.1 10.3 11.5 6.3 32.6 11.0 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.3 25.8 18.8 12.4 23.9 21.9 11.4 20.4 30.0 38.7 28.5 13.4 20.8 7.3 14.8 35.3 23.9 28.5 35.0 33.0 15.3 26.1 13.4 17.1 22.9 29.8 11.1 20.8 22.3 28.9 36.1 21.4 29.3 21.8 9.5 41.9 17.6 7.3 6.9 20.3 12.2 16.9 14.6 12.5 38.8 12.1 11.8 21.5 26.6 18.5 7.0 21.6 9.0 19.7 16.0 8.2 9.3 25.4 4.8 8.8 6.1 22.9 14.4 22.7 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 MRM1 FLJ22578 ENSG00000278619 "Mitochondrial rRNA methyltransferase 1" Q6IN84 17 36601572-36608971 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021598 Supported Supported Mitochondria Mitochondria "HPA021598: AB_1854097" "unprognostic (9.07e-3)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (1.19e-1)" "unprognostic (4.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (4.90e-2)" "unprognostic (2.47e-2)" "unprognostic (8.56e-2)" "unprognostic (2.75e-1)" "unprognostic (5.67e-2)" "unprognostic (2.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.74e-2)" 2.2 6.8 2.9 3.9 6.4 2.9 3.5 1.9 4.9 1.2 4.2 5.2 3.2 5.9 3.2 3.4 3.6 4.0 3.4 3.8 3.7 2.4 4.0 2.2 4.6 6.5 3.0 4.2 4.1 0.9 0.9 1.0 2.8 2.1 5.6 2.4 2.9 4.7 5.9 2.2 4.5 1.2 3.4 5.2 2.5 1.5 3.5 0.9 3.2 1.8 3.8 3.4 0.0 6.7 3.3 0.0 4.4 7.3 7.6 3.7 0.9 6.2 0.0 3.6 3.2 3.9 11.9 0.2 0.0 0.0 0.0 0.4 0.1 0.4 7.2 0.0 15.3 0.1 0.2 0.0 4.7 2.2 10.7 3.5 6.5 1.9 5.2 5.5 3.0 0.3 7.6 0.0 3.8 6.3 4.0 4.4 0.1 10.6 3.2 0.1 0.1 8.5 0.0 13.7 3.1 7.2 2.9 1.9 0.0 4.5 4.6 4.7 1.8 1.8 3.6 6.1 4.2 0.0 9.4 10.9 4.6 0.0 6.0 2.6 0.0 2.9 0.0 4.3 4.4 7.6 6.7 3.6 4.1 2.9 6.1 5.5 5.8 0.0 7.3 1.8 3.3 2.8 3.7 MRM3 "FLJ10581, HC90, RMTL1, RNMTL1" ENSG00000171861 "Mitochondrial rRNA methyltransferase 3" Q9HC36 17 782273-792509 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022534, HPA023031, HPA023292" Enhanced Supported Mitochondria Mitochondria "HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388" "unprognostic (1.66e-1)" "unprognostic (5.83e-3)" "unprognostic (6.72e-2)" "prognostic favourable (2.81e-4)" "unprognostic (2.67e-1)" "unprognostic (1.83e-1)" "unprognostic (2.48e-1)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.20e-2)" "unprognostic (3.72e-3)" "unprognostic (8.47e-2)" "prognostic favourable (3.00e-4)" "unprognostic (3.82e-2)" "unprognostic (9.98e-2)" "unprognostic (1.05e-2)" "unprognostic (1.42e-2)" 10.0 13.8 7.2 12.4 11.9 16.4 10.5 12.8 11.8 7.1 9.1 7.8 8.0 8.6 8.6 8.2 12.0 9.4 10.1 14.7 7.1 7.2 11.1 20.5 6.5 11.9 9.7 7.7 10.3 21.2 8.3 9.2 7.6 10.1 8.2 8.9 7.0 11.4 8.6 31.0 14.6 8.2 8.7 4.8 10.8 12.4 21.4 8.9 12.2 10.1 13.8 10.1 8.7 10.8 22.1 14.8 8.0 14.2 17.6 20.2 14.8 13.3 27.9 6.1 10.4 9.0 7.7 12.0 7.2 6.8 14.5 12.4 16.3 6.3 24.2 7.5 5.7 11.4 17.9 6.4 14.1 8.1 29.2 9.3 16.2 14.2 9.1 8.0 8.5 9.0 8.9 15.5 13.5 11.1 15.6 10.9 7.8 14.4 13.7 10.5 8.9 14.7 16.8 4.3 12.8 9.7 7.3 8.1 9.3 10.3 8.7 13.5 10.8 7.2 8.6 7.8 6.0 11.3 19.8 4.2 6.0 9.7 9.8 11.2 10.5 4.9 14.2 8.0 15.2 11.3 16.4 22.1 16.6 18.5 14.8 20.9 20.2 17.6 1.1 17.6 10.9 11.8 17.2 14.8 7.2 11.9 12.8 11.8 7.1 7.2 9.7 7.7 10.1 8.9 MRPL1 BM022 ENSG00000169288 "Mitochondrial ribosomal protein L1" Q9BYD6 4 77862520-77952790 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043656 Supported Supported Mitochondria Mitochondria "HPA043656: " "unprognostic (9.03e-3)" "unprognostic (3.25e-1)" "unprognostic (1.11e-3)" "unprognostic (2.88e-1)" "unprognostic (4.52e-2)" "unprognostic (5.29e-3)" "unprognostic (4.69e-3)" "unprognostic (5.44e-2)" "unprognostic (1.66e-2)" "unprognostic (5.14e-3)" "unprognostic (8.79e-2)" "unprognostic (2.22e-2)" "prognostic favourable (3.35e-5)" "unprognostic (7.63e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "unprognostic (9.17e-3)" 13.6 16.5 14.8 10.9 16.0 13.5 14.0 12.3 20.3 13.6 16.2 4.4 9.6 11.8 12.5 13.6 17.2 10.5 6.9 23.5 18.5 14.7 22.4 22.4 7.6 12.4 13.5 14.0 12.0 12.0 10.5 18.9 16.1 16.6 17.3 17.9 4.3 11.1 11.5 46.6 8.2 12.0 20.3 12.1 15.4 12.3 5.4 9.5 11.9 11.7 24.7 13.4 17.2 14.3 14.9 12.0 4.7 10.1 12.6 18.3 8.9 12.1 7.6 15.1 12.6 11.6 15.3 13.1 14.0 8.7 18.1 12.4 15.5 22.0 21.5 17.4 11.2 10.3 21.8 25.1 23.7 14.4 11.4 18.3 8.2 16.3 15.4 37.8 8.9 11.9 23.7 16.0 16.3 21.6 26.4 7.3 22.7 13.0 23.7 24.5 16.7 10.1 27.1 18.8 12.3 35.1 11.8 16.4 8.3 10.8 28.1 25.8 13.6 19.1 12.7 12.0 18.0 12.0 19.8 6.5 8.1 22.5 10.1 21.5 15.3 4.7 6.5 3.9 12.7 10.1 12.5 14.9 14.0 13.9 12.0 14.3 16.8 18.3 1.1 12.6 8.5 9.8 16.6 8.9 14.8 16.0 12.3 20.3 18.5 14.7 13.5 14.0 16.6 9.5 MRPL10 "L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8" ENSG00000159111 "Mitochondrial ribosomal protein L10" Q7Z7H8 17 47823272-47831534 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021234, HPA029885" Enhanced Enhanced Mitochondria Mitochondria "HPA021234: AB_1854098, HPA029885: AB_2673233" "unprognostic (6.84e-3)" "unprognostic (1.03e-1)" "unprognostic (8.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.97e-1)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.67e-4)" "unprognostic (5.21e-2)" "unprognostic (1.03e-1)" "unprognostic (8.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.16e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-1)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.87e-2)" 20.8 23.2 18.3 23.8 25.2 17.7 34.3 22.2 25.9 19.2 24.7 11.5 24.4 21.2 22.8 26.5 20.3 25.6 28.7 44.0 18.9 18.1 21.6 26.0 29.6 39.6 18.0 19.4 42.9 34.7 17.8 12.3 19.3 16.9 17.6 19.6 16.5 18.2 27.5 43.2 15.5 17.6 37.9 21.4 19.6 23.8 18.6 13.2 19.2 20.4 26.6 21.2 26.0 19.6 17.7 20.4 11.2 18.3 11.6 31.6 17.7 12.6 27.9 11.8 11.9 28.2 26.0 22.0 11.1 18.7 19.2 16.4 53.7 17.4 20.5 26.0 14.3 12.0 16.7 21.7 17.1 19.7 26.6 16.4 15.0 37.6 24.4 14.7 9.2 29.2 18.9 22.7 32.3 18.4 21.9 20.6 14.7 24.8 15.0 18.5 19.4 26.8 12.1 23.1 22.7 20.9 12.4 14.2 22.8 8.5 9.8 23.7 29.0 15.6 11.3 17.3 14.3 11.6 15.6 36.2 27.9 16.5 15.2 11.2 11.5 11.2 17.6 8.2 31.6 18.3 29.8 15.9 21.8 27.9 20.4 17.7 18.6 21.9 7.1 11.6 14.7 12.4 24.3 17.7 18.3 25.2 22.2 25.9 18.9 18.1 18.0 19.4 16.9 13.2 MRPL11 ENSG00000174547 "Mitochondrial ribosomal protein L11" Q9Y3B7 11 66435075-66466738 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057685 Approved Supported Mitochondria Mitochondria "HPA057685: " "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.21e-2)" "unprognostic (1.79e-2)" "unprognostic (9.30e-2)" "unprognostic (1.12e-2)" "unprognostic (1.81e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-1)" "unprognostic (8.32e-3)" "unprognostic (2.85e-2)" "unprognostic (3.21e-1)" "unprognostic (1.31e-2)" "unprognostic (9.34e-2)" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" 13.9 12.9 10.1 18.9 10.6 18.2 25.6 10.6 12.5 13.7 20.7 7.0 13.5 15.7 16.5 16.2 22.3 16.3 17.5 32.0 8.5 8.7 19.4 33.1 15.7 27.5 9.0 7.5 20.2 36.6 15.1 9.5 14.8 7.7 15.2 23.2 10.8 21.5 17.7 41.4 13.5 21.8 18.5 7.5 18.5 18.5 14.0 6.7 23.3 19.8 29.7 19.0 16.4 17.7 23.4 25.5 3.4 20.2 16.3 20.9 19.2 19.8 15.9 15.1 14.4 7.5 8.5 21.6 11.6 13.3 22.2 17.1 44.3 24.7 25.1 20.3 11.0 17.4 22.0 22.8 15.7 11.5 14.6 15.7 13.6 23.4 9.1 26.0 10.6 10.1 13.6 13.6 17.0 16.4 22.8 11.0 9.6 33.9 29.9 41.5 27.6 23.2 19.0 30.1 31.3 9.6 13.7 15.9 13.8 12.8 19.4 39.9 22.0 13.7 9.2 13.4 18.0 12.6 13.6 8.1 12.6 28.3 13.8 16.8 9.0 0.8 16.3 3.4 17.7 20.2 18.9 23.4 19.7 17.4 25.5 19.3 20.9 19.1 1.1 16.3 17.7 15.4 19.8 19.2 10.1 10.6 10.6 12.5 8.5 8.7 9.0 7.5 7.7 6.7 MRPL12 "MRPL7, MRPL7/L12, RPML12" ENSG00000262814 "Mitochondrial ribosomal protein L12" P52815 17 81703357-81707526 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022853, HPA023043" Supported Supported Mitochondria Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (6.59e-2)" "unprognostic (1.66e-2)" "unprognostic (9.52e-2)" "unprognostic (5.97e-2)" "unprognostic (5.97e-3)" "prognostic unfavourable (2.35e-4)" "unprognostic (1.78e-1)" "unprognostic (6.47e-3)" "unprognostic (8.17e-2)" "unprognostic (3.07e-1)" "unprognostic (8.77e-3)" "unprognostic (3.41e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (9.26e-2)" 15.7 18.6 15.3 14.5 16.9 14.4 27.7 13.6 18.6 9.8 27.2 8.3 14.9 25.2 10.7 8.6 24.4 12.6 14.8 63.7 14.8 13.7 22.8 64.9 15.4 20.4 17.8 10.5 8.9 40.7 13.3 10.7 12.8 13.1 11.6 20.5 9.3 19.6 13.9 79.1 12.6 18.2 11.4 9.4 17.2 15.2 14.4 7.5 16.1 12.2 50.4 16.0 10.9 11.2 24.7 34.6 5.0 30.0 14.7 20.5 17.7 27.7 47.6 12.8 14.8 9.7 10.7 23.6 21.8 13.4 33.0 24.6 39.8 13.4 43.3 13.2 14.3 23.6 16.4 28.0 16.8 10.1 82.0 33.0 25.4 44.5 14.4 36.1 17.3 12.3 20.5 22.6 25.4 27.3 32.1 14.4 16.3 35.0 30.7 53.6 20.0 62.0 29.3 20.8 32.0 24.3 23.2 32.7 42.0 16.0 69.2 35.6 35.1 33.1 14.2 25.1 29.8 19.6 44.1 27.9 9.5 24.6 17.2 26.2 18.8 5.0 24.1 3.2 15.0 30.0 20.5 24.7 15.1 16.6 34.6 23.1 16.0 14.3 2.6 14.7 17.3 28.4 12.9 17.7 15.3 16.9 13.6 18.6 14.8 13.7 17.8 10.5 13.1 7.5 MRPL14 "MRP-L32, RPML32" ENSG00000180992 "Mitochondrial ribosomal protein L14" Q6P1L8 6 44113454-44127457 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038769, HPA076790" Uncertain Supported Mitochondria Mitochondria "HPA038769: AB_10673288, HPA076790: " "unprognostic (4.58e-1)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.21e-2)" "unprognostic (7.20e-2)" "prognostic favourable (4.81e-4)" "unprognostic (1.74e-2)" "unprognostic (3.75e-1)" "prognostic unfavourable (7.46e-5)" "unprognostic (7.13e-2)" "unprognostic (1.65e-1)" "prognostic favourable (1.08e-4)" "unprognostic (3.27e-2)" 10.1 16.1 12.5 9.6 12.8 7.9 11.7 10.5 12.7 10.5 16.4 9.6 8.4 16.2 12.1 12.3 15.7 10.4 14.8 18.5 10.0 8.4 12.4 35.5 25.9 10.4 10.9 11.5 7.1 17.5 4.9 9.6 11.8 10.6 9.7 16.3 13.7 14.0 9.4 61.4 16.0 14.0 12.7 7.9 10.2 12.7 19.0 10.4 13.1 26.3 27.8 12.4 12.3 10.0 33.2 36.4 9.0 36.1 46.7 32.5 30.3 51.5 22.1 15.6 21.6 13.6 13.3 20.0 19.3 19.3 25.8 25.8 46.0 18.2 22.5 21.9 16.4 21.1 17.6 31.4 20.5 26.7 48.0 23.2 19.6 56.2 16.8 21.9 16.3 12.4 17.1 24.3 14.5 21.3 48.7 14.5 22.7 52.1 26.2 34.6 13.7 21.3 18.9 17.6 30.5 42.4 25.6 35.0 13.6 12.4 24.3 24.0 22.3 22.6 16.9 23.0 34.4 16.4 33.3 18.1 16.0 52.8 26.0 21.9 16.7 9.0 36.1 7.5 25.4 32.7 29.9 33.2 32.5 28.6 32.4 30.2 25.8 26.5 2.0 46.7 21.9 36.4 21.9 30.3 12.5 12.8 10.5 12.7 10.0 8.4 10.9 11.5 10.6 10.4 MRPL19 "KIAA0104, MRP-L15, RLX1, RPML15" ENSG00000115364 "Mitochondrial ribosomal protein L19" P49406 2 75646783-75690851 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046805, HPA056622" Approved Supported Mitochondria Mitochondria "HPA046805: , HPA056622: " "unprognostic (9.24e-2)" "unprognostic (3.84e-2)" "prognostic favourable (7.39e-4)" "unprognostic (8.40e-2)" "unprognostic (1.59e-2)" "unprognostic (7.52e-3)" "unprognostic (5.75e-2)" "unprognostic (9.86e-2)" "unprognostic (6.21e-3)" "unprognostic (9.71e-3)" "prognostic unfavourable (1.97e-5)" "unprognostic (2.42e-1)" "unprognostic (3.67e-2)" "unprognostic (1.55e-1)" "unprognostic (3.30e-1)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" 21.3 33.9 22.5 13.0 25.2 8.8 21.1 15.9 26.7 23.0 19.5 24.1 12.1 16.8 19.1 19.6 25.7 13.9 15.6 24.4 21.3 20.4 40.8 44.9 13.0 13.5 26.0 21.2 17.3 17.8 30.9 20.6 18.4 26.6 16.4 23.0 13.2 17.7 19.6 47.3 17.2 16.3 21.1 27.7 18.1 16.3 12.0 24.4 19.2 27.3 22.0 17.3 15.1 15.9 18.5 23.7 9.6 17.1 15.5 18.0 11.1 36.0 21.0 20.0 17.9 21.9 26.4 28.3 23.2 21.0 29.6 23.5 32.4 15.0 20.4 23.4 25.3 25.5 31.0 35.1 44.6 22.6 26.6 27.8 16.5 40.9 23.4 29.5 16.7 17.4 27.1 29.9 27.5 31.0 30.5 12.0 29.1 22.0 26.8 23.3 26.0 23.5 33.8 43.6 26.8 50.1 22.6 22.1 19.1 22.8 26.4 25.8 22.6 11.9 20.8 25.9 28.6 22.9 34.2 12.5 18.7 16.9 20.4 29.3 22.5 9.6 14.1 9.2 16.0 17.1 18.0 18.5 16.5 16.9 19.9 16.1 14.7 18.0 0.9 15.5 15.4 23.7 17.4 11.1 22.5 25.2 15.9 26.7 21.3 20.4 26.0 21.2 26.6 24.4 MRPL20 FLJ10024 ENSG00000242485 "Mitochondrial ribosomal protein L20" Q9BYC9 1 1401908-1407313 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047074 Supported Supported Mitochondria Mitochondria "HPA047074: AB_10964064" "unprognostic (4.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-2)" "unprognostic (5.79e-2)" "unprognostic (3.71e-1)" "unprognostic (2.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (2.80e-2)" "unprognostic (2.33e-1)" "unprognostic (4.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (1.64e-1)" 36.7 36.2 44.4 31.0 40.7 22.6 41.2 30.3 46.8 24.8 33.4 24.2 38.8 30.7 28.1 52.3 33.8 32.7 39.9 75.3 37.3 38.6 40.1 48.8 31.5 59.7 39.9 31.4 26.5 72.8 28.4 36.3 27.2 35.6 35.1 33.1 29.1 50.5 47.7 121.8 27.3 28.9 44.5 39.1 30.5 33.6 27.7 29.7 22.8 34.3 54.8 35.9 27.1 26.9 50.6 77.5 37.5 52.1 40.5 59.9 51.7 39.3 38.1 28.7 29.0 22.1 24.1 21.2 35.3 27.1 46.0 33.0 45.3 48.1 42.1 49.5 30.2 25.1 46.6 38.1 35.8 36.4 66.0 45.5 67.1 44.5 30.7 66.8 29.4 28.1 14.7 35.3 38.0 34.0 45.8 25.2 38.5 39.5 51.3 51.0 29.7 77.2 34.1 26.5 53.7 35.8 26.5 51.0 42.0 33.6 70.4 51.8 30.2 49.5 29.0 28.1 32.7 42.0 43.5 38.6 54.9 82.0 43.4 54.4 19.5 27.8 52.1 37.5 46.8 49.1 52.4 50.6 52.3 46.4 53.2 47.5 59.9 57.3 24.1 40.5 37.7 77.5 45.0 51.7 44.4 40.7 30.3 46.8 37.3 38.6 39.9 31.4 35.6 29.7 MRPL23 "L23MRP, RPL23L" ENSG00000214026 "Mitochondrial ribosomal protein L23" Q16540 11 1947278-1984522 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA050406 Approved Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA050406: " "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "prognostic favourable (3.97e-4)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (2.40e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-2)" "unprognostic (8.32e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (1.82e-1)" "unprognostic (6.33e-2)" "unprognostic (7.23e-3)" "unprognostic (4.08e-2)" 19.4 32.7 19.3 21.8 19.3 37.3 22.1 14.0 25.1 18.1 21.0 17.2 22.5 28.7 19.9 31.4 31.5 30.7 29.9 39.8 16.6 16.8 25.1 43.8 17.4 42.9 18.4 16.9 29.4 69.1 22.6 25.8 14.5 17.4 17.9 21.0 21.2 48.7 25.9 61.0 35.5 23.8 15.9 14.3 22.4 25.6 11.1 11.4 32.5 21.1 44.3 30.1 12.7 17.9 24.1 20.2 12.6 14.5 6.8 22.1 3.3 23.1 27.3 14.7 17.5 6.0 16.9 21.4 6.9 10.3 11.8 8.8 1.7 28.1 23.5 13.8 16.1 23.2 23.7 32.4 5.6 26.2 115.1 8.4 8.6 33.4 15.9 22.2 13.3 13.3 12.6 8.2 2.4 8.4 6.3 12.7 17.1 25.4 17.7 4.6 20.1 20.7 24.4 7.7 24.5 10.5 9.1 29.6 25.0 8.7 20.6 12.8 0.5 28.1 10.6 16.2 10.0 4.0 15.3 17.8 15.8 22.1 25.2 19.3 0.0 1.9 14.5 12.6 7.0 10.7 5.6 24.1 10.3 7.8 20.2 20.3 22.1 6.7 0.8 6.8 7.8 8.6 14.6 3.3 19.3 19.3 14.0 25.1 16.6 16.8 18.4 16.9 17.4 11.4 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 367384-370527 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 18.3 21.7 32.2 18.6 36.6 25.1 19.5 17.9 38.4 15.3 26.0 19.1 14.6 21.7 16.8 21.3 21.1 21.2 20.0 49.6 30.9 22.5 26.9 35.5 15.1 24.5 24.9 20.9 15.7 21.4 23.6 15.5 15.8 17.7 16.2 12.0 16.8 21.7 18.4 42.1 16.0 19.2 19.6 16.8 18.1 15.8 25.7 10.4 24.9 20.3 36.3 20.4 16.9 14.7 38.0 47.1 48.2 42.0 28.0 47.7 33.7 17.6 41.3 17.7 21.2 10.0 12.9 24.2 20.7 27.1 37.5 37.1 50.7 24.6 26.0 23.6 20.9 23.2 27.0 43.7 20.0 23.4 65.6 19.1 31.9 41.6 32.3 23.7 25.8 19.4 21.8 34.8 28.1 27.4 35.0 19.5 23.3 71.5 37.3 27.0 28.4 26.4 46.6 21.6 37.4 30.7 10.9 30.5 27.8 25.6 26.2 21.2 33.7 24.7 21.5 23.1 32.2 18.3 23.0 30.9 23.8 34.5 15.5 17.3 36.1 30.4 42.0 45.8 30.1 40.8 24.6 34.3 26.2 28.4 37.7 38.0 18.6 23.8 48.2 28.0 40.7 47.1 47.7 33.7 32.2 36.6 17.9 38.4 30.9 22.5 24.9 20.9 17.7 10.4 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798386-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 90.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 16.8 20.7 14.3 12.9 14.8 8.2 17.9 9.3 15.4 12.3 15.9 9.0 13.7 14.1 13.5 15.1 20.8 12.7 19.0 32.4 13.5 13.0 22.4 44.6 11.6 13.6 14.2 8.6 16.5 28.9 9.0 10.1 13.9 12.3 17.0 10.5 9.6 27.3 12.3 52.5 11.7 16.2 16.1 11.9 11.5 14.4 46.0 11.1 14.1 18.1 35.8 15.3 16.3 14.4 24.5 90.2 12.9 20.3 18.4 25.8 24.1 22.9 34.1 15.9 30.0 29.4 24.3 20.9 20.1 17.8 24.0 23.0 24.7 18.7 30.9 36.6 21.5 25.1 35.7 33.1 17.4 33.7 39.8 15.0 75.8 39.0 37.6 19.4 11.8 21.4 25.6 26.8 34.9 23.3 22.7 20.0 34.1 42.1 22.7 43.9 15.4 42.0 18.3 11.9 37.3 21.7 18.8 17.7 12.2 43.8 34.2 20.9 20.1 21.1 14.0 20.9 22.7 14.1 22.2 19.2 23.9 40.8 26.2 36.0 28.4 12.9 20.3 12.5 18.6 19.4 22.1 24.5 21.0 22.4 24.3 17.9 18.6 22.1 5.8 18.4 16.5 90.2 25.8 24.1 14.3 14.8 9.3 15.4 13.5 13.0 14.2 8.6 12.3 11.1 MRPL37 "MRP-L2, RPML2" ENSG00000116221 "Mitochondrial ribosomal protein L37" Q9BZE1 1 54184041-54225464 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025767, HPA025826, HPA025951" Supported Supported Mitochondria Mitochondria "HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107" "unprognostic (2.00e-1)" "unprognostic (6.81e-2)" "prognostic favourable (6.99e-4)" "unprognostic (1.71e-3)" "unprognostic (8.24e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (6.45e-5)" "unprognostic (2.49e-2)" "unprognostic (1.56e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-2)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic favourable (9.25e-4)" "unprognostic (2.43e-1)" "unprognostic (2.62e-1)" "unprognostic (7.67e-3)" 21.3 35.0 16.2 15.8 24.0 26.0 18.0 16.9 34.8 15.8 22.9 18.0 13.9 23.5 17.6 13.7 29.0 18.2 18.6 32.0 15.4 14.0 25.1 65.2 13.8 20.6 16.0 14.6 21.2 30.8 15.4 10.9 19.4 23.0 16.2 25.2 20.1 33.5 15.3 68.0 24.0 25.0 19.3 11.9 17.9 20.9 20.0 9.0 31.4 18.1 39.9 28.1 16.2 17.5 39.0 40.8 14.8 35.3 29.1 37.4 38.5 38.8 22.5 20.5 27.6 20.7 27.8 36.7 26.5 24.9 47.3 41.3 44.9 18.0 53.0 24.0 29.6 31.4 40.3 39.2 37.1 25.8 50.8 45.5 47.5 45.3 35.6 53.8 21.2 30.7 33.7 49.1 38.5 42.2 50.2 16.0 33.6 28.7 37.0 52.5 41.9 50.1 40.8 41.7 44.6 26.9 29.2 40.6 18.9 36.6 63.1 48.7 27.3 61.1 21.0 30.4 27.6 38.2 53.1 20.3 28.4 41.3 39.6 55.0 28.7 14.8 35.3 14.6 24.1 29.9 28.2 39.0 29.8 27.2 40.8 32.8 30.3 27.0 1.9 29.1 27.9 34.1 37.4 38.5 16.2 24.0 16.9 34.8 15.4 14.0 16.0 14.6 23.0 9.0 MRPL38 "HSPC262, MGC4810, MRP-L3, RPML3" ENSG00000204316 "Mitochondrial ribosomal protein L38" Q96DV4 17 75898643-75905413 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023054, HPA023135" Approved Supported Mitochondria Mitochondria "HPA023054: AB_1854109, HPA023135: AB_1854110" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.83e-1)" "unprognostic (3.68e-3)" "unprognostic (2.47e-2)" "unprognostic (1.50e-2)" "unprognostic (4.44e-2)" "unprognostic (1.61e-1)" "unprognostic (7.59e-2)" "unprognostic (5.24e-2)" "prognostic favourable (4.23e-4)" "unprognostic (2.16e-3)" "prognostic unfavourable (5.58e-4)" "unprognostic (3.06e-2)" "unprognostic (2.40e-1)" "unprognostic (3.72e-1)" "prognostic favourable (9.21e-5)" 10.8 14.1 12.4 6.7 14.8 6.0 8.2 8.4 20.8 9.6 11.7 23.3 6.5 10.6 9.5 7.8 11.2 15.4 10.2 21.2 11.7 9.2 11.7 17.6 8.4 8.1 15.7 18.1 12.0 17.5 8.7 7.7 7.3 14.8 8.7 8.2 8.8 17.1 13.6 41.8 9.5 8.9 17.9 11.3 8.8 10.3 15.1 14.7 8.3 8.8 14.1 9.5 10.9 7.5 28.5 29.4 9.9 21.8 24.0 24.6 21.3 17.6 24.8 5.0 6.1 7.3 6.0 20.4 6.0 10.5 23.3 16.9 30.3 10.6 17.1 7.1 10.2 12.5 17.8 16.2 6.1 5.1 33.5 11.4 7.0 27.0 18.4 15.1 10.2 8.8 18.5 15.0 12.2 22.6 14.2 7.8 8.3 36.9 18.3 15.0 6.4 24.6 13.7 17.2 18.4 17.3 8.8 9.8 11.0 11.2 26.2 24.2 24.4 15.1 6.9 8.9 15.3 7.0 15.8 10.1 6.3 4.9 10.8 11.7 8.1 4.5 20.0 9.9 23.7 21.8 23.8 28.3 24.5 22.2 29.4 28.5 24.6 23.7 1.6 24.0 17.5 20.9 24.5 21.3 12.4 14.8 8.4 20.8 11.7 9.2 15.7 18.1 14.8 14.7 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19431902-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favourable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 4.0 6.6 5.5 2.5 6.6 1.3 3.9 5.1 5.4 4.3 2.6 2.9 3.0 5.0 3.7 5.0 2.9 11.8 4.6 4.7 6.1 10.3 2.2 3.0 5.1 4.7 7.0 6.4 4.9 2.5 4.6 2.2 8.7 4.2 14.8 3.6 2.3 2.4 5.0 2.7 3.1 2.8 8.2 2.8 3.7 2.5 28.1 21.6 10.3 15.1 10.9 16.4 16.6 13.2 9.2 2.2 8.4 13.7 12.7 7.0 10.0 11.6 14.1 17.6 10.8 7.7 11.6 10.4 11.0 13.1 13.9 15.9 11.8 11.7 21.2 10.5 6.5 13.3 20.2 14.9 7.0 13.1 15.4 10.3 18.5 9.4 42.4 11.0 13.6 10.1 7.8 8.9 3.6 12.5 7.3 14.5 5.3 16.7 5.5 7.6 7.0 15.3 12.9 19.1 11.4 8.7 11.7 18.8 17.3 7.4 9.6 10.6 14.2 16.9 12.2 10.2 13.5 5.9 13.8 10.3 13.0 15.1 14.0 28.1 13.2 13.5 15.0 25.5 16.4 14.3 1.6 10.9 12.0 21.6 15.0 16.6 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551199-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 55.8;skeletal muscle: 60.6" "Cell line enhanced" "Detected in many" "MCF7: 48.3;PC-3: 47.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 15.3 8.0 12.8 3.5 14.4 3.1 2.8 4.1 10.7 2.4 8.3 7.1 2.3 1.0 1.7 2.1 1.5 16.4 10.3 7.7 6.8 10.7 2.6 3.3 8.5 4.2 6.3 1.8 2.9 1.6 9.5 2.2 10.8 3.8 60.6 5.3 6.2 1.5 4.0 6.2 10.5 2.1 2.0 1.5 2.7 2.1 38.3 55.8 43.7 42.5 21.8 42.2 42.8 9.8 16.7 2.8 6.7 4.2 3.5 13.0 12.7 3.3 5.8 4.7 11.6 5.6 7.2 16.7 3.1 21.0 3.8 6.0 0.6 10.6 20.8 6.7 9.2 18.1 9.7 10.8 30.9 7.0 8.3 5.3 1.8 5.3 14.5 3.1 3.1 48.3 3.7 35.3 10.8 47.3 4.6 4.9 10.1 5.0 6.6 9.3 10.0 8.4 15.6 20.6 14.7 9.9 10.5 10.2 14.1 18.2 16.4 9.4 13.1 12.9 11.7 10.7 7.7 43.7 42.5 31.5 31.2 34.1 29.5 38.3 33.8 35.9 34.6 28.5 32.2 30.2 5.1 21.8 31.1 55.8 42.2 42.8 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467488-93516213 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favourable (8.12e-4)" 18.4 35.6 16.7 13.9 23.6 14.6 22.5 23.2 24.4 22.0 21.5 16.6 16.3 17.0 18.7 16.5 26.7 20.5 15.1 24.2 16.8 16.4 31.0 28.9 16.0 15.3 21.4 16.7 18.4 16.3 26.1 35.8 18.5 26.2 19.3 26.4 13.7 17.8 19.0 15.1 15.8 18.4 19.8 20.4 18.8 18.1 34.5 17.1 25.7 19.5 14.9 21.5 19.1 21.0 29.9 18.8 23.3 23.1 29.3 32.0 21.0 17.0 18.3 29.5 23.9 17.6 26.6 25.0 21.1 21.4 32.2 26.2 24.6 13.7 24.0 9.2 19.3 15.4 38.0 28.5 49.5 28.1 29.3 27.7 12.6 30.6 24.2 32.0 13.9 19.6 31.2 28.0 41.5 31.2 36.5 13.1 36.7 18.1 35.9 25.1 44.1 33.8 29.7 14.9 29.3 35.6 35.0 36.2 19.7 18.1 30.2 22.7 29.9 17.7 15.4 23.7 13.5 15.0 28.3 15.7 22.8 26.5 9.3 25.3 35.5 18.0 17.7 23.3 19.0 23.1 24.4 29.9 24.9 20.9 18.8 23.9 26.1 26.8 7.4 29.3 21.5 13.3 32.0 21.0 16.7 23.6 23.2 24.4 16.8 16.4 21.4 16.7 26.2 17.1 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 34.6 34.5 25.9 20.1 24.2 22.5 25.0 24.0 32.9 26.0 26.1 32.5 25.5 28.5 24.7 29.9 31.8 25.9 30.2 25.0 24.4 20.9 37.2 39.6 20.5 20.3 26.5 19.3 32.7 62.2 16.7 21.4 26.6 22.9 31.9 8.3 30.1 61.4 34.4 100.4 26.8 30.1 25.5 32.1 24.8 32.0 28.6 20.3 23.5 45.2 35.2 25.6 27.6 22.6 36.2 36.6 41.3 32.3 36.4 39.4 33.4 30.1 34.4 7.2 12.7 7.6 9.7 22.4 21.1 19.2 16.4 16.7 19.5 23.7 26.0 28.8 8.8 18.9 2.6 17.6 2.2 19.6 44.6 20.5 25.0 30.2 16.2 16.1 16.5 15.1 13.8 13.9 6.2 15.4 10.1 13.3 4.9 31.9 15.0 36.7 11.7 32.4 16.2 24.1 17.4 9.1 15.6 8.1 21.0 15.4 7.5 23.7 40.2 7.8 18.8 15.4 20.6 16.5 22.1 27.9 21.3 13.1 19.7 30.2 11.1 41.3 32.3 35.1 32.3 30.0 33.2 36.2 35.7 32.1 36.6 33.3 34.7 30.9 11.0 36.4 28.8 28.6 39.4 33.4 25.9 24.2 24.0 32.9 24.4 20.9 26.5 19.3 22.9 20.3 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957404-223967714 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" Mitochondria "Nucleoplasm, Plasma membrane" "HPA038147: AB_10671521, HPA038148: " "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favourable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 29.2 15.3 16.8 16.4 32.7 26.7 15.1 24.2 11.7 17.9 12.8 9.2 16.0 13.9 12.6 18.3 14.1 14.8 29.0 14.6 16.9 31.0 38.9 13.0 24.1 15.2 17.0 13.5 26.1 11.0 12.7 17.3 13.8 13.3 19.6 11.8 14.1 13.9 35.3 14.7 15.5 12.3 15.6 18.8 14.9 18.4 12.8 23.6 16.2 22.9 21.0 14.1 11.3 31.5 28.2 39.8 30.1 21.2 26.9 23.3 11.9 10.1 15.1 17.4 14.3 17.0 24.0 13.5 15.1 22.0 23.3 35.9 15.0 18.1 14.7 11.5 16.0 24.5 18.6 20.4 17.0 17.4 19.7 11.7 28.1 21.1 21.8 15.2 19.9 23.3 13.3 17.9 21.5 18.8 14.4 17.6 13.8 16.2 27.6 22.6 10.6 19.2 18.6 11.1 29.3 10.1 20.6 11.9 9.9 22.3 32.5 18.8 31.5 14.1 14.7 11.4 12.5 10.8 15.9 11.0 25.9 14.9 20.8 16.1 31.5 30.1 22.6 20.5 29.1 25.9 31.5 22.1 24.4 28.2 27.0 26.9 23.5 39.8 21.2 25.6 22.6 22.2 23.3 15.3 16.4 15.1 24.2 14.6 16.9 15.2 17.0 13.8 12.8 MRPL45 MGC11321 ENSG00000278845 "Mitochondrial ribosomal protein L45" 17 38297023-38323218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.4;Daudi: 29.7;K-562: 18.0;REH: 14.5;U-266/84: 17.2;U-698: 21.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023373, HPA023385" Enhanced Enhanced Mitochondria Mitochondria "HPA023373: AB_1854114, HPA023385: AB_1854115" "unprognostic (8.56e-3)" "unprognostic (4.09e-2)" "unprognostic (1.11e-2)" "unprognostic (3.08e-1)" "unprognostic (9.50e-2)" "unprognostic (2.22e-3)" "unprognostic (1.11e-2)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.35e-1)" "unprognostic (6.01e-3)" "unprognostic (3.07e-1)" "unprognostic (1.00e-1)" "unprognostic (2.40e-1)" "unprognostic (8.13e-2)" 3.1 0.6 1.4 2.6 2.4 1.8 4.9 1.8 6.3 9.6 3.6 1.4 0.7 0.3 10.3 1.1 2.1 0.4 5.8 3.7 1.2 5.9 7.0 2.6 9.6 1.7 1.7 3.9 9.1 0.3 2.4 2.5 2.7 7.7 6.9 1.8 3.8 1.1 11.1 2.4 13.2 1.4 1.8 1.2 1.4 1.7 1.3 1.2 2.6 2.8 10.5 0.9 1.5 6.1 9.3 1.6 5.9 6.9 8.7 4.3 0.0 0.1 12.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 29.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 14.5 0.0 11.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 8.6 17.2 21.9 0.0 0.0 0.1 0.4 5.7 1.6 4.7 5.9 5.5 6.1 7.0 3.7 9.3 5.2 8.7 5.3 0.1 6.9 1.2 3.3 5.2 4.3 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: " "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favourable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 9.8 31.6 10.4 11.1 14.9 10.9 19.3 14.1 13.2 21.4 19.2 38.9 21.8 23.5 14.5 12.8 24.2 40.0 17.4 17.3 9.5 31.8 19.6 22.8 40.6 9.4 19.1 15.3 12.6 21.2 16.1 11.1 18.4 21.4 10.0 15.5 21.1 16.0 24.1 16.1 19.2 18.4 14.4 17.7 16.6 31.7 15.8 10.3 13.4 21.2 29.0 23.8 23.7 11.3 16.7 15.8 8.8 20.4 9.3 19.2 19.1 18.3 21.0 12.5 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 MRPL47 "CGI-204, NCM1" ENSG00000136522 "Mitochondrial ribosomal protein L47" Q9HD33 3 179588285-179604654 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037553, HPA047779" Approved Supported Mitochondria Mitochondria "HPA037553: AB_10671375, HPA047779: " "unprognostic (6.37e-2)" "prognostic favourable (6.44e-4)" "unprognostic (7.21e-2)" "prognostic unfavourable (3.15e-4)" "unprognostic (1.53e-1)" "unprognostic (8.55e-3)" "unprognostic (1.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.58e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-2)" "unprognostic (1.29e-2)" "unprognostic (5.64e-2)" "unprognostic (3.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.71e-1)" "unprognostic (8.84e-2)" 17.4 23.5 22.3 16.4 21.7 29.6 20.2 23.9 25.0 14.2 22.5 12.8 13.0 16.7 16.8 17.3 21.3 13.3 13.4 35.5 21.1 21.8 34.0 31.8 14.8 19.3 25.6 19.4 15.2 12.1 18.1 23.8 17.8 28.5 15.9 23.6 11.2 14.5 14.7 31.7 13.5 20.3 17.8 20.1 20.2 17.4 32.8 22.0 25.3 20.1 27.8 20.7 16.3 13.9 21.0 28.2 24.6 29.0 22.7 28.1 18.9 31.7 12.4 21.6 19.8 13.7 14.4 24.7 18.7 16.7 29.4 24.6 50.1 13.3 26.1 37.0 15.9 24.1 26.4 19.5 31.7 30.0 23.2 25.0 12.4 28.0 26.7 44.9 14.2 13.2 17.1 21.7 22.3 19.7 14.6 21.0 22.8 24.6 24.0 42.0 37.4 29.7 25.6 21.2 43.7 30.9 20.2 18.8 21.8 20.5 33.3 36.7 51.3 34.5 15.7 16.0 22.9 20.0 50.8 26.6 43.5 57.1 18.7 36.9 19.3 15.9 19.3 24.6 20.0 24.8 19.9 21.0 22.2 21.5 28.2 17.4 19.9 20.2 5.1 22.7 29.0 24.4 28.1 18.9 22.3 21.7 23.9 25.0 21.1 21.8 25.6 19.4 28.5 22.0 MRPL51 "bMRP64, CDA09, HSPC241, MRP64" ENSG00000111639 "Mitochondrial ribosomal protein L51" Q4U2R6 12 6491886-6493841 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039923 Approved Supported Mitochondria Mitochondria "HPA039923: AB_10795373" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (3.81e-3)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.62e-1)" "unprognostic (1.17e-1)" "unprognostic (8.33e-2)" 21.4 32.4 36.3 30.4 31.8 24.4 29.1 14.7 29.5 21.0 29.2 18.8 27.2 20.7 22.0 35.2 35.8 20.8 26.8 48.9 29.3 29.6 38.5 50.1 18.1 29.8 36.9 21.3 20.9 52.7 18.8 26.2 26.6 28.4 23.2 30.0 15.8 36.2 28.7 74.0 19.5 24.3 21.5 28.9 27.3 24.0 46.6 25.8 37.5 32.8 52.1 36.7 21.7 26.7 58.4 85.4 59.7 56.2 50.2 61.2 69.5 36.2 44.4 52.6 35.6 34.5 31.4 56.5 25.4 31.4 38.3 37.1 61.3 48.6 45.0 17.8 38.3 32.4 36.6 41.4 58.3 55.4 46.2 31.1 64.5 52.0 32.0 42.3 30.9 30.3 32.9 35.4 46.1 35.1 22.1 16.9 49.4 56.7 49.6 68.1 106.9 45.1 34.4 51.2 38.6 35.2 49.6 18.9 33.7 39.1 53.8 44.1 16.3 48.5 26.9 34.6 48.6 27.8 56.9 16.7 24.0 115.9 44.1 32.3 46.0 49.1 56.2 59.7 52.2 51.2 58.7 58.4 56.4 57.5 63.4 54.4 57.6 59.4 21.2 50.2 49.6 85.4 61.2 69.5 36.3 31.8 14.7 29.5 29.3 29.6 36.9 21.3 28.4 25.8 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.7 34.4 18.8 23.3 11.7 13.8 45.9 30.6 22.1 27.4 26.1 42.2 61.4 33.4 33.7 21.0 40.0 15.4 42.3 20.7 35.3 25.3 24.8 13.7 95.7 35.8 39.0 35.7 20.7 29.3 35.4 30.2 43.4 25.4 33.3 20.0 61.5 31.5 59.3 34.7 76.2 39.0 23.5 39.3 28.5 26.2 18.8 24.3 23.7 23.2 32.5 22.3 37.3 33.4 28.7 33.6 35.8 46.3 32.9 38.9 40.6 26.1 26.8 45.7 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471958-74473322 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria Mitochondria "HPA034612: , HPA056185: " "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavourable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favourable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 16.8 26.4 15.8 16.9 15.2 14.0 23.2 14.8 17.7 14.1 16.9 15.2 8.5 18.6 15.1 14.6 19.4 17.5 16.8 40.2 14.0 13.2 25.5 44.8 16.0 28.2 16.6 12.3 23.8 31.2 14.8 18.4 19.9 13.3 18.6 8.9 20.1 36.9 19.8 44.1 12.5 16.3 16.1 15.5 20.3 17.8 13.2 12.2 27.7 28.9 20.3 18.9 14.3 14.6 45.9 42.9 26.1 35.6 19.0 42.5 38.9 7.9 29.5 9.8 6.4 11.0 10.0 14.4 8.5 8.0 10.2 8.1 33.3 11.2 6.7 5.2 7.7 9.6 4.4 14.2 3.6 16.8 25.9 9.0 11.0 21.9 8.1 5.6 9.1 12.4 8.6 13.1 6.6 9.7 9.4 18.6 8.7 40.6 13.7 16.9 6.2 16.2 10.5 17.7 16.2 10.4 7.2 10.6 10.0 5.8 18.6 10.5 8.3 7.1 6.1 13.5 12.1 10.9 10.6 19.5 18.1 12.6 10.1 7.3 11.8 24.7 35.6 14.3 21.6 31.9 26.3 44.8 30.2 23.8 29.3 45.9 42.5 31.2 26.1 19.0 29.9 42.9 34.9 38.9 15.8 15.2 14.8 17.7 14.0 13.2 16.6 12.3 13.3 12.2 MRPL57 MRP63 ENSG00000173141 "Mitochondrial ribosomal protein L57" Q9BQC6 13 21176645-21179084 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039779, HPA059370" Supported Supported Mitochondria Mitochondria "HPA039779: AB_10673362, HPA059370: " "unprognostic (1.00e-1)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (9.57e-3)" "unprognostic (1.51e-1)" "unprognostic (5.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.68e-2)" "prognostic favourable (8.35e-4)" "unprognostic (7.65e-2)" "unprognostic (2.01e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (6.78e-2)" 14.0 28.8 23.2 13.8 21.4 16.2 16.5 16.1 22.6 14.6 15.3 12.6 12.9 18.4 13.4 21.0 16.1 17.3 18.7 29.3 20.5 24.7 24.8 40.9 15.0 16.5 21.3 17.9 19.6 30.2 12.3 26.8 12.5 17.1 21.6 12.3 15.1 23.2 18.8 48.0 15.3 17.5 16.4 17.8 16.6 18.1 20.2 13.0 26.4 25.1 24.7 13.8 13.4 12.8 26.1 43.9 23.0 31.5 21.8 32.8 28.8 8.1 14.8 10.5 9.4 8.0 6.6 11.0 9.8 6.1 9.3 7.0 19.4 15.1 4.7 11.5 6.1 14.1 9.1 9.4 7.1 12.3 15.3 21.4 10.6 21.7 11.9 11.7 10.7 6.8 10.4 7.4 7.0 8.9 9.3 6.2 6.5 28.5 25.4 31.0 7.6 17.4 15.5 15.8 8.2 11.4 9.9 21.0 9.8 8.0 10.0 14.4 10.1 11.0 6.1 4.9 9.0 10.3 8.7 8.7 7.0 8.4 4.3 13.9 12.2 17.8 31.5 23.0 22.8 24.4 25.8 26.1 29.0 24.3 27.5 25.8 32.8 26.1 4.8 21.8 20.1 43.9 28.8 28.8 23.2 21.4 16.1 22.2 20.5 24.7 21.3 17.9 17.1 13.0 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003634 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA003634: AB_1851388" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 12.4 23.4 13.9 18.4 14.8 13.7 17.6 18.1 15.7 10.6 15.2 9.8 17.5 13.1 12.5 15.1 19.4 12.5 16.3 31.2 12.2 12.0 25.7 41.7 10.2 15.2 14.3 14.0 10.5 24.2 13.5 9.1 13.9 14.0 13.6 16.3 10.1 17.7 22.5 57.3 16.5 13.4 14.8 12.9 14.6 15.1 7.6 14.0 13.2 14.8 31.2 15.7 14.3 11.6 18.3 28.9 11.2 22.0 20.0 33.5 20.9 26.2 37.1 12.4 14.2 13.3 13.2 17.3 15.6 17.0 32.5 27.7 28.4 16.5 18.3 12.8 15.4 18.8 25.3 26.8 34.4 9.3 30.0 14.3 17.5 23.6 25.2 29.9 9.9 14.3 12.8 21.6 34.6 24.7 23.1 13.4 18.3 32.8 25.8 20.6 9.3 50.3 13.4 22.0 26.6 23.9 19.5 11.5 22.1 13.5 24.7 30.2 32.9 24.8 10.4 17.6 19.3 18.4 29.3 14.0 11.1 20.2 20.1 33.6 14.5 11.2 22.0 10.5 17.3 20.7 14.9 18.3 21.1 17.2 28.9 14.8 15.7 17.6 2.0 20.0 17.4 19.4 33.5 20.9 13.9 14.8 18.1 15.7 12.2 12.0 14.3 14.0 14.0 14.0 MRPL9 ENSG00000143436 "Mitochondrial ribosomal protein L9" Q9BYD2 1 151759643-151763564 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008579 Approved Supported Mitochondria Mitochondria "HPA008579: AB_1079412" "unprognostic (2.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.34e-1)" "unprognostic (7.43e-3)" "unprognostic (7.66e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (1.04e-7)" "unprognostic (1.47e-1)" "unprognostic (5.22e-2)" "unprognostic (9.51e-3)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (6.30e-2)" 28.5 22.3 23.3 26.3 25.3 23.0 26.4 27.3 30.9 22.1 26.7 22.2 19.8 21.7 26.8 25.4 28.4 22.5 24.3 24.5 21.7 24.6 29.9 35.1 19.5 28.7 24.0 19.4 33.2 31.9 35.1 18.4 29.0 27.6 29.0 22.3 19.7 40.6 25.3 50.7 25.7 23.1 23.7 21.2 28.5 23.0 24.0 18.3 41.2 38.2 34.2 29.3 25.3 23.5 30.6 31.5 15.0 16.5 24.4 37.6 21.6 29.0 23.8 15.7 18.4 11.3 12.7 25.7 16.1 15.4 25.2 20.2 36.3 27.1 19.0 32.8 16.2 25.7 27.3 20.3 20.1 25.9 26.4 14.9 20.2 23.0 18.4 41.5 14.1 13.8 18.8 22.4 28.2 24.3 31.1 25.0 19.4 67.6 25.7 29.8 34.0 34.4 22.7 18.8 36.7 15.2 22.9 25.9 26.5 19.2 27.7 22.6 41.9 50.4 18.0 20.0 20.3 17.1 35.7 28.1 39.8 60.5 25.0 27.5 22.2 15.0 13.6 8.8 27.8 16.5 31.8 30.6 32.1 32.3 31.5 27.8 30.9 28.8 1.6 24.4 14.2 26.5 37.6 21.6 23.3 25.3 27.3 30.9 21.7 24.6 24.0 19.4 27.6 18.3 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480773 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria Mitochondria "HPA043752: AB_2678653, HPA050345: " "unprognostic (2.66e-1)" "prognostic favourable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favourable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 12.4 19.1 19.5 9.0 18.3 6.1 13.5 11.2 19.6 7.0 13.4 8.0 11.0 17.6 7.3 9.3 15.1 11.4 10.3 31.0 19.1 17.3 16.5 28.5 8.2 10.5 18.3 15.0 6.0 22.5 9.6 9.3 9.0 15.8 8.9 8.6 8.0 11.4 10.4 44.3 11.5 13.1 10.0 13.7 9.5 10.7 9.9 10.4 12.9 17.7 12.9 10.4 9.7 7.9 18.5 23.0 18.9 19.0 20.9 24.4 17.4 5.5 22.1 3.1 5.7 7.7 3.9 9.1 4.7 7.9 5.8 6.4 15.2 8.6 5.0 9.4 3.7 7.9 9.2 6.2 2.9 6.7 24.1 6.8 14.3 16.5 9.2 2.4 4.5 7.5 6.1 5.0 5.0 7.9 5.0 2.2 9.7 23.6 4.7 9.8 9.2 23.5 10.1 6.3 11.9 8.2 15.1 11.1 5.4 4.9 11.6 18.0 11.0 13.4 3.6 8.4 9.3 5.5 6.5 4.7 8.3 5.8 10.5 5.7 8.7 18.9 18.4 13.2 11.7 19.0 13.3 18.5 13.3 13.6 21.2 12.9 14.1 13.7 6.7 20.9 12.1 23.0 24.4 17.4 19.5 18.3 11.2 19.6 19.1 17.3 18.3 15.0 15.8 10.4 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" "Nuclear membrane, Mitochondria" "HPA051087: " "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.7 23.6 31.8 11.8 27.6 4.5 23.7 19.6 26.3 19.5 14.9 22.9 18.3 13.8 20.1 25.6 15.4 18.0 15.8 16.6 26.9 26.5 23.4 29.7 14.7 16.0 32.7 14.5 21.8 19.1 28.3 26.1 17.1 22.5 23.6 18.1 15.4 18.4 20.4 13.7 12.7 14.7 17.2 33.5 17.4 15.3 15.8 24.5 22.6 26.5 14.5 16.2 14.3 11.7 14.5 13.6 6.5 12.9 14.3 19.2 11.6 11.1 9.0 21.4 7.6 24.2 17.4 6.8 9.8 12.0 16.7 17.4 11.7 9.9 14.2 12.0 13.1 9.9 13.2 11.4 17.8 15.6 18.2 11.7 17.6 13.3 10.2 12.9 10.5 19.0 14.1 9.8 6.9 13.8 14.1 12.6 11.6 6.1 14.1 9.4 11.6 4.8 12.3 11.3 16.9 11.5 9.0 18.0 12.7 14.2 13.2 9.4 15.6 13.8 11.2 5.7 6.3 11.9 8.8 13.9 11.8 17.8 8.1 12.3 11.9 6.5 12.9 6.2 13.4 12.7 18.8 14.5 14.2 14.1 13.6 13.5 19.2 16.2 4.5 14.3 9.7 11.8 15.1 11.6 31.8 27.6 19.6 22.6 26.9 26.5 32.7 14.5 22.5 24.5 MRPS15 FLJ11564 ENSG00000116898 "Mitochondrial ribosomal protein S15" P82914 1 36455718-36464437 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028100, HPA028134, HPA067137" Supported Supported Mitochondria Mitochondria "HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: " "unprognostic (2.05e-2)" "unprognostic (6.98e-2)" "unprognostic (7.57e-2)" "unprognostic (4.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (3.59e-4)" "unprognostic (2.20e-2)" "unprognostic (3.28e-2)" "prognostic favourable (7.83e-4)" "unprognostic (8.48e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (3.55e-4)" "unprognostic (2.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.94e-2)" "unprognostic (1.39e-1)" 22.6 20.7 17.8 16.9 17.3 24.0 23.8 9.5 16.0 13.2 19.9 9.3 13.7 14.3 13.3 23.0 23.0 10.4 16.6 43.2 15.0 15.2 30.6 61.7 16.6 23.3 17.5 10.6 13.8 23.3 14.3 14.3 23.7 18.3 15.0 18.2 13.8 24.0 14.7 89.5 14.1 18.4 15.7 12.3 17.3 18.8 65.5 10.6 20.3 19.1 41.3 19.3 16.0 12.9 24.5 40.7 7.0 28.7 20.3 28.1 28.6 40.2 22.4 24.5 29.9 24.4 35.4 60.9 22.5 32.3 55.8 51.3 39.6 43.4 37.3 36.8 29.6 35.5 35.7 56.8 50.4 24.2 45.3 38.1 29.1 43.2 45.7 47.1 27.0 32.6 50.8 49.7 40.3 45.5 41.1 29.5 34.4 27.6 45.3 50.5 44.0 39.5 35.1 43.1 54.5 49.3 33.9 36.4 20.1 31.2 39.8 57.7 24.6 32.4 21.4 31.5 33.4 38.8 47.4 29.7 40.7 52.1 35.8 32.1 43.9 4.9 26.7 7.0 22.0 28.7 27.2 24.5 25.2 25.0 40.7 21.6 23.9 23.2 1.8 20.3 18.9 27.7 28.1 28.6 17.8 17.3 9.5 16.0 15.0 15.2 17.5 10.6 18.3 10.6 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 16.6 28.4 16.4 16.9 15.8 15.8 28.6 12.6 26.6 13.3 22.1 12.4 18.0 20.8 16.3 16.8 22.7 16.5 20.8 42.2 17.6 15.7 23.4 35.1 17.7 30.0 16.2 16.0 16.5 37.0 15.7 15.5 17.0 15.9 15.4 21.1 14.4 18.4 19.0 53.2 16.8 18.4 18.0 14.7 18.4 18.3 13.7 9.8 32.7 16.9 26.1 20.1 15.5 13.9 30.0 28.3 17.0 24.2 17.7 22.3 24.3 22.5 32.7 12.7 16.7 10.1 8.3 18.6 10.4 18.2 14.6 15.2 38.6 22.2 27.4 11.6 11.0 21.2 14.5 20.8 9.2 15.4 14.2 17.2 17.6 29.2 17.2 22.2 15.4 12.6 15.9 14.9 35.8 15.9 25.1 15.4 15.1 25.1 23.9 20.5 15.3 61.4 21.7 17.0 19.7 15.3 13.5 8.5 15.7 11.9 49.4 22.9 34.7 11.8 12.6 13.9 24.3 15.0 20.2 23.1 24.5 21.3 15.2 25.8 9.4 16.7 22.7 17.0 19.0 24.2 20.5 28.7 20.8 17.8 18.5 30.0 22.3 19.6 10.4 17.7 19.1 28.3 20.6 24.3 16.4 15.8 12.6 26.6 17.6 15.7 16.2 16.0 15.9 9.8 MRPS18B "C6orf14, HSPC183, MRPS18-2, PTD017" ENSG00000204568 "Mitochondrial ribosomal protein S18B" Q9Y676 6 30617709-30626395 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043485, HPA050334" Supported Supported "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA043485: , HPA050334: " "unprognostic (8.18e-3)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (2.51e-2)" "unprognostic (4.20e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (2.98e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-2)" "prognostic favourable (3.99e-5)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.39e-2)" 17.1 18.9 9.9 10.3 10.7 5.4 16.0 8.5 13.1 11.6 13.4 12.8 11.9 12.8 9.3 15.5 15.5 16.5 12.3 26.6 9.0 8.0 22.4 49.1 10.5 17.3 13.1 9.3 16.4 21.8 17.4 10.2 11.8 9.1 10.9 16.4 10.1 17.1 18.0 55.4 13.7 14.0 10.4 12.4 14.4 13.5 10.2 11.2 13.5 21.5 31.1 15.6 11.2 9.3 15.7 8.9 6.3 10.2 12.4 15.2 11.2 9.5 5.8 4.6 6.6 7.0 9.5 8.5 3.6 8.2 11.2 7.0 9.0 4.6 9.8 8.3 5.5 7.7 10.7 10.0 11.0 5.9 11.4 9.5 4.5 10.5 6.2 8.9 4.2 8.2 12.6 9.3 25.5 6.3 14.4 9.5 10.2 7.3 5.9 5.5 3.3 7.4 7.8 6.3 18.8 10.4 4.0 10.1 3.3 3.2 13.4 13.5 17.2 4.7 3.6 7.4 7.1 4.2 6.1 8.0 9.6 8.3 3.5 13.6 10.8 6.3 8.0 4.0 9.1 10.1 12.3 15.7 12.1 9.8 8.9 14.7 15.2 12.2 0.6 12.4 10.2 8.1 11.4 11.2 9.9 10.7 8.5 13.1 9.0 8.0 13.1 9.3 9.1 11.2 MRPS2 CGI-91 ENSG00000122140 "Mitochondrial ribosomal protein S2" Q9Y399 9 135499984-135504673 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029487, HPA057261" Approved Supported Mitochondria Mitochondria "HPA029487: , HPA057261: " "unprognostic (3.18e-3)" "unprognostic (9.42e-3)" "unprognostic (1.46e-1)" "unprognostic (7.81e-2)" "unprognostic (3.55e-1)" "unprognostic (8.45e-2)" "unprognostic (1.63e-1)" "unprognostic (5.63e-3)" "unprognostic (3.83e-1)" "unprognostic (2.90e-2)" "unprognostic (4.81e-2)" "unprognostic (7.58e-2)" "prognostic favourable (6.96e-9)" "unprognostic (2.74e-2)" "unprognostic (1.06e-1)" "unprognostic (8.29e-2)" "unprognostic (2.24e-1)" 18.5 31.7 15.6 14.8 18.4 17.7 32.1 17.9 28.9 15.2 19.6 12.6 31.3 20.9 19.7 15.7 20.7 33.3 20.6 43.6 15.0 15.5 24.5 48.6 17.8 32.7 15.4 15.1 25.6 37.1 21.7 15.5 16.5 14.1 18.3 16.2 15.0 25.7 29.3 43.0 19.7 16.0 22.0 12.8 18.4 20.6 12.3 10.6 18.5 22.5 28.4 18.2 18.5 15.7 20.6 16.2 7.3 15.8 14.5 22.3 13.7 16.2 27.0 9.9 13.5 11.3 12.7 17.1 12.0 10.9 20.3 15.1 40.6 15.4 20.7 16.4 11.0 37.0 24.9 28.1 7.9 12.7 39.1 10.2 27.4 27.2 19.8 20.7 12.6 16.9 21.9 22.1 15.9 18.9 33.6 15.3 11.8 50.1 20.2 36.2 22.7 43.7 22.2 16.3 43.5 16.8 13.9 30.0 15.8 16.3 31.3 17.2 26.0 16.5 11.7 14.9 16.8 25.6 21.5 16.9 33.0 22.9 15.3 18.9 13.7 4.8 15.8 7.3 18.0 14.9 20.4 20.6 18.1 19.2 16.2 20.3 19.7 19.6 1.3 14.5 12.2 13.9 22.3 13.7 15.6 18.4 17.9 28.9 15.0 15.5 15.4 15.1 14.1 10.6 MRPS21 ENSG00000266472 "Mitochondrial ribosomal protein S21" 1 150293720-150308979 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078289 Supported Mitochondria Mitochondria "HPA078289: " "unprognostic (3.48e-2)" "unprognostic (1.94e-2)" "unprognostic (5.46e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (8.45e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (1.15e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (9.71e-2)" "unprognostic (7.59e-2)" "unprognostic (2.12e-2)" "unprognostic (4.02e-2)" "unprognostic (3.97e-2)" "unprognostic (1.46e-1)" 10.5 17.7 10.8 8.6 16.5 8.6 14.2 8.7 18.8 9.7 8.5 8.1 9.7 10.1 10.4 15.1 9.5 12.1 9.3 15.0 8.9 13.3 12.2 8.1 10.3 8.4 16.7 16.4 11.5 10.9 13.6 8.3 15.9 9.3 7.5 10.0 9.9 12.2 16.9 9.0 8.6 10.3 7.9 9.6 9.9 10.3 9.3 6.2 13.8 11.7 11.7 8.7 9.4 37.8 43.7 15.7 25.8 21.2 36.9 30.3 26.6 22.3 28.8 14.6 27.7 27.4 23.8 19.7 16.8 19.6 19.0 4.6 25.4 27.2 13.6 21.5 25.5 24.7 21.0 17.5 18.3 31.8 15.8 33.1 32.5 22.0 23.6 13.9 30.3 22.4 23.5 26.8 24.7 26.0 36.0 26.0 61.1 19.9 21.6 49.2 39.1 18.3 15.0 46.3 22.5 19.6 22.3 47.0 16.6 33.7 31.9 18.4 34.5 17.4 7.6 14.4 20.3 21.6 31.2 32.9 27.1 9.8 13.1 14.4 11.8 25.8 15.7 24.8 24.5 29.7 37.8 32.2 28.3 28.6 33.1 36.9 31.3 6.0 21.2 21.9 43.7 30.1 30.3 MRPS22 "C3orf5, GIBT, GK002, MRP-S22" ENSG00000175110 "Mitochondrial ribosomal protein S22" P82650 3 139005806-139357223 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006083, HPA007830" Enhanced Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA006083: AB_1854122, HPA007830: AB_1854123" "unprognostic (8.38e-2)" "unprognostic (1.52e-2)" "unprognostic (3.04e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (5.22e-3)" "unprognostic (5.45e-3)" "unprognostic (4.85e-2)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" "unprognostic (4.49e-3)" "prognostic unfavourable (1.55e-5)" "prognostic unfavourable (1.85e-4)" "unprognostic (3.22e-3)" "unprognostic (2.56e-2)" "unprognostic (1.49e-1)" "unprognostic (1.77e-1)" "unprognostic (3.40e-1)" 17.6 45.3 16.9 14.5 24.9 22.1 18.3 15.5 26.7 16.3 22.7 14.6 12.2 24.0 17.0 14.7 26.7 14.5 13.8 39.2 23.4 15.0 24.9 43.3 12.9 20.2 18.2 19.7 15.7 22.4 13.6 15.2 16.9 22.6 11.6 22.0 8.8 15.3 15.8 50.8 17.2 21.1 16.8 18.1 14.0 19.0 21.9 19.9 15.3 15.1 31.0 16.0 16.5 16.9 24.9 27.9 21.7 31.6 21.1 27.8 20.9 30.5 13.2 11.2 13.6 16.9 14.3 25.9 17.9 23.2 32.3 26.5 41.9 22.0 21.1 33.8 21.8 34.7 20.3 24.5 31.1 11.9 18.8 33.7 11.4 29.1 18.8 31.4 18.4 15.3 19.2 19.4 20.2 19.6 46.5 13.3 19.5 22.5 15.7 24.7 20.1 23.3 19.9 19.2 29.5 23.3 18.1 13.4 12.0 29.1 42.8 45.6 29.9 28.5 14.0 12.9 13.7 25.6 16.9 20.6 11.3 37.7 16.0 22.4 12.5 21.7 24.0 21.2 22.9 31.6 27.6 24.9 24.7 25.7 27.9 21.6 27.3 25.3 5.4 21.1 30.3 17.8 27.8 20.9 16.9 24.9 15.5 26.7 23.4 15.0 18.2 19.7 22.6 19.9 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavourable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 15.1 28.5 23.0 19.0 27.5 16.0 19.9 16.4 32.0 13.4 16.4 17.6 28.3 18.1 18.0 23.1 18.1 19.3 17.2 53.5 22.5 22.1 36.6 19.9 16.5 21.3 23.6 26.2 16.3 29.9 17.3 16.7 15.5 23.7 28.3 16.0 15.3 16.9 24.7 39.2 14.1 15.5 17.0 19.4 17.4 25.7 21.9 17.2 14.8 28.4 19.8 19.7 15.3 16.5 25.1 30.8 33.4 26.7 23.5 24.3 22.8 32.1 32.5 17.6 18.5 10.7 12.5 20.3 20.9 15.8 29.2 22.6 24.4 19.4 40.8 62.3 16.0 16.0 27.7 24.6 24.5 32.4 32.1 29.5 13.6 42.2 20.5 38.7 28.6 11.4 22.2 21.6 22.6 18.4 43.7 14.8 22.8 27.5 35.7 22.3 21.3 34.0 26.1 29.5 34.1 22.6 15.5 23.6 36.8 15.8 13.3 41.6 41.4 28.8 15.6 24.8 31.7 24.8 44.2 32.4 68.4 45.5 23.7 24.3 22.8 24.9 21.8 33.4 22.4 26.7 23.4 23.6 22.4 22.6 30.8 25.1 24.3 24.0 3.5 23.5 18.8 29.0 21.4 22.8 23.0 27.5 16.4 32.0 22.5 22.1 23.6 26.2 23.7 17.2 MRPS25 "DKFZp313H0817, FLJ00023, MRP-S25, RPMS25" ENSG00000131368 "Mitochondrial ribosomal protein S25" P82663 3 15042460-15065335 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043490 Approved Supported Mitochondria Mitochondria "HPA043490: AB_10794888" "unprognostic (3.98e-2)" "unprognostic (5.36e-2)" "unprognostic (4.58e-3)" "unprognostic (1.24e-2)" "unprognostic (4.66e-2)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.93e-3)" "unprognostic (2.23e-1)" "unprognostic (2.10e-1)" "unprognostic (6.29e-2)" "unprognostic (2.68e-3)" "prognostic favourable (3.60e-7)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.91e-3)" 14.8 18.5 18.7 18.4 28.3 12.0 14.3 24.9 21.9 11.7 20.9 13.1 15.2 31.6 16.8 15.8 15.6 15.4 15.0 41.7 15.2 16.5 18.4 27.5 14.4 17.7 16.3 24.0 18.1 24.1 18.1 21.4 11.4 16.8 14.9 23.3 20.3 14.9 17.4 47.6 18.8 26.4 24.5 13.2 17.4 17.3 33.3 15.0 10.2 28.5 15.7 18.6 14.8 13.5 21.1 16.1 3.6 18.6 6.8 15.3 9.4 8.4 12.5 10.3 14.3 10.9 9.4 32.8 11.6 4.5 9.4 8.1 14.3 9.2 22.2 6.2 5.1 11.0 14.8 11.0 8.1 8.8 20.9 18.4 25.8 17.7 7.7 16.2 14.1 11.3 10.5 14.7 4.5 8.7 19.5 13.4 7.0 27.0 12.6 15.7 10.7 19.8 17.2 8.9 22.9 11.6 14.7 8.2 12.3 8.5 16.2 16.6 21.9 14.1 10.6 8.5 12.5 11.6 14.4 13.0 13.8 15.9 8.6 20.9 7.9 1.1 15.4 3.6 10.1 18.4 11.8 21.1 9.6 10.4 16.1 18.2 15.3 12.5 1.0 6.8 18.6 13.3 7.4 9.4 18.7 28.3 24.9 21.9 15.2 16.5 16.3 24.0 16.8 15.0 MRPS26 "C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13" ENSG00000125901 "Mitochondrial ribosomal protein S26" Q9BYN8 20 3045945-3048254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045472, HPA054610" Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA045472: AB_10962052, HPA054610: " "unprognostic (1.53e-1)" "unprognostic (2.18e-1)" "unprognostic (3.71e-1)" "unprognostic (4.41e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (8.13e-3)" "unprognostic (3.14e-1)" "unprognostic (6.83e-2)" "unprognostic (8.21e-2)" "unprognostic (9.65e-3)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (3.77e-1)" "unprognostic (4.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.93e-3)" 20.2 30.4 27.1 14.4 29.2 13.4 20.9 25.9 31.7 19.2 19.8 15.3 32.3 22.5 18.1 30.6 19.6 24.4 21.2 25.8 24.4 28.2 28.8 39.6 14.7 15.4 24.6 27.0 28.9 43.4 21.0 28.1 16.4 20.0 31.0 16.4 15.2 32.3 27.9 37.1 22.3 20.1 27.8 19.0 16.2 22.1 13.3 20.7 12.3 28.9 23.0 16.9 18.4 19.2 36.5 28.4 10.3 24.4 29.2 30.8 23.0 26.3 35.5 8.1 14.7 8.8 6.7 21.2 10.4 6.9 11.9 9.1 31.0 12.1 26.3 13.2 5.3 25.0 15.9 21.3 6.9 6.7 34.0 12.0 12.9 51.5 12.3 18.8 5.9 7.5 16.6 9.9 15.0 8.8 19.2 6.2 7.0 22.8 19.5 33.2 39.8 35.2 21.6 13.9 28.0 11.6 17.7 25.4 32.9 11.8 39.8 23.9 17.9 10.7 8.2 7.8 12.4 14.0 19.0 28.2 36.3 15.9 5.1 15.8 8.6 7.6 21.4 10.3 24.0 24.4 30.0 36.5 26.6 25.6 28.4 34.9 30.8 26.4 1.7 29.2 19.0 17.2 20.6 23.0 27.1 29.2 25.9 31.7 24.4 28.2 24.6 27.0 20.0 20.7 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219409-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Mitochondria" "Nucleoplasm, Mitochondria" "Nucleoli, Plasma membrane" "HPA071751: " "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 26.9 32.3 19.0 20.9 26.8 13.6 26.1 24.6 31.8 25.1 21.0 20.1 21.8 16.5 28.6 23.7 33.6 26.3 18.0 43.6 18.9 17.5 25.1 30.9 14.9 27.4 18.1 21.7 33.9 25.1 24.5 23.7 17.5 23.5 26.2 26.4 25.5 31.0 26.5 43.7 23.9 17.5 25.0 17.5 22.2 20.9 12.1 12.6 34.2 32.1 26.7 32.4 25.9 21.0 19.6 23.3 6.1 14.1 21.5 21.5 16.1 16.3 22.0 19.6 32.3 25.8 33.3 25.2 15.8 22.7 30.1 24.3 27.3 23.3 42.5 22.2 18.4 18.3 38.0 56.1 32.7 16.0 23.5 21.8 26.5 30.1 25.7 19.1 17.0 31.1 23.7 31.5 35.4 32.0 21.8 12.9 24.9 19.7 28.5 23.2 22.6 13.8 30.4 32.6 43.5 27.8 17.6 30.3 16.2 26.5 21.9 19.6 33.6 23.3 18.1 12.3 18.2 17.3 28.3 13.1 19.6 30.0 21.2 31.5 19.4 6.1 12.1 4.1 14.0 14.1 20.6 19.6 17.4 17.0 23.3 16.5 20.3 21.5 1.8 21.5 11.3 8.9 17.8 16.1 19.0 26.8 24.6 31.8 18.9 17.5 18.1 21.7 23.5 12.6 MRPS28 "HSPC007, MRP-S28, MRPS35" ENSG00000147586 "Mitochondrial ribosomal protein S28" Q9Y2Q9 8 79918717-80030289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027202 Approved Supported Mitochondria Mitochondria "HPA027202: AB_1854126" "unprognostic (3.63e-3)" "unprognostic (6.41e-2)" "unprognostic (9.61e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-3)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (4.55e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "prognostic favourable (1.20e-6)" "unprognostic (4.48e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-1)" "unprognostic (7.18e-2)" 18.1 36.9 27.4 13.2 26.7 10.9 19.9 16.7 23.3 14.1 20.9 20.5 10.9 13.4 11.5 16.5 18.1 14.7 12.0 40.4 24.0 24.7 32.5 44.2 12.2 13.7 32.2 17.9 13.4 19.1 20.6 20.2 18.7 21.9 13.1 17.2 16.7 14.2 14.8 56.9 11.8 12.7 13.4 27.8 12.6 14.0 9.7 19.0 18.1 22.4 27.8 15.7 14.0 11.7 19.6 41.7 26.0 28.1 25.4 26.7 18.0 20.3 20.3 18.4 4.3 15.7 20.4 20.2 22.8 21.3 31.2 26.5 17.7 16.5 25.7 26.5 18.5 16.8 25.4 26.0 25.1 20.3 22.4 31.2 18.5 27.5 17.6 13.9 14.1 17.2 22.4 18.2 24.9 20.1 22.0 10.8 30.8 19.5 31.7 22.6 7.5 34.7 21.7 14.7 14.8 39.2 19.7 8.7 14.7 10.1 89.7 21.2 21.6 16.7 14.4 11.7 29.4 20.4 20.0 11.7 18.7 22.9 19.9 16.1 9.0 26.0 20.7 10.9 19.0 28.1 20.7 18.7 21.4 23.8 36.7 19.6 25.9 24.9 4.5 25.4 24.9 41.7 26.7 18.0 27.4 26.7 16.7 23.3 24.0 24.7 32.2 17.9 21.9 19.0 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729135-40771173 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA039083: , HPA046344: " "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 14.2 20.1 19.3 17.9 21.2 13.2 18.2 27.7 22.9 14.4 16.4 16.9 10.7 15.4 18.0 15.4 18.9 16.6 10.9 24.3 18.4 16.9 26.7 29.9 12.1 22.5 17.9 17.1 21.5 15.0 10.7 35.3 13.1 22.1 12.6 17.0 12.4 14.7 12.5 32.5 14.2 16.3 16.3 16.0 16.0 15.3 17.9 23.3 22.9 21.1 17.2 25.1 18.0 15.9 22.2 11.8 17.2 10.4 15.9 25.7 10.9 8.0 7.8 13.2 8.6 9.0 10.7 13.2 10.4 7.3 13.7 9.3 19.9 12.0 47.5 10.2 5.9 21.4 16.5 12.9 16.4 12.5 12.4 19.7 5.8 12.7 7.5 20.1 9.5 8.5 9.6 11.3 9.6 10.4 13.1 5.0 8.7 9.2 15.6 19.7 12.8 9.2 14.9 10.8 8.9 17.9 9.4 5.7 8.4 7.2 12.0 16.3 10.5 17.8 6.3 4.3 7.2 9.9 10.7 3.9 7.2 23.9 8.8 14.4 8.2 17.2 9.6 14.4 19.1 9.7 18.6 22.2 21.4 19.2 11.8 18.9 25.7 22.6 7.0 15.9 10.4 11.6 21.4 10.9 19.3 21.2 27.7 22.9 18.4 16.9 17.9 17.1 22.1 23.3 MRPS34 "MGC2616, MRP-S12" ENSG00000074071 "Mitochondrial ribosomal protein S34" P82930 16 1771890-1773155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042112 Supported Supported Mitochondria Mitochondria "HPA042112: AB_10796899" "unprognostic (2.02e-1)" "unprognostic (4.83e-2)" "unprognostic (6.79e-2)" "unprognostic (3.42e-2)" "unprognostic (2.27e-1)" "unprognostic (9.59e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (3.52e-1)" "unprognostic (1.37e-2)" "unprognostic (6.60e-2)" "unprognostic (3.18e-1)" "unprognostic (5.44e-2)" 26.8 30.5 15.6 14.1 18.3 21.1 17.8 20.2 26.8 11.5 28.0 14.7 19.2 28.4 15.1 13.6 24.7 13.7 17.9 21.9 14.0 13.1 22.5 27.7 12.9 14.8 14.0 13.1 12.6 42.0 13.0 15.5 12.6 16.3 21.2 7.0 12.5 46.6 19.4 89.8 21.9 23.6 10.8 13.6 25.8 36.5 8.8 15.1 21.5 21.0 28.1 21.1 14.7 15.7 55.5 54.6 27.2 50.8 41.0 51.9 45.5 14.0 15.6 2.2 5.4 1.8 2.2 18.0 15.4 3.0 5.3 4.1 10.6 8.2 17.7 24.7 1.8 16.5 3.1 7.4 0.7 12.5 74.4 12.4 13.9 11.2 4.1 22.6 13.2 2.0 3.6 3.2 1.4 4.1 20.7 3.7 1.5 22.6 12.3 40.4 20.9 47.9 27.7 10.6 38.6 2.0 3.9 27.6 20.7 17.2 8.6 14.8 11.1 9.2 10.3 5.7 18.4 7.7 12.6 32.1 22.2 28.1 4.4 12.9 7.2 15.7 50.8 27.2 41.0 44.0 43.4 50.5 45.8 43.5 54.6 55.5 43.7 39.2 11.0 41.0 37.4 51.0 51.9 45.5 15.6 18.3 20.2 26.8 14.0 13.1 14.0 13.1 16.3 15.1 MRPS36 "DC47, MRP-S36" ENSG00000134056 "Mitochondrial ribosomal protein S36" P82909 5 69217760-69230129 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035802, HPA056795" Supported Enhanced Mitochondria Mitochondria "HPA035802: AB_10600933, HPA056795: " "unprognostic (1.19e-1)" "unprognostic (6.78e-3)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (2.96e-3)" "unprognostic (1.99e-1)" "unprognostic (7.49e-2)" "unprognostic (1.49e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (3.90e-1)" "prognostic favourable (5.02e-6)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.84e-3)" 13.6 13.7 16.7 9.1 21.4 12.8 13.8 10.4 24.8 8.0 16.8 4.7 12.6 17.1 9.1 11.7 14.4 8.2 10.9 42.8 17.6 13.5 34.8 26.5 17.0 12.2 16.3 14.3 8.8 21.7 11.7 10.4 9.3 17.7 10.8 17.8 6.4 9.6 9.5 29.8 8.1 20.9 13.9 11.4 8.0 13.9 6.8 10.0 10.8 12.7 22.3 11.5 9.9 9.0 27.9 24.4 24.7 27.5 21.5 34.7 14.9 15.8 15.3 10.8 14.8 19.1 19.4 28.6 14.2 13.7 18.3 22.7 21.2 17.8 17.1 29.7 12.0 16.3 18.0 21.6 18.2 20.0 18.9 11.6 18.1 23.5 22.6 12.3 15.9 20.1 15.5 17.4 8.3 13.5 13.7 12.9 16.1 17.2 18.8 18.9 8.0 17.9 11.2 18.9 26.1 31.5 18.0 15.2 14.8 14.6 21.4 24.6 16.4 18.0 9.7 8.2 14.0 18.1 24.3 13.6 22.2 22.7 14.3 23.2 10.7 24.4 20.4 24.7 21.4 27.5 23.6 27.9 24.5 23.9 24.4 22.4 22.2 23.4 22.0 21.5 24.7 24.1 34.7 14.9 16.7 21.4 10.4 24.8 17.6 13.5 16.3 14.3 17.7 10.0 MRPS5 "MRP-S5, S5mt" ENSG00000144029 "Mitochondrial ribosomal protein S5" P82675 2 95087207-95149434 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055765 Approved Supported Mitochondria Mitochondria "HPA055765: " "unprognostic (1.18e-1)" "unprognostic (7.79e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (7.98e-7)" "unprognostic (7.51e-3)" "unprognostic (6.30e-3)" "prognostic unfavourable (7.73e-5)" "unprognostic (8.59e-2)" "unprognostic (1.87e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-1)" "prognostic favourable (6.36e-4)" "unprognostic (1.25e-1)" 17.7 25.0 17.6 16.2 24.1 24.0 15.3 31.7 22.7 14.8 24.7 22.6 15.0 27.2 17.6 14.9 23.8 17.3 12.7 36.7 17.9 17.7 30.9 40.4 16.8 17.2 23.4 15.9 18.5 21.2 20.7 30.1 14.7 20.0 14.6 27.8 14.3 19.1 18.0 45.6 12.8 22.0 18.6 19.3 18.2 19.6 13.3 24.5 20.8 19.9 20.4 20.6 17.2 22.8 24.9 29.3 17.5 38.4 19.3 30.5 20.7 36.4 23.1 16.8 14.5 14.8 19.2 31.5 19.6 8.9 17.3 18.0 45.8 21.6 29.0 16.1 16.1 23.9 24.6 20.3 24.5 24.4 30.5 20.3 21.0 41.9 23.9 27.2 16.2 18.9 16.7 23.7 25.4 21.4 28.6 14.7 17.6 22.4 38.5 31.1 15.9 36.4 22.8 16.5 37.2 28.6 30.5 22.9 14.8 15.5 29.1 32.8 13.7 25.2 18.2 21.1 26.1 28.0 29.0 18.1 15.8 26.3 16.4 29.2 18.0 13.4 33.7 17.5 21.9 38.4 21.3 24.9 27.1 23.0 27.5 23.6 24.2 24.1 6.3 19.3 34.7 29.3 30.5 20.7 17.6 24.1 31.7 22.7 17.9 17.7 23.4 15.9 20.0 24.5 MRPS6 "C21orf101, MRP-S6, RPMS6" ENSG00000243927 "Mitochondrial ribosomal protein S6" P82932 21 34073224-34143034 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007861, HPA008163, HPA049676" Supported Supported Mitochondria Mitochondria "HPA007861: , HPA008163: , HPA049676: " "unprognostic (2.71e-2)" "unprognostic (4.85e-2)" "unprognostic (5.16e-3)" "unprognostic (4.01e-2)" "unprognostic (9.84e-3)" "unprognostic (3.72e-2)" "unprognostic (7.58e-3)" "unprognostic (1.80e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.87e-2)" "unprognostic (2.52e-1)" "unprognostic (1.02e-3)" "unprognostic (9.37e-2)" "unprognostic (5.13e-2)" "unprognostic (5.51e-2)" "prognostic favourable (1.06e-5)" 25.3 29.3 26.1 17.5 27.3 8.5 62.4 20.6 25.3 12.6 28.7 12.9 23.6 14.1 21.8 24.5 14.8 22.7 14.0 23.3 28.6 25.6 67.4 24.2 14.4 23.7 28.9 13.0 18.8 9.9 9.6 17.4 28.3 33.2 15.7 18.8 28.0 12.1 25.7 41.7 20.2 16.1 20.1 35.6 12.4 21.0 26.4 22.8 15.8 98.7 12.4 25.3 19.6 52.1 30.9 42.8 22.2 21.1 41.7 40.5 29.9 15.4 12.2 46.8 16.9 16.4 16.5 16.0 17.4 38.0 14.4 15.1 39.5 28.9 23.6 11.8 20.7 6.2 27.2 22.8 13.8 41.5 15.4 20.1 7.5 9.3 8.1 9.3 6.7 7.2 23.2 27.5 24.8 9.8 25.2 5.8 27.7 13.1 15.8 23.2 30.3 28.3 22.3 8.7 22.1 60.6 10.9 42.3 11.2 18.6 9.0 21.7 19.3 11.3 5.6 14.2 8.4 24.3 9.5 29.7 25.8 20.5 46.3 25.2 13.8 22.0 21.1 22.2 38.8 20.2 30.2 30.9 30.9 36.3 22.0 19.4 40.5 39.9 17.5 41.7 20.1 42.8 29.9 29.9 26.1 27.3 20.6 25.3 28.6 25.6 28.9 13.0 33.2 22.8 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105037983-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Enhanced Mitochondria Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 13.9 25.0 14.1 16.9 18.5 13.3 15.4 13.2 20.6 13.7 18.9 15.9 14.3 19.0 17.6 13.2 16.7 16.2 8.9 39.1 14.4 15.3 24.5 23.5 10.0 14.5 18.1 15.7 21.0 17.3 22.0 23.9 8.4 25.2 15.8 22.0 10.9 15.3 16.4 56.8 14.0 17.0 16.6 15.0 14.0 17.4 20.6 16.6 20.7 15.6 28.7 16.8 15.2 12.4 22.1 20.4 7.1 17.2 20.0 22.8 14.5 22.0 9.5 20.1 18.5 10.6 11.0 23.6 14.2 13.6 22.5 20.3 50.8 15.5 23.0 14.1 11.1 20.0 39.4 20.6 24.0 14.2 25.9 22.7 14.1 30.6 17.7 16.8 10.2 13.1 14.0 18.5 15.5 17.2 32.4 12.1 15.3 17.7 22.6 22.1 31.8 21.0 28.9 17.3 32.0 28.2 15.5 17.5 10.5 16.4 24.1 19.1 19.8 17.1 11.2 13.3 26.9 13.2 15.2 11.1 13.1 18.4 11.5 25.8 11.1 7.1 11.6 4.6 19.9 14.6 22.0 22.1 22.0 20.9 20.4 16.5 22.3 21.9 1.3 20.0 17.2 15.2 22.8 14.5 14.1 18.5 13.2 20.6 14.4 15.3 18.1 15.7 25.2 16.6 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell line enhanced" "Detected in all" "HeLa: 859.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria Mitochondria "CAB016241: AB_2229888, HPA069328: " "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favourable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 112.7 170.5 232.0 252.3 531.8 243.6 246.0 257.3 85.7 65.0 108.8 205.2 367.8 298.0 123.7 195.5 428.5 26.5 228.0 93.1 140.8 162.5 178.9 859.1 383.8 73.7 103.2 226.6 284.1 237.4 64.2 142.7 78.2 113.5 213.9 192.4 273.1 84.4 462.1 58.9 139.6 110.6 69.3 178.8 329.5 298.3 110.9 147.9 89.2 345.8 160.5 198.4 347.4 311.5 260.6 177.4 255.7 129.0 101.3 97.0 67.6 128.7 272.4 126.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642623 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Supported Mitochondria 55000 Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favourable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 13.6 19.6 15.6 12.8 20.3 8.3 12.5 14.1 21.3 10.4 22.3 19.3 8.7 28.3 12.6 15.1 21.6 9.9 11.6 15.0 14.0 13.8 40.8 74.8 9.1 13.9 15.2 12.2 9.3 14.4 16.8 9.3 9.5 15.4 11.8 24.7 13.6 13.4 10.0 31.4 12.1 33.9 16.1 11.4 11.4 10.1 44.2 10.2 15.1 15.5 24.9 16.4 11.6 10.7 13.7 25.7 7.9 21.3 12.1 13.6 17.5 19.0 20.9 17.9 24.1 21.2 19.6 13.2 20.6 18.9 27.9 26.5 16.5 19.4 26.3 11.2 25.3 24.0 32.1 27.2 34.1 13.1 29.9 15.0 29.8 33.0 29.2 31.3 15.2 22.2 21.5 18.5 27.8 25.2 27.8 15.8 34.0 27.7 23.9 23.5 19.3 31.7 22.4 27.2 18.9 32.3 24.7 21.3 15.0 28.3 28.6 14.6 41.1 14.7 20.9 25.8 22.5 42.6 26.5 16.9 19.1 29.7 21.3 27.3 23.0 5.9 19.8 7.9 12.7 21.3 12.0 13.7 11.1 11.7 25.7 10.9 9.7 11.2 1.9 12.1 17.0 16.9 13.6 17.5 15.6 20.3 14.1 21.3 14.0 13.8 15.2 12.2 15.4 10.2 MTERF1 MTERF ENSG00000127989 "Mitochondrial transcription termination factor 1" Q99551 7 91692008-91880720 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044894, HPA069560" Uncertain Supported Mitochondria Mitochondria "HPA044894: AB_10966284, HPA069560: " "unprognostic (5.57e-2)" "unprognostic (7.31e-2)" "unprognostic (2.15e-2)" "unprognostic (1.50e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (3.15e-3)" "unprognostic (1.25e-2)" "unprognostic (1.46e-3)" "unprognostic (7.62e-2)" "unprognostic (2.67e-1)" "unprognostic (5.19e-2)" "unprognostic (3.21e-2)" "unprognostic (1.14e-1)" "unprognostic (3.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" 8.9 11.5 16.1 10.9 18.1 13.9 14.4 23.2 18.9 10.4 11.8 12.1 10.0 11.5 11.6 11.0 13.4 9.8 8.3 8.7 15.2 10.5 13.2 17.6 8.3 19.4 20.3 13.1 14.7 11.4 10.0 18.0 10.6 18.8 11.6 12.1 8.5 12.5 9.2 9.3 9.9 13.6 9.7 22.7 17.6 12.5 10.0 18.5 11.9 12.2 10.3 19.0 12.0 11.4 15.0 9.4 24.8 8.8 9.8 19.0 10.0 10.3 9.0 8.7 5.8 8.5 8.9 7.6 8.8 9.0 9.5 11.8 10.9 9.9 21.3 7.3 7.0 9.2 13.0 7.9 13.6 1.2 9.5 9.7 9.8 8.5 7.6 17.0 10.7 10.6 10.5 10.5 11.2 8.2 17.5 8.9 11.1 13.2 17.8 19.5 13.1 10.1 5.1 11.6 14.6 9.8 11.3 8.1 15.4 8.9 18.8 17.8 6.6 12.2 5.3 11.3 13.9 15.3 8.9 12.7 12.8 28.9 8.2 5.6 15.8 24.8 8.8 11.9 10.6 7.5 12.7 14.6 13.8 15.2 9.4 15.0 19.0 15.1 4.2 9.8 8.2 7.4 13.2 10.0 16.1 18.1 23.2 18.9 15.2 10.5 20.3 13.1 18.8 18.5 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002966 Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA002966: AB_2147359" "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavourable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 19.3 12.5 18.7 14.8 13.4 13.9 8.5 14.9 12.3 21.9 22.1 8.9 14.4 17.4 31.5 8.7 10.9 19.3 11.6 26.7 16.7 14.2 24.9 9.6 10.7 18.8 8.4 10.2 13.9 17.4 17.7 16.7 17.8 20.9 9.2 21.9 12.5 35.6 24.8 9.8 19.4 21.6 15.3 13.6 16.0 10.3 12.8 10.1 11.1 3.2 15.8 16.8 11.9 7.9 15.4 10.4 17.7 13.1 10.5 13.1 20.2 16.7 22.5 20.1 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favourable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 14.2 15.5 14.4 17.6 22.1 17.2 18.6 42.2 21.7 16.2 14.6 25.3 12.5 13.4 23.2 14.1 17.6 17.7 12.1 13.4 14.4 12.1 13.4 16.5 14.2 29.8 19.2 19.4 25.7 20.9 11.7 25.7 11.6 20.4 28.9 17.2 16.3 19.5 18.1 38.8 15.5 19.6 17.3 17.8 20.3 14.7 12.7 22.3 23.7 29.4 20.5 29.7 14.3 15.2 16.6 6.2 11.4 5.4 8.0 24.9 10.2 8.6 8.2 16.3 9.4 22.2 9.9 12.1 14.7 16.4 14.3 20.3 5.6 13.0 13.4 5.3 17.0 9.7 22.2 21.0 19.3 18.1 16.0 17.1 15.7 24.7 14.5 20.4 13.1 16.9 20.6 16.7 19.3 16.3 15.2 5.9 17.1 12.2 14.9 14.1 18.6 14.1 14.6 18.5 7.5 13.6 17.3 14.9 12.9 12.0 14.9 11.1 11.0 10.6 22.4 13.2 12.8 15.4 13.1 15.8 4.0 32.7 11.1 12.9 12.1 4.2 5.4 11.4 10.0 5.2 12.5 16.6 15.5 13.7 6.2 15.4 24.9 19.5 1.9 8.0 4.4 4.7 15.8 10.2 14.4 22.1 42.2 21.7 14.4 12.1 19.2 19.4 20.4 22.3 MTFR1 "CHPPR, FAM54A2, KIAA0009" ENSG00000066855 "Mitochondrial fission regulator 1" Q15390 8 65644734-65771261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023152, HPA056120" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA023152: AB_1854176, HPA056120: " "prognostic unfavourable (4.06e-4)" "unprognostic (4.58e-2)" "unprognostic (4.01e-2)" "unprognostic (4.57e-2)" "unprognostic (6.56e-3)" "unprognostic (3.93e-2)" "unprognostic (1.66e-1)" "unprognostic (3.28e-2)" "unprognostic (1.50e-1)" "unprognostic (3.53e-1)" "unprognostic (5.69e-3)" "unprognostic (5.44e-2)" "unprognostic (6.63e-3)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (5.21e-4)" "unprognostic (8.25e-2)" 10.7 17.7 6.6 5.5 11.7 3.9 9.5 10.1 8.8 9.7 10.7 10.8 14.2 11.1 9.9 11.9 12.3 7.2 6.2 8.7 6.8 5.5 28.4 37.7 7.1 3.9 10.3 5.4 7.9 19.1 8.0 15.0 16.2 9.7 8.1 11.2 14.8 11.0 11.5 11.7 8.3 16.2 8.8 11.3 6.5 13.2 16.8 11.7 5.4 13.0 11.2 9.3 10.5 9.7 1.7 3.1 4.3 2.8 0.8 2.9 1.7 14.4 10.8 8.5 10.0 12.0 11.7 6.9 9.5 8.8 11.9 12.5 9.2 15.1 8.1 3.1 9.2 9.5 19.5 13.0 16.1 2.9 10.5 10.0 8.0 18.4 14.9 2.6 4.9 8.0 14.0 15.2 48.7 14.4 13.6 8.4 13.7 13.0 8.8 6.1 9.1 9.7 4.5 11.8 6.7 14.6 13.1 3.8 5.7 9.6 16.3 12.6 17.9 5.7 10.8 7.2 10.0 17.1 8.2 8.2 5.3 5.9 8.8 10.6 9.5 4.3 2.8 1.2 2.0 2.5 2.9 1.7 2.6 2.2 3.1 1.4 2.6 2.9 0.7 0.8 1.2 1.9 2.5 1.7 6.6 11.7 10.1 8.8 6.8 5.5 10.3 5.4 9.7 11.7 MTG1 GTPBP7 ENSG00000148824 "Mitochondrial ribosome associated GTPase 1" Q9BT17 10 133394094-133421307 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA037826, HPA037827" Approved Supported Mitochondria Mitochondria "HPA037826: , HPA037827: AB_10670959" "unprognostic (2.94e-2)" "unprognostic (8.08e-2)" "unprognostic (5.90e-3)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-2)" "unprognostic (5.85e-2)" "unprognostic (6.20e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-1)" "prognostic favourable (5.08e-4)" "unprognostic (4.63e-3)" "prognostic unfavourable (6.79e-7)" "unprognostic (3.88e-2)" "unprognostic (5.96e-2)" "unprognostic (5.19e-2)" "prognostic favourable (1.03e-5)" 14.5 29.4 16.5 20.2 19.0 14.8 17.9 23.9 19.2 16.1 19.7 23.0 16.7 26.6 19.9 13.5 21.7 20.5 17.9 14.1 14.4 13.1 26.6 47.0 14.4 19.3 17.3 14.5 20.0 27.9 18.1 22.3 16.6 16.4 19.8 16.4 16.9 23.8 24.4 26.4 18.2 22.5 17.7 14.1 27.3 21.3 29.1 20.8 21.3 19.5 12.3 21.2 15.1 15.8 22.9 20.2 10.4 18.2 21.0 14.2 9.9 16.5 20.3 12.8 27.6 7.8 6.1 18.3 9.8 10.5 18.4 15.6 25.7 12.0 12.3 15.0 10.0 14.3 14.0 19.5 8.7 11.5 18.5 11.9 10.5 23.1 19.7 8.7 13.0 15.6 11.0 17.4 28.0 26.4 10.4 2.1 14.1 21.2 8.5 12.2 17.2 7.0 12.0 12.2 2.9 16.1 13.5 4.8 15.9 13.9 14.5 21.5 13.2 13.0 14.9 6.5 12.2 6.6 11.1 4.0 2.8 17.5 11.7 7.9 9.1 0.2 10.6 10.4 13.9 16.1 14.2 18.7 12.4 11.6 9.7 22.9 9.7 10.2 1.5 21.0 18.2 20.2 12.5 9.9 16.5 19.0 23.9 19.2 14.4 13.1 17.3 14.5 16.4 20.8 MTHFD1L "DKFZP586G1517, FLJ21145, FTHFSDC1" ENSG00000120254 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like" Q6UB35 6 150865549-151101887 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "One-carbon metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015006, HPA029040, HPA029041, HPA050052, HPA074911" Approved Supported Mitochondria Mitochondria "HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: , HPA074911: " "unprognostic (3.66e-2)" "prognostic unfavourable (1.68e-5)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.28e-4)" "unprognostic (3.25e-1)" "prognostic unfavourable (5.10e-4)" "prognostic unfavourable (8.33e-5)" "unprognostic (6.35e-3)" "unprognostic (2.45e-1)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "unprognostic (2.93e-2)" "unprognostic (3.51e-1)" "unprognostic (2.91e-1)" "prognostic unfavourable (8.69e-5)" 10.4 10.6 8.0 12.1 8.1 12.2 7.1 32.4 10.5 6.5 6.2 7.8 10.2 3.4 8.5 7.2 6.4 8.0 7.3 10.7 7.5 7.9 9.5 6.9 17.1 11.0 12.3 7.6 22.2 13.7 7.1 9.1 15.5 8.5 5.0 9.1 12.7 3.4 10.5 2.5 5.7 4.7 10.9 10.2 8.7 5.6 13.6 6.6 6.7 12.2 5.0 11.4 8.7 5.1 1.1 3.0 0.2 0.8 1.0 5.0 0.6 11.8 10.3 13.5 33.2 3.5 12.4 33.0 18.7 20.5 18.9 23.2 20.8 11.2 43.8 12.5 28.5 12.7 21.6 18.2 23.4 18.0 19.6 18.3 18.4 19.0 22.3 33.3 3.0 14.6 23.3 18.2 33.3 31.4 43.2 23.0 19.4 25.0 16.3 6.9 13.7 9.6 19.6 10.1 19.5 12.7 5.8 13.5 10.0 24.7 11.0 15.3 3.4 23.3 23.8 12.6 27.7 28.0 26.5 19.1 17.8 45.7 21.0 31.2 16.3 0.2 0.7 0.0 0.8 0.8 1.3 0.8 1.9 2.1 3.0 1.1 1.8 1.9 0.0 1.0 0.8 1.5 5.0 0.6 8.0 8.1 32.4 9.5 7.5 7.9 12.3 7.6 8.5 6.6 MTIF2 IF-2mt ENSG00000085760 "Mitochondrial translational initiation factor 2" P46199 2 55236595-55269347 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006021, HPA061422" Uncertain Enhanced Mitochondria Mitochondria "HPA006021: AB_2147687, HPA061422: " "unprognostic (2.91e-2)" "unprognostic (9.58e-2)" "unprognostic (1.52e-2)" "unprognostic (1.87e-3)" "unprognostic (8.86e-2)" "unprognostic (5.57e-2)" "unprognostic (9.76e-3)" "unprognostic (1.88e-1)" "unprognostic (6.85e-3)" "unprognostic (3.01e-2)" "unprognostic (6.58e-3)" "unprognostic (1.76e-1)" "unprognostic (3.98e-2)" "unprognostic (2.54e-2)" "unprognostic (1.66e-1)" "unprognostic (9.45e-3)" "unprognostic (1.33e-1)" 13.8 17.8 13.6 12.0 15.8 9.6 15.5 9.4 17.7 12.0 21.1 11.2 17.7 21.0 10.0 15.9 17.5 10.6 11.2 24.5 13.5 12.1 27.4 32.2 10.6 17.5 15.5 11.8 10.4 24.6 20.2 20.2 12.5 22.6 12.2 25.1 9.7 16.3 14.3 31.5 12.3 26.9 15.0 16.9 16.3 16.3 9.0 14.6 16.1 20.6 27.1 15.2 14.5 11.6 9.6 13.9 9.4 12.8 17.2 12.7 6.9 15.2 14.8 8.8 15.0 10.9 15.0 20.1 14.1 11.3 13.6 11.9 17.6 14.8 25.2 26.7 12.9 13.7 20.8 20.2 22.5 27.9 16.1 23.2 11.6 32.4 20.9 36.5 13.8 16.4 21.0 18.8 39.4 10.9 41.0 14.4 14.1 12.7 11.2 24.6 18.7 18.3 11.9 28.2 24.3 13.2 13.5 15.8 10.1 12.5 20.7 25.4 11.0 12.2 10.7 14.2 16.4 16.9 23.0 27.1 24.2 6.9 15.1 27.3 11.2 5.4 11.0 9.4 10.1 12.8 12.6 8.3 10.3 9.4 13.9 9.6 12.5 12.7 4.2 17.2 10.7 6.8 11.7 6.9 13.6 15.8 9.4 17.7 13.5 12.1 15.5 11.8 22.6 14.6 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favourable (8.41e-4)" 36.9 30.4 29.8 21.9 26.3 8.5 28.4 22.8 26.7 21.5 24.8 16.9 25.9 23.7 15.1 38.5 25.5 16.5 20.5 55.7 27.5 22.8 41.5 38.7 15.1 22.2 28.9 19.7 23.1 28.3 14.5 40.3 20.2 28.3 22.7 24.8 17.4 43.3 28.1 46.1 21.6 29.7 18.2 28.7 24.9 22.7 28.3 26.2 29.7 22.9 38.5 24.0 27.8 16.4 25.3 44.3 35.9 26.5 18.5 24.1 19.4 13.4 9.4 21.1 10.6 23.7 35.6 10.8 19.9 21.8 14.6 14.9 12.4 16.6 14.7 13.5 21.6 11.6 11.4 15.6 20.2 15.4 14.1 18.6 8.6 15.5 23.1 19.2 17.8 19.9 28.8 12.0 15.3 25.4 10.6 5.9 22.2 23.7 16.8 23.5 11.0 10.7 9.9 11.5 16.8 30.2 13.8 15.6 9.5 12.1 17.7 22.5 13.8 29.0 17.3 9.9 5.9 25.5 13.5 4.6 6.4 8.5 10.3 19.4 14.1 34.2 26.5 35.9 17.1 25.5 18.4 25.3 21.8 17.2 27.9 21.7 19.3 19.6 17.7 18.5 22.1 44.3 24.1 19.4 29.8 26.3 22.8 26.7 27.5 22.8 28.9 19.7 28.3 26.2 MTPAP "FLJ10486, mtPAP, PAPD1, SPAX4" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria Mitochondria "HPA038620: AB_10673015, HPA058232: " "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 10.9 12.7 9.9 10.2 12.4 32.8 11.1 12.4 16.1 9.6 9.9 7.3 6.5 11.0 10.4 7.0 12.6 9.5 7.6 11.5 7.8 7.2 10.6 11.1 9.4 10.5 11.9 13.0 11.4 18.9 9.5 7.2 10.0 11.4 8.0 12.0 8.2 10.7 10.2 22.3 13.1 10.0 14.3 9.0 9.3 9.7 10.6 8.3 6.7 11.0 12.4 10.5 11.7 9.1 15.6 22.9 18.4 24.4 16.9 17.1 8.3 14.2 14.2 9.0 13.1 8.9 8.4 11.7 9.9 3.5 10.1 10.6 15.0 20.0 20.3 7.1 6.5 16.8 17.4 11.5 12.4 10.2 13.6 20.6 13.4 15.1 9.3 13.4 16.2 8.2 10.8 11.3 6.8 11.0 22.2 16.0 7.6 11.9 16.1 11.9 6.1 7.7 16.3 16.0 18.9 9.3 9.5 14.9 12.0 9.0 9.4 13.8 9.0 8.7 10.5 10.7 13.8 14.9 11.0 3.6 8.6 27.8 9.2 24.7 3.7 16.4 18.5 18.4 16.2 24.4 17.1 15.6 15.4 15.6 22.9 13.1 16.7 16.8 3.0 16.9 18.1 12.0 15.5 8.3 9.9 12.4 12.4 16.1 7.8 7.2 11.9 13.0 11.4 8.3 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208699-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Supported Mitochondria Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavourable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 15.4 19.8 11.6 9.9 12.6 22.9 15.8 5.7 18.1 15.8 15.9 12.2 14.8 12.4 14.9 13.9 18.0 21.4 13.5 11.8 10.8 10.0 24.4 36.4 12.8 18.7 11.8 12.9 14.0 26.3 23.4 12.0 28.4 11.7 12.3 12.7 14.6 20.7 19.2 10.4 13.8 13.7 12.7 10.2 17.1 14.7 60.0 9.0 14.5 19.3 14.3 18.0 11.6 11.5 14.4 23.1 43.8 26.8 12.2 14.0 14.4 17.2 28.4 9.1 12.9 17.0 15.4 28.8 8.9 18.1 26.6 18.5 35.3 28.9 14.2 29.6 20.5 17.3 13.3 25.2 9.7 10.4 31.4 9.0 22.7 34.0 26.9 16.6 12.7 19.6 23.6 27.4 18.5 23.4 18.2 7.1 15.7 41.9 18.6 20.9 18.1 33.0 15.4 5.7 33.8 23.9 15.0 14.9 18.5 11.1 35.2 10.2 28.5 27.0 9.7 12.7 14.4 8.4 15.0 13.7 11.4 14.5 16.8 8.6 13.5 10.2 26.8 6.3 9.8 13.7 9.2 14.4 12.1 10.3 23.1 12.4 12.1 10.9 43.8 12.2 7.9 12.4 14.0 14.4 11.6 12.6 5.7 18.1 10.8 10.0 11.8 12.9 11.7 9.0 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavourable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 13.2 26.4 21.3 12.0 22.3 5.5 18.8 15.0 44.9 13.0 20.7 18.5 16.6 15.4 15.5 27.9 22.2 20.0 12.0 33.6 23.6 26.3 31.5 20.2 10.6 8.9 21.5 16.5 13.2 16.4 23.7 25.7 17.3 21.8 18.9 24.6 16.3 24.7 16.5 45.0 12.5 14.8 17.6 25.7 9.4 14.6 40.6 14.0 10.2 14.7 19.8 13.6 14.4 13.6 16.2 12.1 4.7 12.6 15.1 13.4 7.9 17.8 10.6 21.6 13.2 14.5 16.8 20.8 19.3 18.1 17.7 20.7 18.2 19.5 22.9 32.7 17.0 12.1 23.5 23.7 24.4 22.7 17.0 21.8 13.4 32.1 23.0 33.7 7.4 18.7 29.6 18.5 32.0 25.2 28.9 17.8 20.8 16.3 11.8 34.3 20.6 16.8 0.0 15.7 20.4 50.2 32.5 30.9 26.5 16.1 21.5 39.7 12.0 22.0 22.1 17.7 15.7 18.5 20.1 20.0 20.8 27.4 22.0 17.0 21.4 4.7 7.7 3.2 8.5 12.6 11.5 16.2 10.9 9.6 12.1 11.4 13.2 13.4 0.0 15.1 10.9 9.8 13.4 7.9 21.3 22.3 15.0 44.9 23.6 26.3 21.5 16.5 21.8 14.0 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favourable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 16.9 16.4 9.5 19.6 20.6 11.6 10.3 16.9 20.2 21.0 20.3 10.1 28.2 12.8 18.9 23.8 25.9 17.0 24.4 15.3 12.7 13.5 9.8 11.1 14.6 24.3 13.4 16.8 18.9 32.2 21.5 22.4 13.7 12.7 15.6 22.8 8.6 8.0 9.0 9.7 15.7 7.9 11.9 16.5 24.7 9.5 9.7 14.3 15.1 16.2 20.7 11.4 12.9 15.4 20.5 11.8 17.8 15.1 18.3 15.9 13.8 16.1 18.2 19.0 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 MYO19 "FLJ22865, MYOHD1" ENSG00000278259 "Myosin XIX" Q96H55 17 36495633-36543435 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059715 Approved Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA059715: " "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (8.44e-3)" "unprognostic (1.46e-1)" "unprognostic (2.02e-1)" "unprognostic (4.89e-3)" "prognostic unfavourable (8.33e-6)" "unprognostic (1.07e-3)" "unprognostic (1.39e-2)" "unprognostic (2.41e-1)" "unprognostic (1.67e-1)" "unprognostic (3.70e-3)" "unprognostic (1.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.57e-1)" "unprognostic (1.89e-1)" "unprognostic (4.17e-2)" 5.2 1.9 3.1 5.4 6.2 7.8 4.7 2.7 6.5 4.7 7.7 7.0 6.8 7.5 4.3 4.1 9.8 3.4 4.1 1.4 4.7 5.7 7.0 3.8 5.2 6.1 3.1 2.9 5.8 9.8 7.2 8.1 5.0 2.8 11.2 4.8 9.5 9.3 6.3 13.1 7.9 5.2 5.4 3.0 8.3 8.0 5.7 5.8 4.2 5.6 7.2 3.3 2.8 2.2 3.4 1.7 1.7 3.7 3.9 1.4 13.8 17.0 8.1 9.3 4.5 4.5 9.9 13.8 11.0 22.0 22.5 16.8 14.5 8.7 5.5 9.4 21.0 19.2 14.5 15.8 6.2 13.0 13.9 18.6 10.5 3.0 13.5 15.2 4.2 7.2 15.7 17.2 9.8 16.3 9.2 11.1 10.5 9.4 11.0 9.0 10.0 10.9 13.1 10.3 10.3 11.3 14.0 8.7 18.4 11.3 5.8 18.5 5.5 6.3 12.4 14.0 16.8 24.3 7.1 14.0 8.0 7.7 8.3 14.4 1.7 1.7 1.7 3.8 1.2 2.8 2.2 2.4 2.6 3.4 1.7 1.7 3.9 0.1 3.7 0.5 1.9 2.0 1.4 NAGS "AGAS, ARGA, NAT7" ENSG00000161653 "N-acetylglutamate synthase" Q8N159 17 44004546-44009063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Urea cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.4;liver: 30.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.3;HHSteC: 6.4;TIME: 7.9;U-87 MG: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA027300 Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA027300: " "unprognostic (1.51e-3)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (8.67e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.38e-2)" "unprognostic (1.98e-1)" "unprognostic (3.14e-2)" "unprognostic (2.73e-2)" "unprognostic (2.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.19e-2)" "unprognostic (6.99e-2)" "unprognostic (1.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" 0.6 0.6 0.5 0.4 2.4 0.0 1.0 0.7 1.5 0.3 7.2 0.5 5.6 16.4 0.5 2.6 0.9 0.3 0.3 0.9 0.7 1.5 4.4 30.2 2.5 0.2 1.8 0.6 0.5 0.3 3.6 0.4 0.4 1.2 0.8 0.4 0.1 0.9 6.5 0.1 0.6 13.4 0.3 2.0 0.5 0.3 0.4 1.1 0.2 2.9 0.0 0.1 0.8 0.8 1.5 2.0 2.3 2.7 1.0 3.5 1.3 3.4 0.2 0.0 0.5 0.0 6.3 0.1 0.6 0.0 0.2 0.0 2.2 0.8 0.0 1.3 0.0 1.4 0.0 1.2 0.1 0.3 0.8 0.1 0.2 2.6 6.4 0.0 0.0 2.7 0.1 0.2 0.0 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.1 0.2 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.2 0.1 7.9 3.0 0.8 0.2 0.7 0.2 0.2 0.2 11.9 0.1 0.4 1.8 1.4 2.3 3.5 1.5 2.8 1.2 2.2 2.9 2.0 1.5 1.1 1.7 0.8 1.0 2.7 0.3 1.7 1.3 0.5 2.4 0.7 1.5 0.7 1.5 1.8 0.6 1.2 1.1 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA029768: , HPA054359: " "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favourable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 34.5 37.3 26.7 28.4 32.2 20.4 33.4 27.3 24.9 19.2 23.9 20.8 28.9 28.1 42.1 28.5 33.4 37.4 26.2 22.0 38.9 51.7 29.2 68.1 46.7 25.0 44.6 32.5 33.2 35.7 20.4 15.9 23.8 15.8 43.8 26.3 61.1 31.7 42.3 39.4 66.7 32.1 25.4 84.6 57.8 49.2 19.5 25.7 56.1 69.6 37.4 17.6 52.6 30.6 16.4 16.6 34.0 53.2 40.4 50.0 36.8 29.7 53.0 20.2 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025402 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" 12000 Mitochondria "CAB070846: AB_11152346, HPA059529: , HPA067045: " "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favourable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 19.0 37.5 19.7 18.2 30.4 20.3 19.5 26.2 31.5 14.5 31.0 24.5 18.6 30.4 14.8 18.4 28.5 18.8 17.1 66.0 28.6 18.7 36.3 40.6 13.1 13.8 21.4 27.7 19.8 23.5 25.1 15.5 15.9 33.4 13.7 34.7 16.2 20.6 26.7 67.0 26.1 24.3 18.6 27.0 13.8 24.9 15.4 19.8 13.2 16.9 34.1 20.2 19.3 17.7 24.6 35.7 11.0 27.7 21.2 24.6 24.5 16.8 16.6 12.3 20.7 14.9 24.8 20.2 14.3 18.5 20.7 20.8 16.5 21.1 12.5 6.6 15.9 22.6 27.8 25.7 26.5 16.6 18.4 16.4 15.6 35.3 22.5 22.4 13.3 24.1 21.0 16.5 22.6 26.2 24.9 8.8 22.1 25.8 21.2 23.0 14.5 18.0 21.7 27.5 21.9 29.3 33.1 19.5 12.8 14.1 32.0 22.3 29.8 22.7 16.3 14.8 15.0 18.7 15.9 15.2 6.8 19.9 16.0 20.5 17.6 6.3 26.1 11.0 18.9 27.7 24.6 24.6 19.1 20.5 35.7 18.3 19.0 19.0 5.8 21.2 23.4 12.7 22.0 24.5 19.7 30.4 26.2 31.5 28.6 18.7 21.4 27.7 33.4 19.8 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria Mitochondria "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 40.9 44.6 37.3 26.5 30.6 28.5 27.7 19.6 28.8 42.8 38.8 55.0 21.2 47.2 11.6 29.9 31.0 38.3 45.2 48.6 40.6 46.0 39.4 37.2 55.4 31.5 55.9 48.2 30.6 57.1 35.9 44.0 35.0 36.8 21.9 41.4 59.5 38.7 86.5 28.3 77.6 29.6 32.3 53.8 41.9 61.6 35.5 21.5 33.2 48.4 25.4 47.8 36.9 40.0 22.7 23.1 33.0 33.3 35.9 53.2 72.0 13.6 46.8 34.7 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.7 24.9 46.0 45.8 47.0 38.2 43.2 40.2 44.5 45.3 44.3 40.3 50.7 44.9 94.6 48.5 27.4 32.6 43.6 18.7 27.4 73.7 34.3 39.7 49.4 42.1 64.4 48.4 51.2 39.7 31.8 36.7 32.6 37.8 64.3 36.0 67.1 76.4 64.0 46.9 69.4 43.9 29.9 68.6 66.1 48.5 43.8 55.4 40.9 48.2 40.0 29.8 88.7 33.9 44.5 15.1 51.8 49.9 45.8 36.0 48.3 39.2 50.0 32.4 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Supported Mitochondria 18000 Mitochondria "HPA055323: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favourable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 12.6 21.8 37.2 42.7 21.1 19.8 17.1 16.1 15.3 15.1 13.3 27.3 34.8 24.7 15.3 23.1 22.4 24.7 19.1 16.5 12.2 18.0 20.7 25.6 25.4 18.4 28.5 20.4 21.3 19.3 18.5 16.4 21.0 30.7 33.6 31.5 24.4 12.7 25.1 40.7 44.2 17.3 26.5 27.7 38.3 27.5 23.3 24.2 25.5 73.5 14.5 46.4 35.0 18.3 18.1 24.9 25.9 26.5 20.4 26.1 28.3 24.9 30.9 56.0 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 NDUFA7 B14.5a ENSG00000267855 "NADH:ubiquinone oxidoreductase subunit A7" O95182 19 8308768-8321396 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA059251, HPA071866" Enhanced Supported Mitochondria Mitochondria "HPA059251: AB_2683960, HPA071866: " "unprognostic (6.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (3.85e-1)" "unprognostic (2.18e-1)" "unprognostic (5.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (3.40e-1)" "unprognostic (1.13e-3)" "unprognostic (1.81e-2)" "unprognostic (1.43e-1)" "unprognostic (1.09e-2)" "unprognostic (5.53e-2)" "unprognostic (1.29e-2)" "unprognostic (2.59e-2)" "unprognostic (9.35e-3)" 17.7 30.0 28.0 15.5 30.5 15.3 18.9 15.4 32.0 9.0 17.2 11.3 15.7 12.6 9.9 32.1 18.9 26.2 16.1 69.1 22.1 21.0 26.5 30.9 20.3 22.1 25.9 19.7 10.1 28.5 11.9 30.2 13.0 26.7 20.5 17.6 16.7 23.0 20.7 110.6 16.2 16.0 13.1 18.5 14.7 19.3 13.8 11.1 19.3 22.0 47.5 16.8 14.3 9.1 30.6 65.5 25.1 39.7 24.9 33.5 26.7 15.5 13.3 17.0 8.7 11.6 6.2 9.6 4.4 5.8 16.7 11.2 14.1 13.2 8.8 6.9 10.7 13.6 7.7 23.4 7.9 23.0 48.6 6.5 20.5 33.3 18.1 9.8 9.0 12.5 15.2 9.0 8.3 19.5 11.1 45.9 20.8 17.0 18.7 48.6 13.7 50.9 10.4 3.1 19.1 34.0 9.3 14.3 10.9 6.4 20.0 11.1 7.5 16.2 5.7 9.4 7.6 13.2 12.6 17.9 13.8 10.6 13.4 17.0 14.8 14.2 38.9 25.1 22.6 39.7 24.4 29.9 24.7 22.2 47.9 30.6 24.1 23.4 9.7 24.9 34.4 65.5 33.5 26.7 28.0 30.5 15.4 32.0 22.1 21.0 25.9 19.7 26.7 11.1 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favourable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 19.4 36.0 23.9 31.4 25.8 23.7 29.6 22.6 26.9 31.1 26.2 45.6 19.4 28.4 22.4 26.4 48.9 45.2 48.9 30.6 27.8 31.3 22.4 60.4 39.3 27.8 39.5 23.1 25.9 47.9 31.1 20.0 44.6 34.1 21.4 35.4 49.4 24.5 25.7 21.8 69.3 19.6 37.7 41.4 44.7 27.0 41.4 16.3 35.6 42.3 28.1 44.8 19.1 28.9 17.3 17.4 32.4 25.3 24.2 39.0 28.1 36.0 25.6 28.5 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA042268: AB_2677922, HPA073212: " "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favourable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.7 19.5 9.6 12.7 7.1 7.1 27.9 8.3 8.4 16.0 12.2 42.2 21.7 12.2 4.4 8.9 18.2 13.9 12.2 10.5 23.6 24.4 11.9 20.7 31.9 15.6 17.4 12.9 9.0 11.9 10.9 14.9 12.0 8.3 23.1 11.8 20.9 17.3 20.0 24.8 16.2 24.5 14.2 12.7 22.0 24.7 7.0 7.8 10.4 28.1 14.5 5.8 16.6 8.4 12.2 24.8 11.1 19.1 4.5 5.3 20.1 12.7 10.8 13.3 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054364 Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA054364: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favourable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 27.7 20.5 25.7 22.9 18.3 19.9 35.8 21.4 15.9 21.6 17.8 17.8 22.6 46.0 35.2 15.4 23.0 44.7 25.4 17.1 26.0 51.6 24.7 36.8 87.3 19.2 45.7 20.5 18.4 35.4 15.9 17.2 27.4 51.6 23.4 23.3 42.0 35.4 69.6 66.8 47.7 48.7 28.9 62.5 19.8 25.0 35.4 27.6 23.9 43.9 40.0 35.4 38.3 21.5 19.8 20.9 19.2 29.3 29.9 43.4 51.5 22.2 37.1 22.4 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 NDUFAF2 "B17.2L, mimitin, MMTN, NDUFA12L" ENSG00000164182 "NADH:ubiquinone oxidoreductase complex assembly factor 2" Q8N183 5 60945129-61153037 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048082, HPA054776" Supported Enhanced Mitochondria Mitochondria "HPA048082: AB_2680254, HPA054776: AB_2682598" "unprognostic (7.28e-2)" "unprognostic (6.83e-2)" "unprognostic (1.37e-1)" "unprognostic (2.46e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (2.56e-4)" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (8.40e-3)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (1.79e-2)" "unprognostic (6.10e-2)" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" 25.5 25.9 22.5 16.7 24.9 11.4 27.1 13.6 24.4 16.9 20.5 11.7 8.2 16.0 16.3 12.2 19.3 12.6 15.0 33.6 19.9 21.2 19.1 27.2 11.9 13.4 20.5 14.2 23.5 41.2 14.2 25.3 9.8 18.5 19.0 18.2 13.2 16.0 16.8 56.3 12.9 13.3 23.9 18.3 10.0 17.2 20.1 12.6 4.9 17.7 16.0 12.3 26.9 19.5 15.9 20.9 1.5 13.1 17.3 20.3 9.1 31.0 16.4 11.3 36.5 22.1 31.3 21.4 36.4 19.4 23.1 28.4 27.3 22.5 39.1 37.7 24.7 12.9 19.4 31.8 28.7 20.7 27.8 13.5 29.3 25.5 33.3 19.5 8.0 16.9 34.4 21.0 63.9 20.6 22.2 20.9 24.1 24.6 17.3 28.8 9.4 39.0 19.1 31.2 53.0 22.0 13.4 23.9 10.7 22.7 19.7 35.3 23.5 13.8 19.1 16.7 25.4 35.8 40.2 15.3 22.0 43.0 22.1 35.1 19.3 0.0 13.1 1.5 12.5 11.9 14.3 15.9 15.9 14.6 20.9 11.0 13.9 14.3 0.6 17.3 9.1 7.5 20.3 9.1 22.5 24.9 13.6 24.4 19.9 21.2 20.5 14.2 18.5 12.6 NDUFAF4 "bA22L21.1, C6orf66, HRPAP20, HSPC125, My013" ENSG00000123545 "NADH:ubiquinone oxidoreductase complex assembly factor 4" Q9P032 6 96889313-96897881 "Disease related genes, Predicted intracellular proteins" Calmodulin-binding "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046560 Uncertain Supported Mitochondria Mitochondria "HPA046560: AB_10966700" "prognostic unfavourable (1.31e-4)" "unprognostic (1.32e-1)" "unprognostic (1.09e-2)" "unprognostic (1.14e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (6.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (2.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" 7.9 10.1 16.1 5.4 19.0 2.7 9.0 20.4 27.4 8.9 9.1 5.0 5.7 6.2 7.3 6.4 7.1 6.0 6.0 30.2 18.7 17.3 17.3 18.1 4.3 5.4 18.1 12.3 10.4 7.2 7.3 6.5 6.1 28.5 9.5 9.7 4.5 7.7 12.8 25.0 6.2 6.5 7.3 9.6 7.6 6.4 5.7 8.4 4.9 9.5 11.2 5.8 8.2 5.1 6.4 4.5 0.6 4.3 3.3 10.0 4.1 1.5 4.2 7.4 9.9 7.4 4.3 3.9 4.1 3.9 6.1 4.7 5.7 2.6 13.9 7.5 3.8 3.0 17.1 6.3 6.0 9.7 13.5 15.4 2.3 4.9 8.0 16.1 6.5 4.0 9.9 5.3 5.4 4.8 13.8 9.5 9.6 4.7 10.3 8.7 14.0 6.9 4.9 4.1 7.1 10.2 4.1 12.6 5.9 2.1 7.5 11.7 2.3 10.8 4.0 3.2 2.4 11.3 6.7 2.2 3.5 13.7 4.4 12.1 4.7 0.2 2.2 0.6 5.1 4.3 6.6 6.4 6.7 6.7 3.8 6.3 10.0 8.8 0.4 3.3 2.6 4.5 6.8 4.1 16.1 19.0 20.4 27.4 18.7 17.3 18.1 12.3 28.5 8.4 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "HPA063737: " "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favourable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.9 56.7 46.1 29.7 30.2 22.6 21.1 34.5 19.4 20.5 19.0 34.1 47.6 25.3 32.1 19.3 35.0 26.3 28.0 18.5 39.7 60.3 48.9 89.0 40.7 24.0 38.6 28.0 27.8 17.0 21.4 19.0 18.2 26.5 52.0 28.0 105.8 38.1 34.6 23.3 69.5 34.1 43.8 37.5 51.0 69.3 30.8 22.4 67.6 41.1 43.8 61.6 60.4 40.7 13.0 24.8 26.1 23.0 41.1 64.2 56.1 39.3 28.6 26.9 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051739 Enhanced Supported "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA051739: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favourable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.9 37.9 45.3 45.4 28.7 34.2 36.9 29.2 38.8 38.0 42.0 36.8 39.9 26.4 59.3 32.7 50.3 34.9 37.2 28.7 40.4 40.3 40.8 39.8 37.0 17.4 35.8 48.3 30.8 49.7 18.5 24.4 47.4 24.1 40.6 40.8 40.7 70.8 51.9 36.1 103.9 41.0 25.9 58.0 61.6 32.5 51.1 52.4 34.2 38.4 62.2 64.7 57.2 36.3 33.7 44.3 14.2 40.7 50.2 45.2 79.8 53.1 50.4 45.5 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favourable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.2 6.5 16.3 19.7 21.5 29.0 22.1 14.8 18.7 21.2 21.4 19.6 17.0 20.4 44.9 12.5 25.8 17.6 19.6 21.4 42.1 14.7 21.9 11.9 16.3 19.8 26.1 17.4 26.7 25.4 11.9 19.9 24.3 18.4 29.7 22.7 16.6 15.0 20.3 23.5 26.5 16.7 18.9 63.1 38.3 18.0 11.6 19.5 9.0 50.6 34.9 77.1 42.6 15.6 14.0 13.3 19.1 35.2 39.5 40.9 30.1 22.6 28.0 19.9 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria Mitochondria "HPA044001: AB_10959448, HPA053334: " "unprognostic (4.09e-1)" "prognostic favourable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favourable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 29.8 18.4 20.5 23.4 13.9 13.0 13.1 20.0 16.4 18.5 20.5 18.0 13.5 22.3 20.9 13.8 17.0 19.3 22.1 14.0 30.6 30.9 53.0 28.2 18.5 13.6 26.4 13.7 13.4 10.8 16.7 12.7 16.7 16.9 25.2 20.7 17.3 35.5 62.4 21.6 40.9 24.5 17.2 20.6 20.7 11.3 20.6 23.3 23.2 26.7 13.5 25.2 20.5 14.8 20.3 30.7 22.3 29.4 11.2 21.0 36.2 33.9 18.6 9.5 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favourable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.4 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 32.9 29.7 22.6 24.5 33.2 40.5 69.6 19.0 42.0 28.5 21.6 19.0 21.2 33.0 23.7 51.4 23.5 43.0 24.1 20.7 90.2 34.0 43.3 20.6 59.4 23.0 15.6 39.0 34.1 24.4 28.6 22.4 30.9 254.7 30.4 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044556 Approved Supported Mitochondria Mitochondria "HPA044556: AB_10794402" "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favourable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favourable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favourable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.6 3.6 10.6 13.1 7.6 8.3 8.4 10.7 7.1 7.9 6.0 6.4 10.8 3.8 3.9 7.5 5.1 20.6 7.0 6.3 5.4 6.6 6.0 7.1 10.2 9.5 5.0 3.3 11.9 10.5 7.5 11.1 7.8 13.8 16.2 5.4 6.1 7.3 12.3 8.1 4.9 6.2 6.5 28.7 12.7 5.6 8.9 6.8 7.6 9.4 4.9 10.3 9.7 3.8 7.8 3.7 5.4 6.0 13.0 22.9 9.5 8.4 13.1 6.2 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favourable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.1 45.2 24.6 15.5 23.4 14.8 30.3 44.3 26.6 35.2 25.1 121.1 40.7 21.7 81.3 20.9 38.2 18.5 26.0 13.5 41.1 52.3 23.3 46.9 95.3 40.0 50.9 23.2 20.4 24.2 27.0 10.2 23.9 45.9 36.6 19.6 62.4 33.2 91.8 27.7 57.1 29.1 46.8 73.3 26.6 54.5 34.8 30.8 31.5 65.0 22.8 51.5 42.3 31.2 34.3 42.3 81.7 37.9 33.7 66.1 49.9 19.5 30.6 32.8 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 10.3;EFO-21: 8.4;RPMI-8226: 7.4;U-2 OS: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " 7.1 11.3 6.3 5.8 7.9 9.7 8.9 13.8 11.7 9.6 7.4 5.5 13.8 27.3 8.8 5.9 9.5 9.7 5.6 11.3 7.7 7.1 6.9 18.7 6.6 6.7 6.4 9.1 6.6 8.8 5.4 5.6 5.6 7.7 8.4 6.3 5.1 18.0 11.8 10.1 5.7 10.6 5.9 5.9 5.9 15.9 4.9 3.7 4.5 12.7 8.3 4.8 4.6 6.1 30.7 37.7 30.7 33.7 16.5 33.2 39.7 0.0 2.1 0.6 0.6 0.6 0.0 1.3 1.5 0.9 1.2 2.9 10.3 1.2 0.2 8.4 0.0 0.3 1.7 0.0 0.7 5.9 0.0 1.2 0.0 0.0 0.7 0.8 2.1 0.0 0.3 0.3 1.8 0.9 0.3 0.1 0.2 0.0 3.0 1.1 5.2 0.3 1.0 0.1 7.4 0.0 0.0 1.5 2.3 0.0 1.1 3.3 0.6 1.1 0.9 0.5 12.9 4.2 0.0 1.2 1.4 2.9 0.8 0.3 1.4 22.5 33.7 30.7 24.5 24.1 19.3 30.7 22.8 23.0 37.7 23.7 20.5 21.5 10.0 16.5 25.7 37.5 33.2 39.7 6.3 7.9 13.8 11.7 7.7 7.1 6.4 9.1 7.7 3.7 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Approved Supported Mitochondria Mitochondria "CAB070844: , HPA064605: " "prognostic unfavourable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favourable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 13.0 18.8 13.6 17.6 14.3 21.9 19.1 20.7 31.9 23.2 33.5 15.2 14.7 16.9 23.8 18.2 25.1 18.5 28.4 6.7 11.8 29.4 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 24.8 31.7 14.9 20.8 16.2 17.4 14.0 17.5 23.1 17.7 26.3 25.4 26.4 23.8 18.4 14.4 22.0 21.6 31.2 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.7 17.6 18.0 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favourable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 18.0 29.1 18.4 21.3 27.0 24.0 15.9 16.4 24.1 32.4 25.6 31.8 18.8 22.9 30.9 25.2 24.2 29.3 29.3 28.7 15.2 24.7 22.4 21.8 27.8 28.0 24.2 20.8 34.6 25.9 26.2 30.0 37.1 28.6 12.5 30.4 20.8 15.3 12.9 33.5 26.8 13.3 19.0 32.2 38.5 21.6 19.5 29.0 19.8 48.9 27.9 44.0 63.4 23.7 15.8 13.5 11.0 22.1 17.6 27.9 19.2 24.1 20.5 20.3 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004484 Approved Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favourable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 21.9 18.6 19.3 16.1 16.6 15.9 11.0 18.8 27.1 25.8 32.2 20.3 25.6 10.9 15.6 21.3 26.2 19.7 22.1 13.7 42.3 15.5 30.8 31.1 16.5 37.9 20.2 16.2 14.3 10.2 17.0 17.0 22.6 17.8 17.5 35.2 25.9 49.2 26.3 31.0 31.7 26.7 21.1 23.2 18.0 20.8 15.0 14.0 24.1 24.8 26.9 36.3 11.9 16.2 18.2 18.8 24.7 20.4 27.0 28.4 16.5 29.2 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683340 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favourable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 27.5 26.5 29.8 15.7 35.7 14.3 34.0 23.3 35.3 20.8 30.0 12.9 21.3 27.6 24.0 24.2 27.0 22.9 20.9 65.1 24.4 23.2 45.3 48.1 18.7 14.9 28.5 34.4 35.7 19.5 22.2 24.9 20.7 26.7 22.9 30.5 16.4 24.4 26.3 105.5 23.0 25.5 34.3 27.0 13.6 24.1 20.9 24.6 12.9 25.1 67.3 19.3 21.7 22.4 24.3 41.0 6.7 32.8 24.5 25.2 21.9 30.0 26.7 53.2 31.4 36.4 52.8 44.8 36.6 35.8 40.8 50.0 32.5 39.6 21.4 48.3 31.2 22.2 18.8 43.7 47.1 19.8 36.0 14.7 26.6 29.2 38.8 35.4 25.6 43.8 50.6 28.1 49.6 35.4 12.5 23.4 37.2 28.1 26.6 29.7 16.1 30.2 32.1 30.1 42.1 43.4 29.1 24.6 26.6 25.1 24.4 43.0 39.1 37.3 27.0 25.1 26.7 18.2 47.8 18.0 22.4 25.8 26.7 52.0 36.0 6.7 28.9 2.4 17.5 32.8 19.5 24.3 22.2 20.2 41.0 16.5 25.1 25.2 2.4 24.5 32.4 31.0 23.5 21.9 29.8 35.7 23.3 35.3 24.4 23.2 28.5 34.4 26.7 24.6 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018524 Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA018524: AB_1854355" "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favourable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 26.0 62.0 29.9 16.9 40.5 21.0 19.1 18.4 50.1 18.6 24.7 19.7 24.3 34.7 18.2 15.1 28.3 19.0 22.7 82.4 26.5 27.5 50.3 47.6 16.3 19.1 28.3 22.4 20.8 41.3 25.4 26.7 18.0 25.9 22.9 18.3 30.1 41.3 32.2 156.6 17.3 26.7 19.8 18.2 20.3 25.0 21.1 15.7 29.6 29.2 53.9 24.2 19.1 14.8 37.3 66.6 23.6 46.1 59.0 39.6 42.6 26.8 66.7 18.5 25.1 13.8 12.4 24.3 19.1 16.6 29.6 23.0 62.1 28.7 20.8 34.8 16.5 33.2 21.2 23.2 10.6 24.8 48.8 18.9 42.5 32.6 33.0 17.7 20.9 15.6 24.1 21.7 24.9 19.8 19.4 22.6 19.3 63.7 38.9 37.9 22.7 56.6 27.1 17.9 67.3 37.2 21.8 23.2 18.9 13.9 32.2 67.5 44.2 19.4 15.3 28.7 25.3 41.6 26.3 30.9 32.5 17.6 46.2 21.3 20.0 15.8 46.1 23.6 39.6 45.1 37.0 37.3 34.2 36.0 63.3 30.2 33.0 36.7 4.4 59.0 24.9 66.6 39.6 42.6 29.9 40.5 18.4 50.1 26.5 27.5 28.3 22.4 25.9 15.7 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Approved Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: " "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favourable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 26.2 28.2 14.4 28.8 18.0 18.1 26.9 16.4 15.8 25.7 17.2 53.3 31.8 48.5 34.6 14.1 35.4 30.3 25.6 8.1 24.6 23.9 19.9 38.3 26.3 25.5 27.0 22.2 26.8 24.8 20.9 18.7 22.7 36.1 39.7 15.6 39.4 31.5 53.5 14.1 35.5 36.6 27.9 78.7 20.8 19.7 22.9 21.6 20.7 72.5 54.7 36.8 27.5 18.0 24.9 18.6 35.4 17.2 38.8 22.1 24.2 29.0 28.6 23.9 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Mitochondria Mitochondria "HPA003404: AB_1079466, HPA077896: " "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 19.6 20.7 23.9 22.2 17.8 25.3 20.3 24.8 39.5 32.9 31.2 38.6 16.3 30.4 22.8 23.3 10.0 23.2 25.8 31.5 15.3 20.5 19.4 21.3 52.1 20.5 54.0 24.2 21.3 21.6 20.2 22.0 35.4 30.9 96.1 30.1 24.7 37.7 47.4 20.0 25.8 18.0 17.7 115.3 52.4 32.0 25.2 18.7 24.5 28.0 31.2 26.2 41.2 21.6 41.9 29.8 30.0 32.2 27.8 41.2 34.1 29.8 24.0 27.0 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.3 11.0 18.0 13.6 11.8 13.6 19.2 11.0 11.4 9.6 20.7 11.9 10.7 15.2 7.1 10.5 12.8 16.9 7.5 6.1 15.4 35.2 13.3 16.2 21.3 12.0 18.5 13.3 14.7 11.6 18.4 14.4 27.9 13.9 13.1 18.9 8.0 18.2 14.3 22.4 13.8 8.0 33.4 15.4 12.8 8.0 8.4 19.2 22.8 12.7 19.5 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.1 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.2 9.6 15.1 8.4 3.7 1.2 4.1 3.2 3.9 2.9 3.5 1.7 4.6 2.8 4.9 4.8 9.3 2.3 5.7 1.9 8.6 4.4 4.4 5.3 5.4 5.1 3.3 5.0 8.5 3.7 4.7 3.5 5.5 5.7 2.3 3.5 4.8 2.1 4.5 4.3 7.4 5.4 2.2 4.1 12.8 9.6 12.1 8.0 6.3 3.5 2.6 7.3 5.7 9.4 4.0 6.1 7.3 3.7 19.6 4.9 4.1 5.3 7.6 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 97.3;skeletal muscle: 144.4" "Cell line enhanced" "Detected in all" "A-431: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria Mitochondria "HPA063084: " "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favourable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 14.5 19.3 18.4 8.4 22.9 8.6 16.6 11.8 24.5 12.6 14.6 8.9 11.8 8.1 11.0 11.1 12.9 13.4 8.0 97.3 18.7 15.9 16.6 5.2 13.2 16.6 17.0 16.7 9.5 13.5 11.8 8.6 8.0 17.2 14.3 14.2 6.8 18.9 15.5 144.4 6.3 8.3 21.6 19.3 6.5 11.6 5.8 12.1 7.4 22.6 39.8 7.2 12.4 7.8 14.3 34.1 14.1 33.1 15.2 14.1 24.7 78.8 14.0 18.5 30.7 10.7 18.7 9.1 6.6 15.7 19.2 14.9 9.7 17.5 11.6 11.2 12.4 10.5 13.9 14.0 19.1 7.3 20.5 8.2 8.4 12.3 15.4 17.7 8.3 17.0 21.6 6.5 17.9 20.2 14.5 11.4 14.9 3.5 17.6 18.4 18.1 14.2 17.9 8.6 23.7 25.9 12.5 19.8 22.3 15.1 18.3 20.6 35.4 19.2 11.8 8.8 13.3 3.1 13.7 9.4 7.9 21.4 9.7 11.2 25.9 13.4 33.1 14.1 8.7 31.8 10.6 14.3 11.7 9.3 34.1 12.3 14.1 10.1 5.8 15.2 23.9 14.1 13.6 24.7 18.4 22.9 11.8 24.5 18.7 15.9 17.0 16.7 17.2 12.1 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: " "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favourable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favourable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.0 12.0 1.3 9.6 4.1 4.8 1.9 5.4 6.3 2.7 4.7 0.6 10.1 7.3 16.7 6.9 10.2 3.7 3.1 0.9 9.4 3.9 9.6 4.1 6.5 6.3 3.3 5.6 5.3 13.0 3.5 6.9 5.5 0.1 4.9 2.8 10.8 5.6 8.1 5.9 6.8 11.1 1.6 2.4 6.5 5.2 1.8 6.3 8.0 4.3 3.5 13.9 9.9 6.4 5.4 4.9 4.8 2.8 1.7 1.9 2.4 0.8 10.3 3.8 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 NME4 "NDPKD, nm23-H4, NM23H4" ENSG00000103202 "NME/NM23 nucleoside diphosphate kinase 4" O00746 16 396725-410367 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid transport, Nucleotide metabolism, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045997, HPA072588" Approved Supported Mitochondria Mitochondria "CAB045997: AB_11126630, HPA072588: " "unprognostic (3.27e-1)" "prognostic unfavourable (6.53e-4)" "unprognostic (3.70e-2)" "unprognostic (7.16e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (4.46e-3)" "unprognostic (1.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.74e-2)" "unprognostic (7.79e-3)" "prognostic unfavourable (1.61e-7)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "unprognostic (3.08e-1)" 34.5 34.4 21.5 13.9 17.6 46.8 34.6 10.4 13.6 25.6 44.6 12.8 40.7 9.7 21.7 33.7 25.1 20.0 39.9 26.9 16.6 16.5 20.2 61.2 13.5 27.5 16.9 11.3 31.9 19.2 22.0 17.3 19.4 11.7 46.9 10.6 32.2 44.4 44.0 13.7 7.5 15.3 83.9 12.4 17.8 27.1 13.3 10.9 19.6 21.0 14.2 14.5 64.1 27.5 13.1 28.6 18.2 6.3 1.2 13.7 5.2 0.1 49.5 44.0 60.4 17.6 31.0 9.8 23.3 28.0 35.3 30.3 33.0 28.8 0.4 17.6 37.1 0.6 23.8 25.0 10.4 19.9 35.5 24.0 6.7 44.0 33.3 17.4 8.8 39.9 13.2 21.6 2.1 22.6 24.8 4.3 26.2 40.5 15.2 22.0 44.8 11.0 76.9 9.8 12.5 24.4 0.2 12.9 69.6 5.9 0.4 21.6 29.4 41.0 28.1 25.2 36.7 16.8 5.8 0.5 0.3 13.1 11.0 3.2 29.0 4.1 6.3 18.2 7.5 5.6 6.5 12.3 7.7 8.3 8.7 13.1 13.7 7.1 2.2 1.2 4.8 28.6 0.4 5.2 21.5 17.6 10.4 13.6 16.6 16.5 16.9 11.3 11.7 10.9 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA039077, HPA057402" Approved Supported Mitochondria Mitochondria "HPA039077: , HPA057402: " "unprognostic (9.45e-3)" "prognostic favourable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favourable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favourable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 6.2 6.3 9.9 7.0 9.8 14.1 10.8 7.7 9.8 7.4 7.4 6.8 2.7 7.8 7.9 7.3 6.5 11.6 7.9 12.6 11.9 8.1 7.9 6.2 4.7 3.6 7.7 14.0 17.9 10.0 6.2 6.6 1.8 6.7 7.6 6.4 12.7 7.5 4.8 21.9 14.9 6.5 7.3 7.0 4.2 4.8 16.8 8.4 2.4 8.3 9.0 4.8 6.3 6.8 7.2 4.2 11.9 5.0 6.1 5.1 2.1 6.8 2.9 3.3 3.7 0.8 0.7 4.4 2.9 0.3 0.5 0.4 3.9 5.2 4.8 8.7 0.6 3.5 2.2 1.0 0.7 4.3 3.9 22.2 6.3 5.0 1.8 4.2 4.3 1.2 5.8 0.9 1.4 0.4 3.8 10.5 0.5 4.7 3.9 3.7 7.4 2.9 3.5 3.7 3.2 0.9 5.2 7.2 4.4 6.8 3.8 2.5 9.5 11.1 3.9 4.7 10.3 5.6 4.3 17.4 8.3 3.3 3.1 6.7 4.3 11.9 5.0 3.0 4.1 4.5 3.0 3.6 3.6 3.4 3.6 7.2 5.1 5.1 10.8 6.1 4.4 4.2 2.2 2.1 9.9 9.8 7.7 9.8 11.9 8.1 7.7 14.0 6.7 8.4 NOA1 "C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3" ENSG00000084092 "Nitric oxide associated 1" Q8NC60 4 56963370-56978823 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 22.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035838, HPA035839" Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA035838: AB_10669531, HPA035839: AB_10669658" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (1.65e-3)" "unprognostic (5.19e-2)" "unprognostic (9.06e-2)" "unprognostic (1.49e-2)" "unprognostic (2.04e-2)" "unprognostic (1.29e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.33e-1)" "prognostic favourable (2.38e-4)" "unprognostic (8.97e-2)" "unprognostic (6.87e-2)" "unprognostic (1.79e-2)" "unprognostic (4.27e-2)" 4.5 4.7 2.6 3.0 3.2 5.4 5.3 4.3 2.8 4.3 5.3 7.0 5.9 3.8 6.1 6.0 2.9 3.5 2.5 2.1 3.6 2.8 3.3 5.1 2.1 5.6 13.9 3.6 2.1 2.3 3.8 4.9 5.9 3.7 10.5 6.8 4.9 3.2 2.6 3.8 6.0 1.7 4.0 5.8 6.7 4.5 20.2 16.5 7.0 14.1 20.3 22.3 14.3 7.5 6.9 5.2 9.1 9.5 17.0 14.2 5.9 10.7 6.8 6.9 11.9 14.0 26.8 10.3 5.0 8.1 9.8 10.5 6.5 4.9 12.6 6.7 6.2 12.8 7.4 12.2 7.3 15.8 12.8 6.3 11.1 11.4 11.3 9.7 9.2 10.8 17.4 16.3 6.7 10.7 12.2 5.5 10.1 9.8 11.2 11.9 10.1 6.1 24.8 8.8 11.1 8.7 7.5 5.5 13.3 6.7 11.0 12.5 5.2 14.0 5.7 7.8 7.0 6.2 14.1 7.0 12.2 13.0 18.3 20.2 18.2 15.2 16.5 17.0 22.3 18.4 4.8 20.3 11.2 13.3 21.1 14.3 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavourable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.0 20.5 1.5 0.0 13.5 15.1 1.8 15.8 18.9 13.6 15.8 1.5 13.5 8.9 7.2 23.1 9.6 0.1 12.4 16.9 5.0 7.0 2.3 27.8 4.4 12.7 9.2 7.1 10.9 16.1 22.4 21.9 5.1 3.3 34.0 12.0 3.6 5.4 6.6 4.1 4.3 1.9 14.3 18.9 4.0 0.7 2.7 2.1 27.6 4.0 6.6 1.8 13.3 12.1 33.2 6.6 15.8 11.9 6.9 6.2 14.0 17.4 9.5 11.5 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267856-90332137 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA047050: , HPA050583: " "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 7.3 9.1 7.3 7.7 10.1 16.4 8.0 17.6 9.3 6.9 8.1 10.8 4.4 13.5 14.6 8.0 8.1 7.7 6.3 6.3 6.2 5.4 7.4 9.8 7.1 6.8 8.2 4.2 8.7 7.2 10.6 13.8 11.6 8.5 7.0 6.5 10.8 9.2 6.1 23.5 11.1 9.7 7.3 8.4 8.5 7.9 7.1 8.7 11.3 9.4 4.8 8.3 9.2 10.2 3.3 3.5 6.0 2.7 2.2 2.6 0.6 1.3 2.6 3.6 2.2 0.5 1.9 2.5 2.6 1.8 1.9 2.1 3.2 2.3 2.3 1.4 2.5 3.4 2.0 3.4 3.6 4.4 3.3 3.0 8.6 2.2 1.0 8.0 4.2 3.5 2.5 1.8 1.1 1.6 1.4 3.6 1.7 2.5 3.6 3.4 1.2 2.1 3.2 5.3 0.9 1.1 5.2 3.3 3.9 1.1 6.9 1.7 3.1 3.3 2.2 2.9 1.3 1.7 1.1 3.0 3.2 2.5 2.7 1.5 3.3 4.5 2.7 3.4 2.6 1.5 2.0 2.5 1.9 2.1 1.3 3.3 1.9 2.2 6.0 2.2 1.2 3.5 1.6 0.6 7.3 10.1 17.6 9.3 6.2 5.4 8.2 4.2 8.5 8.7 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422582-87459454 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" 9000 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: , HPA078535: " "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favourable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favourable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 14.2 25.6 19.5 10.0 22.7 4.0 31.1 22.5 22.3 17.9 19.6 11.8 18.0 27.0 17.3 24.5 12.8 16.2 11.4 18.0 21.8 19.4 28.1 30.9 15.8 12.2 22.9 16.5 18.4 64.1 35.4 33.1 17.5 20.0 22.5 18.3 11.3 20.2 18.7 23.8 10.2 30.0 16.0 17.0 9.9 14.1 14.1 22.6 7.6 22.7 16.0 9.7 13.6 35.9 13.9 13.8 3.7 13.9 9.3 18.3 10.6 10.6 11.5 12.8 6.4 25.4 16.0 10.4 20.5 13.3 7.9 7.9 8.1 18.4 15.6 21.0 16.6 7.3 11.8 14.4 12.7 11.7 9.1 5.1 13.4 14.1 16.0 9.3 8.4 15.4 19.2 9.4 8.9 15.8 14.3 10.5 14.9 14.0 13.0 10.1 10.3 4.7 15.3 11.4 9.1 59.7 9.8 15.5 10.6 13.2 23.4 10.4 13.4 13.5 16.2 12.8 12.4 9.3 10.0 8.1 6.3 12.7 18.4 8.8 16.1 0.9 11.7 3.7 13.4 13.8 12.4 13.9 13.4 13.2 13.8 12.0 15.9 18.3 1.3 9.3 13.9 13.0 12.3 10.6 19.5 22.7 22.5 22.3 21.8 19.4 22.9 16.5 20.0 22.6 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: " "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 41.4 7.5 4.9 17.6 50.3 48.5 16.8 25.1 51.3 22.5 24.7 19.2 5.4 0.0 18.3 42.4 44.2 22.5 47.0 24.5 7.3 31.2 46.4 5.3 14.3 25.9 0.0 30.6 31.7 24.3 20.2 23.6 26.1 79.8 8.9 31.3 10.7 12.2 2.6 9.8 10.6 11.4 18.8 11.2 21.5 0.6 10.3 11.0 15.8 42.1 35.3 14.0 11.4 20.1 12.8 12.0 21.2 15.6 7.6 8.0 11.2 17.7 12.5 6.1 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 OCIAD2 MGC45416 ENSG00000145247 "OCIA domain containing 2" Q56VL3 4 48885019-48906937 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.5;U-251 MG: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040979, HPA041090" Enhanced Enhanced Mitochondria Mitochondria "HPA040979: AB_10795497, HPA041090: AB_10796236" "unprognostic (4.29e-1)" "unprognostic (2.69e-1)" "unprognostic (3.76e-2)" "prognostic favourable (7.37e-4)" "unprognostic (3.49e-2)" "unprognostic (1.66e-2)" "unprognostic (9.05e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-1)" "prognostic favourable (6.56e-4)" "prognostic unfavourable (6.89e-4)" "unprognostic (1.38e-1)" "prognostic favourable (2.67e-5)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (8.24e-3)" "prognostic favourable (2.34e-4)" 4.0 10.7 24.5 15.7 18.3 4.7 8.1 3.7 14.0 7.2 23.0 1.9 14.0 41.6 8.9 19.5 12.4 7.7 22.3 7.2 19.9 11.7 51.6 43.6 6.6 10.7 9.7 9.9 3.7 13.2 9.4 18.7 2.9 8.8 8.8 17.3 6.6 18.3 12.9 1.8 9.0 37.5 5.2 4.1 5.2 27.9 4.1 5.7 24.9 14.9 5.8 13.3 9.3 8.5 29.7 22.9 32.7 0.6 27.1 60.8 26.1 34.6 18.4 0.2 0.0 0.0 0.0 0.5 9.0 4.1 4.9 4.6 0.0 43.0 6.0 40.3 5.1 11.2 5.1 56.5 5.0 14.1 3.8 0.0 13.6 0.0 4.6 16.9 0.0 2.7 25.8 0.0 11.0 20.2 0.0 3.0 5.2 13.0 28.5 11.5 17.7 25.0 6.4 0.0 10.0 50.2 22.8 40.0 12.1 13.0 4.4 0.9 4.5 4.2 33.6 0.0 37.4 0.2 67.1 8.6 9.8 19.1 28.8 0.0 0.0 32.7 0.6 12.4 20.4 0.2 27.0 29.7 38.4 29.2 3.4 27.0 50.2 33.6 2.1 27.1 0.2 22.9 60.8 26.1 24.5 18.3 3.7 14.0 19.9 11.7 9.7 9.9 8.8 5.7 OGDH E1k ENSG00000105953 "Oxoglutarate dehydrogenase" Q02218 7 44606572-44709066 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019514, HPA020347" Supported Enhanced Mitochondria 53000 Mitochondria "HPA019514: AB_1854772, HPA020347: AB_1854773" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (4.39e-1)" "unprognostic (5.64e-3)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (3.45e-1)" "unprognostic (7.58e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-2)" "unprognostic (3.38e-1)" "unprognostic (3.30e-2)" "prognostic favourable (2.22e-14)" "unprognostic (1.53e-1)" "unprognostic (1.62e-1)" "unprognostic (2.23e-2)" "unprognostic (5.88e-3)" 18.9 20.8 12.3 14.5 18.5 8.7 11.0 14.3 23.7 10.1 19.4 15.9 13.5 29.0 16.2 11.1 19.5 11.1 11.8 73.9 11.3 12.8 28.8 14.8 13.0 11.1 14.2 11.7 9.8 13.0 25.5 11.0 14.5 22.2 12.3 13.3 22.3 23.7 15.9 99.3 15.6 35.5 16.4 10.1 12.1 14.9 11.3 11.0 11.3 17.8 39.8 15.8 13.0 10.8 7.2 13.4 7.5 20.4 11.2 25.7 11.6 10.8 22.8 13.7 20.8 21.2 23.3 13.4 17.0 16.6 19.4 16.9 20.8 22.5 47.8 20.2 24.7 33.8 27.0 25.4 18.9 27.9 7.1 14.5 46.2 10.2 10.8 17.9 16.3 21.6 19.3 27.4 19.7 26.2 16.7 14.3 20.4 15.3 17.7 10.3 12.6 25.8 17.0 9.6 53.7 22.2 32.4 23.4 11.2 24.6 34.1 10.6 20.2 18.0 20.6 14.0 12.6 24.2 19.6 13.0 24.9 26.4 25.3 20.3 25.3 4.8 12.1 7.3 11.7 17.7 12.8 7.2 13.5 11.7 13.4 5.9 5.8 7.0 7.5 11.2 20.4 6.6 25.7 11.6 12.3 18.5 14.3 23.7 11.3 12.8 14.2 11.7 22.2 11.0 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1, mitochondrial dynamin like GTPase" O60313 3 193593144-193697823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria 13000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: " "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavourable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favourable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 17.0 19.7 18.2 13.5 31.7 25.9 15.9 20.2 30.9 13.9 21.8 11.1 12.6 20.0 15.2 11.8 18.8 11.8 12.8 43.9 23.0 19.4 21.8 24.1 10.7 15.3 19.0 22.4 13.2 13.4 20.9 15.6 13.8 28.0 15.5 20.5 9.1 15.7 20.8 38.4 14.6 17.3 16.5 17.0 13.1 16.7 7.6 10.8 18.0 16.8 18.4 14.2 16.5 13.6 8.3 8.8 8.2 17.6 5.0 7.5 5.9 25.9 8.3 8.5 9.3 7.5 11.9 9.0 12.6 11.6 13.9 13.6 20.3 8.8 17.3 27.3 11.8 16.9 14.8 14.3 24.6 20.8 12.0 29.9 7.4 10.1 11.7 24.5 13.8 13.2 12.8 13.4 19.0 11.7 12.6 17.0 13.8 20.5 9.5 13.6 11.9 27.9 12.5 18.6 18.5 10.4 16.2 18.5 11.2 18.9 21.1 13.4 27.7 19.4 11.7 12.9 9.8 13.8 26.5 15.3 17.8 33.8 14.2 19.7 12.9 8.2 8.1 7.7 7.2 9.3 6.6 8.3 6.8 6.8 8.8 6.3 6.9 7.3 3.2 5.0 17.6 4.6 7.5 5.9 18.2 31.7 20.2 30.9 23.0 19.4 19.0 22.4 28.0 10.8 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavourable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favourable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 6.6 17.0 8.6 6.5 12.1 2.6 11.1 12.9 10.9 7.3 5.6 14.8 2.9 5.0 11.8 9.1 7.0 8.1 4.8 13.0 8.4 7.3 13.0 11.6 5.8 11.2 18.9 9.3 13.8 6.1 7.5 9.8 6.1 11.6 6.9 6.1 9.0 9.7 6.1 16.6 9.2 6.5 8.1 13.4 9.6 5.8 9.4 15.4 10.6 8.2 7.3 9.2 8.0 5.8 9.3 6.0 2.1 2.6 6.6 11.5 3.0 5.7 3.2 14.1 10.8 11.2 6.2 8.4 8.9 6.3 12.7 13.7 3.7 6.0 3.8 10.0 3.7 8.4 12.5 10.6 14.5 9.8 9.6 12.4 7.8 4.8 5.9 7.0 6.5 6.8 9.0 9.6 4.7 9.4 4.5 6.1 8.3 3.2 5.5 8.0 6.8 14.6 6.0 11.3 6.5 8.2 3.2 8.6 9.5 6.0 10.9 19.4 8.5 7.7 3.9 8.3 7.3 12.1 5.5 6.2 5.2 6.2 11.0 9.0 9.0 0.2 2.6 2.1 7.3 2.4 10.5 7.4 7.7 8.4 3.5 9.3 11.5 10.2 0.4 6.6 2.1 6.0 5.9 3.0 8.6 12.1 12.9 10.9 8.4 7.3 18.9 9.3 11.6 15.4 OTC ENSG00000036473 "Ornithine carbamoyltransferase" P00480 X 38352545-38421450 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 59.1;liver: 90.3" "Cell line enhanced" "Detected in some" "NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8" "Cancer enriched" "Detected in some" 20 "liver cancer: 59.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000243, HPA000570" Enhanced Supported Mitochondria 1800000 Mitochondria "HPA000243: AB_1079535, HPA000570: AB_1079534" "unprognostic (6.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.89e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.70e-3)" "unprognostic (5.61e-2)" 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.8 16.5 0.0 0.2 26.9 1.1 0.2 0.2 0.3 5.3 0.2 0.1 0.2 0.1 90.3 0.7 2.3 0.2 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.1 0.1 59.1 0.8 0.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.6 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L, mitochondrial inner membrane protein" Q15070 14 22766522-22773041 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favourable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 27.8 36.0 11.9 21.2 15.5 25.1 28.4 13.5 23.0 25.4 30.9 18.5 24.3 27.2 22.7 23.9 30.2 21.5 30.6 48.3 12.9 13.0 31.9 58.4 25.8 45.0 15.2 10.9 31.4 59.6 30.0 12.3 18.3 17.9 25.3 24.2 28.1 24.9 27.5 76.3 24.9 32.8 23.9 13.5 32.9 29.9 17.0 10.3 32.7 37.3 49.0 38.3 31.3 22.3 22.1 39.9 7.2 29.4 16.3 22.6 19.9 20.9 29.0 13.0 21.8 37.0 55.2 24.1 16.0 33.7 23.3 26.9 21.7 24.0 39.4 21.5 18.6 30.0 25.1 31.1 23.5 16.4 16.2 19.5 20.0 79.3 41.5 36.3 24.3 54.0 34.6 19.2 29.8 66.9 14.4 32.2 25.5 30.8 21.5 14.1 13.2 36.5 22.1 21.6 30.0 29.7 26.3 8.9 17.2 23.2 51.7 30.6 22.1 29.5 21.3 13.9 16.2 25.3 18.3 24.3 19.3 18.5 10.9 21.0 14.9 4.8 27.9 7.2 13.4 29.4 16.3 22.1 19.2 16.9 39.9 21.9 21.9 16.3 6.3 16.3 22.9 11.3 22.6 19.9 11.9 15.5 13.5 23.0 12.9 13.0 15.2 10.9 17.9 10.3 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.8" "Cell line enhanced" "Detected in many" "HeLa: 56.1;SiHa: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" 1000000 Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favourable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 21.9 8.0 17.3 7.5 30.3 5.8 9.5 26.6 36.8 6.7 9.2 8.3 10.7 4.4 8.6 8.7 13.1 6.9 7.5 108.8 19.3 15.2 25.3 1.2 4.2 9.5 13.1 25.7 7.2 3.0 20.9 8.4 2.8 21.2 12.5 10.4 6.6 8.5 14.7 13.4 10.7 6.5 17.0 8.9 5.2 14.6 6.2 5.3 22.8 13.0 10.7 11.8 8.0 7.5 8.0 4.6 3.3 1.6 7.5 15.6 5.1 7.8 0.3 6.5 7.7 20.1 10.8 0.0 14.1 8.9 11.7 7.1 1.2 5.4 20.4 3.5 10.7 4.6 17.8 12.7 13.8 17.4 2.0 14.3 56.1 2.6 8.8 27.7 4.8 10.1 3.4 11.5 19.4 10.7 2.9 26.3 13.4 1.0 23.1 1.3 1.4 5.6 18.4 18.2 15.4 9.5 0.6 6.5 6.7 72.9 0.0 8.6 0.1 6.0 6.4 9.3 12.2 15.9 11.3 4.3 3.6 0.8 14.1 20.4 7.1 1.0 1.0 3.3 9.1 1.1 10.9 8.0 9.2 9.8 4.6 6.1 10.8 8.9 0.3 7.5 1.6 1.8 15.6 5.1 17.3 30.3 26.6 36.8 19.3 15.2 13.1 25.7 21.2 5.3 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favourable (1.35e-4)" "prognostic favourable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favourable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 13.7 6.7 9.8 10.5 3.7 10.3 8.3 11.9 6.0 11.8 6.2 13.7 10.1 6.4 16.2 10.3 7.7 7.9 13.5 6.6 6.4 14.9 26.1 10.0 7.7 6.6 6.5 6.4 18.7 8.3 13.0 7.3 7.0 8.0 13.8 10.4 15.5 15.6 19.4 8.3 8.9 5.8 6.7 9.6 8.9 19.9 8.0 8.1 11.7 12.3 11.3 7.9 6.4 8.4 9.0 3.7 6.5 10.3 11.8 6.6 7.6 12.9 2.7 7.6 8.0 8.8 7.9 6.2 9.0 11.6 8.3 9.8 9.2 14.3 8.4 5.6 8.1 11.3 11.8 11.0 8.5 11.5 15.7 10.9 11.8 9.8 12.7 10.0 8.2 14.8 9.3 9.7 10.0 16.1 11.6 9.8 11.5 9.2 9.8 0.5 14.8 12.4 7.2 23.3 17.1 4.8 3.9 7.2 9.8 16.9 12.6 18.5 11.8 6.1 7.3 8.7 9.5 8.9 11.1 12.7 4.5 10.3 11.2 7.4 2.1 5.4 3.7 9.4 6.0 10.8 8.4 9.7 11.6 8.6 8.2 11.4 11.8 0.9 10.3 6.5 9.0 6.0 6.6 6.7 10.5 8.3 11.9 6.6 6.4 6.6 6.5 7.0 8.0 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Cell line enhanced" "Detected in all" "U-2197: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria "Nucleoplasm, Mitochondria" Microtubules "HPA062721: " "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavourable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favourable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.8 7.6 4.1 10.1 2.8 3.9 10.7 9.3 2.3 3.5 2.8 5.3 5.8 11.4 10.5 2.8 8.0 3.8 4.1 1.6 11.0 25.0 11.9 7.1 3.7 4.5 8.3 8.9 5.7 5.4 4.3 4.6 2.8 13.9 5.4 2.9 10.5 7.5 14.5 6.7 17.0 14.3 3.5 10.9 3.7 3.8 15.8 12.2 8.1 6.9 9.5 9.1 10.0 3.5 7.1 9.1 35.9 10.2 8.1 8.7 14.1 2.6 8.1 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848233-66958376 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 41.1;liver: 76.0" "Cell line enhanced" "Detected in many" "HeLa: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria 96000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favourable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 41.1 10.7 11.1 2.8 14.6 3.1 12.9 13.1 14.9 2.4 3.8 10.7 21.4 5.6 2.1 2.4 5.0 2.7 2.9 4.0 11.3 8.9 18.7 76.0 2.1 1.6 15.5 11.5 4.4 4.3 19.4 4.0 4.1 10.9 5.4 3.1 3.4 24.2 24.4 5.7 2.8 6.7 1.8 9.4 1.5 3.3 6.1 13.1 0.6 4.2 2.5 2.5 2.2 2.1 0.6 2.6 0.0 3.8 0.3 2.9 2.0 2.9 8.9 3.3 8.1 13.7 5.4 3.5 1.8 7.8 3.5 3.4 4.4 3.2 0.0 3.7 2.9 3.8 3.7 20.6 1.0 1.7 5.2 4.4 27.7 17.0 10.7 0.0 5.7 20.6 5.3 2.8 6.4 2.9 8.4 0.0 1.2 19.0 5.0 2.4 6.3 7.4 3.7 6.9 1.8 3.2 0.9 7.2 10.2 17.3 9.2 7.0 7.5 1.2 3.2 3.9 3.6 4.6 2.0 1.9 2.2 0.0 4.0 2.8 3.3 0.0 3.8 0.0 1.2 0.9 1.4 0.2 0.5 1.9 2.6 0.6 2.9 1.6 0.0 0.3 0.5 1.0 1.5 2.0 11.1 14.6 13.1 13.6 11.3 8.9 15.5 11.5 10.9 13.1 PCCA ENSG00000175198 "Propionyl-CoA carboxylase alpha subunit" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 106.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 53.2;SCLC-21H: 29.5;U-937: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria 120000 Mitochondria "HPA041716: , HPA047792: " "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favourable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 15.6 26.2 9.7 11.3 11.1 3.2 12.0 24.0 10.7 12.0 17.5 12.0 14.3 6.7 16.4 106.7 8.8 8.4 7.6 12.4 9.5 7.5 51.3 44.3 8.1 4.0 11.2 8.2 9.7 12.7 5.5 12.4 10.5 12.6 13.1 13.7 11.7 12.2 10.4 10.7 7.7 7.8 17.0 12.0 8.2 16.1 4.7 10.9 4.2 11.9 5.0 6.9 10.8 8.8 3.7 13.0 1.6 10.8 7.3 6.1 4.7 3.2 5.8 9.6 3.1 9.2 8.0 5.4 3.2 4.8 3.0 2.8 7.2 4.4 0.2 4.9 3.2 3.7 2.8 4.5 5.0 5.3 3.2 7.5 4.1 15.4 5.1 0.3 3.7 7.4 4.8 2.8 4.7 6.2 3.0 4.3 5.5 3.5 0.8 16.9 5.9 2.6 6.6 4.1 5.2 53.2 6.4 29.5 3.5 2.2 12.3 5.4 8.9 13.4 4.5 3.1 2.6 2.1 2.2 4.2 3.8 0.1 6.0 41.0 2.2 1.5 8.5 1.6 4.6 10.3 6.1 3.7 3.0 4.3 13.0 2.6 4.1 5.1 1.3 7.3 10.8 1.1 6.0 4.7 9.7 11.1 24.0 10.7 9.5 7.5 11.2 8.2 12.6 10.9 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 156.3;liver: 115.1" "Cell line enhanced" "Detected in many" "HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria 3300000 Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favourable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 8.2 2.5 1.0 4.9 1.9 1.0 4.3 1.3 1.3 1.3 69.7 1.4 6.9 51.8 1.3 8.5 4.5 1.2 4.2 2.6 1.5 1.0 26.4 115.1 6.0 4.4 1.7 1.2 1.8 8.5 3.4 1.7 1.2 1.8 2.0 5.4 1.9 11.5 4.9 1.0 2.7 156.3 1.1 1.7 6.7 3.3 3.9 1.3 1.3 5.8 1.9 4.6 2.8 1.9 8.8 10.8 2.4 15.1 1.5 6.5 3.9 5.4 3.1 0.9 5.8 3.6 3.7 14.8 6.8 8.2 5.7 9.3 5.1 6.3 13.9 0.8 10.5 8.0 6.0 8.8 4.7 7.1 0.2 2.5 1.7 27.2 34.9 4.8 11.0 4.3 33.9 3.6 8.8 4.6 7.1 25.8 2.2 23.7 1.2 2.4 1.0 4.1 2.8 3.4 7.9 1.7 8.5 3.7 5.9 5.2 6.8 32.1 9.1 7.5 0.8 1.2 6.6 1.8 1.9 17.7 5.5 3.4 3.5 7.7 3.0 0.1 8.2 2.4 3.1 15.1 3.4 8.8 3.5 3.5 10.8 6.1 2.2 2.0 1.0 1.5 14.4 1.9 6.5 3.9 1.0 1.9 1.3 1.3 1.5 1.0 1.7 1.2 1.8 1.3 PDHA1 PDHA ENSG00000131828 "Pyruvate dehydrogenase E1 alpha 1 subunit" P08559 X 19343893-19361705 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria "Intracellular and membrane" 15000 Mitochondria "HPA047487: , HPA047864: , HPA063053: " "unprognostic (5.71e-3)" "unprognostic (2.46e-3)" "unprognostic (5.71e-2)" "unprognostic (3.36e-3)" "unprognostic (3.12e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-2)" "unprognostic (4.28e-1)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (6.90e-2)" "unprognostic (8.68e-2)" "prognostic favourable (1.13e-7)" "unprognostic (3.72e-2)" "unprognostic (3.03e-1)" "unprognostic (1.92e-2)" "unprognostic (9.06e-2)" 22.5 16.1 14.7 11.7 24.3 20.4 14.7 18.6 25.0 12.3 28.6 13.0 27.7 22.7 13.0 21.6 17.2 12.4 11.8 89.3 15.5 12.2 36.6 26.6 10.5 8.9 14.8 19.9 12.2 28.7 25.0 11.6 14.9 19.0 10.8 28.2 12.7 41.8 18.3 107.3 12.7 21.1 21.2 12.7 11.5 24.9 6.3 12.0 11.3 15.0 44.9 14.9 13.1 12.4 39.4 45.1 34.8 46.1 35.5 36.6 31.9 25.7 32.1 23.3 24.5 22.6 17.3 28.6 17.8 15.9 37.0 28.6 45.7 16.6 44.1 13.2 21.4 33.7 71.4 30.9 39.0 14.6 39.8 21.9 55.3 40.2 24.0 34.9 17.9 22.3 28.8 34.1 33.8 22.4 19.2 18.7 25.8 34.1 29.1 35.9 23.7 56.2 30.1 39.0 54.0 63.6 26.4 12.9 13.7 28.4 36.0 32.2 38.0 24.5 13.9 19.1 17.2 52.0 22.5 15.9 16.4 29.2 18.0 24.5 16.5 34.8 35.0 24.2 30.3 46.1 36.6 39.4 29.4 32.8 45.1 29.3 29.0 30.6 6.1 35.5 39.1 29.8 31.1 31.9 14.7 24.3 18.6 25.0 15.5 12.2 14.8 19.9 19.0 12.0 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 alpha 2 subunit" P29803 4 95840019-95841474 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 60.5" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria Mitochondria "HPA047487: , HPA047864: , HPA063053: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 beta subunit" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria 6500000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favourable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 21.8 34.3 22.5 19.5 28.4 8.6 17.1 15.1 26.2 18.0 21.6 18.4 19.2 16.2 17.2 18.2 22.8 15.0 16.5 64.2 24.1 20.8 38.7 41.8 13.9 18.2 23.7 23.3 11.0 17.2 26.0 20.0 21.6 26.4 19.5 23.9 16.1 17.6 22.1 92.2 14.3 17.3 24.5 22.8 23.2 21.4 21.8 17.5 20.9 16.1 33.8 20.6 17.9 14.4 37.0 50.1 33.6 39.8 43.4 38.6 38.3 19.0 26.7 27.7 20.8 28.2 34.7 33.2 24.1 30.2 35.6 36.7 48.1 18.5 40.7 13.6 30.4 11.1 33.7 22.1 27.3 23.5 24.7 36.3 50.4 36.3 28.5 29.4 20.4 30.2 20.4 28.7 16.9 30.6 18.7 18.4 38.6 18.2 27.8 31.0 38.1 30.3 13.3 21.6 39.2 56.2 26.1 19.2 21.2 22.3 32.1 23.9 47.5 31.6 22.4 19.1 25.4 20.0 27.2 25.7 36.5 28.7 29.3 35.0 18.0 16.4 35.4 33.6 31.5 39.8 33.2 37.0 31.2 30.0 50.1 33.3 35.1 31.4 7.0 43.4 35.9 33.7 38.6 38.3 22.5 28.4 15.1 26.2 24.1 20.8 23.7 23.3 26.4 17.5 PDK1 ENSG00000152256 "Pyruvate dehydrogenase kinase 1" Q15118 2 172555373-172608669 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 31.3;U-87 MG: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8" "Low region specificity" "Detected in all" "CAB017554, HPA027376, HPA059083" Approved Approved Nucleoli,Mitochondria 22000 "Nucleoli, Mitochondria" "CAB017554: AB_2161138, HPA027376: AB_1855139, HPA059083: " "unprognostic (2.14e-1)" "prognostic unfavourable (7.30e-5)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "unprognostic (6.47e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (9.69e-3)" "unprognostic (6.44e-2)" "unprognostic (5.44e-3)" "unprognostic (1.55e-1)" "prognostic unfavourable (1.10e-8)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" "unprognostic (2.56e-2)" "unprognostic (5.34e-2)" 9.9 16.2 6.8 11.0 10.5 13.4 16.7 7.1 15.6 7.3 15.3 3.3 2.9 15.5 5.4 8.0 11.2 4.4 5.8 27.6 6.9 5.2 6.8 14.2 6.1 21.4 7.2 5.2 19.5 7.2 3.4 7.5 7.9 7.2 6.5 13.1 7.6 14.1 7.6 9.6 24.7 8.4 5.2 10.7 14.2 12.5 11.0 6.7 10.3 5.1 5.0 20.8 18.0 9.8 5.9 2.3 16.0 2.2 1.4 15.8 6.2 14.1 0.6 3.7 9.1 1.5 2.3 5.2 12.5 10.1 6.3 13.4 3.6 3.0 13.5 6.9 3.8 6.2 2.5 7.8 20.1 2.7 5.0 16.4 3.3 4.2 2.7 8.1 6.1 2.9 2.8 4.3 7.3 3.3 3.4 9.3 8.3 1.4 5.1 10.2 8.9 3.9 5.4 6.0 21.7 3.2 4.6 6.9 7.9 3.2 3.8 4.7 2.4 3.4 3.8 10.0 3.2 5.2 3.3 31.3 18.1 11.1 32.0 5.9 2.0 12.2 2.2 16.0 2.5 1.5 3.0 4.7 4.2 2.8 2.3 5.9 15.8 9.6 8.5 1.4 1.9 0.4 8.0 6.2 6.8 10.5 7.1 15.6 6.9 5.2 7.2 5.2 7.2 6.7 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favourable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favourable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.4 11.3 10.1 11.9 9.0 1.2 7.1 10.5 10.6 10.3 0.9 7.1 8.2 11.9 19.8 3.1 7.5 2.8 10.5 16.5 10.4 7.3 9.2 6.9 6.4 0.0 8.0 18.9 11.0 6.9 0.5 9.2 2.9 8.2 6.0 8.3 6.1 0.0 2.4 9.1 9.2 25.2 11.1 5.8 5.5 7.5 11.4 10.0 3.2 4.7 18.5 7.3 4.7 12.5 10.3 8.5 5.1 16.2 15.3 4.4 18.3 2.6 8.0 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465221-24539837 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA046583: , HPA072492: " "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavourable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 9.6 5.6 5.7 9.8 17.3 16.3 12.8 3.3 23.6 8.0 14.7 5.5 5.6 13.6 7.3 15.7 9.5 13.2 7.0 16.9 12.5 6.8 13.7 11.1 11.2 13.4 6.2 13.7 11.0 7.3 12.8 14.1 7.7 14.9 8.3 10.1 9.9 19.3 5.2 3.9 14.2 15.6 8.6 6.1 17.9 12.7 23.1 4.8 12.5 6.2 4.1 14.9 10.3 9.2 4.5 7.2 36.4 10.9 7.1 11.0 6.7 9.0 4.6 3.9 6.5 0.1 0.0 4.1 2.7 2.4 3.7 6.5 0.4 11.0 9.1 1.8 0.7 2.0 11.3 6.9 9.9 7.8 5.4 4.9 5.3 2.6 1.3 4.1 4.8 0.7 3.0 0.9 0.9 5.5 0.9 13.9 0.5 16.9 7.8 5.4 7.0 5.4 4.0 7.0 13.4 3.2 17.6 2.5 3.2 14.7 6.0 4.5 8.2 1.6 0.1 2.6 3.8 4.8 3.2 8.9 6.8 11.0 7.1 6.4 5.3 9.4 8.9 21.3 7.6 10.9 11.0 4.5 6.2 6.2 7.2 4.1 4.9 5.7 36.4 7.1 10.4 2.3 5.1 6.7 5.7 17.3 3.3 23.6 12.5 6.8 6.2 13.7 14.9 4.8 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.2;TIME: 33.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavourable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favourable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 8.9 4.4 9.6 4.0 8.0 14.6 3.2 7.0 7.8 8.3 9.8 4.6 33.2 5.0 23.7 11.2 19.9 4.1 5.9 12.3 0.5 2.0 2.3 5.5 1.6 9.1 1.1 3.3 9.4 11.8 14.1 22.6 18.7 0.8 8.2 10.1 2.1 6.9 3.6 4.4 5.7 1.7 5.7 0.9 5.7 6.2 0.8 4.2 4.6 0.5 21.6 1.5 1.4 33.2 10.1 6.5 23.6 8.3 4.6 1.9 4.2 12.9 4.2 8.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 PDP2 "KIAA1348, PPM2B, PPM2C2" ENSG00000172840 "Pyruvate dehyrogenase phosphatase catalytic subunit 2" Q9P2J9 16 66878589-66895754 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019950, HPA062059" Approved Supported Mitochondria Mitochondria "HPA019950: AB_1855156, HPA062059: " "unprognostic (8.42e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.31e-2)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (4.90e-3)" "unprognostic (1.57e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" "unprognostic (1.39e-1)" "prognostic favourable (9.75e-7)" "unprognostic (1.89e-1)" "unprognostic (5.10e-1)" "unprognostic (3.20e-1)" "unprognostic (6.15e-2)" 10.7 7.2 7.4 3.7 10.5 3.2 8.7 11.5 16.5 4.9 7.5 10.1 5.7 10.4 7.9 7.2 8.9 7.2 6.0 4.8 7.4 7.1 18.1 16.5 8.6 5.0 9.0 9.4 14.9 13.8 12.0 7.0 7.7 16.0 7.8 8.4 8.5 7.1 6.9 6.3 4.7 6.2 4.6 6.3 4.0 6.7 8.6 8.9 4.6 18.0 4.0 5.9 6.3 5.5 3.3 1.3 1.8 0.4 6.1 6.3 2.0 7.2 8.8 5.5 10.7 14.7 7.6 6.9 3.7 14.7 8.8 13.2 17.9 5.1 10.0 5.4 5.3 9.1 15.8 8.5 8.5 2.3 8.0 5.0 4.4 11.6 8.0 6.4 8.9 5.7 6.4 12.4 12.9 3.7 9.6 7.2 7.8 4.7 12.5 4.6 6.4 11.2 12.3 7.6 15.8 4.6 7.7 11.0 6.2 12.1 5.0 4.5 6.6 3.1 3.5 5.4 7.3 3.2 5.5 12.8 11.8 10.0 7.4 5.1 5.3 1.3 0.4 1.8 6.3 0.3 5.2 1.8 3.1 5.1 1.3 3.3 4.5 5.0 1.3 6.1 0.2 0.8 0.9 2.0 7.4 10.5 11.5 16.5 7.4 7.1 9.0 9.4 16.0 8.9 PGAM5 "BXLBv68, MGC5352" ENSG00000247077 "PGAM family member 5, mitochondrial serine/threonine protein phosphatase" Q96HS1 12 132710819-132722734 "Enzymes, Predicted intracellular proteins" Necrosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036978, HPA036979, CAB068215" Enhanced Supported Mitochondria "Intracellular and membrane" Mitochondria "CAB068215: , HPA036978: AB_10964347, HPA036979: AB_10960559" "unprognostic (9.57e-2)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (3.11e-2)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.13e-6)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (5.67e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (6.42e-3)" "unprognostic (1.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (5.53e-2)" 12.2 16.5 11.7 14.3 14.0 12.5 18.6 14.6 22.1 8.4 13.9 8.3 9.9 13.6 10.4 9.9 22.0 11.5 13.4 22.6 14.2 12.1 13.9 26.3 8.5 17.6 9.9 11.8 11.9 30.2 8.1 9.6 10.3 10.4 10.1 10.4 8.5 16.0 11.4 27.4 15.2 12.0 10.2 7.5 13.0 11.7 13.6 5.1 17.6 16.3 17.4 14.5 11.6 12.9 4.0 6.7 7.7 3.1 3.3 3.7 1.4 19.1 36.9 7.9 22.2 5.6 4.5 18.5 9.9 6.1 16.7 9.4 46.0 11.1 24.8 18.3 8.5 16.8 37.0 18.6 6.8 12.2 29.1 29.7 17.3 23.9 12.7 28.1 17.4 5.5 13.7 19.4 20.9 12.1 37.2 10.3 6.5 34.7 38.1 28.1 29.9 26.2 29.2 8.8 19.8 10.8 26.6 29.0 16.3 17.1 24.1 10.6 30.4 15.6 10.4 8.5 18.5 17.0 24.0 21.5 31.5 35.6 11.0 23.1 14.2 7.7 2.4 0.7 2.5 2.5 3.7 3.6 2.9 2.8 2.0 4.0 2.9 3.6 2.0 3.3 3.1 6.7 2.0 1.4 11.7 14.0 14.6 22.1 14.2 12.1 9.9 11.8 10.4 5.1 PHB PHB1 ENSG00000167085 Prohibitin P35232 17 49404049-49414905 "Plasma proteins, Predicted intracellular proteins" "DNA synthesis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 189.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003280 Supported Supported Vesicles,Mitochondria "Intracellular and membrane" 3800000 Mitochondria Vesicles "HPA003280: AB_1855732" "unprognostic (2.31e-2)" "unprognostic (5.70e-2)" "unprognostic (1.19e-2)" "unprognostic (7.88e-3)" "unprognostic (8.33e-2)" "prognostic unfavourable (1.58e-4)" "prognostic unfavourable (9.91e-4)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (7.36e-2)" "prognostic favourable (3.77e-4)" "unprognostic (5.10e-2)" "unprognostic (1.77e-1)" "unprognostic (2.71e-2)" "unprognostic (3.09e-3)" 27.4 31.6 21.8 19.9 24.9 19.0 30.6 12.9 25.9 21.6 38.9 24.0 17.0 26.9 24.1 17.7 28.6 24.3 18.6 41.6 21.9 20.9 54.0 53.7 19.2 18.5 27.6 21.4 27.1 24.1 27.8 18.8 24.1 22.0 25.3 40.7 24.7 41.8 20.2 41.7 19.5 32.7 26.6 20.5 22.7 25.0 16.6 18.2 23.3 42.5 35.6 22.3 22.4 24.0 33.4 84.6 6.3 28.0 28.4 34.7 40.2 36.1 67.5 16.2 31.8 21.8 17.3 45.1 26.7 17.8 43.4 28.5 189.6 32.5 67.0 49.0 24.6 23.6 44.0 38.6 45.0 29.1 57.9 33.8 43.8 85.7 16.1 66.6 20.9 19.2 26.8 46.9 17.3 31.6 60.2 18.1 28.1 61.5 46.2 41.7 30.1 64.5 37.0 61.6 55.0 29.5 38.3 32.8 27.9 20.2 23.6 37.5 40.2 31.1 27.5 41.2 31.8 32.1 57.3 23.2 63.4 64.8 27.0 44.4 35.6 6.3 25.3 6.2 32.3 28.0 34.7 33.4 28.7 31.0 38.1 29.9 30.4 30.9 2.5 28.4 21.0 84.6 28.1 40.2 21.8 24.9 12.9 25.9 21.9 20.9 27.6 21.4 22.0 18.2 PHB2 "Bap37, BCAP37, p22, REA" ENSG00000215021 "Prohibitin 2" Q99623 12 6965327-6970825 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014889, CAB026335, HPA039874" Supported Enhanced Mitochondria 780000 Mitochondria "CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448" "unprognostic (4.64e-3)" "unprognostic (4.32e-2)" "unprognostic (9.65e-2)" "prognostic unfavourable (3.80e-4)" "unprognostic (3.07e-3)" "unprognostic (1.67e-1)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (7.18e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.07e-1)" "unprognostic (8.17e-2)" "unprognostic (5.61e-2)" 36.2 46.2 20.0 41.5 21.3 33.5 37.1 21.6 29.7 42.7 48.6 19.8 42.8 40.0 46.3 36.2 55.6 37.7 29.1 44.3 17.9 17.2 36.0 72.8 24.0 64.9 18.8 18.8 68.9 92.3 28.0 22.1 27.4 17.2 48.6 39.5 25.8 62.7 29.1 72.9 39.5 46.3 56.0 17.5 36.6 37.5 20.5 19.0 57.2 50.4 77.4 45.7 46.4 39.9 36.4 47.6 20.9 35.9 38.1 41.6 34.4 36.5 35.3 29.6 40.1 24.0 42.0 66.2 25.9 33.4 45.9 36.4 55.7 38.5 76.1 11.4 25.0 29.9 54.1 45.7 37.2 42.2 45.2 40.0 22.9 52.3 40.4 64.4 29.4 43.3 31.2 29.0 63.4 45.0 35.6 17.5 32.3 36.3 59.1 58.9 113.3 31.5 41.5 47.6 47.3 36.7 41.1 15.3 53.0 20.9 59.7 66.9 9.4 51.6 27.1 19.8 32.4 15.6 54.6 17.6 21.3 78.3 26.7 33.6 28.1 20.9 30.0 14.6 30.8 35.9 37.3 36.4 35.3 35.8 47.6 34.8 32.0 31.8 12.4 38.1 30.4 44.4 41.6 34.4 20.0 21.3 21.6 29.7 17.9 17.2 18.8 18.8 17.2 19.0 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 26.7 39.4 22.7 20.4 34.4 31.0 21.5 29.7 47.8 21.6 23.4 29.8 19.1 19.1 27.6 27.2 25.0 21.3 23.7 41.0 22.1 19.3 28.8 47.1 23.6 21.2 22.9 25.6 35.3 25.7 31.2 26.0 17.8 38.8 27.2 22.4 29.2 25.1 23.8 62.0 28.0 25.3 26.3 19.1 18.9 21.6 41.6 20.4 48.6 28.7 33.0 26.8 26.0 22.4 11.5 13.7 6.0 13.9 12.4 13.9 9.1 25.4 20.6 8.2 11.1 23.3 25.3 9.4 37.8 17.6 30.2 16.5 18.6 15.6 12.8 13.2 23.6 19.7 13.1 29.2 22.8 22.1 18.7 18.1 16.9 13.9 13.3 7.0 21.6 20.8 21.7 33.0 18.9 31.4 18.3 16.9 39.9 22.0 17.6 7.3 5.6 25.1 8.7 11.4 18.2 24.0 19.5 10.5 6.4 28.6 21.0 15.9 24.4 8.4 38.5 23.9 6.7 58.4 18.1 13.6 14.2 13.3 36.5 12.9 11.7 6.0 9.4 4.9 13.1 12.0 12.9 11.5 11.3 12.2 13.7 6.8 12.1 13.9 1.4 12.4 13.9 7.6 13.8 9.1 22.7 34.4 29.7 47.8 22.1 19.3 22.9 25.6 38.8 20.4 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Supported Mitochondria Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 3.1 4.0 3.2 5.4 5.9 2.1 2.5 2.5 2.3 3.5 1.2 5.2 3.6 2.6 1.5 1.5 2.9 1.6 1.5 1.1 1.1 1.1 4.3 0.7 5.2 0.9 0.3 5.5 3.9 2.6 5.6 2.6 0.6 2.2 2.6 0.5 3.4 2.2 4.8 1.3 4.4 3.0 2.1 3.6 1.6 2.8 2.4 1.2 0.6 1.0 1.2 1.0 1.7 2.6 1.0 0.8 0.3 7.3 4.5 1.1 1.2 2.0 1.0 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 PLEKHO1 "CKIP-1, OC120" ENSG00000023902 "Pleckstrin homology domain containing O1" Q53GL0 1 150149183-150164720 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 60.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061018 Supported Mitochondria Mitochondria "HPA061018: " "unprognostic (1.41e-2)" "unprognostic (7.04e-3)" "unprognostic (2.01e-2)" "unprognostic (1.78e-2)" "unprognostic (3.23e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-2)" "unprognostic (8.33e-2)" "unprognostic (3.84e-2)" "unprognostic (3.18e-2)" "unprognostic (8.71e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (6.47e-11)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (1.87e-1)" "unprognostic (6.52e-2)" 10.9 17.0 14.2 34.4 22.1 10.2 10.5 17.0 14.4 9.6 44.5 5.4 6.4 11.8 16.9 7.7 16.8 11.9 14.1 17.8 10.2 6.9 5.8 5.8 12.9 29.0 8.2 13.1 13.5 2.5 1.4 3.5 10.1 8.0 18.2 8.3 7.9 4.7 12.1 15.8 3.6 17.4 60.7 6.5 29.4 22.3 24.8 7.3 15.0 3.8 3.1 17.4 29.3 17.7 11.0 16.0 18.7 15.8 2.1 5.1 5.4 5.1 1.2 17.2 13.4 5.5 4.9 1.4 8.9 12.3 12.1 10.7 0.3 0.1 0.1 1.7 10.4 0.4 8.6 0.4 3.9 30.6 4.3 0.9 0.7 3.1 10.5 7.0 29.1 7.2 0.4 15.0 2.3 11.4 1.9 13.4 16.4 2.3 26.7 13.9 16.1 2.3 24.2 9.3 5.8 2.0 1.4 10.8 17.6 0.7 0.0 6.7 0.9 7.0 15.9 8.0 9.1 8.2 10.6 5.1 0.1 3.2 31.8 0.0 3.0 1.5 15.8 0.3 3.5 14.1 3.8 11.0 5.1 3.7 11.7 10.5 3.5 3.0 18.7 2.1 12.8 16.0 3.7 5.4 14.2 22.1 17.0 14.4 10.2 6.9 8.2 13.1 8.0 7.3 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394843 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria Mitochondria "HPA048387: , HPA068609: " "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 21.9 11.5 6.2 17.8 6.1 5.2 31.0 4.4 7.9 24.0 12.7 7.4 16.3 5.6 29.2 22.0 21.6 15.6 17.7 25.3 5.6 5.7 15.3 12.9 25.0 67.2 5.8 7.6 19.9 10.0 10.1 9.0 17.3 8.4 15.4 6.3 10.2 12.5 17.8 16.1 17.8 10.5 21.4 13.1 29.0 11.6 8.6 6.4 12.1 12.2 26.0 21.0 21.5 20.1 12.9 9.5 1.9 13.3 6.6 30.8 12.1 14.2 3.2 2.7 8.4 10.3 18.1 3.6 13.0 11.9 11.1 10.4 4.9 3.3 3.6 10.6 18.6 19.5 3.4 21.2 5.6 9.8 1.9 3.4 4.3 3.4 13.9 1.2 4.5 13.1 14.4 11.1 16.7 17.1 2.0 2.8 14.4 7.3 3.8 1.0 2.5 9.2 7.8 2.3 3.8 10.4 9.2 2.4 8.1 6.6 4.8 3.0 8.2 0.6 27.8 7.6 7.8 8.7 5.4 3.2 3.6 1.4 11.9 4.3 8.8 1.9 10.0 1.1 16.8 13.3 17.1 12.9 30.5 17.1 9.5 12.0 25.2 15.0 1.0 6.6 10.9 1.1 30.8 12.1 6.2 6.1 4.4 7.9 5.6 5.7 5.8 7.6 8.4 6.4 PMPCA "Alpha-MPP, INPP5E, KIAA0123" ENSG00000165688 "Peptidase, mitochondrial processing alpha subunit" Q10713 9 136410570-136423761 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021648, HPA063735" Supported Enhanced Mitochondria 6500 Mitochondria "HPA021648: AB_1855491, HPA063735: AB_2685108" "unprognostic (9.80e-2)" "unprognostic (1.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.69e-2)" "unprognostic (4.01e-2)" "unprognostic (8.19e-2)" "unprognostic (6.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.97e-1)" "unprognostic (3.32e-2)" "prognostic favourable (8.00e-5)" "unprognostic (9.47e-3)" "prognostic favourable (2.14e-6)" "unprognostic (4.27e-3)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (3.54e-2)" 15.2 27.3 19.8 14.6 23.8 20.1 13.2 20.3 24.3 12.3 15.1 13.0 10.4 18.6 14.2 14.1 16.5 13.6 14.9 37.0 15.6 14.8 17.0 48.3 12.3 18.4 15.2 21.9 15.5 18.2 14.7 19.5 15.6 16.8 15.2 11.9 12.8 20.3 17.1 56.7 17.5 17.0 13.8 14.1 18.9 16.3 23.2 12.5 14.0 15.0 19.8 15.3 13.1 13.4 25.5 30.1 17.0 25.1 32.1 30.8 28.2 14.3 26.9 12.9 26.0 9.8 14.3 19.8 15.0 12.1 21.0 15.3 30.7 17.2 20.1 15.8 15.2 33.6 23.8 22.0 9.3 28.9 28.8 16.2 34.7 37.1 17.3 21.0 14.1 21.0 15.2 16.3 8.4 17.7 41.0 13.3 13.0 39.8 19.8 27.1 26.3 25.5 24.7 18.3 44.5 14.4 10.3 26.5 17.4 20.2 28.8 17.5 39.2 28.7 14.6 15.0 16.1 12.3 19.0 8.2 10.9 21.7 19.7 18.4 13.4 15.4 25.1 17.0 27.2 24.4 26.4 25.5 25.7 29.3 30.1 23.7 30.8 26.9 5.9 32.1 23.2 15.3 24.3 28.2 19.8 23.8 20.3 24.3 15.6 14.8 15.2 21.9 16.8 12.5 PMPCB "MPPB, MPPP52" ENSG00000105819 "Peptidase, mitochondrial processing beta subunit" O75439 7 103297422-103329511 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040674, HPA074168" Approved Enhanced Mitochondria 57000 Mitochondria "HPA040674: AB_10961998, HPA074168: " "prognostic favourable (2.79e-4)" "unprognostic (3.11e-1)" "unprognostic (7.18e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" "unprognostic (1.06e-1)" "unprognostic (7.67e-2)" "unprognostic (7.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.42e-3)" "prognostic favourable (2.95e-8)" "unprognostic (2.59e-2)" "unprognostic (9.79e-2)" "unprognostic (2.40e-1)" "unprognostic (4.39e-2)" 29.1 41.8 31.8 23.0 34.3 41.5 31.6 41.1 38.4 29.0 26.9 21.6 28.2 35.1 32.0 25.9 27.9 26.9 23.5 41.4 27.7 20.1 45.9 47.2 21.9 31.3 32.6 35.0 36.8 40.6 41.1 33.9 24.8 34.2 31.6 31.5 20.8 30.6 31.0 31.5 31.6 31.0 25.7 27.8 27.9 33.6 31.3 35.9 37.2 33.2 24.2 30.0 30.7 27.9 19.5 18.4 9.7 16.1 12.9 21.9 15.7 12.1 17.6 20.8 27.9 12.6 25.6 15.7 11.3 19.5 22.9 27.3 18.8 14.0 31.3 18.2 19.3 15.8 24.9 18.2 21.9 10.9 29.7 10.8 30.2 25.0 15.4 14.8 12.8 23.4 17.0 17.9 17.3 12.1 20.9 31.8 20.9 28.3 24.6 35.0 25.4 22.1 17.2 14.5 31.8 21.5 21.8 26.1 31.9 15.3 45.2 22.3 18.5 19.9 10.0 20.3 24.3 36.0 21.0 24.4 31.2 24.0 15.0 24.0 15.9 9.7 14.1 9.3 14.7 16.1 16.1 19.5 17.1 14.7 18.4 14.3 21.5 17.4 4.4 12.9 13.6 9.4 21.9 15.7 31.8 34.3 41.1 38.4 27.7 20.1 32.6 35.0 34.2 35.9 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2" ENSG00000127838 "Paroxysmal nonkinesigenic dyskinesia" Q8N490 2 218270392-218346793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria 31000 Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavourable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 21.8 28.3 33.2 15.9 41.0 13.4 16.4 26.6 51.1 29.8 27.5 14.3 28.9 18.1 14.6 37.0 13.3 28.3 30.4 37.3 31.0 26.5 42.4 107.0 23.4 34.2 33.2 23.6 18.1 18.8 22.3 15.6 28.1 26.8 34.8 25.1 15.9 27.3 27.1 33.8 12.9 15.9 16.6 25.7 18.0 29.5 23.3 20.6 11.6 29.7 15.3 16.3 19.0 13.4 64.0 32.7 44.9 35.4 38.4 43.3 38.9 15.2 20.0 14.7 23.0 22.1 18.7 27.1 9.6 20.8 22.8 25.7 32.8 15.1 17.9 19.3 16.0 15.8 28.2 18.0 16.1 37.1 35.2 26.0 36.6 48.4 24.2 16.8 11.6 25.4 17.8 15.6 4.5 24.6 19.1 23.3 20.2 43.7 21.8 40.1 14.6 20.5 21.5 14.8 14.9 26.2 23.2 14.2 12.0 6.9 46.9 27.3 15.6 16.3 15.2 9.5 16.3 11.2 13.0 9.7 9.9 19.2 24.2 27.7 11.4 33.7 35.4 44.9 32.1 34.1 30.4 64.0 35.1 38.3 32.7 52.0 38.8 37.3 9.8 38.4 31.0 30.4 43.3 38.9 33.2 41.0 26.6 51.1 31.0 26.5 33.2 23.6 26.8 20.6 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634265-55693910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Enhanced Mitochondria Mitochondria "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavourable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavourable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 11.1 11.7 13.3 6.5 21.7 11.7 10.8 13.3 18.8 5.7 8.2 12.8 5.4 5.7 8.3 8.8 9.5 7.9 5.8 11.0 12.4 10.9 9.8 11.4 9.1 7.1 24.1 7.4 6.9 9.1 7.4 14.3 5.1 15.2 7.7 10.1 4.2 9.0 6.3 23.5 10.1 7.0 7.9 17.6 10.4 7.6 13.5 22.5 9.6 10.0 7.8 5.9 5.3 7.4 9.8 7.4 6.1 6.5 3.8 8.6 4.7 6.7 3.6 5.0 2.3 3.6 6.3 6.7 10.0 6.1 15.9 10.7 10.5 3.2 14.1 4.2 4.7 5.4 6.4 7.8 7.4 5.0 14.2 8.1 4.6 5.3 9.5 18.3 5.5 7.0 5.4 6.6 5.7 4.9 8.5 3.2 6.3 3.8 11.2 12.8 12.1 6.1 11.1 8.4 12.4 6.7 4.2 12.2 7.3 3.6 11.1 12.2 3.0 8.1 5.1 3.8 3.2 3.3 10.2 14.3 1.1 3.0 7.2 16.0 6.4 4.2 6.5 6.1 8.1 5.7 4.8 5.4 3.7 8.6 2.8 9.8 6.9 7.9 6.1 3.8 5.1 7.4 2.4 4.7 13.3 21.7 13.3 18.8 12.4 10.9 24.1 7.4 15.2 22.5 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria Mitochondria "HPA056821: , HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 17.8 15.2 19.8 19.0 19.2 16.8 24.6 23.2 20.9 14.1 16.0 14.6 13.6 20.0 17.6 9.0 20.7 14.3 14.0 17.4 16.7 8.8 14.9 19.5 17.8 21.8 17.3 15.3 16.6 17.9 17.7 12.9 16.2 16.0 15.4 13.2 10.5 15.9 12.0 35.9 19.8 18.5 14.1 12.7 22.9 16.2 12.4 17.3 29.0 15.4 12.1 19.2 16.5 18.9 6.0 9.0 9.0 6.5 9.2 10.9 6.7 6.8 13.0 9.0 11.7 14.7 9.4 11.5 13.7 7.3 14.1 11.1 19.0 17.2 10.8 21.2 10.8 14.9 24.0 11.6 4.7 23.3 20.6 16.4 13.7 6.8 12.5 15.2 27.1 8.5 17.0 9.7 8.3 16.8 14.4 12.2 11.4 12.1 17.3 15.5 8.1 5.8 17.7 11.0 15.3 8.0 16.8 20.0 7.3 19.5 14.3 15.9 11.9 17.1 12.5 19.1 13.2 28.0 13.1 13.1 7.6 15.0 12.2 17.5 15.2 4.9 6.3 9.0 9.2 6.5 8.0 3.3 7.6 10.9 9.0 6.0 6.6 6.9 2.3 9.2 5.2 6.0 4.3 6.7 19.8 19.2 23.2 20.9 16.7 8.8 17.3 15.3 16.0 17.3 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497036 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017030, HPA023202" Approved Approved "Nuclear bodies,Mitochondria" "Nuclear bodies" Mitochondria "CAB017030: , HPA023202: AB_1855523" "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavourable (6.59e-4)" "prognostic unfavourable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 6.7 9.3 5.4 17.5 10.0 8.1 8.2 10.9 8.7 7.7 7.8 7.0 11.1 7.9 10.2 6.8 6.4 7.5 7.9 7.3 5.6 4.4 7.8 7.8 10.4 12.2 10.8 5.2 13.0 9.4 5.0 9.9 6.9 8.7 8.0 5.7 5.8 8.6 11.9 10.7 10.5 8.4 9.3 5.6 11.5 6.9 24.2 7.9 9.8 9.6 5.4 13.3 6.6 11.5 12.2 10.5 6.5 8.2 6.0 12.2 4.4 6.7 8.3 6.0 7.4 5.7 4.6 7.3 4.0 3.8 6.1 5.3 8.6 5.4 12.4 4.9 2.1 5.6 8.2 3.8 7.7 3.5 9.4 8.4 10.0 8.5 6.4 11.9 9.4 4.6 4.4 4.9 7.3 4.4 14.7 4.8 5.9 9.0 12.6 15.7 6.3 9.3 11.8 19.6 13.1 5.6 2.0 8.4 9.4 3.2 7.3 7.4 7.1 10.0 4.9 6.6 8.9 5.7 10.4 8.5 5.7 9.4 5.2 11.1 4.6 6.5 5.9 6.5 7.9 3.5 7.5 12.2 8.8 7.6 10.5 12.1 12.2 11.6 1.2 6.0 8.2 4.8 8.4 4.4 5.4 10.0 10.9 8.7 5.6 4.4 10.8 5.2 8.7 7.9 POLRMT "APOLMT, h-mtRPOL, MTRNAP, MTRPOL" ENSG00000099821 "RNA polymerase mitochondrial" O00411 19 617224-633604 "Enzymes, Predicted intracellular proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006366 Uncertain Supported Mitochondria Mitochondria "HPA006366: AB_1079654" "unprognostic (3.24e-1)" "unprognostic (4.31e-2)" "unprognostic (7.96e-2)" "prognostic favourable (4.50e-4)" "unprognostic (9.46e-2)" "unprognostic (2.94e-2)" "unprognostic (3.04e-2)" "unprognostic (9.41e-2)" "unprognostic (1.45e-1)" "unprognostic (3.48e-1)" "unprognostic (7.64e-3)" "unprognostic (1.81e-2)" "unprognostic (1.62e-1)" "unprognostic (1.28e-3)" "unprognostic (1.66e-1)" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" 10.2 10.7 10.1 16.3 11.9 6.9 8.1 12.1 20.7 9.5 11.6 12.3 4.4 16.7 9.8 12.2 14.4 8.7 12.7 24.7 11.5 8.9 12.9 21.4 7.3 11.8 9.4 15.1 10.1 15.9 9.5 10.7 6.2 9.7 10.2 8.8 8.5 9.6 11.7 42.2 16.7 12.8 10.8 8.4 12.8 11.2 32.1 6.3 11.6 11.1 8.6 10.4 10.1 7.8 8.2 7.3 3.1 5.5 7.5 9.0 5.3 10.4 19.0 4.3 19.1 9.1 5.2 16.0 4.9 5.8 7.3 6.7 19.1 7.2 10.8 10.0 4.5 10.9 16.1 9.4 5.4 12.1 38.3 8.4 11.8 24.5 9.5 14.1 16.0 5.0 13.3 7.4 9.1 10.3 15.7 10.8 6.7 14.8 18.7 19.4 17.3 13.4 18.1 6.0 18.4 9.7 9.0 14.0 9.9 4.4 12.2 12.2 6.9 12.9 6.1 7.9 10.2 12.4 14.4 25.8 21.2 16.5 17.0 11.8 9.7 0.0 3.7 3.1 9.0 5.2 7.1 7.8 6.7 6.6 7.3 8.2 5.7 6.3 0.6 7.5 5.5 7.2 4.1 5.3 10.1 11.9 12.1 20.7 11.5 8.9 9.4 15.1 9.7 6.3 PPCS FLJ11838 ENSG00000127125 "Phosphopantothenoylcysteine synthetase" Q9HAB8 1 42456117-42473385 "Enzymes, Predicted intracellular proteins" Ligase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031361, HPA031363" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" 16000 "Nucleoli fibrillar center, Mitochondria" Nucleoplasm "HPA031361: AB_10602150, HPA031363: AB_2673844" "unprognostic (1.49e-1)" "unprognostic (6.71e-2)" "unprognostic (8.15e-2)" "unprognostic (1.55e-1)" "unprognostic (3.84e-3)" "unprognostic (1.68e-2)" "prognostic unfavourable (5.96e-5)" "unprognostic (2.71e-1)" "unprognostic (7.79e-3)" "unprognostic (9.13e-3)" "unprognostic (3.24e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-2)" "unprognostic (6.45e-2)" "unprognostic (2.32e-1)" "unprognostic (2.80e-1)" "unprognostic (4.30e-2)" 23.4 36.3 18.9 20.5 21.9 10.7 30.7 12.0 26.0 23.2 32.0 12.4 27.3 25.5 18.2 34.4 31.6 14.5 30.9 22.1 17.8 16.4 41.4 43.9 26.5 28.1 19.3 14.9 19.6 47.0 22.8 16.1 37.6 17.2 27.2 27.3 19.6 36.6 35.0 19.6 21.9 41.0 27.6 18.9 24.4 27.2 13.5 13.4 22.6 31.3 26.0 20.5 24.0 19.4 41.9 44.4 76.1 55.7 42.0 41.0 52.0 22.5 9.4 5.5 8.5 17.1 17.8 20.5 11.4 13.1 15.4 13.7 7.9 27.6 6.8 22.5 14.4 13.3 3.6 17.3 13.0 17.9 10.9 11.4 10.4 9.4 23.5 11.7 20.2 15.7 31.4 10.8 20.0 14.3 4.6 4.9 15.7 13.5 5.7 11.5 6.3 14.6 6.5 5.6 12.1 33.7 21.3 6.5 7.1 14.0 34.2 35.4 16.1 51.8 8.9 8.5 11.3 12.9 13.0 16.2 10.1 4.9 3.5 13.5 17.3 58.1 55.7 76.1 30.7 55.1 35.7 41.9 37.0 33.0 44.4 39.9 41.0 34.9 41.2 42.0 51.8 33.2 36.4 52.0 18.9 21.9 12.0 26.0 17.8 16.4 19.3 14.9 17.2 13.4 PPIF "Cyp-D, hCyP3" ENSG00000108179 "Peptidylprolyl isomerase F" P30405 10 79347469-79355337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Necrosis" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 32.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077416 Supported Mitochondria 27000000 Mitochondria "HPA077416: " "unprognostic (2.21e-1)" "unprognostic (5.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.72e-3)" "unprognostic (1.69e-1)" "unprognostic (3.16e-3)" "unprognostic (3.45e-1)" "unprognostic (4.33e-3)" "unprognostic (1.66e-1)" "unprognostic (1.97e-1)" "unprognostic (2.82e-1)" "unprognostic (9.37e-3)" "unprognostic (1.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.88e-2)" 16.5 76.2 12.1 15.7 18.8 52.0 16.9 7.1 21.3 8.3 18.1 27.1 13.2 13.3 5.2 7.6 21.0 8.8 10.0 36.5 13.0 14.5 21.0 73.1 9.4 19.4 23.3 16.6 7.2 42.0 12.0 6.2 11.3 25.2 6.6 19.9 7.5 12.7 21.9 44.4 22.5 11.1 9.9 28.0 19.6 34.0 20.8 18.0 8.8 10.0 73.9 19.8 12.5 11.0 8.0 18.6 32.8 14.9 3.6 5.0 6.5 35.1 15.0 10.5 20.7 9.8 12.8 13.5 20.5 27.0 45.2 42.8 35.0 17.1 36.6 11.4 14.4 21.1 32.6 19.1 70.5 11.6 30.7 57.3 14.7 61.6 16.7 39.4 13.6 30.0 13.8 44.8 44.9 7.9 55.7 45.2 15.3 18.1 10.2 33.0 8.8 83.4 17.6 16.3 18.7 17.5 32.9 21.0 15.6 10.5 42.7 15.8 18.7 30.5 7.1 19.8 18.0 23.3 39.5 21.0 21.3 29.6 19.6 51.4 5.3 5.1 14.9 7.3 4.7 11.4 5.0 8.0 4.2 4.3 18.6 3.9 3.8 3.7 32.8 3.6 4.1 2.3 4.2 6.5 12.1 18.8 7.1 21.3 13.0 14.5 23.3 16.6 25.2 18.0 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 59.1" "Cell line enhanced" "Detected in many" "Daudi: 27.1;Karpas-707: 23.6;U-698: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 3.6 6.1 19.2 8.8 17.2 5.9 9.3 21.1 26.8 12.9 3.8 12.5 2.5 3.0 21.8 5.5 7.6 14.1 6.0 59.1 23.1 14.6 11.8 5.1 6.5 14.5 21.6 15.9 22.0 7.3 10.4 8.4 6.4 17.0 11.1 4.3 4.7 7.1 5.3 8.3 1.9 6.7 18.2 15.0 10.9 5.4 12.3 19.4 7.3 5.4 1.9 15.8 6.5 8.1 31.8 38.8 5.5 3.4 7.9 16.1 7.1 2.1 0.7 2.8 4.9 4.2 5.5 1.1 3.4 6.3 11.6 13.7 5.6 0.5 27.1 3.8 2.2 0.2 8.2 2.6 4.6 20.9 3.4 4.8 2.1 5.0 3.3 6.6 2.6 3.6 1.3 7.1 6.2 1.9 7.2 23.6 3.3 3.1 8.7 3.6 1.7 1.1 5.0 4.6 10.3 4.0 0.9 2.2 1.9 2.1 0.2 2.5 11.2 1.8 0.3 4.0 2.1 1.3 2.0 7.4 6.8 22.7 4.4 5.4 6.7 5.5 2.9 2.3 12.4 3.4 16.1 30.4 11.8 12.4 5.5 31.8 11.7 14.1 0.9 7.9 0.9 38.8 13.3 7.1 19.2 17.2 21.1 26.8 23.1 14.6 21.6 15.9 17.0 19.4 PRDX1 "NKEFA, PAGA" ENSG00000117450 "Peroxiredoxin 1" Q06830 1 45511036-45523047 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004682, HPA007730" Approved Supported Mitochondria 110000000 Mitochondria "CAB004682: AB_437046, HPA007730: AB_1855204" "unprognostic (1.28e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.68e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.39e-2)" "unprognostic (5.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (2.89e-4)" 43.3 58.2 71.0 43.8 57.4 12.0 75.5 31.6 60.0 46.9 51.1 72.2 42.6 78.5 40.8 75.7 136.1 49.7 46.9 84.2 56.5 73.0 121.7 136.5 52.9 51.0 99.1 51.2 43.0 20.4 34.1 34.3 58.3 87.8 42.2 53.0 48.8 53.5 52.2 78.9 46.9 77.6 52.4 98.3 46.5 52.5 25.7 72.6 29.7 130.1 114.3 91.0 49.1 56.3 44.7 50.3 64.4 64.5 20.4 72.3 58.7 65.4 120.6 49.7 63.2 56.4 48.3 106.4 74.4 77.4 80.8 67.2 59.9 28.3 57.8 78.6 79.8 67.8 107.9 71.9 80.0 44.5 83.3 43.7 170.2 167.6 24.5 50.5 57.2 41.4 53.8 80.2 19.0 92.6 79.8 20.0 80.2 52.5 67.7 49.3 155.8 126.4 119.4 62.7 76.1 145.2 56.4 66.2 33.3 68.3 185.5 4.8 50.4 40.9 78.7 32.3 73.1 69.1 99.0 14.0 78.1 110.1 53.4 35.2 18.9 64.4 55.6 18.4 28.5 60.6 37.5 44.7 45.5 37.9 50.3 36.2 28.3 31.0 2.4 20.4 64.5 33.5 72.3 58.7 71.0 57.4 31.6 60.0 56.5 73.0 99.1 51.2 87.8 72.6 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318088-64321811 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Enhanced Mitochondria 19000000 Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favourable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 28.7 69.7 70.3 38.6 60.3 57.0 35.5 69.3 73.9 47.2 79.3 31.9 49.0 49.5 26.6 54.8 69.6 94.9 44.8 102.4 56.7 74.2 57.3 54.2 50.3 25.0 68.6 70.2 42.2 72.0 36.0 53.7 49.1 71.4 30.7 71.2 33.9 77.5 62.6 104.7 27.0 51.2 30.9 44.1 27.3 64.5 35.0 29.3 25.1 82.0 64.8 33.5 34.4 50.4 55.2 69.2 115.0 66.9 48.4 40.5 75.3 26.0 53.2 32.3 53.3 34.8 52.3 37.3 32.7 52.4 24.0 30.0 38.7 53.6 38.3 57.2 52.2 59.7 30.1 69.4 15.3 53.1 23.7 38.6 83.8 44.1 71.4 14.6 32.9 53.0 90.7 40.3 40.9 36.5 21.7 91.0 33.8 66.2 25.5 63.5 48.9 68.2 24.6 33.1 135.2 90.0 51.8 27.4 52.0 27.3 60.7 93.2 44.4 33.3 35.1 34.4 32.0 39.7 14.4 46.6 55.4 45.0 41.6 29.5 26.8 79.8 66.9 85.4 37.7 59.6 32.7 53.8 35.0 30.8 52.4 55.2 34.8 35.0 115.0 48.4 52.5 69.2 40.5 75.3 70.3 60.3 69.3 73.9 56.7 74.2 68.6 70.2 71.4 29.3 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303774-177306959 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavourable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 18.9 25.0 21.9 33.9 20.3 30.3 21.6 12.0 31.1 16.9 44.6 14.8 15.4 43.5 18.3 15.5 35.6 17.4 20.6 16.8 19.3 18.6 46.1 62.3 18.9 43.0 20.2 14.7 20.3 91.6 12.3 17.7 29.4 21.0 19.8 35.0 18.9 40.1 16.4 11.9 26.2 70.6 19.0 14.8 43.5 24.6 12.9 13.5 25.2 29.3 27.2 33.7 18.0 18.9 27.1 77.4 111.7 94.2 30.4 26.4 49.2 31.8 30.0 18.3 48.7 16.4 17.8 60.8 22.8 15.9 33.3 32.2 67.1 36.6 27.1 26.9 21.4 18.1 32.5 60.9 22.8 116.1 45.0 23.4 31.1 44.6 17.3 36.8 33.0 16.0 21.9 26.3 22.5 41.2 25.8 39.3 32.4 82.8 23.6 53.9 37.2 49.6 7.6 36.9 48.7 21.7 26.7 29.2 36.7 21.3 42.5 39.6 27.4 45.3 22.7 30.5 26.7 25.0 54.5 22.0 37.7 39.4 26.3 49.7 31.7 31.5 75.7 111.7 26.4 94.2 25.8 27.1 21.9 26.2 77.4 21.1 19.3 21.1 55.2 30.4 90.3 28.3 23.3 49.2 21.9 20.3 12.0 31.1 19.3 18.6 20.2 14.7 21.0 13.5 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106182-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favourable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favourable (6.86e-4)" 13.9 18.6 18.5 12.2 23.2 18.0 14.5 24.5 22.7 13.0 17.5 19.7 11.3 14.3 15.2 15.5 12.7 13.6 9.6 35.0 17.7 16.6 18.0 21.9 11.7 15.4 20.2 19.0 20.2 13.8 17.9 22.7 13.2 21.4 13.0 19.7 11.4 11.1 12.9 45.4 14.2 14.2 13.4 17.9 15.8 14.8 22.8 20.5 20.4 14.9 13.1 15.3 12.4 13.0 13.4 9.4 6.3 11.1 11.9 14.7 7.5 7.6 18.5 11.0 9.2 8.2 8.6 13.2 17.0 6.8 9.0 9.1 34.4 7.4 19.3 6.0 8.9 14.2 22.2 8.7 11.6 8.6 19.5 15.3 11.5 28.4 8.6 12.4 11.6 10.2 6.4 6.8 12.3 7.8 15.9 7.3 7.9 7.1 10.2 14.8 10.0 11.9 13.8 15.5 14.6 12.3 15.5 12.0 7.4 7.4 12.4 14.5 6.6 7.6 5.5 7.2 7.7 7.3 9.3 17.4 22.3 15.6 7.0 14.2 5.5 3.4 8.6 6.3 11.6 5.9 13.6 13.4 10.5 12.2 9.4 13.4 14.7 10.7 0.3 11.9 11.1 9.4 11.8 7.5 18.5 23.2 24.5 22.7 17.7 16.6 20.2 19.0 21.4 20.5 PTPMT1 "DUSP23, MOSP, PLIP" ENSG00000110536 "Protein tyrosine phosphatase, mitochondrial 1" Q8WUK0 11 47565430-47573461 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040348, HPA043932" Approved Supported Mitochondria Mitochondria "HPA040348: , HPA043932: " "unprognostic (6.61e-2)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "prognostic unfavourable (3.04e-5)" "unprognostic (3.29e-2)" "unprognostic (2.77e-2)" "unprognostic (1.93e-3)" "unprognostic (6.76e-2)" "unprognostic (1.72e-1)" "unprognostic (2.68e-3)" "unprognostic (1.21e-1)" "unprognostic (5.39e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 24.0 24.5 22.3 13.1 23.2 19.8 23.3 16.5 25.2 15.7 14.8 18.5 17.5 14.6 14.7 21.4 14.3 16.9 17.9 17.1 18.5 21.9 20.1 21.8 25.1 16.7 23.1 16.2 15.7 39.3 18.3 18.7 21.8 14.4 15.8 11.5 20.1 26.4 19.5 23.4 11.2 13.1 12.7 17.6 14.7 16.9 44.6 10.3 10.8 19.9 15.7 15.0 11.0 11.5 20.4 40.8 22.1 24.4 15.4 17.5 16.8 22.0 12.5 1.5 10.0 11.6 8.9 4.3 13.0 12.3 13.0 12.4 20.7 11.8 15.9 14.4 9.7 18.9 10.3 13.5 13.9 19.4 31.0 7.3 25.6 26.0 17.0 14.2 9.7 8.8 15.3 6.1 18.7 9.2 18.6 12.2 9.5 41.6 12.1 18.3 9.3 23.2 22.2 8.4 13.5 15.6 14.1 9.3 11.4 19.7 7.2 11.7 33.5 15.3 9.9 9.7 14.8 15.6 19.5 18.6 12.4 10.8 7.6 12.3 5.8 6.0 24.4 22.1 16.0 20.9 15.4 20.4 15.2 17.3 27.7 18.0 15.2 14.4 1.9 15.4 19.4 40.8 17.5 16.8 22.3 23.2 16.5 25.2 18.5 21.9 23.1 16.2 14.4 10.3 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 15.9 22.9 17.1 12.4 17.1 9.9 20.7 12.5 22.1 15.6 17.2 11.8 16.3 11.6 14.3 36.7 16.4 13.8 13.1 12.6 19.3 17.8 14.8 34.7 12.1 12.5 16.7 15.2 14.2 19.9 10.3 18.3 13.6 21.0 15.9 20.7 8.1 13.7 18.7 23.3 11.4 11.0 16.8 17.1 15.5 14.3 15.7 18.1 9.0 11.8 13.5 16.9 13.0 10.5 15.6 21.6 12.6 29.3 13.1 15.5 13.0 19.8 37.9 12.2 11.1 23.2 20.0 13.1 19.1 16.9 16.4 24.0 24.4 15.6 14.4 29.0 16.0 19.8 26.2 24.6 23.9 27.7 35.7 25.7 19.7 44.8 35.8 22.7 14.6 22.5 32.1 25.4 29.6 27.2 28.6 16.1 24.3 47.9 19.4 18.5 10.5 30.0 10.6 20.5 21.0 27.3 28.6 15.8 20.5 9.9 10.8 23.4 25.2 16.2 17.9 21.4 21.7 12.8 20.7 20.9 23.2 21.4 14.1 14.2 16.3 1.9 25.8 1.1 9.2 24.4 12.4 15.6 10.8 10.4 18.5 13.1 15.5 11.1 12.6 13.1 29.3 21.6 12.3 13.0 17.1 17.1 12.5 22.1 19.3 17.8 16.7 15.2 21.0 18.1 PUS1 ENSG00000177192 "Pseudouridylate synthase 1" Q9Y606 12 131929200-131945896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051636, HPA057593" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051636: , HPA057593: " "unprognostic (2.72e-1)" "unprognostic (9.13e-2)" "unprognostic (1.81e-1)" "unprognostic (2.69e-2)" "unprognostic (8.12e-3)" "unprognostic (8.07e-2)" "unprognostic (4.57e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (2.06e-1)" "unprognostic (5.30e-2)" "prognostic unfavourable (3.49e-8)" "unprognostic (1.80e-3)" "unprognostic (8.06e-2)" "unprognostic (8.59e-2)" "unprognostic (1.56e-2)" 12.7 15.8 18.8 19.5 23.3 26.2 11.2 8.8 16.9 8.7 11.9 9.4 11.0 12.4 13.6 18.7 16.5 12.9 25.1 8.6 15.6 8.3 10.7 22.8 11.0 21.4 11.7 15.8 10.1 19.8 7.2 9.5 8.3 11.7 11.7 10.5 7.6 11.4 15.7 13.5 15.4 13.9 9.7 6.2 17.4 13.6 11.9 16.4 11.6 10.3 11.6 15.8 10.8 12.8 5.9 4.6 1.9 2.0 9.1 4.0 1.3 15.2 20.0 4.7 8.4 4.6 7.9 29.2 11.8 5.0 9.0 5.8 22.1 10.0 18.3 13.7 6.4 19.4 15.6 11.2 5.9 8.1 31.6 18.4 9.7 19.3 12.4 31.4 16.9 7.9 9.1 10.3 8.8 8.8 22.8 5.6 5.2 26.6 20.6 28.2 25.1 30.5 19.7 6.8 18.9 7.3 21.3 13.3 7.4 9.9 13.6 10.9 14.9 34.0 7.7 7.2 15.4 15.3 17.1 15.5 11.6 21.7 7.4 25.2 9.9 1.2 2.0 0.4 3.2 1.4 2.2 5.9 2.7 3.3 1.6 5.5 4.0 2.1 1.9 9.1 1.3 4.6 2.4 1.3 18.8 23.3 8.8 16.9 15.6 8.3 11.7 15.8 11.7 16.4 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: " "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavourable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favourable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.4 18.0 11.1 12.2 6.1 5.3 25.4 8.5 3.9 11.4 14.5 7.6 10.0 9.1 12.6 5.8 5.9 14.9 12.0 21.3 22.2 30.7 12.8 20.2 28.9 6.0 16.5 11.5 3.1 10.8 12.7 10.3 12.7 19.9 12.5 9.7 77.6 23.3 23.0 3.0 16.7 15.1 17.6 17.2 6.9 9.7 13.8 12.8 6.8 3.3 12.8 10.1 17.5 4.0 9.6 25.6 8.7 10.3 11.8 43.8 26.7 9.8 16.3 11.0 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 RBFA "C18orf22, FLJ21172, HsT169" ENSG00000101546 "Ribosome binding factor A" Q8N0V3 18 80034358-80046397 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040485, HPA041479" Approved Supported Mitochondria Mitochondria "HPA040485: AB_10795368, HPA041479: AB_10795697" "unprognostic (5.31e-3)" "unprognostic (3.21e-2)" "unprognostic (1.87e-1)" "unprognostic (4.55e-2)" "unprognostic (7.33e-2)" "unprognostic (5.00e-3)" "prognostic unfavourable (2.06e-6)" "unprognostic (2.98e-1)" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (4.28e-2)" "unprognostic (3.76e-2)" "unprognostic (2.43e-1)" "unprognostic (3.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.82e-1)" "unprognostic (5.00e-3)" 19.4 21.0 11.3 14.4 15.8 16.7 30.9 20.4 17.3 12.1 12.5 15.9 10.0 14.8 13.6 14.3 17.7 11.4 12.9 13.8 10.6 8.6 14.5 36.9 11.0 18.5 12.5 14.2 12.3 20.0 12.5 9.7 12.6 12.7 11.8 12.7 11.3 13.4 12.3 21.3 18.6 11.1 18.3 13.8 13.2 12.1 13.8 12.8 9.9 11.6 18.6 15.7 14.0 14.2 10.7 8.3 0.3 10.1 7.5 11.7 5.7 14.2 16.0 11.3 10.4 11.5 13.7 14.6 12.1 7.7 17.9 16.1 9.4 12.5 30.0 4.6 10.9 13.5 12.5 15.6 14.4 10.9 13.0 17.8 11.6 24.7 8.8 28.1 8.8 13.1 15.3 11.8 17.2 15.0 9.5 18.7 10.9 13.7 27.9 19.4 11.8 15.9 18.8 10.5 36.6 17.2 16.7 19.5 11.8 10.9 13.0 8.3 9.4 14.2 10.2 20.3 19.0 3.0 13.1 6.9 11.9 25.1 11.8 24.5 11.6 0.0 5.1 0.0 7.5 7.0 11.7 10.7 7.6 7.3 8.3 8.3 8.4 7.9 0.3 7.5 10.1 6.5 5.8 5.7 11.3 15.8 20.4 17.3 10.6 8.6 12.5 14.2 12.7 12.8 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favourable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 4.4 6.8 4.0 6.0 6.6 5.5 4.2 8.7 9.4 7.5 8.3 3.5 9.0 5.1 5.0 5.0 17.6 4.2 7.1 11.4 3.0 5.4 8.8 7.5 5.6 5.1 4.7 5.2 3.8 10.7 8.8 6.1 34.0 10.0 5.7 4.0 6.4 11.6 13.1 9.4 18.0 6.9 5.2 2.2 6.8 9.5 4.4 3.0 2.1 7.2 8.6 8.9 8.5 10.2 7.4 6.0 5.4 6.7 6.1 8.5 3.5 3.1 3.6 0.6 1.9 0.4 0.4 5.8 2.9 0.3 2.1 1.5 5.4 3.6 1.8 2.4 0.7 3.2 3.8 2.3 0.2 1.6 10.2 2.0 4.7 3.8 0.9 4.8 1.4 1.3 0.9 1.9 1.4 2.8 4.0 1.0 0.7 5.2 0.8 3.2 0.8 4.7 2.5 1.0 10.1 1.3 5.5 2.2 2.7 2.8 8.0 3.6 3.9 4.7 2.9 0.3 1.1 0.2 3.9 2.0 3.6 2.2 1.5 3.4 2.0 4.1 4.1 5.4 8.5 6.7 7.7 6.1 7.0 7.7 4.5 7.4 8.4 6.8 2.6 6.1 5.9 6.0 5.7 3.5 4.0 6.6 8.7 9.4 3.0 5.4 4.7 5.2 10.0 3.0 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favourable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavourable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.4 16.0 6.2 16.6 49.9 53.0 14.8 46.5 36.4 23.5 30.0 41.9 47.0 15.1 46.9 41.1 17.5 13.9 41.2 38.9 14.6 10.8 16.6 22.1 26.0 65.6 12.1 5.3 36.6 39.5 29.7 31.6 42.0 30.7 9.3 52.6 6.5 8.8 15.2 19.1 28.3 7.8 20.2 54.9 33.7 22.3 11.0 6.9 21.4 16.5 19.6 33.6 6.3 39.7 30.3 36.3 23.3 28.5 7.3 8.7 25.5 20.9 28.6 16.1 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668086-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favourable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favourable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 15.2 22.8 19.9 26.4 22.3 25.8 16.4 33.3 22.6 14.6 27.2 14.7 19.5 29.5 16.4 27.6 17.3 17.3 28.5 26.5 18.4 11.5 21.8 23.0 15.7 23.4 20.1 20.5 17.3 25.1 18.1 25.3 17.7 19.9 23.3 8.9 30.5 31.7 20.2 21.9 25.3 25.1 13.8 10.4 27.0 24.5 15.8 15.3 20.2 22.1 14.6 20.8 16.6 16.3 11.0 16.4 16.9 18.6 8.7 20.1 13.2 9.4 18.1 10.6 16.3 5.3 5.5 18.8 15.8 7.4 13.5 10.3 25.2 14.5 10.5 11.3 6.4 17.7 7.5 15.0 3.4 15.0 31.0 12.6 22.4 18.0 9.8 11.5 17.2 8.9 12.9 10.0 5.8 9.5 22.8 8.9 7.1 38.5 12.1 12.8 26.0 12.5 28.2 11.8 22.0 8.6 17.9 22.9 27.1 14.8 19.6 8.6 20.2 18.1 15.3 10.5 16.9 8.9 11.3 23.8 15.0 14.7 6.9 11.0 14.9 4.5 16.1 16.9 20.1 18.6 12.2 10.1 16.0 15.9 15.9 11.0 12.2 10.3 13.8 8.7 14.3 16.4 18.0 13.2 19.9 22.3 33.3 22.6 18.4 11.5 20.1 20.5 19.9 15.3 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favourable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.3 22.1 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.4 29.2 10.3 16.4 0.6 19.0 14.7 23.2 22.7 13.6 29.0 15.5 18.5 14.1 14.8 11.1 9.2 10.5 24.2 20.0 5.9 17.1 11.6 10.0 7.4 15.4 18.3 11.2 16.8 11.5 14.3 22.5 8.2 17.5 23.7 8.2 18.6 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.2 16.6 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452181 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria Mitochondria "HPA031397: , HPA031398: , HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.9 15.7 9.0 6.8 12.1 4.0 17.0 14.5 15.6 10.5 12.8 7.7 6.4 13.2 10.9 11.7 8.3 12.2 8.0 11.4 9.9 11.7 34.0 29.1 7.8 8.2 10.1 13.5 15.7 9.9 6.9 11.2 14.4 14.0 8.0 11.5 10.5 7.3 8.0 10.9 7.9 14.9 11.2 8.9 6.9 8.0 8.6 7.0 11.2 18.9 6.0 9.5 10.6 11.9 11.3 7.2 6.8 12.2 13.2 11.3 5.0 8.0 3.7 8.3 17.2 11.2 25.5 11.3 12.7 12.3 9.8 13.6 10.6 6.1 7.7 9.1 8.1 7.0 15.2 7.9 17.1 8.8 12.1 12.1 5.9 21.7 22.9 27.1 3.9 17.8 10.2 14.0 21.4 12.7 13.2 6.2 14.9 26.3 9.2 8.7 6.1 7.4 10.5 10.2 9.5 13.9 3.6 13.9 13.4 9.0 11.4 15.1 19.1 17.5 7.2 7.7 10.1 16.0 9.9 6.4 8.4 8.8 19.3 21.2 8.9 2.1 5.9 6.8 7.1 8.2 11.2 11.3 8.5 9.9 7.2 9.0 11.2 10.2 2.9 13.2 12.2 3.3 11.3 5.0 9.0 12.1 14.5 15.6 9.9 11.7 10.1 13.5 14.0 7.0 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 54.7;hTCEpi: 17.4;HUVEC TERT2: 16.1;TIME: 16.1;U-698: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: , HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.6 3.2 3.5 0.0 0.1 54.7 15.0 0.6 4.7 0.0 4.6 4.6 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.4 1.2 3.9 16.1 0.0 0.0 0.8 0.5 0.4 0.0 0.4 0.3 0.2 0.5 3.3 9.8 3.0 0.5 0.0 0.3 7.0 5.2 8.2 0.1 16.1 2.5 0.5 0.2 0.3 0.0 0.0 46.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9" "Cell line enhanced" "Detected in some" "HDLM-2: 10.8;HL-60: 14.4;NB-4: 14.2;REH: 40.1;U-937: 13.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria Mitochondria "HPA060601: , HPA067232: " "prognostic favourable (3.13e-4)" "prognostic favourable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favourable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favourable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 2.0 0.5 0.7 8.3 0.3 14.9 1.3 0.6 0.7 0.5 0.9 0.4 0.2 0.8 0.7 0.7 1.2 1.4 0.7 2.1 0.3 0.2 1.2 1.4 6.4 35.9 0.3 0.4 0.7 0.3 0.0 0.2 1.7 0.6 0.7 0.0 1.0 1.3 0.2 1.1 0.4 7.1 0.2 0.5 34.2 3.9 0.3 0.3 10.2 1.5 0.2 10.7 1.9 0.6 14.1 7.3 44.2 15.3 5.4 23.1 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.1 0.0 0.1 0.0 0.0 0.0 10.8 0.0 4.6 0.1 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 40.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 13.7 0.0 16.4 10.4 27.4 11.8 11.6 10.5 11.3 14.7 11.4 7.3 14.1 12.4 11.9 44.2 5.4 15.3 6.6 23.1 7.2 0.7 0.3 0.6 0.7 0.3 0.2 0.3 0.4 0.6 0.3 SAMM50 "CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W" ENSG00000100347 "SAMM50 sorting and assembly machinery component" Q9Y512 22 43955421-44010531 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034537 Enhanced Supported Mitochondria 3700000 Mitochondria "HPA034537: AB_10602794" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-3)" "prognostic favourable (2.63e-7)" "unprognostic (2.43e-3)" "unprognostic (2.28e-1)" "unprognostic (5.28e-3)" "unprognostic (1.70e-3)" "unprognostic (3.37e-2)" "unprognostic (1.95e-1)" "unprognostic (2.42e-1)" "unprognostic (3.52e-1)" "prognostic favourable (4.43e-8)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" "unprognostic (1.60e-1)" 21.7 25.1 12.4 13.9 13.6 10.2 16.0 10.5 20.1 17.4 15.6 11.2 17.2 18.9 12.6 13.5 14.6 16.3 18.2 34.3 11.3 11.9 18.5 18.8 8.9 18.6 12.7 14.7 16.0 16.7 60.6 12.2 7.6 16.4 10.4 13.7 14.3 19.3 13.6 79.5 15.8 21.2 14.2 12.3 12.2 18.5 11.5 8.6 17.4 10.8 34.6 15.1 11.5 11.0 27.7 34.0 22.4 19.6 18.2 29.3 18.5 21.9 20.9 20.4 24.6 26.4 28.0 28.5 21.6 23.2 32.0 27.6 29.8 16.2 36.5 15.9 24.6 26.6 30.1 28.9 28.8 10.0 37.2 19.7 27.5 35.1 18.5 62.5 29.8 32.3 23.2 27.5 12.8 32.8 16.8 12.1 28.6 31.3 24.4 24.5 19.9 25.1 28.7 22.1 29.5 26.6 28.2 12.2 19.9 23.9 25.6 35.3 24.0 20.6 20.1 20.7 25.0 19.1 17.6 18.0 24.7 28.1 26.0 22.8 20.7 19.2 19.6 22.4 21.2 19.2 29.3 27.7 19.8 21.5 34.0 24.5 20.8 19.5 3.2 18.2 14.7 13.4 22.7 18.5 12.4 13.6 10.5 20.1 11.3 11.9 12.7 14.7 16.4 8.6 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-256700 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.1;skeletal muscle: 114.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria 780000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavourable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favourable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 17.6 31.4 15.3 11.5 20.3 10.6 12.8 18.8 29.0 10.2 29.4 17.3 10.0 44.3 11.3 12.1 15.3 12.6 14.8 100.1 15.8 14.5 36.5 55.4 10.7 11.7 19.6 19.3 14.5 14.7 23.2 9.5 9.2 29.7 10.7 24.6 14.5 17.3 12.0 114.0 11.5 39.9 16.5 13.2 13.9 21.2 14.6 14.8 15.7 12.5 39.6 12.5 13.2 11.1 28.3 31.9 29.1 29.2 27.1 48.9 32.4 18.4 29.9 12.3 20.1 21.2 15.9 33.4 14.2 18.1 24.5 25.0 32.4 25.1 22.8 45.0 16.2 23.9 21.7 29.0 14.5 48.6 19.9 11.6 82.6 42.0 13.1 14.4 15.1 15.8 18.7 18.3 9.7 26.5 18.6 19.0 11.5 28.2 19.1 39.0 4.2 37.9 24.7 17.9 44.2 52.2 24.5 13.6 7.8 67.0 43.3 17.6 26.3 18.3 19.2 18.2 17.9 10.8 11.7 20.2 8.6 16.8 17.6 20.9 11.5 17.8 24.4 29.1 36.4 29.2 32.1 28.3 34.8 35.1 31.9 24.5 34.5 31.7 5.9 27.1 24.1 20.5 48.9 32.4 15.3 20.3 18.8 29.0 15.8 14.5 19.6 19.3 29.7 14.8 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.3 22.0 13.1 9.1 19.0 15.5 10.2 11.9 17.2 16.1 12.4 20.6 16.5 15.4 21.8 17.1 16.6 17.0 16.9 17.3 22.8 16.1 13.3 18.1 29.6 19.8 15.6 18.5 19.2 20.7 17.5 17.1 25.9 15.2 19.9 19.4 33.8 15.9 35.5 20.2 32.4 17.2 16.9 28.5 22.9 22.7 14.0 17.5 16.3 19.1 33.0 29.7 18.7 16.1 16.4 13.3 19.4 14.1 12.3 19.0 19.6 15.9 13.9 17.1 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: , CAB068234: , CAB068235: , HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favourable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 25.5 25.4 14.5 18.5 28.2 28.1 16.5 22.4 28.8 51.4 46.5 35.7 30.8 35.1 28.0 30.2 30.2 57.7 44.7 58.0 20.6 47.3 31.6 26.4 27.4 34.6 49.4 23.6 28.8 29.5 44.4 75.3 36.3 26.4 40.7 35.7 21.1 32.8 28.2 12.0 51.1 23.6 27.9 43.5 47.3 14.5 27.3 15.0 30.4 38.1 63.9 22.3 27.9 18.0 19.8 22.3 36.3 29.5 17.0 20.9 35.9 30.3 75.3 21.8 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 34.2;T-cells: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Uncertain Enhanced Mitochondria Mitochondria "HPA019543: AB_1856789, HPA063745: " "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 5.6 14.0 15.2 12.0 20.9 12.9 8.1 20.7 24.5 6.5 18.8 7.9 5.3 13.2 6.5 6.0 12.6 6.6 7.1 9.4 14.5 18.3 28.3 66.8 5.3 17.0 15.3 17.0 13.6 9.7 7.4 11.8 10.4 15.1 7.6 12.5 5.7 7.7 8.0 11.7 6.3 13.4 8.1 15.0 8.2 10.1 5.0 11.0 13.9 7.7 7.3 17.8 11.3 9.1 4.5 3.0 34.2 2.6 4.8 16.0 5.6 10.0 32.0 16.4 17.7 5.6 12.2 26.4 25.8 10.9 21.8 21.2 40.1 20.4 21.1 20.1 13.5 13.0 31.4 45.0 23.7 51.6 26.3 15.5 28.9 17.5 8.3 30.2 19.6 9.9 8.8 24.1 10.6 16.7 22.2 16.8 15.8 35.3 35.3 2.4 12.9 10.6 29.7 16.8 22.6 8.2 39.7 28.0 17.9 24.9 23.6 12.6 11.4 10.0 16.2 17.3 27.4 12.6 33.6 21.4 25.2 48.2 28.3 27.3 17.9 34.2 2.1 10.4 11.3 2.6 9.4 4.5 16.0 12.6 3.0 3.8 12.7 12.9 0.6 4.8 1.7 1.4 12.7 5.6 15.2 20.9 20.7 24.5 14.5 18.3 15.3 17.0 15.1 11.0 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria 81000 Mitochondria "HPA008028: AB_1079938, HPA048105: " "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavourable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 14.4 8.1 11.5 8.7 13.9 4.1 10.7 40.2 22.9 14.5 19.0 15.5 13.6 24.4 13.8 17.7 6.5 14.9 12.9 11.3 12.5 9.8 9.2 3.4 16.4 5.4 18.3 13.7 10.6 7.0 17.1 6.9 16.2 18.4 8.8 8.4 9.1 8.4 13.8 2.7 15.7 44.8 19.9 13.7 8.3 8.2 5.6 16.9 4.3 7.5 5.1 5.5 10.7 11.2 2.2 15.7 8.9 14.8 4.3 9.8 8.3 15.4 6.0 0.6 1.8 16.3 17.3 1.6 9.4 33.5 12.1 9.8 9.9 17.1 0.6 9.1 22.1 11.4 2.8 20.6 5.3 4.3 3.6 1.8 10.0 7.1 11.2 1.4 15.1 11.9 3.0 10.6 10.0 26.5 0.1 0.5 19.6 2.5 0.6 2.2 0.7 14.6 1.5 11.9 4.2 17.8 2.4 3.3 16.2 5.1 0.6 14.0 5.0 11.0 21.7 10.7 8.4 9.4 4.6 2.4 0.9 0.0 26.1 8.4 8.5 8.9 14.8 7.1 9.8 11.1 7.5 2.2 6.7 6.6 15.7 1.0 4.1 5.1 2.8 4.3 6.1 2.5 7.0 8.3 11.5 13.9 40.2 22.9 12.5 9.8 18.3 13.7 18.4 16.9 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229327-57234935 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.1" "Cell line enhanced" "Detected in all" "RH-30: 208.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Enhanced Microtubules,Mitochondria 160000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavourable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 13.0 13.5 5.9 15.0 7.1 12.6 9.5 9.6 9.5 10.5 11.5 6.1 5.0 13.4 10.2 8.5 22.1 8.6 10.3 11.0 6.5 5.4 15.5 103.1 11.8 18.7 8.7 4.6 17.9 38.9 4.5 8.1 16.8 6.5 10.3 9.4 7.1 44.6 5.7 16.5 13.7 11.5 9.9 7.6 23.5 13.4 5.4 6.3 26.1 13.2 19.0 25.6 11.2 13.8 33.6 14.5 6.5 11.7 9.7 48.7 12.3 24.6 11.4 11.6 30.6 9.1 14.0 23.0 13.4 21.8 17.9 16.5 16.4 11.9 45.7 22.2 16.5 15.8 20.9 21.7 9.7 25.5 18.6 18.8 7.0 11.6 67.4 31.1 16.7 17.9 31.6 14.4 48.2 17.8 19.7 43.5 13.6 16.2 24.7 17.0 9.9 18.6 16.7 208.3 42.3 9.0 11.4 24.9 11.9 7.0 16.5 48.4 22.4 38.3 11.2 7.3 14.8 9.4 18.1 58.3 31.9 38.8 15.7 29.0 13.0 6.5 9.8 5.9 6.9 11.7 8.0 33.6 12.1 7.4 14.5 32.4 5.3 5.4 0.5 9.7 7.5 4.8 48.7 12.3 5.9 7.1 9.6 9.5 6.5 5.4 8.7 4.6 6.5 6.3 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884669-67918390 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: " "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 17.2 32.3 12.6 21.1 17.8 17.0 18.1 22.6 14.5 24.2 20.5 15.7 14.0 9.2 19.0 12.7 12.7 15.1 15.2 14.7 14.1 10.4 13.9 17.3 12.6 16.1 17.0 10.1 26.6 14.4 16.4 13.3 14.7 12.1 21.7 12.5 12.1 12.3 16.1 19.9 12.9 15.0 21.0 17.7 13.5 13.2 25.4 16.3 28.1 15.2 9.3 14.7 21.6 37.5 4.9 3.9 3.8 3.5 3.6 7.1 1.8 8.2 9.4 15.0 16.7 14.3 11.1 9.4 11.5 11.9 15.8 14.1 10.4 7.1 17.4 6.2 7.6 6.6 18.6 3.8 17.0 9.3 10.8 9.2 7.1 8.1 13.1 9.9 7.1 10.2 9.3 9.5 16.4 6.3 11.7 9.5 11.5 6.6 9.2 13.7 18.6 15.2 16.7 11.8 6.8 7.4 5.1 9.7 13.3 21.0 13.9 14.5 10.1 9.2 5.3 12.3 11.5 10.9 11.1 8.0 9.5 34.5 6.3 15.1 5.0 3.8 2.4 3.2 3.4 3.0 4.9 4.9 3.7 4.7 3.9 3.3 7.1 4.2 3.1 3.6 3.5 3.5 2.9 1.8 12.6 17.8 22.6 14.5 14.1 10.4 17.0 10.1 12.1 16.3 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574529-13615158 "FDA approved drug targets, Predicted intracellular proteins" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favourable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 5.9 6.2 8.8 6.8 10.4 5.9 9.2 11.1 13.5 4.9 7.2 6.4 12.5 8.1 6.8 6.7 5.7 8.0 6.6 22.9 8.5 8.3 9.9 29.9 9.8 6.9 9.5 6.9 8.8 10.5 12.9 7.6 5.3 8.3 6.5 8.3 6.2 8.6 8.7 25.8 8.8 8.5 6.2 6.9 9.5 7.6 6.6 6.1 7.5 8.5 7.0 6.5 6.8 6.0 9.2 4.6 10.9 9.3 7.3 10.0 5.6 6.0 4.7 6.0 7.8 3.8 5.0 4.6 3.1 3.3 3.4 5.1 7.6 7.2 8.7 18.9 2.4 9.8 4.2 6.1 5.2 4.0 7.0 5.5 4.4 12.2 6.3 4.4 4.8 5.4 12.4 3.0 10.8 6.1 7.8 3.3 4.0 7.3 4.8 8.8 5.1 7.5 8.7 3.9 15.8 7.0 6.6 10.0 3.6 3.5 6.1 13.8 7.0 2.9 5.4 5.2 3.0 3.2 3.4 8.1 9.1 5.9 2.9 4.4 5.0 0.5 4.5 10.9 8.1 6.1 8.2 9.2 10.0 7.9 4.6 9.1 9.5 8.5 1.5 7.3 9.3 4.6 7.2 5.6 8.8 10.4 11.1 13.5 8.5 8.3 9.5 6.9 8.3 6.1 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favourable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 11.3 15.1 12.8 9.6 26.2 9.6 20.8 14.7 22.1 20.8 11.3 38.2 8.4 35.3 12.3 12.7 17.3 15.4 12.1 12.9 14.5 14.2 16.1 18.0 18.6 7.9 40.0 15.4 10.4 20.6 29.8 21.7 16.4 29.7 18.0 11.8 18.7 26.9 14.8 17.6 15.6 11.6 11.0 33.1 9.5 12.5 8.7 31.0 15.8 29.9 8.7 16.5 12.9 13.9 4.1 9.8 3.0 9.5 8.3 7.1 4.6 7.5 9.8 13.1 12.0 14.5 12.3 43.7 8.3 30.1 7.9 9.3 12.4 14.4 4.7 16.4 9.2 10.6 11.8 7.8 9.3 6.8 7.1 11.2 12.0 14.1 15.4 7.6 22.7 13.5 9.8 14.7 15.0 9.4 9.7 2.4 9.2 8.8 9.0 5.1 19.3 6.8 5.8 11.9 8.3 9.6 11.4 9.0 8.0 6.3 19.2 8.4 21.6 5.1 11.3 8.1 6.8 9.0 4.3 5.9 8.0 1.9 22.8 4.1 3.4 0.7 6.6 2.4 6.4 9.5 5.8 3.6 5.0 6.3 9.8 4.1 7.1 6.6 3.0 8.3 6.0 4.1 3.8 4.6 12.8 26.2 14.7 22.1 14.5 14.2 40.0 15.4 29.7 31.0 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell line enhanced" "Detected in many" "Hep G2: 49.6;SK-BR-3: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" HPA023048 Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favourable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favourable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favourable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.0 26.0 2.5 12.4 0.9 0.7 5.0 6.0 1.9 7.7 5.8 15.7 6.0 6.3 4.7 1.4 9.0 3.5 6.2 1.4 4.6 20.1 5.1 15.8 49.6 1.1 11.5 6.3 0.5 3.2 5.4 1.0 4.4 8.6 7.9 2.6 26.4 16.8 12.2 2.5 19.6 12.8 5.3 19.9 6.8 12.7 16.4 11.1 5.6 38.2 1.3 16.3 6.4 1.9 5.9 19.5 8.6 10.8 4.9 2.5 3.6 2.6 12.2 5.1 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 SLC25A13 "ARALAR2, CITRIN, CTLN2" ENSG00000004864 "Solute carrier family 25 member 13" Q9UJS0 7 96120220-96322147 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 79.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018997 Approved Supported Mitochondria Mitochondria "HPA018997: AB_1857023" "unprognostic (3.61e-2)" "unprognostic (7.99e-2)" "unprognostic (6.99e-2)" "unprognostic (7.19e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (1.42e-2)" "unprognostic (6.67e-2)" "unprognostic (2.31e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-1)" "unprognostic (6.99e-2)" "prognostic favourable (9.14e-4)" "unprognostic (1.15e-1)" "unprognostic (1.05e-1)" "unprognostic (3.32e-1)" "unprognostic (7.09e-2)" 7.7 10.3 4.2 4.9 11.8 4.1 6.7 3.0 7.5 5.4 12.5 21.1 15.6 8.9 5.1 8.0 6.9 5.9 6.7 4.5 5.6 5.3 17.7 79.1 5.5 4.9 14.5 4.8 5.9 7.3 8.2 8.8 8.9 12.4 5.9 10.2 12.6 5.7 17.3 4.6 8.2 9.7 5.0 13.1 7.2 7.9 4.3 12.6 1.8 7.9 3.0 4.8 5.0 5.3 3.7 8.9 3.1 6.7 2.8 2.4 2.1 16.4 14.6 16.8 5.8 2.9 2.3 23.6 4.2 3.2 10.1 10.3 26.1 15.5 7.4 19.9 2.6 9.8 18.8 6.0 12.0 2.9 12.4 8.4 13.7 20.3 6.8 10.7 6.7 6.2 6.4 8.7 7.8 11.6 23.7 2.8 4.9 18.1 0.0 10.0 29.6 9.0 4.2 10.0 17.1 24.3 15.6 8.1 26.5 14.5 30.7 24.8 9.1 8.2 6.8 7.6 16.9 17.8 12.7 5.8 14.5 4.7 9.3 10.3 12.4 0.6 4.6 3.1 2.2 6.3 2.4 3.7 1.8 2.0 8.9 2.0 1.2 1.5 0.8 2.8 6.7 4.7 1.8 2.1 4.2 11.8 3.0 7.5 5.6 5.3 14.5 4.8 12.4 12.6 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell line enhanced" "Detected in many" "Karpas-707: 34.6;RPMI-8226: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Supported Mitochondria,Cytosol 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.4 3.5 4.9 11.3 4.3 0.7 7.8 4.2 5.5 5.7 5.5 6.8 6.5 5.5 12.3 1.4 8.7 3.5 4.1 16.4 4.1 9.0 6.9 6.9 5.1 9.4 17.4 5.5 4.0 7.4 1.2 7.0 8.0 34.6 7.2 3.7 10.3 4.7 1.8 9.9 3.7 2.1 47.7 5.9 3.4 1.4 5.0 7.2 0.0 4.0 11.0 4.4 5.7 6.2 1.1 9.1 5.7 12.9 8.9 7.5 9.0 6.7 8.2 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria Mitochondria "HPA009675: , HPA050883: " "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favourable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 19.8 8.0 11.7 36.7 15.7 6.9 5.3 5.7 9.5 11.3 13.6 20.2 13.3 11.1 14.2 14.6 16.9 23.8 13.8 9.0 0.0 20.0 8.0 17.0 16.1 14.6 0.5 19.0 19.8 12.2 10.0 4.4 11.7 23.1 14.2 2.2 14.5 7.0 11.4 8.4 24.7 3.4 3.1 17.1 30.2 3.6 0.8 11.5 4.1 25.6 10.5 13.3 17.6 4.0 3.5 15.3 0.9 3.8 2.6 3.5 9.8 1.6 18.9 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 SLC25A24 "APC1, DKFZp586G0123" ENSG00000085491 "Solute carrier family 25 member 24" Q6NUK1 1 108134036-108200849 "Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028519, HPA063636" Enhanced Enhanced Mitochondria 8900 Mitochondria "HPA028519: AB_10603890, HPA063636: AB_2685068" "unprognostic (1.94e-2)" "unprognostic (7.30e-3)" "prognostic favourable (1.01e-4)" "unprognostic (7.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.91e-1)" "unprognostic (8.54e-4)" "unprognostic (1.51e-2)" "unprognostic (7.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-3)" "unprognostic (6.18e-2)" "unprognostic (6.76e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 19.8 10.8 3.0 13.1 3.3 3.8 25.2 2.3 4.5 15.9 26.6 3.9 9.6 13.6 12.4 11.8 11.4 9.0 16.1 12.4 2.8 3.3 15.3 2.9 17.8 10.8 3.0 2.7 13.5 7.2 13.2 7.7 10.4 5.3 12.4 18.2 9.8 11.2 9.7 7.4 6.9 42.4 9.7 4.0 17.0 9.0 5.1 1.5 10.3 13.7 10.8 9.4 10.8 18.2 2.9 4.8 4.4 7.1 1.7 4.3 2.1 23.9 5.3 16.4 5.1 11.3 14.9 8.2 8.4 9.9 15.0 16.5 6.5 8.0 0.0 7.7 15.4 9.4 4.8 13.5 20.3 5.9 2.5 1.5 8.0 3.1 9.3 3.9 3.2 11.1 9.6 8.7 11.2 11.4 4.0 8.1 18.8 15.7 2.2 0.8 9.7 6.2 4.0 21.5 7.2 10.1 12.4 3.1 5.4 11.8 8.5 11.1 8.2 6.8 7.7 8.5 4.3 15.1 9.0 2.2 1.3 0.0 2.9 7.0 5.0 2.8 4.9 4.4 2.3 5.7 2.9 2.9 2.7 2.3 4.8 2.3 1.3 2.3 0.6 1.7 7.1 1.4 4.3 2.1 3.0 3.3 2.3 4.5 2.8 3.3 3.0 2.7 5.3 1.5 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favourable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favourable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 29.2 15.8 7.3 8.1 12.8 5.5 10.6 8.8 20.0 14.4 7.2 6.3 20.0 7.9 14.6 8.2 22.7 17.5 31.6 5.6 7.6 9.0 9.5 48.4 12.4 6.7 7.5 8.0 13.6 52.6 12.1 19.0 7.6 15.0 8.5 5.5 13.6 7.6 63.5 31.3 9.5 10.0 17.3 8.7 7.8 10.5 7.3 5.3 5.4 10.8 20.2 9.7 8.6 9.6 2.9 4.6 3.8 8.4 1.5 7.6 3.9 5.8 6.1 8.7 12.6 6.6 5.7 5.8 12.1 11.3 10.2 6.8 11.0 6.1 7.6 3.7 5.6 10.4 6.8 4.0 3.9 8.8 5.6 4.4 12.4 6.5 10.5 5.0 10.1 7.2 3.8 10.0 7.4 6.9 15.8 16.4 6.4 14.1 8.9 5.1 8.8 9.6 8.8 7.5 15.9 3.9 6.1 21.7 9.3 12.7 8.2 16.9 9.0 2.9 4.4 11.6 6.9 8.7 11.9 14.4 25.1 8.1 7.8 2.7 9.5 3.8 2.3 1.2 4.8 7.3 2.4 1.7 5.3 4.8 4.6 2.9 4.5 7.6 0.4 1.5 8.4 1.5 3.9 3.9 7.3 12.8 8.8 20.0 7.6 9.0 7.5 8.0 15.0 5.3 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favourable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 11.8 12.9 20.2 8.5 14.8 13.3 16.5 7.9 27.2 10.3 12.6 15.8 9.2 9.7 11.1 12.9 14.3 13.1 10.1 19.5 16.9 12.8 15.7 22.7 10.0 15.2 17.6 11.8 20.0 21.2 16.2 11.6 11.9 14.6 10.8 13.4 12.6 16.1 12.6 29.8 16.5 11.0 16.8 14.3 11.4 12.7 18.3 12.6 12.0 19.0 14.2 12.9 13.4 10.8 12.0 12.2 3.6 7.1 10.5 14.4 9.1 6.3 6.1 3.8 7.7 8.4 8.7 8.0 5.3 10.1 7.2 6.8 8.1 8.5 6.5 3.2 9.7 4.7 4.4 9.9 7.4 6.7 10.3 9.8 4.9 11.7 10.2 13.8 8.4 11.9 19.6 5.7 13.7 5.3 4.3 8.7 8.6 7.9 5.7 15.8 11.1 3.6 6.0 6.9 11.0 5.9 4.7 2.9 8.9 7.7 6.7 12.6 5.6 10.9 6.0 7.6 7.2 9.5 9.3 12.9 16.7 8.4 10.4 13.2 8.2 1.3 6.8 3.6 10.9 7.1 9.9 12.0 12.1 11.1 12.2 10.2 14.4 12.3 0.4 10.5 4.1 11.6 11.1 9.1 20.2 14.8 7.9 27.2 16.9 12.8 17.6 11.8 14.6 12.6 SLC25A27 "FLJ33552, UCP4" ENSG00000153291 "Solute carrier family 25 member 27" O95847 6 46652915-46678193 "Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 25.8;hTCEpi: 14.6;U-698: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069732 Supported Mitochondria Mitochondria "HPA069732: " "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (9.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.87e-1)" "unprognostic (2.03e-1)" "unprognostic (2.81e-1)" "unprognostic (1.24e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "prognostic favourable (6.16e-4)" "unprognostic (3.82e-3)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.74e-1)" "unprognostic (7.47e-3)" 13.3 15.0 18.5 6.6 28.8 1.5 18.7 63.8 30.2 11.8 13.2 20.2 11.3 5.0 28.4 50.9 7.6 13.9 14.2 11.9 17.6 10.5 12.6 12.2 10.1 4.2 24.7 28.9 39.4 9.7 25.8 37.8 2.6 19.6 31.0 11.5 23.6 14.3 17.9 11.2 28.1 6.8 17.0 18.0 6.3 9.1 12.6 26.9 0.4 21.7 7.7 3.8 11.4 17.6 0.0 0.4 0.3 0.0 0.0 0.3 0.0 2.0 1.3 2.3 7.8 8.9 6.2 0.1 1.1 3.6 1.1 0.2 0.0 2.8 0.8 5.4 1.9 4.0 1.1 3.4 0.7 0.0 11.6 0.0 25.8 2.8 4.7 0.1 0.3 9.6 14.6 0.0 9.2 0.2 0.1 0.0 0.9 0.8 0.0 0.1 1.2 3.0 0.0 3.0 0.1 5.9 7.3 7.1 0.7 5.4 0.3 2.9 5.8 0.0 0.8 4.9 3.3 0.5 0.9 3.1 0.0 15.9 0.7 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 18.5 28.8 63.8 30.2 17.6 10.5 24.7 28.9 19.6 26.9 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favourable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 75.6 59.1 78.4 64.9 71.4 118.8 101.1 66.4 88.5 86.1 72.0 106.1 39.8 103.4 39.5 80.4 65.2 79.5 89.7 90.8 38.9 63.4 61.6 43.6 70.3 88.0 72.1 49.0 112.3 80.3 62.5 90.0 121.5 66.4 30.7 102.6 56.4 66.9 80.5 72.6 97.1 76.5 81.7 114.7 111.3 76.0 40.3 54.0 79.5 71.5 109.6 96.6 78.9 81.6 48.0 45.3 52.6 66.4 52.0 61.1 72.3 37.8 42.6 61.7 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: , HPA071684: " "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A32 MFTC ENSG00000164933 "Solute carrier family 25 member 32" Q9H2D1 8 103398635-103415189 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024763, HPA047402" Uncertain Supported Mitochondria Mitochondria "HPA024763: , HPA047402: " "unprognostic (2.45e-3)" "unprognostic (8.19e-2)" "unprognostic (3.87e-3)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.06e-2)" "unprognostic (6.50e-3)" "unprognostic (1.22e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (9.47e-2)" "unprognostic (8.43e-2)" "unprognostic (2.08e-1)" "unprognostic (9.21e-2)" "prognostic unfavourable (1.53e-6)" "unprognostic (7.82e-2)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (4.49e-2)" 24.1 14.9 11.1 19.6 17.0 21.6 21.6 22.1 21.9 16.3 14.7 15.4 8.8 11.0 19.4 13.0 13.1 18.8 19.6 16.4 12.6 16.5 15.2 29.6 16.1 23.9 16.4 11.6 21.0 13.4 17.3 30.1 16.5 24.2 14.9 14.2 15.7 13.0 13.1 17.8 13.9 14.1 18.5 14.1 25.1 14.4 15.3 13.6 17.2 14.9 11.7 19.8 18.3 14.2 8.9 5.0 1.8 4.6 5.7 9.3 6.5 14.9 5.4 7.3 8.9 10.1 11.7 4.9 12.7 18.0 14.3 14.9 6.5 9.2 32.5 12.1 13.7 9.6 10.5 10.7 22.2 19.8 7.5 24.0 4.6 8.3 17.5 11.7 10.9 11.5 8.9 16.1 24.0 14.8 14.8 12.8 14.2 6.0 19.9 9.6 8.8 10.8 15.0 7.8 22.4 9.7 6.9 20.5 9.0 6.2 10.2 21.3 9.1 8.4 10.2 17.8 11.8 20.4 16.3 9.1 8.6 33.9 15.1 17.2 13.1 0.7 3.9 1.8 7.7 4.4 9.3 8.9 8.3 8.8 5.0 6.5 8.6 8.7 1.1 5.7 4.6 4.3 6.5 6.5 11.1 17.0 22.1 21.9 12.6 16.5 16.4 11.6 24.2 13.6 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143241-185150382 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria Mitochondria "HPA046835: , HPA071684: " "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favourable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favourable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 3.0 4.2 6.9 2.0 10.8 1.4 3.1 19.4 14.4 2.6 6.6 3.7 2.9 2.8 3.0 3.4 6.7 3.7 3.5 163.7 7.4 7.3 8.3 4.3 3.0 2.0 6.3 6.1 3.6 3.0 4.6 4.6 2.2 12.8 6.2 3.4 7.9 4.4 8.5 92.5 2.3 4.1 5.5 4.5 2.1 5.3 3.1 2.3 0.0 4.6 62.4 3.4 4.4 2.1 3.5 3.0 0.4 0.0 0.7 4.1 1.5 0.7 3.2 2.7 5.4 2.9 0.3 4.9 2.7 0.9 3.3 3.3 7.0 1.8 2.3 1.9 3.2 2.6 10.3 2.8 2.1 4.0 8.8 1.6 4.9 8.2 6.0 1.4 1.6 2.2 7.0 5.0 1.4 2.4 3.8 1.8 2.0 5.1 1.6 3.1 4.3 7.0 2.6 1.4 3.3 7.4 5.0 8.7 6.6 3.2 1.4 12.4 2.5 1.2 1.8 0.2 1.5 1.6 3.4 7.8 3.5 3.0 2.4 0.3 3.0 0.0 0.0 0.0 4.1 0.0 3.1 3.5 1.4 3.5 0.1 2.2 1.2 3.0 0.4 0.7 0.0 3.0 1.2 1.5 6.9 10.8 19.4 14.1 7.4 7.3 6.3 6.1 12.8 2.3 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell line enhanced" "Detected in many" "K-562: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favourable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favourable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.3 0.8 1.6 2.9 6.3 5.2 2.6 3.1 4.7 4.8 5.5 1.2 12.8 4.6 7.3 2.9 1.2 3.3 2.6 2.8 1.1 6.3 1.6 1.7 10.2 5.0 0.7 3.2 5.2 1.8 3.6 2.2 2.1 17.8 8.3 2.5 5.7 7.6 7.3 0.9 6.6 5.9 2.9 8.8 1.9 1.2 1.8 1.3 3.3 0.1 1.4 5.8 3.6 1.9 3.6 2.0 7.4 3.0 9.6 5.2 3.6 3.8 9.8 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 SLC25A46 ENSG00000164209 "Solute carrier family 25 member 46" Q96AG3 5 110738136-110765161 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039601, HPA071582" Approved Supported Mitochondria Mitochondria "HPA039601: , HPA071582: " "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "prognostic favourable (8.41e-4)" "unprognostic (4.91e-2)" "unprognostic (2.27e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "unprognostic (1.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.97e-2)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (2.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "prognostic unfavourable (2.52e-4)" "unprognostic (1.98e-1)" 16.9 15.6 11.9 12.7 19.3 11.3 13.6 17.6 25.7 12.5 14.0 12.2 8.5 15.7 13.4 9.5 16.4 9.5 10.0 20.8 10.4 10.0 18.7 22.0 11.4 13.7 14.5 14.8 10.2 12.4 12.7 20.2 11.5 27.7 10.2 14.7 8.3 14.2 10.7 55.6 13.0 15.4 13.9 15.0 12.1 12.9 15.8 12.3 20.4 12.5 14.3 17.5 13.1 10.9 14.6 15.1 20.2 17.3 17.7 16.3 14.9 12.4 9.6 9.1 7.4 21.2 20.0 3.7 15.6 20.3 17.9 22.4 13.2 10.6 33.6 16.0 18.2 10.3 14.4 25.8 20.3 21.5 8.3 14.4 14.0 9.5 18.9 12.6 14.5 16.9 7.6 21.1 14.9 11.1 10.9 21.1 18.5 10.0 18.3 5.3 6.8 9.7 9.0 20.4 25.0 11.4 14.6 16.1 11.9 13.5 10.4 16.4 11.4 10.4 14.6 15.8 8.0 14.3 18.7 40.6 25.4 25.2 16.4 14.7 8.4 20.2 14.7 11.5 12.3 17.3 12.4 14.1 13.7 12.6 15.1 14.6 14.8 14.8 6.2 17.7 15.2 10.6 16.3 14.9 11.9 19.3 17.6 25.7 10.4 10.0 14.5 14.8 27.7 12.3 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468400-119471319 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria 7800000 Mitochondria "HPA046835: , HPA071684: " "unprognostic (1.25e-2)" "prognostic favourable (7.35e-4)" "prognostic favourable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favourable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 26.0 28.9 26.8 32.2 29.5 36.5 36.6 21.8 39.0 23.0 74.1 16.3 26.0 120.7 22.5 18.3 64.1 17.5 39.5 31.4 22.5 18.8 80.7 71.0 38.3 53.8 27.2 23.8 18.1 128.2 22.5 14.6 30.7 24.2 18.9 84.9 20.1 58.3 21.5 16.6 42.1 157.5 33.6 20.5 34.3 68.2 16.8 17.1 87.0 31.1 59.9 47.0 30.8 33.8 51.6 97.8 18.5 113.2 33.4 48.0 84.9 81.9 78.8 30.9 53.1 19.8 29.2 57.4 30.6 33.4 64.7 58.0 65.5 52.0 104.1 41.3 29.4 57.7 75.7 64.0 59.2 27.5 73.0 35.1 47.6 46.6 25.1 95.2 58.0 31.7 72.0 66.6 42.5 67.1 28.1 43.1 35.3 182.5 84.2 96.7 65.0 127.1 46.3 39.1 80.8 49.3 66.0 37.4 35.4 52.7 80.2 62.1 33.1 48.2 27.9 30.6 44.3 68.2 109.9 50.6 62.9 83.3 33.9 97.4 49.5 10.1 68.1 18.5 20.7 113.2 23.9 51.6 30.1 26.9 97.8 39.7 30.1 28.3 11.3 33.4 84.9 53.9 48.0 84.9 26.8 29.5 21.8 39.0 22.5 18.8 27.2 23.8 24.2 17.1 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392724 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria 7200000 Mitochondria "HPA046835: , HPA071684: " "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 18.5 19.7 12.1 12.2 14.0 23.7 14.4 8.2 12.2 9.8 16.5 28.9 14.3 4.8 16.4 10.4 7.0 9.4 10.3 8.2 18.4 5.4 11.1 14.4 9.4 25.6 38.7 10.1 14.0 8.6 12.4 8.8 45.0 12.5 6.1 14.9 23.3 7.7 5.8 15.4 19.2 2.4 16.3 9.5 14.2 11.2 62.2 85.7 3.7 69.0 30.1 43.6 71.2 22.0 48.3 34.3 35.0 23.8 46.4 37.1 33.8 32.4 24.9 24.8 63.8 27.0 81.9 27.3 22.2 14.3 23.0 40.3 7.9 20.5 73.1 44.8 33.1 72.8 55.8 32.2 54.7 76.5 74.3 19.5 28.7 37.0 31.2 19.3 24.4 46.9 59.6 61.7 43.5 65.0 30.1 28.4 63.5 30.4 55.4 56.0 88.0 22.8 69.4 96.1 38.5 66.4 42.2 25.5 14.3 49.7 33.6 50.1 8.0 55.3 3.8 31.1 13.8 2.4 58.1 3.7 29.4 69.0 43.6 62.2 40.4 34.8 85.7 47.5 38.1 37.2 3.0 30.1 67.9 41.0 38.7 71.2 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell line enhanced" "Detected in many" "ASC diff: 71.8;ASC TERT1: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064714 Supported Nucleoplasm,Mitochondria 270000 Mitochondria Nucleoplasm "HPA064714: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favourable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.7 5.7 1.5 1.9 71.8 56.8 4.9 5.7 14.9 3.7 5.0 6.0 18.0 9.0 2.9 21.5 13.5 4.6 8.2 6.4 7.8 3.8 11.2 4.0 7.5 4.8 2.2 5.8 31.5 6.8 7.1 6.5 11.7 0.3 18.8 4.2 9.6 8.9 2.5 8.7 5.5 1.8 6.0 6.8 5.1 15.9 7.5 2.9 8.0 8.9 8.0 8.8 6.8 10.0 3.7 3.4 4.0 4.1 14.5 9.5 6.8 7.2 4.9 4.9 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 10.1" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: , HPA052726: " "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 10.1 0.1 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" Mitochondria "Centriolar satellite" "HPA058971: , HPA065520: " "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.5 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 1.3 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria 38000 Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 31.9 36.0 65.2 25.0 55.1 33.6 49.9 24.3 54.7 29.2 49.8 30.6 23.2 37.2 23.7 65.1 38.1 24.4 26.5 63.6 47.5 50.5 57.5 69.8 19.1 24.3 53.7 40.6 26.1 49.3 19.3 34.8 30.0 44.9 25.2 46.7 27.8 36.9 30.6 105.7 20.5 42.1 31.9 46.3 26.3 32.0 31.7 34.4 16.5 27.4 72.9 34.6 27.9 23.5 35.2 52.2 20.9 59.6 18.3 33.0 40.5 41.2 82.0 33.7 32.8 22.2 22.4 45.4 23.4 22.1 46.6 40.7 110.9 37.9 30.0 24.8 26.6 40.9 61.4 47.8 61.9 16.4 68.9 30.3 77.6 110.2 34.1 20.0 21.8 23.9 31.5 37.3 41.6 38.3 29.6 17.2 40.5 133.5 30.6 54.9 52.2 116.0 28.2 28.2 33.5 47.8 78.7 43.1 28.2 24.8 52.8 33.8 55.3 35.6 22.2 23.8 42.8 25.7 40.8 18.6 33.8 56.1 32.7 39.4 30.5 17.4 59.6 20.9 23.8 56.5 25.0 35.2 31.7 23.3 50.8 31.2 33.0 27.3 19.1 18.3 56.9 52.2 31.7 40.5 65.2 55.1 24.3 54.7 47.5 50.5 53.7 40.6 44.9 34.4 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: " "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favourable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favourable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favourable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.0 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 2.5 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.2 5.0 3.1 5.1 3.5 5.8 4.9 5.3 1.1 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130875436-130916509 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Supported Mitochondria Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favourable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 22.3 23.1 24.0 16.9 30.6 10.0 17.2 18.0 38.0 17.1 23.8 35.6 25.3 17.1 22.9 32.5 17.9 19.8 20.4 22.6 22.8 22.2 24.1 25.6 17.5 15.3 31.0 15.3 20.6 26.6 32.9 28.5 18.5 28.0 21.7 22.2 23.7 23.1 27.2 26.4 19.0 17.8 26.0 30.8 18.5 22.3 36.2 28.2 24.6 31.1 12.1 18.1 23.0 16.4 5.9 5.4 11.3 6.6 3.6 6.2 5.2 6.7 7.4 9.6 13.4 28.9 20.4 6.3 18.0 21.4 9.1 9.5 8.4 13.0 6.4 12.6 19.8 12.3 1.4 12.9 11.7 10.3 5.8 11.6 7.4 0.0 21.0 0.0 9.1 23.2 16.0 9.3 10.2 11.1 10.2 0.0 19.4 4.9 9.4 7.7 2.9 9.5 7.2 9.1 3.7 9.9 12.2 9.4 8.7 7.7 12.4 6.1 22.0 7.3 14.7 12.8 9.5 10.4 10.5 2.2 0.0 0.0 5.3 7.7 14.6 11.3 6.0 4.4 4.8 6.4 6.2 5.9 4.7 5.7 5.3 4.4 5.6 4.4 3.6 3.6 6.6 5.4 4.1 5.2 24.0 30.6 18.0 38.0 22.8 22.2 31.0 15.3 28.0 28.2 SOD2 ENSG00000112096 "Superoxide dismutase 2" 6 159669057-159745186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 254.9;skeletal muscle: 475.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 181.9;HSkMC: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "neutrophil: 254.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 254.9" "HPA001814, CAB002013" Supported Enhanced Mitochondria Mitochondria "CAB002013: , HPA001814: AB_1080134" "unprognostic (2.47e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "unprognostic (1.37e-1)" "unprognostic (6.67e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.99e-2)" "unprognostic (1.82e-1)" 77.8 28.6 6.2 82.8 13.8 147.9 32.5 3.6 12.5 13.1 25.6 5.7 3.6 9.1 13.3 16.6 20.3 12.6 19.9 42.4 5.8 6.4 157.4 197.5 33.9 52.7 14.3 2.6 31.8 24.9 6.9 7.0 10.0 16.1 27.1 6.1 6.4 39.9 7.4 475.1 9.0 8.1 27.9 25.5 18.4 13.8 13.6 7.3 3.0 36.8 20.8 11.8 43.4 52.8 2.3 5.8 254.9 22.7 0.9 4.5 15.0 3.6 4.6 4.1 9.4 26.6 44.5 2.1 5.3 181.9 6.5 15.1 9.5 2.1 7.5 16.0 5.9 6.3 4.3 4.6 4.9 7.3 8.9 7.9 7.8 16.2 19.7 7.5 3.4 80.3 7.7 20.6 15.4 3.3 10.8 9.0 6.2 3.9 6.2 4.8 6.9 5.8 8.4 5.6 6.9 12.1 6.0 7.8 3.0 11.2 5.7 2.3 3.5 3.5 3.1 19.1 6.9 10.1 9.2 3.8 9.8 9.0 21.1 5.8 2.4 6.2 19.2 9.4 2.2 14.9 2.4 2.3 3.1 2.2 5.8 1.8 2.6 2.1 254.9 0.9 22.7 0.8 4.5 15.0 6.2 13.8 3.6 12.5 5.8 6.4 14.3 2.6 16.1 7.3 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051331-52097292 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 41.7;testis: 65.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.7;BEWO: 14.8;BJ hTERT+: 9.5;HSkMC: 18.2;hTCEpi: 17.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036854, HPA036855" Enhanced Supported Mitochondria Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favourable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favourable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 4.2 2.6 1.2 3.3 0.0 3.7 0.1 1.1 6.8 2.3 3.6 5.3 1.2 2.5 9.9 4.9 41.7 11.5 1.5 3.1 2.8 3.7 4.4 12.0 0.3 0.6 0.6 7.6 1.6 4.2 6.1 1.8 12.5 3.5 3.5 1.4 13.2 6.0 1.1 4.3 2.8 1.8 0.8 0.5 2.9 65.7 0.8 1.3 1.6 4.1 3.1 2.3 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 7.9 19.7 14.8 5.5 9.5 0.3 0.4 0.0 0.9 0.0 0.0 7.2 0.1 0.0 4.2 0.2 0.0 0.6 0.0 0.0 4.6 7.0 0.0 0.0 18.2 17.5 0.6 2.7 4.1 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.1 1.2 0.6 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.3 0.1 1.1 3.1 2.8 0.6 0.6 12.5 0.8 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691294 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 64.4;RPTEC TERT1: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA017079, HPA041589" Enhanced Supported Mitochondria 30000 Mitochondria "HPA017079: AB_1857467, HPA041589: " "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favourable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavourable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 23.6 8.6 4.4 33.5 5.7 12.0 16.7 1.6 3.8 11.9 54.7 3.0 12.1 14.2 11.7 11.4 38.7 8.4 15.2 12.2 2.8 2.3 16.9 34.2 27.1 22.4 6.8 2.3 8.7 27.7 7.4 7.5 7.0 4.8 18.0 48.5 11.2 21.5 15.2 66.9 14.3 31.5 21.5 4.9 21.4 19.7 4.6 3.1 11.7 19.0 36.6 30.3 24.6 20.7 11.0 27.8 62.3 43.5 10.0 29.2 29.2 7.6 13.8 0.0 0.8 28.5 34.3 0.0 8.3 28.3 5.1 7.7 0.5 12.1 7.2 8.2 6.4 6.9 0.4 64.4 3.1 24.2 0.2 0.5 3.0 9.6 8.3 3.9 1.1 10.0 19.1 11.9 27.1 14.1 0.0 8.9 5.4 6.1 2.4 9.1 0.0 8.3 0.3 1.4 9.6 40.8 11.3 0.2 0.2 2.0 5.6 2.7 11.9 12.5 15.6 2.0 0.5 30.0 1.8 11.3 11.7 0.4 20.6 21.2 2.2 18.4 43.5 16.2 16.3 32.9 22.8 11.0 21.6 18.3 27.8 9.5 11.3 12.2 62.3 10.0 29.0 8.1 29.2 29.2 4.4 5.7 1.6 3.8 2.8 2.3 6.8 2.3 4.8 3.1 SSBP1 "mtSSB, SSBP" ENSG00000106028 "Single stranded DNA binding protein 1" Q04837 7 141738321-141787922 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002866 Supported Supported Mitochondria 250000 Mitochondria "HPA002866: AB_1080092" "unprognostic (2.95e-1)" "unprognostic (2.99e-1)" "unprognostic (2.49e-2)" "unprognostic (3.62e-2)" "unprognostic (7.36e-3)" "unprognostic (2.86e-2)" "prognostic unfavourable (4.42e-4)" "unprognostic (3.68e-2)" "unprognostic (6.03e-2)" "prognostic favourable (3.40e-4)" "unprognostic (9.23e-3)" "unprognostic (4.02e-1)" "unprognostic (9.65e-3)" "unprognostic (1.62e-1)" "unprognostic (9.38e-2)" "unprognostic (1.25e-2)" "unprognostic (9.58e-2)" 41.1 52.5 45.4 40.9 52.6 41.7 51.6 26.8 44.3 41.7 42.4 33.9 38.7 36.9 45.2 58.9 61.0 37.1 36.8 57.8 38.6 38.6 55.2 83.4 31.0 56.0 42.7 41.0 45.2 49.6 40.7 44.4 47.2 44.4 38.8 44.8 34.1 41.2 39.0 62.9 42.4 40.8 45.5 36.7 50.7 44.6 38.3 33.3 62.9 45.6 67.4 54.7 42.8 38.6 42.6 41.2 31.3 35.9 36.3 48.7 40.8 39.1 45.4 40.6 51.1 18.1 29.4 37.3 28.3 27.2 36.2 40.7 47.9 44.9 61.2 40.1 23.7 29.5 47.0 49.4 51.4 29.4 49.0 30.0 34.2 42.3 35.8 88.0 23.9 27.7 33.7 37.8 53.3 44.0 75.6 25.9 49.4 57.5 62.3 114.9 89.5 56.8 36.1 36.9 79.7 47.3 38.6 36.6 50.2 33.0 43.9 43.9 29.7 38.8 31.7 25.7 24.9 39.7 75.0 46.8 61.9 109.6 52.8 79.3 56.1 31.3 29.1 26.6 30.1 35.5 44.0 42.6 48.7 40.2 36.8 37.0 45.1 48.1 7.5 36.3 35.9 41.2 46.4 40.8 45.4 52.6 26.8 44.3 38.6 38.6 42.7 41.0 44.4 33.3 SUCLA2 ENSG00000136143 "Succinate-CoA ligase ADP-forming beta subunit" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria 6600 Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favourable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (1.22e-4)" 21.6 18.5 19.2 8.6 22.1 5.2 17.5 29.7 32.4 15.3 15.7 11.7 15.6 24.5 12.7 12.1 14.6 11.3 9.4 42.1 20.0 21.6 34.0 12.9 7.9 11.4 22.6 19.1 14.4 10.8 19.8 14.9 12.2 28.7 16.2 16.5 8.9 13.9 14.8 89.0 10.0 22.7 14.7 18.3 9.7 12.3 8.0 15.4 15.6 16.9 25.6 10.2 11.0 12.6 17.1 29.5 12.4 25.0 23.4 25.2 17.2 17.2 20.0 25.4 15.2 29.1 22.0 15.3 26.4 29.6 27.5 18.7 35.5 19.6 24.2 20.2 25.8 24.0 33.5 25.1 34.9 23.1 28.7 27.2 19.0 23.0 20.3 27.5 15.9 20.7 29.6 18.7 22.1 20.2 18.3 8.8 27.3 11.9 28.3 31.5 26.3 25.6 24.1 23.2 18.7 39.7 16.7 14.1 16.8 22.0 20.4 15.5 18.1 24.4 15.4 15.3 9.9 21.7 18.3 9.1 14.2 28.2 9.5 20.1 22.4 5.7 24.5 12.4 17.6 25.0 21.2 17.1 19.7 21.6 29.5 16.3 25.2 24.9 4.5 23.4 20.0 24.3 21.6 17.2 19.2 22.1 29.7 32.4 20.0 21.6 22.6 19.1 28.7 15.4 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Supported "Plasma membrane,Mitochondria" "Intracellular and membrane" 330000 Mitochondria "Plasma membrane" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavourable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favourable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 23.5 25.9 20.5 25.0 38.6 26.0 35.5 26.9 23.0 34.6 25.3 59.3 19.5 32.4 18.6 32.1 34.4 42.1 31.6 41.2 31.3 38.3 28.1 22.4 33.7 32.6 28.6 23.0 30.9 26.0 29.1 39.8 30.8 28.5 26.7 31.5 36.0 40.6 26.2 10.7 46.4 25.8 47.5 35.5 46.4 28.6 24.9 13.9 21.4 44.5 42.7 27.1 22.6 24.8 27.2 26.3 33.3 32.9 23.5 33.3 28.0 31.7 39.7 23.9 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming beta subunit" Q96I99 3 67360460-67654614 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Supported "Plasma membrane,Mitochondria" 290000 "Plasma membrane, Mitochondria" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favourable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favourable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 17.0 19.3 8.8 26.5 10.0 3.4 12.4 2.4 7.2 15.3 38.9 9.5 16.4 31.4 11.5 18.3 18.6 9.9 27.9 23.6 6.6 6.2 38.3 90.9 14.6 21.1 9.8 6.5 16.5 20.9 5.9 8.5 8.5 7.6 14.0 34.5 9.6 21.0 17.3 57.0 9.3 42.4 23.5 8.6 24.7 25.4 6.5 8.1 9.6 16.4 27.0 16.7 19.9 13.2 19.2 10.2 5.8 18.2 27.1 31.1 18.9 13.8 12.1 12.0 14.6 20.2 35.1 14.7 16.6 24.4 19.6 21.9 13.4 31.0 17.7 5.4 23.4 7.1 9.3 23.0 25.5 7.5 6.4 16.1 11.0 20.8 26.1 21.1 11.3 26.2 20.0 15.3 35.3 20.8 12.2 16.3 42.6 9.7 7.9 6.7 11.2 7.5 5.5 18.6 26.5 33.2 21.6 2.3 8.2 26.4 30.6 22.0 23.5 13.6 18.1 19.5 12.8 21.4 19.7 11.1 16.2 12.5 28.6 16.5 22.9 5.8 15.3 5.2 13.8 18.2 16.7 19.2 20.0 17.4 10.2 16.7 31.1 23.7 0.7 27.1 14.8 4.0 18.5 18.9 8.8 10.0 2.4 7.2 6.6 6.2 9.8 6.5 7.6 8.1 SUPV3L1 SUV3 ENSG00000156502 "Suv3 like RNA helicase" Q8IYB8 10 69180232-69209099 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038380, HPA038405" Supported Supported Mitochondria Mitochondria "HPA038380: AB_2675983, HPA038405: AB_10675797" "unprognostic (4.70e-2)" "unprognostic (1.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.74e-2)" "unprognostic (3.32e-2)" "unprognostic (1.44e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (9.47e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (5.48e-3)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (5.27e-2)" "unprognostic (1.33e-1)" 12.8 17.0 11.1 12.6 17.3 26.1 17.7 21.9 19.9 10.8 14.4 12.6 7.8 11.2 13.5 12.4 13.2 11.9 12.6 19.2 12.0 11.3 16.4 22.2 9.6 15.2 9.9 13.1 15.8 18.2 15.4 14.7 10.9 16.1 11.4 16.7 12.4 11.8 13.9 31.1 15.6 12.5 13.9 9.9 15.5 13.0 26.6 9.9 12.7 14.1 13.4 14.8 12.4 11.6 10.1 7.3 5.6 7.7 7.4 13.7 6.2 11.3 7.9 7.1 21.8 8.0 6.8 9.4 7.0 10.9 14.3 13.5 20.3 9.6 20.4 5.8 7.1 13.0 17.1 11.0 13.8 8.5 13.4 8.9 6.2 10.7 20.3 21.1 6.8 8.6 13.9 13.1 30.2 8.2 23.2 10.6 7.8 7.3 12.8 13.1 8.5 43.4 11.8 10.1 8.9 6.5 5.5 10.2 7.7 9.7 20.4 18.5 6.3 9.3 5.1 5.7 10.3 8.6 13.6 8.4 9.8 19.0 9.4 22.4 3.6 5.6 5.2 4.3 12.3 7.7 13.7 10.1 8.9 10.5 7.3 8.3 9.9 10.6 0.9 7.4 5.2 4.0 8.7 6.2 11.1 17.3 21.9 19.9 12.0 11.3 9.9 13.1 16.1 9.9 TACO1 CCDC44 ENSG00000136463 "Translational activator of cytochrome c oxidase I" Q9BSH4 17 63600872-63608365 "Disease related genes, Predicted intracellular proteins" "Translation regulation" Activator "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021626, HPA021643, HPA024294" Enhanced Enhanced Mitochondria Mitochondria "HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150" "unprognostic (1.26e-1)" "unprognostic (2.92e-2)" "unprognostic (4.55e-3)" "unprognostic (9.82e-2)" "unprognostic (1.30e-1)" "unprognostic (9.30e-3)" "unprognostic (2.83e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (7.38e-2)" "prognostic favourable (3.73e-4)" "unprognostic (1.35e-1)" "unprognostic (4.12e-3)" "unprognostic (5.21e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" 8.3 11.3 8.7 6.3 11.1 4.9 6.9 6.4 14.2 5.9 12.1 7.6 6.2 13.0 7.6 7.2 7.5 6.7 10.1 21.2 7.6 8.6 20.7 42.5 7.0 7.3 9.3 7.2 6.0 10.7 8.3 5.7 7.5 9.3 6.4 11.4 8.1 11.4 6.9 37.5 6.1 15.7 6.9 6.5 7.3 8.0 8.1 6.2 8.7 8.7 15.9 8.1 6.3 5.1 8.9 9.9 7.9 8.1 16.6 13.6 7.9 17.0 27.0 8.7 8.9 7.6 10.9 11.6 12.6 11.9 25.4 20.2 17.7 10.2 14.1 9.7 14.4 15.8 19.1 18.4 23.9 7.5 26.5 13.9 13.8 30.9 21.0 16.4 9.8 13.3 12.8 21.9 23.2 13.1 18.8 10.7 11.8 30.9 19.1 12.4 7.5 28.1 12.1 21.4 17.6 14.8 12.0 13.4 14.6 8.6 28.6 23.8 23.8 12.8 11.6 18.1 13.7 12.3 22.1 11.7 11.5 16.8 13.8 11.3 13.1 2.1 8.1 7.9 9.5 7.5 10.6 7.1 13.6 9.5 9.9 8.9 12.8 10.3 1.4 16.6 6.6 6.4 9.0 7.9 8.7 11.1 6.4 14.2 7.6 8.6 9.3 7.2 9.3 6.2 TBC1D15 "DKFZp761D0223, FLJ12085" ENSG00000121749 "TBC1 domain family member 15" Q8TC07 12 71839707-71927248 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013388, HPA015592" Supported Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA013388: AB_2199233, HPA015592: AB_1857789" "unprognostic (3.87e-2)" "prognostic favourable (7.06e-4)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "unprognostic (6.13e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-2)" "unprognostic (4.07e-2)" "unprognostic (2.18e-1)" "prognostic favourable (5.34e-4)" "unprognostic (5.73e-2)" "unprognostic (4.34e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" 37.4 27.4 20.2 14.3 22.5 35.2 26.4 19.6 23.7 21.8 20.2 17.0 19.8 15.1 22.9 15.4 20.2 15.1 20.4 15.4 16.9 16.4 22.3 32.9 24.5 19.0 28.9 18.7 22.7 26.3 19.1 38.0 25.4 23.8 18.0 14.8 12.0 20.6 14.4 44.0 19.2 20.8 19.5 26.3 21.4 17.8 19.4 27.5 22.2 25.9 14.5 18.6 27.5 16.3 5.9 6.3 13.9 8.8 7.2 13.5 6.7 13.8 13.8 11.6 11.9 23.4 23.4 17.7 15.0 34.0 18.7 23.7 9.7 11.7 17.6 10.1 13.7 8.7 14.3 10.4 20.5 15.5 12.1 16.7 13.3 9.9 19.7 21.2 12.2 22.7 13.3 14.3 27.1 15.5 16.1 9.9 15.9 10.2 14.1 13.2 24.1 12.0 11.2 13.4 19.6 14.1 13.4 12.8 11.0 19.8 17.5 16.7 17.9 15.5 15.7 16.1 7.3 18.3 8.9 25.4 23.4 22.5 9.7 14.1 14.5 2.0 6.8 8.6 8.1 7.0 9.3 5.7 10.1 7.9 6.3 5.9 12.9 11.1 13.9 7.2 8.8 3.8 13.5 6.7 20.2 22.5 19.6 23.7 16.9 16.4 28.9 18.7 23.8 27.5 TBRG4 "Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948" ENSG00000136270 "Transforming growth factor beta regulator 4" Q969Z0 7 45100100-45112047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020582, HPA050430" Approved Enhanced Mitochondria Mitochondria "HPA020582: AB_1857804, HPA050430: " "unprognostic (2.22e-1)" "unprognostic (4.75e-2)" "unprognostic (1.19e-1)" "unprognostic (3.46e-3)" "unprognostic (1.41e-2)" "unprognostic (9.29e-3)" "prognostic unfavourable (1.40e-4)" "unprognostic (3.15e-2)" "unprognostic (1.86e-1)" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (1.25e-2)" "unprognostic (3.66e-3)" "unprognostic (3.91e-2)" "unprognostic (3.84e-2)" "unprognostic (3.30e-1)" "unprognostic (1.52e-1)" 13.7 16.8 10.8 16.0 15.6 14.9 13.0 12.9 22.1 10.5 20.8 15.6 14.1 21.8 14.2 8.2 20.1 12.8 12.4 26.2 9.8 10.0 20.9 27.7 10.5 17.0 10.6 8.9 15.6 16.9 11.3 10.1 16.2 14.7 13.6 14.1 10.8 14.2 12.4 42.6 16.9 17.8 13.9 9.9 16.2 14.0 22.5 9.5 15.0 13.8 23.7 20.3 14.5 13.3 15.8 20.1 10.9 24.2 9.7 21.0 17.5 12.9 30.1 9.6 21.1 8.7 8.1 19.4 10.5 9.7 20.4 16.9 32.5 18.3 24.7 16.2 10.7 33.9 22.3 23.9 10.4 12.8 20.9 17.0 19.7 22.2 14.6 19.3 17.5 10.7 22.2 19.4 14.0 12.5 46.9 12.5 12.4 21.8 19.6 44.2 30.5 24.0 17.4 12.4 36.0 11.9 13.3 19.1 18.1 10.7 59.6 20.7 26.6 32.1 9.7 15.2 18.4 9.2 17.0 22.4 22.4 36.2 14.0 27.8 34.1 7.4 13.3 10.9 18.4 24.2 17.6 15.8 15.4 17.8 20.1 12.3 21.0 19.9 1.0 9.7 20.4 7.5 14.6 17.5 10.8 15.6 12.9 22.1 9.8 10.0 10.6 8.9 14.7 9.5 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906820 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria Mitochondria "HPA023788: AB_1848818, HPA053044: " "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavourable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 7.0 9.6 11.8 10.2 13.7 4.0 11.1 23.3 16.6 7.5 8.1 7.4 7.2 10.6 8.6 9.6 9.7 7.6 6.8 12.7 10.1 6.9 13.0 12.3 6.9 10.0 15.4 8.5 10.5 7.3 10.8 16.8 10.4 10.6 10.6 10.3 8.6 7.9 10.4 7.7 8.5 9.1 9.6 11.0 13.7 7.4 5.7 13.3 8.6 10.7 6.7 9.8 7.9 11.8 6.7 6.4 4.9 10.0 4.3 6.7 4.8 6.0 9.7 5.8 7.3 4.5 5.8 5.0 5.9 5.0 13.4 11.2 6.4 2.9 7.7 5.9 4.4 8.6 10.7 4.3 11.7 2.4 13.4 3.7 9.7 6.4 4.8 6.7 4.8 4.4 5.1 7.7 3.0 5.7 8.3 7.0 8.8 4.3 5.8 9.9 4.4 5.0 3.0 10.2 6.1 10.0 5.7 9.9 3.0 5.4 4.3 5.1 9.7 4.6 3.9 5.2 6.1 5.9 5.7 3.4 5.6 5.4 4.2 5.6 5.1 3.5 6.6 4.9 4.6 10.0 5.8 6.7 5.6 4.2 6.4 6.4 6.7 6.6 1.9 4.3 7.3 5.8 5.7 4.8 11.8 13.7 23.3 16.6 10.1 6.9 15.4 8.5 10.6 13.3 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385022-58399221 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favourable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favourable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 19.3 21.2 11.1 21.0 12.1 28.5 15.3 15.4 13.9 16.8 21.0 7.7 12.5 17.6 20.7 12.1 17.4 15.3 11.0 15.9 10.2 11.2 22.4 31.4 11.5 21.5 12.5 10.7 18.4 14.3 12.3 23.9 22.2 12.9 17.2 14.7 9.2 16.3 10.6 21.7 10.2 18.7 16.1 10.8 21.0 14.5 40.2 11.6 35.4 22.2 14.8 18.4 16.6 11.8 13.1 14.1 7.2 9.5 14.3 13.1 6.8 21.3 12.2 13.7 14.2 4.1 5.1 15.7 9.7 9.7 12.2 13.6 42.8 22.9 42.5 14.3 4.4 16.7 25.1 13.6 19.4 18.1 22.3 16.1 9.3 15.9 6.3 40.8 13.3 5.0 6.3 14.8 13.6 10.5 38.0 19.6 8.5 11.6 32.2 16.0 26.0 12.7 25.7 29.6 19.1 7.5 14.4 18.4 12.6 19.4 27.0 23.8 29.4 12.2 8.1 9.1 29.1 10.3 26.0 19.9 30.4 53.6 11.6 31.5 6.8 1.0 9.5 3.7 8.5 9.0 11.0 12.2 10.3 8.9 11.5 13.1 13.1 10.4 7.2 14.3 7.2 14.1 8.5 6.8 11.1 12.1 15.4 13.9 10.2 11.2 12.5 10.7 12.9 11.6 TFB2M "FLJ22661, FLJ23182, Hkp1" ENSG00000162851 "Transcription factor B2, mitochondrial" Q9H5Q4 1 246540560-246566324 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028482, HPA028554, HPA030265" Approved Enhanced Mitochondria Mitochondria "HPA028482: , HPA028554: , HPA030265: AB_10696209" "unprognostic (4.38e-2)" "unprognostic (2.45e-2)" "unprognostic (3.79e-3)" "unprognostic (5.63e-2)" "unprognostic (1.10e-1)" "unprognostic (8.13e-2)" "unprognostic (8.76e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-2)" "unprognostic (1.68e-2)" "unprognostic (2.46e-1)" "unprognostic (6.81e-2)" "unprognostic (5.26e-2)" "unprognostic (2.27e-1)" "unprognostic (9.44e-2)" "unprognostic (6.41e-2)" "unprognostic (3.53e-2)" 10.6 23.1 4.2 7.2 8.4 15.5 9.0 8.4 9.9 7.0 8.9 6.5 9.4 8.2 9.5 7.2 9.5 6.9 8.5 11.3 4.3 5.5 15.5 42.3 5.9 8.7 4.8 5.7 6.5 19.7 5.6 7.8 10.5 7.6 8.9 9.6 5.9 13.6 8.9 21.4 8.7 10.3 6.8 6.5 9.0 9.6 8.7 5.7 13.0 15.6 7.3 12.0 9.1 6.5 10.6 11.0 1.2 7.5 12.6 10.4 4.5 12.6 12.2 4.7 8.4 5.9 8.5 16.6 9.3 9.6 10.6 9.7 14.8 12.2 22.6 14.6 9.4 11.0 11.3 9.9 14.6 8.7 4.4 11.4 7.5 12.9 9.7 20.1 10.4 8.4 11.8 9.1 10.2 8.2 33.0 7.7 9.1 5.8 10.1 9.0 21.0 12.4 10.2 9.4 27.4 9.6 14.0 10.5 21.2 9.0 16.3 30.7 11.9 19.4 5.9 7.4 9.0 10.4 24.2 22.5 37.5 17.8 9.1 19.9 9.2 0.2 4.7 1.2 8.4 4.8 10.4 10.6 7.5 8.8 11.0 10.4 9.6 8.2 1.0 12.6 7.5 9.5 10.3 4.5 4.2 8.4 8.4 9.9 4.3 5.5 4.8 5.7 7.6 5.7 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528463-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 22.2 19.5 29.1 16.7 28.5 18.3 27.4 14.8 34.3 16.6 21.6 17.1 25.9 16.8 13.7 29.1 20.2 16.0 15.4 25.2 25.1 22.7 26.7 41.3 13.1 25.1 27.2 24.6 13.0 25.8 18.3 14.3 13.8 19.9 14.4 23.1 15.8 23.8 20.2 32.3 15.3 12.4 17.2 21.0 20.1 15.9 20.5 16.1 18.4 18.5 25.9 29.8 13.6 12.1 45.1 38.8 5.9 22.6 16.5 33.4 32.4 26.9 41.2 19.4 18.5 16.8 14.4 24.5 23.1 18.6 37.0 21.1 30.3 23.7 51.4 26.6 20.5 20.7 27.5 26.8 33.5 17.4 20.3 32.6 15.8 38.9 17.8 42.6 36.8 13.5 21.8 35.8 25.0 22.8 36.0 23.5 27.1 57.4 22.9 57.1 20.4 44.4 38.6 40.8 44.8 18.7 18.7 15.7 20.2 24.4 48.7 29.5 36.3 16.3 14.3 21.4 39.9 36.6 44.3 32.9 43.0 41.3 19.7 21.5 35.5 5.9 22.6 5.0 19.9 21.4 22.8 45.1 24.5 21.9 38.7 41.9 33.4 29.1 1.3 16.5 19.8 38.8 21.3 32.4 29.1 28.5 14.8 34.3 25.1 22.7 27.2 24.6 19.9 16.1 TIMM13 "Tim13, TIMM13B" ENSG00000099800 "Translocase of inner mitochondrial membrane 13" Q9Y5L4 19 2425624-2427894 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048985 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA048985: " "unprognostic (5.47e-2)" "unprognostic (6.63e-2)" "unprognostic (7.15e-2)" "prognostic favourable (4.68e-5)" "unprognostic (8.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.37e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-1)" "unprognostic (1.53e-1)" "prognostic favourable (9.77e-4)" "unprognostic (4.91e-2)" "prognostic favourable (3.88e-5)" "unprognostic (4.00e-2)" "unprognostic (3.35e-2)" "unprognostic (4.33e-1)" "unprognostic (2.47e-2)" 18.5 38.2 21.7 21.3 19.9 25.0 15.7 15.9 28.6 14.6 26.4 18.5 19.8 43.0 14.2 20.4 32.5 17.1 22.9 28.1 20.6 19.1 29.4 49.8 13.6 20.7 23.1 19.3 22.5 57.0 9.7 16.9 21.5 21.1 20.6 14.7 16.7 32.7 26.1 56.6 22.3 34.5 13.7 17.3 21.7 25.6 33.3 17.4 23.6 20.0 44.6 18.5 15.7 17.4 21.1 72.7 10.5 36.1 19.6 21.0 24.5 28.7 30.2 11.0 21.7 6.2 6.3 15.1 16.8 5.9 12.4 9.1 43.5 14.6 17.3 6.0 5.5 21.3 17.0 22.8 3.4 15.9 59.9 14.4 29.4 33.1 17.8 28.0 15.8 14.6 12.4 13.6 9.3 14.8 29.3 26.1 4.9 12.0 32.9 38.4 30.8 44.4 24.9 8.8 46.7 12.0 24.7 41.0 37.7 7.6 31.1 19.4 20.7 31.1 13.8 14.7 16.2 27.4 33.5 41.2 21.1 18.1 15.0 38.3 22.2 6.3 36.1 10.5 14.5 33.2 17.8 21.1 16.6 15.2 32.6 19.9 21.0 17.9 2.3 19.6 19.5 72.7 16.3 24.5 21.7 19.9 15.9 28.6 20.6 19.1 23.1 19.3 21.1 17.4 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavourable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 25.9 26.5 24.1 28.8 20.3 21.4 40.7 41.6 29.8 34.1 30.7 31.1 27.1 36.1 15.3 35.5 20.8 44.1 24.8 36.9 26.4 27.6 19.9 35.3 29.3 21.0 42.3 21.4 24.6 27.7 34.9 29.2 35.6 50.1 20.3 40.0 16.6 22.7 22.9 30.5 14.3 22.4 28.0 45.1 41.9 24.8 36.4 25.7 25.4 65.2 38.4 36.0 28.8 28.5 22.8 24.2 26.5 43.1 30.7 33.1 30.3 24.3 32.3 25.4 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972449-46003734 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA031408 Approved Supported Mitochondria Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavourable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favourable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 5.7 4.6 1.2 6.8 3.8 6.0 13.6 4.1 8.6 2.6 4.2 1.5 5.8 6.1 2.9 7.3 4.2 2.4 3.2 11.5 5.3 6.6 8.3 4.8 9.9 1.6 2.5 2.2 2.8 3.0 3.4 8.1 5.5 3.4 4.1 2.6 7.5 5.2 16.2 2.4 3.5 3.6 2.2 2.5 2.8 17.2 1.4 4.5 4.5 4.0 4.4 3.3 1.7 29.5 39.7 18.5 45.3 26.7 29.8 39.6 40.4 42.7 28.4 28.6 23.6 22.2 27.7 33.5 40.3 40.8 43.4 53.8 32.3 36.3 27.8 35.2 35.0 43.3 35.8 40.5 26.9 42.7 23.1 32.1 57.8 38.1 42.9 25.9 26.5 31.9 34.9 49.7 37.7 40.9 20.5 35.8 40.6 38.3 59.7 34.3 13.3 29.7 27.4 26.6 45.8 28.4 33.4 30.7 18.6 41.4 33.4 43.8 25.7 27.6 19.8 34.5 25.2 47.5 21.9 36.1 50.9 36.8 62.2 16.4 15.7 35.6 18.5 28.0 45.3 28.7 29.5 27.1 29.8 39.7 27.9 24.6 27.2 8.2 26.7 39.3 32.8 29.6 39.6 TIMM29 C19orf52 ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928733-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favourable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favourable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 13.4 11.4 13.8 11.0 18.0 18.4 8.0 19.9 16.4 8.5 9.9 10.3 7.6 17.5 11.3 7.1 13.8 8.6 9.4 12.5 15.1 8.9 10.5 13.5 8.1 11.6 13.5 9.3 8.3 17.1 7.0 10.8 12.2 11.9 9.9 5.1 11.3 16.8 9.5 30.9 12.1 12.4 10.3 8.3 11.7 15.0 11.3 13.2 12.0 9.2 8.9 9.7 10.1 10.6 13.6 10.3 8.7 8.7 10.9 12.0 3.2 10.7 3.9 3.0 5.2 2.6 2.6 8.8 7.4 3.7 5.3 4.9 7.0 3.5 9.0 13.2 3.3 10.0 1.6 4.4 0.9 10.8 13.0 10.5 4.0 4.7 4.2 7.4 8.0 2.2 4.2 3.7 1.5 3.2 11.3 7.6 2.0 8.7 8.5 14.5 11.2 17.2 11.6 4.4 11.0 2.2 4.1 8.0 8.3 8.6 4.5 8.7 6.5 8.1 5.4 8.6 5.2 11.0 11.3 26.5 25.8 9.7 5.4 9.5 7.1 3.5 7.9 8.7 5.6 8.7 8.8 13.6 10.8 12.0 5.6 10.6 10.1 8.5 1.7 10.9 6.7 10.3 11.0 3.2 13.8 18.0 19.9 16.4 15.1 8.9 13.5 9.3 11.9 13.2 TIMM44 TIM44 ENSG00000104980 "Translocase of inner mitochondrial membrane 44" O43615 19 7926718-7943920 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043052 Supported Enhanced Mitochondria Mitochondria "HPA043052: AB_10795713" "unprognostic (1.75e-1)" "unprognostic (7.44e-3)" "unprognostic (2.68e-2)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-2)" "unprognostic (5.81e-3)" "unprognostic (8.78e-2)" "unprognostic (2.42e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (8.93e-2)" "unprognostic (1.80e-2)" "unprognostic (6.01e-2)" "unprognostic (6.43e-2)" "unprognostic (2.07e-2)" "unprognostic (4.18e-2)" 12.8 15.3 11.8 13.0 12.4 7.5 12.7 16.2 17.2 10.8 15.3 8.5 14.1 16.1 12.1 11.8 19.4 10.8 12.6 39.2 12.9 10.3 13.5 19.7 9.0 9.2 11.7 7.7 13.8 20.2 7.4 10.3 8.9 12.3 10.8 6.3 8.5 17.3 21.4 48.8 12.6 10.5 17.7 9.0 12.2 12.2 9.4 11.6 5.8 12.5 26.6 8.8 13.0 9.4 9.0 16.2 10.1 12.2 9.6 12.1 8.4 18.2 10.7 5.7 10.0 10.0 9.3 8.4 11.0 9.0 15.3 13.9 23.6 3.9 26.8 12.8 9.2 12.8 23.5 12.4 3.9 12.5 35.8 13.5 9.1 19.8 24.5 16.1 5.6 10.8 15.9 13.0 16.2 9.7 24.7 9.6 6.6 18.6 14.0 10.6 16.6 45.4 14.8 8.2 12.6 6.7 11.8 13.7 7.1 9.8 13.4 31.3 8.2 15.7 5.1 7.3 11.5 18.5 20.8 18.8 23.7 26.1 5.2 23.5 12.3 10.1 11.7 3.7 12.1 12.2 10.7 8.7 11.1 11.2 16.2 9.0 10.7 10.4 0.6 9.6 7.2 13.2 9.4 8.4 11.8 12.4 16.2 17.2 12.9 10.3 11.7 7.7 12.3 11.6 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: " "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.6 64.0 11.9 29.7 10.5 9.6 21.7 21.1 10.8 25.0 20.5 45.9 18.9 30.2 22.4 14.2 15.3 23.8 21.8 13.4 26.3 34.7 28.0 18.7 31.6 16.0 54.5 19.4 12.2 15.5 18.7 17.2 16.2 44.7 18.1 15.7 35.3 33.3 20.9 20.7 24.5 34.0 23.8 23.2 17.2 36.8 31.6 17.7 25.3 37.0 43.3 17.3 29.6 16.3 31.1 29.0 25.6 49.0 17.1 31.5 45.5 23.3 27.4 34.5 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 TIMM8A "DDP, DFN1, MTS" ENSG00000126953 "Translocase of inner mitochondrial membrane 8A" O60220 X 101345659-101349196 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Deafness, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003628 Supported Supported Mitochondria Mitochondria "HPA003628: AB_1080284" "prognostic unfavourable (7.89e-5)" "unprognostic (1.36e-1)" "unprognostic (2.80e-1)" "prognostic unfavourable (8.87e-5)" "unprognostic (2.06e-1)" "unprognostic (9.28e-3)" "unprognostic (5.14e-3)" "unprognostic (8.32e-2)" "unprognostic (1.90e-2)" "unprognostic (1.86e-3)" "unprognostic (6.41e-2)" "unprognostic (8.57e-3)" "prognostic favourable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (7.75e-2)" "unprognostic (1.70e-1)" "unprognostic (3.86e-2)" 6.8 6.9 7.6 7.5 12.2 7.0 8.0 5.2 13.3 5.6 7.8 6.1 3.1 6.9 6.5 5.7 10.4 6.2 4.1 11.8 7.6 7.2 12.1 27.7 4.9 8.4 8.6 8.2 7.2 17.0 5.5 4.5 6.9 11.9 7.5 8.6 5.7 6.7 4.2 10.1 8.1 7.4 5.4 6.1 6.3 5.6 4.0 6.5 6.5 7.1 16.4 9.4 4.9 6.5 14.1 11.6 1.9 5.3 5.8 11.1 4.8 10.6 9.3 5.3 9.9 4.2 4.5 6.9 7.4 3.6 6.7 13.3 8.3 6.7 11.0 10.1 5.7 8.3 14.0 8.2 9.8 5.1 9.4 21.4 12.3 13.8 3.9 12.1 74.9 4.3 6.6 9.5 5.9 6.7 15.3 12.6 8.5 15.8 5.8 12.0 17.9 15.6 9.5 9.7 15.5 5.8 7.2 7.0 6.2 9.3 7.1 6.7 6.0 6.1 5.0 8.7 10.7 12.1 8.3 6.1 13.9 14.6 4.7 16.3 6.6 1.9 4.4 0.2 6.7 5.3 7.8 12.2 7.3 7.7 5.1 14.1 11.1 9.3 0.6 5.8 3.0 11.6 3.8 4.8 7.6 12.2 5.2 13.3 7.6 7.2 8.6 8.2 11.9 6.5 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408494-58427614 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria Mitochondria "HPA002932: AB_1080287" "prognostic favourable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favourable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 22.2 20.8 23.0 14.6 33.9 14.6 25.0 18.7 25.2 18.2 22.5 16.4 19.5 19.7 20.3 29.7 23.3 18.8 19.7 18.7 20.8 19.1 23.7 21.4 14.5 25.9 20.2 20.6 31.8 42.8 11.9 18.9 17.5 22.1 19.5 15.0 15.4 29.1 20.3 33.5 17.8 13.9 25.9 20.9 18.5 20.2 21.4 22.3 20.1 25.2 24.8 19.3 26.6 17.9 17.6 14.3 4.0 10.6 16.5 19.2 7.6 25.1 21.5 17.1 16.5 19.7 35.9 23.3 24.5 13.0 18.5 16.4 21.8 27.2 33.6 26.4 14.2 17.6 22.6 23.7 27.0 22.5 12.9 17.5 14.6 24.7 49.5 28.1 16.8 28.4 30.2 18.0 36.7 19.0 28.1 20.9 18.6 42.6 26.0 35.0 14.6 37.9 22.1 25.9 21.2 24.6 22.4 21.9 13.1 15.6 40.3 42.6 28.6 16.5 18.9 23.5 32.2 15.5 26.5 14.4 14.2 30.9 18.4 27.3 27.5 4.0 9.0 2.2 9.4 10.1 17.4 17.6 15.0 13.9 13.1 14.4 19.2 17.7 0.9 16.5 10.6 14.3 15.1 7.6 23.0 33.9 18.7 25.2 20.8 19.1 20.2 20.6 22.1 22.3 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498532-119525090 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053214: , HPA055846: " "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 13.6 17.2 18.1 10.4 16.7 5.9 13.8 8.6 16.2 16.4 12.2 20.4 21.5 9.2 13.3 19.4 18.5 13.6 14.9 43.9 15.9 15.4 22.8 20.5 13.0 15.9 20.9 11.9 11.8 12.5 20.4 17.4 21.4 16.4 15.2 14.5 14.0 14.3 21.6 37.2 16.0 15.3 12.7 21.9 14.3 12.3 13.3 15.6 9.9 19.9 20.3 14.5 16.7 11.1 12.4 13.8 16.3 15.5 8.5 15.8 15.5 14.0 13.2 6.6 5.6 25.7 17.3 14.9 4.1 13.8 12.0 13.8 8.9 8.7 10.3 7.1 14.5 6.6 16.5 13.4 19.6 8.6 5.9 7.6 6.2 10.0 13.5 5.9 5.0 15.1 20.7 9.6 12.5 16.9 10.3 9.9 22.0 17.5 6.1 12.5 8.8 16.5 5.2 4.6 13.5 18.0 7.0 8.8 16.3 4.2 6.4 15.8 10.6 16.2 8.4 6.8 5.1 6.1 7.1 6.4 6.0 14.0 11.5 15.0 10.6 6.8 13.8 16.3 8.4 13.0 10.1 12.2 8.3 10.3 13.8 12.4 10.4 9.0 3.4 8.5 15.5 11.9 15.8 15.5 18.1 16.7 8.6 16.2 15.9 15.4 20.9 11.9 16.4 15.6 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Cell line enhanced" "Detected in some" "HSkMC: 7.4;hTCEpi: 7.4;RPTEC TERT1: 7.6;RT4: 9.3;THP-1: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 3.9 0.0 0.1 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 3.5 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.5 7.4 7.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.4 1.5 0.1 0.0 0.0 7.6 9.3 0.0 0.2 0.4 0.0 1.8 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 TMEM11 "C17orf35, PM1, PMI" ENSG00000178307 "Transmembrane protein 11" P17152 17 21197280-21214624 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051795, HPA062854" Uncertain Supported Mitochondria Mitochondria "HPA051795: , HPA062854: " "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (3.55e-1)" "unprognostic (3.36e-3)" "unprognostic (1.45e-2)" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (1.40e-1)" "unprognostic (1.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.17e-2)" "unprognostic (4.61e-2)" 9.7 6.5 5.5 6.2 5.8 13.2 9.7 6.2 8.7 6.1 6.1 6.3 4.3 5.4 6.8 7.6 8.5 5.1 5.2 8.3 5.1 5.1 8.0 9.0 5.9 5.0 5.6 4.5 6.2 10.7 4.5 5.1 10.6 6.5 7.4 4.1 6.4 11.0 6.2 30.2 8.2 7.2 6.3 5.3 6.0 6.5 8.4 4.5 7.3 8.8 12.8 7.9 5.9 5.7 8.0 7.0 11.7 12.2 5.5 6.5 7.6 4.4 3.2 4.6 3.2 6.7 3.7 5.7 9.1 2.5 8.0 5.6 10.5 2.0 4.3 5.0 7.0 5.8 6.5 6.6 1.8 4.5 6.5 3.0 3.0 1.8 7.5 3.5 4.3 5.1 5.3 9.1 4.2 3.9 3.8 1.6 3.7 2.7 5.7 5.4 5.0 2.7 4.0 8.7 2.6 3.6 1.3 2.7 4.6 3.6 4.3 4.4 2.7 3.1 3.2 4.5 6.8 6.4 8.5 2.2 2.1 10.2 3.6 4.6 2.6 4.7 12.2 11.7 5.4 8.7 4.9 6.1 5.5 4.9 7.0 8.0 6.5 4.9 9.8 5.5 10.9 6.1 4.9 7.6 5.5 5.8 6.2 8.7 5.1 5.1 5.6 4.5 6.5 4.5 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 15.5 17.0 28.9 13.5 28.0 6.4 22.1 26.7 33.2 19.7 21.2 12.2 15.5 21.7 21.9 35.4 16.5 15.9 19.1 26.2 27.2 31.7 27.5 19.9 16.5 18.9 28.7 25.7 15.9 15.3 13.9 28.0 14.6 28.8 19.8 20.0 14.2 16.8 16.6 15.7 15.1 20.8 24.2 24.9 19.3 18.9 11.7 27.0 15.1 22.6 17.5 18.8 20.8 14.3 14.0 14.9 12.5 13.2 15.8 19.6 11.5 14.5 12.0 13.6 6.4 25.7 20.6 4.3 12.9 14.1 10.3 15.7 33.3 14.8 15.5 28.6 11.0 17.7 21.7 13.3 9.8 21.4 19.7 11.7 21.2 14.6 14.6 28.6 14.5 15.0 17.0 15.7 19.1 15.7 27.8 12.8 25.5 18.7 11.4 35.5 14.7 19.8 9.9 10.2 13.0 20.2 16.3 12.4 7.7 12.2 10.0 12.6 20.2 17.7 8.2 15.8 11.1 39.7 13.5 6.0 33.5 18.7 8.0 23.4 8.3 12.5 11.7 5.7 15.4 13.2 19.6 14.0 19.1 18.4 14.9 12.9 19.1 18.9 4.5 15.8 9.6 13.4 18.3 11.5 28.9 28.0 26.7 33.2 27.2 31.7 28.7 25.7 28.8 27.0 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791355-136793257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: " "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favourable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 10.0 15.5 15.7 23.4 15.3 15.5 22.9 11.6 28.3 17.2 54.4 21.0 22.4 21.9 9.4 31.1 35.5 22.6 27.9 22.8 15.2 12.2 38.5 43.4 14.4 23.0 19.9 19.3 13.8 46.3 20.6 23.1 31.7 22.0 49.0 51.4 12.5 32.5 27.5 13.5 22.0 25.6 10.5 19.1 14.1 23.3 16.5 13.8 16.3 28.6 26.0 15.2 16.4 16.3 11.1 42.7 9.0 19.4 12.4 11.3 12.2 16.0 11.6 10.4 6.5 13.1 10.6 22.5 9.1 14.2 11.2 9.0 15.3 14.6 15.4 14.2 9.8 23.9 4.4 26.5 3.6 11.2 8.0 8.6 6.5 17.1 19.2 8.9 10.8 10.1 45.5 8.6 24.4 16.7 8.5 8.3 14.7 32.7 12.2 6.9 5.0 13.1 10.2 11.0 45.3 25.5 9.0 17.5 7.9 9.8 37.2 10.2 66.4 8.7 11.4 8.0 6.4 14.6 5.9 5.4 8.4 8.2 12.1 12.9 11.5 6.5 13.8 9.0 11.3 19.4 10.2 8.7 7.9 8.1 11.2 11.1 10.9 10.0 3.3 12.4 16.0 42.7 7.5 12.2 15.7 15.3 11.6 28.3 15.2 12.2 19.9 19.3 22.0 13.8 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284968 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved Supported Mitochondria Mitochondria "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 29.9 29.6 42.7 28.3 63.3 23.8 27.2 40.3 55.1 33.4 31.3 36.8 22.3 21.2 31.9 25.7 30.1 24.6 30.6 22.9 45.6 48.2 39.6 48.1 45.0 23.9 43.8 41.0 25.2 41.0 57.0 45.5 29.4 50.5 33.6 36.8 20.5 31.9 31.7 18.6 19.4 22.5 39.8 45.3 28.9 28.0 14.1 40.3 21.1 43.1 17.0 29.3 32.8 22.8 9.1 24.3 42.7 26.8 13.1 16.3 16.7 10.4 10.1 18.7 15.6 47.1 44.3 15.4 42.6 33.5 16.6 25.4 10.8 24.4 12.2 29.5 37.4 12.3 8.3 23.7 44.4 15.6 12.3 11.7 11.0 11.1 26.9 14.1 20.6 41.0 23.5 23.0 12.9 52.7 11.4 21.6 32.3 6.9 4.9 10.2 6.6 8.7 8.2 13.2 15.3 64.3 25.7 13.1 12.8 21.6 10.7 14.3 11.8 44.1 45.7 21.0 23.5 13.1 30.0 17.8 24.2 5.2 16.6 27.2 32.9 12.3 26.8 17.7 12.7 26.6 15.3 9.1 13.0 12.2 24.3 7.5 12.5 12.6 42.7 13.1 25.6 10.6 16.3 16.7 42.7 63.3 40.3 52.7 45.6 48.2 43.8 41.0 50.5 40.3 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: " "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.0 8.8 7.1 7.4 8.4 7.2 7.3 9.4 8.6 10.6 8.6 8.3 6.4 15.0 8.2 6.4 10.1 13.6 9.1 12.0 9.7 9.3 15.0 5.8 11.0 8.4 8.1 8.0 6.7 8.4 6.7 3.6 8.9 11.2 7.4 11.2 8.2 18.5 15.4 6.6 11.0 13.1 7.0 12.7 11.2 10.5 16.2 7.2 5.8 42.5 11.9 8.8 7.5 5.6 6.2 7.5 11.2 8.9 11.0 9.4 14.7 9.0 6.4 6.8 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria Mitochondria "HPA058401: , HPA070655: " "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.7 8.0 0.3 0.5 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.2 0.9 32.3 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.9 1.4 0.0 1.6 1.2 0.7 0.2 0.1 1.1 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.5 0.7 3.3 0.0 1.6 0.0 5.7 19.1 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 TMLHE "BBOX2, FLJ10727, TMLH, XAP130" ENSG00000185973 "Trimethyllysine hydroxylase, epsilon" Q9NVH6 X 155490115-155669944 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034589, HPA040331" Approved Supported Mitochondria Mitochondria "HPA034589: AB_10670571, HPA040331: " "unprognostic (1.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.04e-1)" "unprognostic (5.41e-2)" "unprognostic (6.66e-3)" "unprognostic (1.10e-3)" "unprognostic (6.50e-2)" "unprognostic (1.00e-1)" "unprognostic (3.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.20e-3)" "unprognostic (6.97e-2)" "prognostic favourable (3.68e-6)" "unprognostic (1.69e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-1)" "unprognostic (7.75e-2)" 10.1 15.0 8.5 6.7 10.5 6.7 10.4 17.1 13.5 11.3 10.5 10.0 9.1 10.7 10.9 10.1 9.5 9.5 7.4 22.3 10.3 7.5 15.8 16.9 6.9 14.6 12.5 7.4 12.4 10.7 18.4 17.5 7.6 11.5 7.7 11.6 10.6 16.2 9.6 28.1 7.8 10.0 13.8 13.7 9.2 9.8 3.1 11.2 12.2 10.5 5.3 8.7 10.2 9.1 9.1 10.3 14.7 15.7 4.3 5.6 4.5 15.2 7.5 6.2 18.1 7.7 11.9 0.0 6.2 9.1 7.8 20.4 5.3 8.6 0.0 25.0 10.8 8.3 13.2 6.0 8.9 6.2 9.1 6.8 12.2 6.2 10.8 6.4 4.9 12.6 12.7 8.7 13.2 12.3 9.5 5.6 12.9 5.7 7.7 7.2 1.9 0.1 7.7 9.9 5.8 9.4 5.2 5.9 8.9 5.8 0.3 6.7 6.7 7.3 10.3 6.6 6.3 13.0 7.6 7.0 7.5 5.9 8.0 10.0 6.0 1.9 10.1 11.3 3.9 11.4 2.9 6.2 4.3 3.3 10.3 9.1 5.6 4.9 14.7 4.3 15.7 4.7 4.2 4.5 8.5 10.5 17.1 13.5 10.3 7.5 12.5 7.4 11.5 11.2 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.6" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: , HPA024251: " "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 17.9 11.8 18.1 17.9 17.2 29.4 20.6 35.1 23.6 35.0 29.9 16.7 17.9 16.4 36.0 19.5 19.6 27.5 29.2 13.6 14.2 9.6 15.6 11.8 19.2 12.9 15.5 16.7 30.3 18.4 36.9 14.7 19.7 13.2 25.4 15.1 25.2 17.0 24.4 13.6 18.9 16.9 40.1 12.6 15.3 21.4 14.0 16.6 7.2 20.6 12.8 9.4 27.0 21.4 2.0 4.3 17.6 3.2 2.6 1.5 0.1 21.3 19.1 15.9 13.3 13.4 16.0 41.1 15.2 14.4 8.4 9.0 7.8 18.8 14.6 15.0 22.2 23.9 9.1 18.2 7.1 6.4 5.8 9.3 16.3 12.7 11.7 30.5 34.3 16.1 21.5 16.8 19.6 9.5 13.1 8.3 10.7 35.5 7.1 37.3 1.4 14.6 8.0 7.9 10.8 6.9 27.3 6.9 16.6 11.8 31.3 11.3 32.7 31.6 23.6 24.5 34.5 14.5 10.9 11.9 12.3 13.8 13.7 21.7 28.5 9.4 3.2 2.7 1.4 1.2 1.0 1.6 1.0 0.8 1.1 2.0 0.7 1.5 17.6 2.6 1.5 4.3 1.4 0.1 18.1 17.2 35.1 23.6 14.2 9.6 15.5 16.7 13.2 16.6 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109336-235128936 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 27.2 35.0 46.3 15.3 60.2 32.7 52.8 40.0 66.2 36.1 25.5 28.4 29.0 24.4 34.5 39.0 28.0 40.0 27.9 33.9 47.1 48.7 41.2 35.2 24.2 33.6 42.5 40.5 50.9 63.6 38.6 25.4 27.1 48.2 34.0 28.2 23.5 47.8 30.7 33.4 33.0 21.3 33.8 54.5 19.0 27.2 16.3 23.0 18.0 58.7 28.4 21.9 36.2 28.9 15.9 20.9 16.4 13.8 9.8 22.6 14.2 35.9 19.0 25.0 21.0 19.7 39.8 38.8 25.9 22.4 24.4 17.8 24.5 25.4 43.8 34.5 22.4 28.8 27.7 25.1 32.2 10.5 59.2 26.7 25.4 46.3 33.0 59.8 16.1 35.5 34.5 24.4 33.7 26.4 56.0 16.2 26.7 10.5 25.4 27.1 56.2 10.3 31.1 19.1 56.7 27.4 25.9 32.9 77.1 20.1 28.2 55.1 43.6 65.8 23.3 21.5 13.0 27.1 54.9 38.4 36.1 32.1 25.2 28.7 36.2 16.4 12.4 4.1 13.9 12.9 17.1 15.9 18.1 17.3 15.1 12.7 22.6 17.6 3.9 9.8 13.8 20.9 15.5 14.2 46.3 60.2 40.0 66.2 47.1 48.7 42.5 40.5 48.2 23.0 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681948-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 27.6 26.2 25.6 30.1 24.3 29.5 29.4 17.6 28.2 22.2 26.8 14.7 22.4 28.0 20.1 25.6 34.1 24.4 23.8 31.6 23.2 21.0 29.4 46.0 18.1 32.1 24.0 19.8 27.8 47.5 10.9 12.6 27.6 18.5 21.0 32.8 15.8 31.4 26.7 38.2 24.6 29.7 22.8 20.0 27.7 23.3 24.7 11.3 44.2 27.4 40.4 33.5 24.1 30.2 22.5 29.7 6.9 22.9 18.0 21.3 28.6 19.6 11.6 17.9 18.9 13.2 12.3 19.3 16.3 11.4 23.9 18.0 21.1 11.8 20.0 13.5 15.9 16.4 27.1 24.7 19.3 17.2 29.8 26.9 9.1 20.2 17.3 71.1 19.1 16.8 17.6 21.5 14.1 17.5 20.3 16.0 15.9 15.3 21.3 33.1 27.3 23.7 23.7 23.2 18.9 15.9 14.5 21.0 13.9 19.1 24.2 18.5 16.8 23.6 17.8 14.7 27.6 13.4 24.6 22.2 26.8 31.0 18.4 24.7 20.0 4.7 22.9 6.9 16.9 22.0 21.3 22.5 18.3 17.8 29.7 18.0 18.7 20.0 2.2 18.0 18.1 25.8 21.1 28.6 25.6 24.3 17.6 28.2 23.2 21.0 24.0 19.8 18.5 11.3 TOMM40 "C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40" ENSG00000130204 "Translocase of outer mitochondrial membrane 40" O96008 19 44890569-44903689 "Predicted intracellular proteins, Transporters" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036231, HPA036232" Supported Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA036231: , HPA036232: " "unprognostic (2.14e-1)" "unprognostic (9.58e-3)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (2.37e-1)" "unprognostic (2.17e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-2)" "unprognostic (7.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (5.86e-3)" "unprognostic (5.30e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-1)" 16.0 25.3 13.6 16.9 15.6 19.7 20.6 17.7 27.0 10.2 20.5 10.9 10.1 20.0 11.8 10.5 22.9 13.5 11.4 21.5 15.3 14.9 16.5 36.9 15.1 22.3 15.6 13.3 18.2 19.2 16.2 11.9 15.3 20.2 11.2 16.7 11.5 11.5 13.5 32.3 14.7 15.1 11.6 11.9 12.7 12.6 12.3 8.8 14.2 11.6 18.6 15.6 10.9 12.5 7.3 7.0 5.1 6.8 4.7 8.7 2.0 30.8 52.3 19.1 26.3 7.1 6.4 24.3 22.2 12.3 42.1 30.2 56.8 21.4 45.6 23.9 14.6 33.4 49.5 31.9 19.2 17.6 44.9 30.6 20.5 44.7 15.2 39.0 27.5 10.1 18.1 32.6 20.7 14.5 48.2 15.9 16.4 38.5 42.3 28.7 33.4 32.6 43.3 21.7 26.5 19.3 42.9 29.8 19.1 23.6 49.8 15.8 16.7 39.6 11.9 29.2 29.6 20.3 57.9 17.2 35.6 44.7 21.7 41.5 30.7 0.7 5.5 5.1 4.7 6.8 5.2 7.3 4.5 6.5 7.0 4.2 7.9 8.7 1.1 4.7 5.9 6.9 4.8 2.0 13.6 15.6 17.7 27.0 15.3 14.9 15.6 13.3 20.2 8.8 TOMM5 "bA613M10.3, C9orf105, Tom5" ENSG00000175768 "Translocase of outer mitochondrial membrane 5" Q8N4H5 9 37582646-37592642 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA048712 Approved Supported Mitochondria Mitochondria "HPA048712: " "unprognostic (1.81e-2)" "unprognostic (1.96e-1)" "unprognostic (3.37e-2)" "unprognostic (3.34e-2)" "unprognostic (2.02e-1)" "unprognostic (2.82e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (9.89e-3)" "prognostic unfavourable (5.49e-4)" "prognostic favourable (2.37e-4)" "unprognostic (7.80e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.37e-1)" "unprognostic (9.09e-2)" 33.2 37.8 34.5 31.2 39.7 28.3 44.1 24.3 38.5 26.7 34.7 13.1 28.3 37.5 28.7 32.7 36.9 25.4 31.1 39.6 30.9 34.7 44.3 45.3 24.4 37.4 37.6 26.3 27.4 83.8 12.7 28.8 19.6 32.3 25.2 31.2 17.3 49.6 36.2 51.5 24.1 34.8 34.1 23.9 38.9 31.2 33.0 27.2 24.5 36.3 46.1 37.8 26.7 35.3 59.1 43.1 14.0 33.9 40.2 54.9 50.5 54.3 63.5 37.7 33.7 43.3 42.5 20.8 41.5 26.6 40.5 43.4 67.5 22.6 37.3 34.1 39.3 18.9 33.4 49.5 42.3 52.3 52.9 32.8 88.3 96.7 35.6 53.6 21.7 36.7 27.2 44.6 44.2 46.1 79.7 41.9 41.1 43.6 45.1 47.2 65.5 40.3 38.4 31.4 54.8 46.3 34.1 32.6 30.0 21.3 29.0 30.3 20.3 62.9 31.2 28.1 60.1 44.1 64.0 15.9 46.2 62.2 34.4 46.4 43.2 12.3 32.2 14.0 43.0 33.9 52.7 59.1 53.1 47.7 39.0 49.1 54.9 50.5 3.7 40.2 28.5 43.1 42.1 50.5 34.5 39.7 24.3 38.5 30.9 34.7 37.6 26.3 32.3 27.2 TOMM6 "OBTP, Tom6" ENSG00000214736 "Translocase of outer mitochondrial membrane 6" Q96B49 6 41787662-41789898 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004801 Approved Supported Mitochondria Mitochondria "HPA004801: AB_1859553" 44.1 68.7 54.2 47.4 51.9 55.4 66.4 26.0 52.6 44.0 44.7 43.6 37.1 29.1 38.9 83.4 62.1 49.0 32.1 64.6 45.3 43.8 80.9 92.6 37.7 60.4 45.1 36.3 56.9 84.5 31.6 39.7 49.9 42.3 47.1 53.1 48.4 83.1 43.8 80.2 47.2 48.7 39.4 41.5 58.7 42.0 53.1 37.2 56.7 65.9 78.3 71.9 44.7 38.7 66.2 75.2 39.0 70.5 33.8 56.9 89.2 64.0 32.1 38.8 39.2 36.5 44.1 41.3 32.2 34.1 41.6 40.3 55.5 30.0 29.4 39.5 38.4 20.5 61.8 53.4 53.8 41.2 65.2 52.7 41.0 90.3 28.9 70.2 34.3 39.5 56.1 45.7 39.3 50.0 131.3 36.1 51.1 75.8 50.4 111.4 34.1 32.6 37.0 24.3 86.5 56.0 33.0 34.4 48.0 22.0 38.0 53.6 46.4 142.7 35.0 28.6 35.5 28.4 48.0 33.4 71.3 129.4 16.2 59.7 36.8 15.1 69.1 39.0 49.1 68.7 47.7 66.2 50.2 48.7 72.0 61.8 56.9 55.4 9.0 33.8 70.5 75.2 46.5 89.2 54.2 51.9 26.0 52.6 45.3 43.8 45.1 36.3 42.3 37.2 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401398 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria 120000 Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: " "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 21.7 16.1 16.2 12.4 52.4 9.6 21.3 23.6 26.5 16.9 18.2 12.5 13.8 19.4 17.4 15.0 20.8 14.2 12.2 25.2 16.5 19.8 24.9 40.7 10.5 13.5 16.1 20.6 21.7 18.0 20.1 17.1 15.5 29.0 19.0 20.6 13.3 14.5 19.4 42.8 13.3 17.8 22.3 14.0 12.1 14.8 14.7 15.6 18.7 20.5 19.9 16.6 22.3 22.5 4.3 3.0 2.5 2.5 5.6 5.4 1.8 23.6 16.6 14.2 20.3 20.0 21.8 18.4 20.3 17.3 18.5 19.2 23.5 13.6 28.3 17.9 17.1 23.5 25.5 18.5 27.4 10.7 11.8 32.5 11.0 22.8 12.5 39.5 15.0 19.4 17.2 16.5 27.0 13.5 23.1 23.1 22.1 17.5 26.7 16.0 19.5 35.4 24.6 28.7 30.1 15.0 17.9 25.7 21.4 14.7 23.7 26.4 30.7 22.5 12.2 16.4 21.8 9.1 15.1 25.2 35.9 48.1 15.8 23.9 12.4 2.2 2.2 2.5 4.1 2.2 5.1 4.3 5.1 4.5 2.9 3.1 5.3 5.4 0.6 5.6 2.5 3.0 2.0 1.8 16.2 52.4 23.6 26.5 16.5 19.8 16.1 20.6 29.0 15.6 TOP1MT ENSG00000184428 "DNA topoisomerase I mitochondrial" Q969P6 8 143304384-143359979 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001915, HPA021542" Approved Supported Mitochondria Mitochondria "HPA001915: AB_1080331, HPA021542: AB_1858186" "unprognostic (5.02e-3)" "unprognostic (3.79e-2)" "unprognostic (6.57e-2)" "unprognostic (6.92e-3)" "unprognostic (2.32e-2)" "unprognostic (1.04e-2)" "unprognostic (3.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (1.52e-7)" "unprognostic (3.66e-2)" "unprognostic (3.62e-2)" "unprognostic (8.55e-3)" "unprognostic (5.66e-3)" 11.7 13.5 8.1 13.7 9.8 33.0 22.1 2.2 10.3 14.7 10.7 4.5 3.9 6.0 10.0 7.4 14.9 11.3 11.0 5.9 8.8 5.6 9.6 22.5 8.5 11.4 6.9 8.1 27.0 15.9 5.9 8.6 5.9 7.3 14.7 8.0 5.9 11.0 10.8 5.7 15.4 8.3 8.8 6.8 11.4 9.3 18.1 6.4 25.1 19.2 9.6 11.4 14.0 30.9 16.7 18.8 11.7 5.5 0.2 14.3 4.7 7.5 11.6 4.9 18.2 7.0 7.8 8.7 3.5 4.5 6.4 6.6 14.5 10.9 22.2 13.2 4.9 8.1 10.4 6.5 5.5 8.7 15.9 19.5 6.5 14.6 7.9 13.0 21.2 7.9 6.9 5.3 7.8 7.6 23.3 8.7 5.6 31.5 57.7 25.9 8.5 19.9 7.3 6.4 33.2 4.7 12.2 8.7 10.6 10.0 9.0 18.1 5.9 21.7 5.0 4.4 18.1 5.0 9.0 4.7 4.9 11.3 7.5 19.5 5.3 11.7 5.5 0.2 3.5 3.2 3.6 16.7 6.4 4.8 18.8 8.0 14.3 10.4 0.4 0.2 0.6 16.4 1.7 4.7 8.1 9.8 2.2 10.3 8.8 5.6 6.9 8.1 7.3 6.4 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36487027-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Supported Nucleoli,Mitochondria Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favourable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 13.0 11.0 12.9 8.5 17.0 31.8 11.9 18.1 15.0 10.6 10.7 13.6 8.2 9.5 12.9 9.8 12.4 11.5 9.4 13.9 9.8 7.1 11.2 12.3 15.2 9.2 14.8 10.6 14.6 11.3 11.0 11.9 10.3 12.7 9.6 10.5 10.5 11.0 9.3 13.9 12.7 12.5 12.1 10.1 13.0 10.3 15.0 12.8 18.5 15.6 6.7 10.8 11.3 13.0 10.6 7.7 27.7 11.4 9.6 13.1 8.5 5.1 6.5 12.6 7.1 11.9 8.7 5.5 7.8 8.4 7.2 9.5 5.7 3.5 6.8 4.8 8.2 9.7 10.0 7.9 12.0 11.1 11.7 6.5 5.1 5.1 7.7 7.2 8.0 8.1 11.1 3.9 11.8 10.1 9.7 7.4 9.0 6.3 11.5 3.9 6.8 6.0 7.6 17.1 3.8 8.7 10.7 2.1 11.1 7.8 7.6 5.5 8.7 7.0 8.0 10.3 9.1 9.4 9.4 8.7 7.3 7.3 5.8 5.2 7.7 27.7 8.0 20.9 11.9 11.4 11.7 10.6 10.3 11.6 7.7 8.1 10.0 13.1 11.1 9.6 8.2 4.5 8.0 8.5 12.9 17.0 18.1 15.0 9.8 7.1 14.8 10.6 12.7 12.8 TRAP1 "HSP75, HSP90L" ENSG00000126602 "TNF receptor associated protein 1" Q12931 16 3651639-3717597 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041082, HPA044227" Enhanced Enhanced Mitochondria 1100000 Mitochondria "HPA041082: AB_2677291, HPA044227: AB_2678864" "unprognostic (1.18e-1)" "unprognostic (1.51e-1)" "prognostic favourable (1.80e-4)" "unprognostic (7.10e-2)" "unprognostic (6.80e-2)" "unprognostic (2.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.61e-2)" "unprognostic (8.58e-2)" "unprognostic (5.71e-3)" "unprognostic (1.54e-1)" "unprognostic (7.69e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "unprognostic (9.90e-2)" "unprognostic (3.82e-2)" 19.1 20.3 19.1 15.9 29.7 14.2 17.5 21.1 38.5 16.8 23.0 18.1 13.1 18.6 17.1 14.2 34.4 28.5 20.8 40.0 22.1 20.4 24.6 62.6 12.3 20.6 17.1 30.7 23.5 54.7 18.3 13.6 15.5 23.2 15.4 17.8 16.4 19.7 13.7 80.3 31.2 14.1 20.9 12.3 15.2 19.7 20.0 15.1 16.4 16.0 39.8 21.2 17.2 18.2 20.0 24.6 1.3 17.0 12.7 22.3 13.8 18.9 47.7 9.9 26.2 11.0 11.3 29.4 11.5 10.5 26.8 16.9 59.2 27.1 61.1 21.9 11.1 35.7 38.6 28.8 11.8 23.4 42.2 17.8 40.9 41.4 18.9 31.9 12.3 13.3 20.1 21.2 33.3 18.3 55.9 22.3 8.7 62.0 22.9 23.7 18.4 24.3 52.7 20.8 84.3 19.8 14.1 47.3 18.0 12.0 44.4 23.1 32.1 23.2 10.3 11.3 20.2 19.7 16.8 23.8 26.2 48.1 7.0 25.8 15.3 0.0 10.8 0.3 11.7 17.0 22.3 20.0 17.1 14.8 24.6 13.9 20.3 17.1 1.3 12.7 12.3 3.6 14.2 13.8 19.1 29.7 21.1 38.5 22.1 20.4 17.1 30.7 23.2 15.1 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561862-101566446 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavourable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favourable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 18.0 21.2 13.1 13.6 14.1 14.4 19.7 16.4 19.1 16.1 15.3 5.5 12.9 11.6 14.6 13.1 20.9 15.0 10.7 20.4 13.0 13.4 26.6 34.6 10.0 19.3 12.5 16.7 18.8 12.1 9.9 19.9 18.2 18.5 16.2 14.2 5.5 14.5 13.0 35.2 15.2 16.5 15.3 14.3 19.6 15.6 14.7 10.6 23.0 16.6 30.5 18.5 15.6 11.3 21.6 15.4 27.4 14.8 12.2 23.1 11.8 20.8 10.2 13.6 13.7 12.5 10.7 12.7 12.4 12.2 16.3 18.2 15.5 14.1 43.4 16.3 7.7 21.1 26.2 19.0 22.4 15.5 12.9 29.1 8.1 11.2 9.6 25.5 12.4 12.5 19.8 14.2 13.3 15.8 24.6 9.7 17.5 14.3 20.4 18.7 25.2 22.1 15.2 11.1 19.4 20.8 17.7 33.9 19.4 9.7 20.7 27.4 27.3 28.2 10.4 8.9 16.8 5.9 13.1 11.3 20.6 41.6 15.0 18.4 13.3 27.4 11.2 7.3 13.6 14.4 18.8 21.6 16.8 15.8 13.5 20.4 23.1 21.1 4.9 12.2 14.8 15.4 15.0 11.8 13.1 14.1 16.4 19.1 13.0 13.4 12.5 16.7 18.5 10.6 TRMU "FLJ10140, MTO2, TRMT" ENSG00000100416 "TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA000824: , HPA035273: AB_10602901, HPA043300: " "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavourable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favourable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavourable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 8.5 16.1 11.5 9.9 16.0 6.4 7.5 17.8 16.0 9.7 8.7 11.5 10.2 10.9 12.1 18.0 10.9 6.2 7.3 16.8 11.3 11.9 20.5 18.8 7.1 10.2 15.7 11.8 8.0 22.7 20.0 13.6 9.7 11.2 8.7 10.2 9.0 12.5 15.5 17.8 9.8 7.6 9.4 11.4 8.7 9.2 8.3 13.9 6.5 9.6 8.3 9.8 7.1 9.1 6.2 7.6 3.9 9.6 7.5 11.3 6.3 10.8 9.9 4.3 9.6 8.0 5.7 10.7 11.3 8.0 16.1 12.5 14.0 2.7 7.1 8.0 10.1 9.7 18.1 10.1 13.8 4.6 24.4 8.4 15.2 16.5 6.9 16.1 5.8 5.4 11.4 16.6 5.3 10.3 11.7 1.7 9.7 11.4 6.2 13.2 16.1 17.5 7.4 9.2 13.1 8.0 7.5 10.2 12.3 10.0 11.8 18.9 6.7 6.7 7.5 7.2 12.8 10.1 12.6 4.2 4.5 7.6 10.1 11.7 14.4 0.0 6.8 3.9 11.1 9.4 9.4 5.7 9.4 10.0 7.6 6.2 8.6 8.0 1.4 7.5 9.6 6.0 11.3 6.3 11.5 16.0 17.8 16.0 11.3 11.9 15.7 11.8 11.2 13.9 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126916-3150879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 15.2 16.9 17.5 17.8 20.7 8.7 18.2 14.5 22.7 12.9 13.2 13.2 17.4 11.1 18.4 14.7 15.9 12.2 15.6 13.9 17.1 16.0 21.1 16.1 13.7 19.0 17.5 15.6 14.6 13.9 14.3 31.0 19.0 21.3 23.9 16.4 10.1 13.2 13.1 14.8 15.3 12.5 15.3 19.3 20.5 15.5 13.5 15.1 22.1 20.9 10.6 19.8 17.8 13.0 15.1 10.5 29.0 12.0 15.1 16.6 7.4 11.9 17.3 13.4 7.6 16.0 13.7 14.3 13.7 11.4 13.7 14.2 16.0 14.7 21.8 9.1 13.2 8.6 17.7 12.4 17.5 16.2 8.5 20.3 18.4 16.0 21.4 21.4 16.5 12.8 17.5 14.1 4.8 13.5 15.7 9.2 23.6 22.3 13.8 19.4 10.6 12.6 13.2 18.1 21.2 18.3 17.8 7.7 11.0 19.8 14.4 11.4 13.3 12.2 11.0 15.5 13.5 16.0 17.5 9.4 18.8 27.5 11.6 19.3 17.2 29.0 8.8 22.5 12.1 11.8 11.9 15.1 15.0 12.7 10.5 9.5 16.6 14.3 11.7 15.1 12.0 9.6 11.1 7.4 17.5 20.7 14.5 22.7 17.1 16.0 17.5 15.6 21.3 15.1 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782589-57808071 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 153.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favourable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 14.5 46.2 16.6 14.7 21.5 15.3 18.5 18.2 24.3 12.7 18.8 13.3 17.6 17.8 11.6 13.7 16.1 12.4 10.3 27.7 14.6 15.6 27.0 30.2 10.1 14.6 15.4 20.8 10.3 19.6 17.0 13.1 11.6 17.8 11.7 18.3 11.1 13.5 14.1 33.5 14.7 13.4 17.7 11.6 12.5 14.0 23.2 13.6 11.3 15.4 26.9 13.4 14.4 13.0 18.5 18.7 9.0 16.8 20.0 23.5 16.0 8.2 9.6 5.8 8.6 5.4 5.4 8.4 6.9 6.2 11.3 7.9 11.2 10.9 20.7 13.3 6.1 9.8 9.7 10.0 8.6 8.4 11.8 12.6 8.1 9.8 8.2 16.0 7.6 6.2 10.2 8.6 4.9 7.0 16.2 11.2 8.5 9.5 9.5 17.4 8.8 12.8 11.6 153.6 18.5 10.7 9.4 12.5 7.7 7.4 13.1 12.6 22.7 11.7 5.1 6.2 8.7 9.0 7.4 8.3 17.0 16.1 8.7 9.7 7.3 3.7 14.8 9.0 18.6 13.8 23.5 18.5 20.9 18.4 18.7 16.4 21.2 21.7 4.2 20.0 16.8 14.7 18.1 16.0 16.6 21.5 18.2 24.3 14.6 15.6 15.4 20.8 17.8 13.6 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260" Uncertain Approved Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" Vesicles "CAB011232: , HPA046260: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.1 23.4 1.6 22.2 8.9 29.6 1.7 35.3 17.3 17.8 18.9 4.5 36.1 0.0 24.4 27.3 39.1 4.4 27.3 2.3 7.9 18.4 4.8 25.7 1.6 32.4 10.7 24.2 22.9 45.1 10.5 9.4 42.0 3.9 8.9 18.2 39.4 0.1 29.9 1.9 58.4 10.6 0.0 80.5 22.6 28.5 2.3 10.9 16.7 33.4 41.1 12.5 41.5 43.3 22.0 16.5 22.5 14.8 3.6 0.6 0.4 28.6 34.8 28.2 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 TST RDS ENSG00000128311 "Thiosulfate sulfurtransferase" Q16762 22 37010859-37020183 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 16.0" "Group enriched" "Detected in all" 6 "dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003044, HPA003643, CAB009546" Enhanced Supported Mitochondria 2800000 Mitochondria "CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411" "unprognostic (3.09e-2)" "unprognostic (2.70e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-1)" "unprognostic (7.96e-3)" "unprognostic (4.38e-2)" "unprognostic (1.78e-1)" "prognostic favourable (7.59e-6)" "unprognostic (6.08e-3)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "prognostic favourable (1.04e-4)" 8.5 29.7 6.0 13.5 7.6 5.7 6.1 5.0 10.5 9.5 38.4 12.9 10.9 37.4 5.9 4.0 16.6 6.8 38.4 14.1 5.1 4.9 19.7 102.1 6.2 3.2 8.2 7.0 7.2 23.9 1.8 2.3 5.0 5.9 8.1 21.6 6.2 13.6 6.9 8.3 5.4 39.5 3.8 4.7 3.5 22.8 3.3 6.7 1.8 8.5 12.8 10.5 7.2 9.2 1.6 16.0 14.3 11.5 2.2 1.2 5.2 15.1 33.7 4.3 14.4 10.4 4.1 8.0 8.4 7.2 4.9 7.4 9.8 10.0 4.0 7.1 6.6 13.1 3.1 8.4 1.1 11.7 18.9 4.2 6.4 19.0 26.1 5.8 10.0 8.0 9.6 3.6 3.1 12.0 5.0 7.0 2.3 34.7 0.2 18.8 7.3 14.8 13.6 4.6 7.0 13.8 14.2 2.5 6.5 8.9 16.0 11.4 16.5 14.8 9.0 5.6 10.5 9.3 2.6 5.3 5.3 1.2 2.0 16.9 3.3 5.3 11.5 4.9 0.6 3.0 1.1 1.6 0.5 0.4 16.0 0.8 0.3 0.2 14.3 2.2 0.8 1.1 1.2 5.2 6.0 7.6 5.0 10.5 5.1 4.9 8.2 7.0 5.9 6.7 TTC19 "FLJ20343, MGC19520" ENSG00000011295 "Tetratricopeptide repeat domain 19" Q6DKK2 17 15999380-16045015 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023010, HPA052380" Enhanced Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA023010: AB_1858429, HPA052380: " "unprognostic (1.04e-2)" "unprognostic (4.90e-3)" "unprognostic (2.87e-2)" "unprognostic (4.80e-3)" "unprognostic (8.09e-2)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.84e-2)" "unprognostic (8.34e-2)" "unprognostic (1.72e-2)" "unprognostic (2.30e-3)" "unprognostic (5.14e-2)" "prognostic favourable (5.67e-4)" "unprognostic (1.31e-1)" "unprognostic (3.22e-1)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" 8.5 13.6 10.3 10.1 16.6 16.4 11.2 16.5 22.6 10.1 13.8 10.3 10.5 18.7 11.1 8.9 9.3 9.9 11.8 13.4 17.0 10.4 15.4 13.2 10.8 7.9 9.2 15.3 12.7 24.8 11.5 15.5 10.1 15.7 12.0 9.6 13.1 14.0 12.7 8.6 13.9 16.1 7.2 8.9 8.3 13.3 6.3 6.8 6.0 18.7 8.0 8.4 10.0 10.9 3.5 2.8 9.0 2.0 1.7 3.3 1.0 7.2 6.1 6.2 10.5 5.3 5.2 4.7 6.1 4.3 2.9 3.2 6.0 12.9 10.2 13.5 3.4 9.2 8.5 7.0 3.6 16.7 14.4 8.4 7.5 5.1 8.1 8.4 13.0 5.3 5.8 2.4 10.1 6.1 4.9 7.3 6.0 6.9 9.0 5.2 10.3 4.2 13.6 7.0 7.3 9.2 8.6 6.5 4.9 7.8 8.4 15.5 7.2 3.7 11.3 4.0 1.7 5.6 7.7 6.0 2.6 4.8 9.5 9.4 9.0 9.0 2.0 3.8 2.0 2.0 3.3 2.8 2.5 3.3 2.5 3.5 2.8 3.1 1.7 1.7 1.6 2.8 2.6 1.0 10.3 16.6 16.5 22.6 17.0 10.4 9.2 15.3 15.7 6.8 TTC21B "FLJ11457, IFT139B, JBTS11, NPHP12, THM1" ENSG00000123607 "Tetratricopeptide repeat domain 21B" Q7Z4L5 2 165857475-165953843 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035494, HPA035495, HPA073293" Supported Supported Mitochondria Mitochondria "HPA035494: , HPA035495: AB_10672866, HPA073293: " "unprognostic (1.63e-2)" "unprognostic (1.17e-1)" "unprognostic (3.10e-1)" "unprognostic (1.60e-2)" "unprognostic (2.96e-1)" "unprognostic (2.51e-1)" "unprognostic (7.09e-3)" "unprognostic (2.81e-2)" "unprognostic (2.98e-2)" "unprognostic (7.57e-2)" "unprognostic (3.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavourable (1.36e-4)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (1.84e-2)" 10.4 9.0 11.3 7.0 18.3 8.6 11.7 39.6 19.8 12.3 9.2 7.1 5.3 6.5 13.8 10.0 6.7 15.3 7.5 10.4 10.1 8.1 12.5 8.9 9.4 8.9 12.3 11.9 17.5 10.1 10.4 17.6 9.8 15.7 14.9 8.9 6.3 9.1 10.2 16.4 10.7 8.2 9.7 12.2 8.4 8.5 9.7 13.8 16.2 9.4 7.1 8.0 9.8 11.8 3.8 3.1 8.7 2.7 3.7 4.7 1.8 4.9 3.8 17.4 7.1 11.8 11.4 4.6 9.9 8.1 8.0 7.9 5.4 3.3 11.5 6.0 7.0 5.2 11.7 6.2 9.5 8.0 5.8 9.4 6.7 13.1 6.9 8.8 0.0 6.2 4.0 9.2 6.7 8.6 12.4 8.7 10.1 2.7 10.8 7.0 7.2 9.4 12.0 14.0 3.9 6.2 10.6 12.5 7.3 7.8 1.9 8.7 2.9 6.3 6.3 14.1 6.3 7.8 7.3 5.0 7.0 10.6 5.9 5.5 8.8 8.7 1.9 3.3 2.9 2.3 4.2 3.8 3.4 2.9 3.1 3.2 4.4 4.7 0.8 3.7 2.7 1.6 4.2 1.8 11.3 18.3 39.6 19.8 10.1 8.1 12.3 11.9 15.7 13.8 TUFM "EF-TuMT, EFTu" ENSG00000178952 "Tu translation elongation factor, mitochondrial" P49411 16 28842411-28846408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Elongation factor" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018991, HPA024087, CAB075730, CAB075731, CAB075732" Enhanced Enhanced Mitochondria 2800000 Mitochondria "CAB075730: , CAB075731: , CAB075732: , HPA018991: AB_1858458, HPA024087: AB_1858459" "unprognostic (1.40e-1)" "unprognostic (7.56e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (2.55e-2)" "unprognostic (3.39e-1)" "unprognostic (1.23e-3)" "unprognostic (8.05e-2)" "unprognostic (8.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "prognostic favourable (2.69e-6)" "unprognostic (5.26e-2)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (7.36e-2)" 27.3 47.8 28.8 32.3 31.3 27.2 40.4 22.3 41.4 25.3 41.7 27.1 34.4 44.0 26.6 22.3 40.0 32.7 37.6 69.2 25.6 25.8 45.6 68.4 28.6 46.2 33.1 24.4 25.9 75.0 48.3 22.7 23.0 27.3 23.4 37.6 25.4 40.9 33.1 77.3 28.1 36.1 26.2 25.8 28.4 36.9 47.0 21.5 32.5 37.0 55.4 33.9 26.8 23.3 30.6 57.3 21.7 44.2 25.5 38.8 45.4 29.1 55.4 17.8 37.1 25.8 23.7 36.5 21.4 24.9 34.1 32.4 59.7 32.3 65.6 39.5 21.4 57.2 42.1 41.4 20.5 26.1 64.4 25.0 44.8 72.2 30.7 44.8 23.3 30.2 32.8 36.9 36.7 40.6 56.1 25.9 24.8 59.4 42.9 43.8 39.8 34.4 59.5 32.3 95.4 29.5 28.6 31.2 38.1 18.7 66.7 29.2 39.7 36.5 25.8 20.4 23.8 25.3 32.6 39.6 40.9 28.5 26.1 56.3 26.7 21.7 44.2 19.5 31.3 42.3 34.8 30.6 29.7 32.7 57.3 27.5 28.5 29.5 9.1 25.5 31.6 34.9 38.8 45.4 28.8 31.3 22.3 41.4 25.6 25.8 33.1 24.4 27.3 21.5 TXN2 MT-TRX ENSG00000100348 "Thioredoxin 2" Q99757 22 36467036-36482030 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000994, CAB008681" Approved Enhanced Mitochondria Mitochondria "CAB008681: AB_1623682, HPA000994: AB_1080267" "unprognostic (5.11e-2)" "unprognostic (4.40e-3)" "unprognostic (4.40e-3)" "unprognostic (1.07e-2)" "unprognostic (5.85e-2)" "unprognostic (4.28e-2)" "unprognostic (4.02e-2)" "unprognostic (5.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic favourable (2.04e-4)" "prognostic favourable (1.17e-6)" "unprognostic (1.49e-2)" "unprognostic (2.78e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" 22.1 69.9 33.4 24.7 33.2 23.5 41.9 23.2 51.1 23.0 25.9 20.8 24.5 36.9 19.8 22.7 28.7 26.9 27.6 60.1 28.0 28.6 33.4 51.7 27.9 35.5 30.3 31.7 35.0 51.1 30.8 17.3 19.6 30.4 21.6 26.2 24.6 25.0 27.5 72.3 21.0 28.1 26.3 35.6 25.2 26.7 19.1 21.2 16.2 29.2 37.3 23.0 23.0 19.8 31.7 51.3 14.4 43.3 32.0 30.0 45.1 14.5 19.9 21.8 37.3 32.8 35.7 25.1 20.0 31.4 33.8 38.4 24.1 15.4 36.8 18.6 31.2 22.2 41.7 34.3 19.7 25.2 36.3 42.0 27.2 35.5 27.7 50.4 40.1 47.7 27.3 28.2 22.1 30.6 43.9 30.5 30.2 21.5 22.9 39.1 17.7 26.3 21.0 23.0 25.5 34.2 23.7 30.4 30.7 20.2 44.3 36.1 31.2 49.0 24.0 37.7 29.4 20.7 19.6 24.8 17.6 35.8 34.0 31.5 21.4 5.2 40.8 7.1 25.7 43.3 26.8 31.7 25.6 27.0 51.3 29.0 30.0 27.9 14.4 32.0 35.2 39.1 24.8 45.1 33.4 33.2 23.2 51.1 28.0 28.6 30.3 31.7 30.4 21.2 TXNRD2 "TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941992 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2 OS: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Supported Mitochondria,Cytosol 410000 Mitochondria Cytosol "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favourable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 9.8 30.2 8.5 8.3 10.1 11.6 7.4 19.0 15.0 8.3 10.3 9.0 7.6 9.2 11.9 12.3 8.8 8.4 13.0 22.6 8.3 7.5 13.9 40.9 10.8 8.4 7.8 9.7 11.9 13.0 9.9 9.9 14.0 7.1 17.9 4.5 10.0 15.2 8.8 16.5 6.0 10.2 5.4 5.6 11.2 14.6 10.5 6.8 4.9 12.6 9.2 10.5 7.5 7.9 4.8 9.1 5.8 12.1 4.8 4.9 4.9 6.3 13.2 1.2 5.1 2.4 3.4 3.0 6.1 7.2 11.1 8.2 12.2 6.6 3.5 14.9 6.4 11.3 6.1 8.4 4.2 6.7 15.1 5.9 10.5 7.2 4.6 6.6 2.9 3.3 6.4 5.7 4.8 31.4 32.8 6.0 8.6 15.4 2.2 9.9 6.1 9.4 3.4 29.3 3.2 6.7 6.9 6.5 5.7 10.5 13.8 7.0 11.2 9.0 17.4 8.1 48.8 6.7 12.8 6.0 4.4 2.2 7.8 5.1 10.2 3.2 12.1 5.8 4.3 9.2 3.3 4.8 3.8 3.9 9.1 3.6 4.9 4.0 1.3 4.8 8.7 3.4 2.4 4.9 8.5 10.1 19.0 15.0 8.3 7.5 7.8 9.7 7.1 6.8 UBE2H "GID3, UBC8, UBCH" ENSG00000186591 "Ubiquitin conjugating enzyme E2 H" P62256 7 129830732-129952949 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003302 Approved Supported Mitochondria Mitochondria "HPA003302: AB_1858526" "unprognostic (1.15e-1)" "unprognostic (5.85e-2)" "unprognostic (5.67e-3)" "unprognostic (2.76e-1)" "unprognostic (2.25e-1)" "unprognostic (3.08e-2)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (6.19e-2)" "prognostic unfavourable (2.33e-5)" "unprognostic (1.13e-1)" "unprognostic (3.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.12e-1)" "unprognostic (3.58e-1)" "unprognostic (1.23e-1)" 29.0 49.9 31.1 16.6 31.0 22.5 24.5 36.1 30.2 31.1 27.3 33.2 26.6 15.2 35.5 25.3 32.1 29.4 26.6 61.0 26.4 25.4 27.6 28.1 26.3 17.5 28.1 23.4 27.6 52.3 41.8 29.5 37.9 33.3 24.1 16.8 22.9 28.5 28.8 46.3 21.3 16.5 31.5 26.2 19.1 22.7 24.7 29.5 24.7 37.7 23.6 29.5 25.5 34.3 6.1 3.7 7.8 2.2 1.3 6.5 1.9 22.7 12.3 14.6 14.8 36.4 31.3 25.3 21.1 27.2 12.9 14.4 6.6 24.4 9.4 26.4 20.7 17.3 12.5 22.4 16.9 11.6 6.6 3.2 18.1 7.9 28.6 6.5 10.4 42.0 29.8 17.4 28.0 25.1 7.7 27.4 19.9 8.1 8.6 7.1 23.0 14.7 6.7 7.5 20.1 27.0 29.9 5.6 16.9 19.3 43.2 11.3 4.5 6.4 25.5 14.1 7.1 19.8 20.9 25.0 18.0 15.6 28.0 7.8 13.7 3.5 2.2 5.1 4.7 1.7 6.4 3.8 4.7 4.2 2.0 6.1 6.0 6.4 7.8 1.3 2.1 3.7 6.5 1.9 31.1 31.0 36.1 30.2 26.4 25.4 28.1 23.4 33.3 29.5 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974667-73983307 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 219.1;lymphoid tissue: 144.8" "Cell line enhanced" "Detected in many" "Daudi: 66.9;SK-BR-3: 86.1;U-698: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria Mitochondria "CAB025583: , HPA075202: " "unprognostic (1.13e-1)" "prognostic favourable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavourable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 19.8 9.8 5.3 40.4 9.5 24.5 15.9 1.1 4.9 8.1 7.7 10.2 20.3 11.4 4.2 12.0 4.5 37.9 13.1 11.5 4.4 5.5 12.8 10.6 20.2 85.6 7.8 2.4 7.2 4.7 1.2 6.2 8.7 6.5 6.5 8.9 14.2 17.4 17.2 45.3 4.3 24.7 6.4 9.0 91.1 12.3 5.5 5.9 144.8 17.9 19.3 55.7 19.4 2.9 141.6 219.1 101.8 135.3 119.8 180.2 172.1 0.1 14.1 3.2 9.6 1.8 0.0 2.4 2.3 1.6 9.7 2.8 24.7 12.0 66.9 33.5 3.6 0.6 2.3 0.0 4.5 16.9 0.8 39.0 5.9 5.1 5.8 20.5 16.4 2.1 0.0 9.1 0.0 1.2 17.9 27.3 1.9 24.1 21.2 11.1 2.6 2.8 19.6 22.3 37.9 27.0 39.9 4.9 6.0 12.6 86.1 4.8 25.4 18.3 1.8 0.0 12.4 2.8 4.6 9.4 4.4 55.7 1.7 8.1 0.1 45.7 81.5 101.8 112.6 135.3 69.9 141.6 92.3 95.0 88.4 134.2 86.9 91.1 11.4 119.8 111.3 219.1 180.2 172.1 5.3 9.5 1.1 4.9 4.4 5.5 7.8 2.4 6.5 5.9 UQCC2 "bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1" ENSG00000137288 "Ubiquinol-cytochrome c reductase complex assembly factor 2" Q9BRT2 6 33694293-33711727 "Disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039111 Uncertain Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA039111: " "unprognostic (3.58e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.35e-3)" "unprognostic (2.43e-2)" "unprognostic (5.93e-2)" "unprognostic (2.33e-2)" "unprognostic (7.43e-2)" "unprognostic (5.77e-2)" "unprognostic (3.88e-1)" "unprognostic (1.07e-1)" 13.4 22.9 26.1 13.3 31.4 14.6 17.7 15.0 22.9 12.4 15.8 12.0 12.3 12.8 17.4 23.4 15.2 10.9 9.2 71.0 19.2 23.0 18.3 23.4 8.9 12.3 22.8 22.6 11.5 25.3 7.9 24.5 14.4 20.6 15.7 17.2 18.9 19.6 14.3 76.4 12.2 10.4 20.0 20.0 12.9 15.9 30.9 18.3 12.3 19.0 22.0 14.9 10.9 11.0 39.7 38.9 7.2 39.6 21.9 31.5 34.8 42.4 30.6 34.3 29.7 28.5 28.8 27.0 24.3 24.4 33.8 33.5 49.1 18.0 17.1 39.2 29.2 22.9 23.3 33.9 30.1 21.8 38.3 33.5 20.3 67.8 46.8 31.2 27.5 29.3 54.6 27.1 43.9 25.1 35.6 35.5 39.7 45.7 30.2 64.9 20.8 34.9 21.9 28.1 58.0 23.9 40.4 59.0 20.9 26.8 41.0 33.5 36.0 79.5 23.2 38.9 33.0 25.0 49.9 27.4 38.0 28.9 11.7 47.3 44.8 7.2 27.0 5.2 24.0 39.6 29.1 39.7 30.3 27.4 31.9 32.8 31.5 28.4 2.6 21.9 32.7 38.9 31.1 34.8 26.1 31.4 15.0 22.9 19.2 23.0 22.8 22.6 20.6 18.3 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell line enhanced" "Detected in all" "PC-3: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria,Cytosol 1300000 Mitochondria Cytosol "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favourable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.0 16.2 5.9 3.6 8.7 8.0 26.7 18.5 15.0 15.4 14.0 25.2 3.0 25.9 11.7 8.3 9.7 7.4 21.5 2.8 15.4 35.5 26.6 14.1 27.4 17.3 16.7 11.5 11.0 24.4 10.5 17.2 15.2 14.3 1.7 9.3 17.4 12.0 19.1 14.8 64.6 8.2 15.7 21.2 15.9 11.0 6.3 11.2 25.1 3.0 14.8 6.4 2.6 15.3 4.3 16.3 13.4 19.1 15.8 13.9 15.0 9.4 19.3 13.7 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21952660-21983660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria 4000000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favourable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 22.7 26.8 20.6 17.1 32.7 20.5 21.3 29.2 33.7 17.7 38.4 17.4 19.5 45.0 20.8 18.6 28.7 20.0 19.1 94.9 19.8 19.3 35.1 35.8 15.9 23.6 20.9 28.5 21.9 20.8 36.6 20.2 17.8 29.6 17.7 40.5 18.5 22.1 20.2 103.9 22.2 42.0 30.4 16.5 16.5 29.3 10.3 19.2 25.2 21.4 70.0 22.9 27.9 20.0 20.0 30.6 14.3 29.3 18.7 25.7 27.4 18.9 20.9 12.9 8.6 14.4 20.2 18.3 18.4 15.0 16.9 17.2 33.7 18.8 37.7 16.6 15.8 34.7 20.9 18.5 19.5 17.2 19.4 21.3 18.4 47.6 15.3 27.1 54.0 23.6 23.2 13.2 18.2 22.1 23.0 19.7 18.3 25.2 28.1 17.6 14.1 16.1 32.9 29.9 41.2 25.3 22.4 17.8 13.0 26.1 33.0 19.8 37.8 28.8 19.5 12.0 11.3 11.7 16.4 14.3 10.3 33.4 19.6 28.8 13.7 14.3 24.7 12.8 16.9 29.3 21.9 20.0 20.5 18.6 30.6 15.8 22.8 20.8 9.1 18.7 27.6 13.2 25.7 27.4 20.6 32.7 29.2 33.7 19.8 19.3 20.9 28.5 29.6 19.2 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria Mitochondria "HPA046693: AB_10968453, HPA053323: " "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favourable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.6 63.9 37.7 91.2 56.6 46.0 32.7 33.1 46.9 53.1 66.3 89.9 53.4 18.8 70.1 43.4 46.3 34.3 80.8 45.7 34.3 72.2 24.9 100.7 70.6 49.1 28.2 42.9 49.0 56.4 37.9 52.3 41.4 31.8 60.6 55.6 86.5 64.8 65.1 26.7 57.7 42.5 41.8 80.7 68.7 89.2 63.3 52.7 41.0 46.3 70.8 69.0 65.0 25.7 48.7 61.5 39.9 67.0 67.0 88.9 33.6 64.8 52.6 48.4 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavourable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.6 7.0 16.5 11.9 14.3 17.7 16.3 18.5 12.6 12.4 16.5 6.4 15.0 16.5 12.5 16.7 13.6 20.3 14.9 18.9 16.0 13.9 35.3 26.1 11.6 12.8 17.7 18.9 14.3 12.9 12.6 14.1 36.6 27.7 46.8 15.2 7.3 14.6 23.0 10.4 12.6 20.6 16.6 19.3 14.3 12.4 20.1 12.5 17.4 16.0 41.8 8.2 21.4 25.9 13.4 11.1 16.4 10.7 37.5 26.6 16.4 12.9 22.0 19.7 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 VDAC2 ENSG00000165637 "Voltage dependent anion channel 2" P45880 10 75210154-75231448 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043475 Enhanced Supported Mitochondria 4000000 Mitochondria "HPA043475: AB_10795615" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (9.47e-2)" "unprognostic (9.00e-3)" "unprognostic (5.74e-2)" "prognostic unfavourable (4.51e-4)" "prognostic unfavourable (4.55e-4)" "unprognostic (1.83e-3)" "unprognostic (5.89e-2)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (1.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (6.28e-2)" "unprognostic (1.34e-2)" 26.2 31.9 27.8 18.7 40.5 25.1 59.7 34.2 55.4 29.0 39.1 24.2 19.9 31.8 25.5 20.3 63.7 25.0 18.5 141.7 28.1 24.1 38.2 24.4 23.2 23.0 27.6 37.7 29.6 38.9 37.6 18.4 24.1 36.5 24.2 40.3 23.0 30.5 30.6 99.7 30.7 30.5 43.7 27.9 17.8 31.1 30.4 16.9 15.6 27.5 31.9 30.0 33.7 39.1 44.8 63.2 39.0 62.9 36.0 49.6 54.6 41.6 34.5 41.8 52.9 37.2 50.8 43.8 54.3 61.2 59.6 56.3 52.0 39.9 49.7 30.6 45.3 56.2 76.5 53.8 58.6 26.9 44.5 28.9 29.2 58.6 37.3 54.9 32.2 44.9 63.8 50.8 108.7 44.0 48.8 40.6 62.5 30.8 35.3 44.7 35.9 133.5 42.4 33.1 31.5 58.6 26.2 26.5 31.3 29.9 100.4 63.5 58.5 24.7 33.9 29.8 40.8 43.9 58.1 32.7 44.5 51.3 43.1 54.4 25.2 39.0 51.5 38.0 32.5 54.0 39.6 44.8 44.7 36.4 63.2 36.0 45.5 41.7 17.7 36.0 62.9 30.8 49.6 54.6 27.8 40.5 34.2 55.4 28.1 24.1 27.6 37.7 36.5 16.9 VDAC3 HD-VDAC3 ENSG00000078668 "Voltage dependent anion channel 3" Q9Y277 8 42391624-42405897 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 187.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026864 Uncertain Supported Mitochondria 9300000 Mitochondria "HPA026864: AB_1858733" "unprognostic (2.55e-2)" "unprognostic (1.96e-2)" "unprognostic (9.88e-3)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-1)" "unprognostic (4.98e-2)" "unprognostic (2.25e-2)" "unprognostic (1.40e-2)" "unprognostic (5.76e-2)" "unprognostic (3.74e-1)" "unprognostic (1.19e-2)" "unprognostic (6.16e-3)" "unprognostic (2.96e-2)" "unprognostic (1.76e-1)" "unprognostic (8.78e-3)" "unprognostic (6.94e-3)" 19.9 18.8 26.0 13.7 29.8 18.6 17.3 38.3 39.1 16.0 23.7 14.5 12.3 19.1 19.1 17.7 26.8 21.5 13.9 85.8 28.2 35.3 27.9 22.1 12.5 14.6 32.5 24.6 18.1 15.0 17.5 16.5 15.4 44.3 17.6 26.2 16.0 22.2 20.8 187.5 13.0 22.7 22.1 19.6 17.3 16.6 27.4 13.0 20.5 21.6 39.7 18.4 23.1 13.3 34.4 59.4 47.5 44.4 31.4 52.4 81.9 48.2 48.6 38.3 40.7 32.3 28.1 19.0 38.6 33.0 49.7 45.5 37.5 41.3 49.6 37.1 32.7 30.9 51.6 41.4 54.8 25.1 42.6 75.4 32.5 53.3 23.1 36.3 42.1 21.8 31.5 37.6 17.6 60.3 59.1 34.6 50.6 26.7 77.4 41.7 45.4 31.7 41.0 70.5 35.1 53.4 43.0 33.8 29.0 24.4 29.0 24.3 61.3 27.7 32.2 19.4 33.8 48.2 37.4 32.2 53.7 56.5 26.0 51.3 32.6 31.1 44.4 47.5 42.1 43.8 42.4 34.4 45.1 41.7 59.4 24.2 45.1 43.3 22.0 31.4 38.5 43.8 52.4 81.9 26.0 29.8 38.3 39.1 28.2 35.3 32.5 24.6 44.3 13.0 WARS2 TrpRS ENSG00000116874 "Tryptophanyl tRNA synthetase 2, mitochondrial" Q9UGM6 1 119031216-119140671 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069692 Enhanced Supported "Plasma membrane,Mitochondria" Mitochondria "Plasma membrane" "HPA069692: " "unprognostic (1.00e-1)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (5.64e-2)" "unprognostic (3.42e-1)" "unprognostic (7.05e-2)" "unprognostic (7.73e-3)" "unprognostic (3.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.17e-2)" "unprognostic (3.96e-2)" "unprognostic (6.76e-3)" "prognostic favourable (1.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.83e-1)" "unprognostic (9.88e-3)" "unprognostic (4.71e-2)" 17.3 16.7 6.8 11.7 8.3 2.8 14.6 7.5 8.7 12.9 11.2 7.7 7.6 12.3 13.5 10.4 13.4 14.9 8.8 12.1 6.2 6.1 15.3 14.9 9.2 12.4 6.4 6.1 14.7 17.8 15.1 12.3 14.9 8.3 14.1 12.7 11.3 10.5 10.4 12.2 10.0 13.1 9.0 5.4 9.9 11.2 6.9 6.1 11.6 12.8 13.2 14.2 14.3 10.4 7.2 9.0 0.5 6.9 5.3 7.4 4.9 10.2 4.5 6.0 6.3 7.7 17.4 6.5 5.8 8.2 6.1 7.3 11.2 4.7 15.1 9.4 9.2 6.9 10.8 9.8 9.3 8.1 14.1 7.1 12.0 10.7 15.7 11.5 4.1 13.3 7.6 8.8 16.1 9.0 11.1 11.0 11.2 11.9 6.8 6.7 8.1 9.2 5.0 20.0 7.6 16.5 14.3 8.9 5.4 9.0 12.6 13.0 5.6 9.0 6.9 6.6 8.0 12.4 10.9 5.3 3.6 6.7 8.1 9.7 12.2 0.0 6.9 0.5 5.1 4.9 7.4 6.6 5.4 6.7 9.0 7.2 6.5 6.2 0.3 5.3 3.0 4.5 6.0 4.9 6.8 8.3 7.5 8.7 6.2 6.1 6.4 6.1 8.3 6.1 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 32.7;BJ hTERT+ SV40 Large T+ RasG12V: 33.8;HHSteC: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: " "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 1.9 0.1 0.2 0.5 2.7 6.2 0.2 2.5 10.3 32.7 33.8 0.2 2.9 0.5 0.8 3.8 1.2 0.0 0.5 3.7 4.4 0.1 0.7 0.3 0.4 15.0 0.4 3.1 2.8 0.0 4.3 0.1 2.7 0.2 10.6 1.0 0.1 2.2 8.7 0.2 0.8 4.2 0.1 0.2 0.0 1.8 0.2 0.2 1.2 0.2 5.5 0.3 12.0 0.3 0.4 0.3 0.9 0.1 1.5 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755902 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: , HPA074097: " "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavourable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 12.6 15.8 11.0 12.6 15.3 13.9 13.8 11.6 14.9 13.1 11.8 11.5 18.4 9.8 13.3 12.9 17.5 11.3 9.1 12.1 11.9 9.7 12.4 16.3 9.2 15.5 10.8 11.7 13.3 21.0 11.0 16.6 15.9 13.5 12.9 13.7 11.3 17.4 10.0 15.9 12.0 10.8 11.1 12.6 13.3 12.3 12.5 12.6 17.5 12.3 16.0 16.4 13.3 11.8 11.8 9.5 9.4 9.9 12.9 12.7 5.2 9.5 11.5 6.7 8.0 7.4 8.7 21.3 7.3 7.5 9.1 8.9 28.8 12.3 17.3 12.0 7.4 12.4 13.4 19.3 10.3 7.5 20.9 11.4 8.7 16.0 10.7 12.1 6.7 8.1 12.4 8.5 15.6 14.3 16.1 8.0 9.6 7.8 9.0 14.7 37.1 14.2 10.2 14.4 10.2 11.5 13.7 10.4 5.0 11.2 9.8 7.2 18.3 11.0 9.6 8.6 9.2 14.0 12.3 4.8 5.1 18.0 8.0 9.1 7.1 9.4 7.0 4.1 10.1 8.9 10.6 8.8 10.7 10.4 9.5 11.8 11.2 12.7 1.4 12.9 9.9 9.3 9.3 5.2 11.0 15.3 11.6 14.9 11.9 9.7 10.8 11.7 13.5 12.6 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA066953: " "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavourable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.0 30.1 36.1 17.8 35.4 38.1 29.5 39.6 23.2 40.7 46.7 40.7 49.4 42.8 26.4 43.7 38.8 43.3 35.0 45.0 38.8 26.0 40.6 26.9 28.5 38.9 27.7 33.4 31.2 41.4 35.5 36.0 42.5 47.1 43.6 44.9 27.1 51.2 16.0 28.6 14.1 44.3 57.9 39.5 33.2 19.1 27.8 35.6 39.6 30.8 39.7 29.5 34.8 41.6 24.7 34.5 41.4 35.5 21.9 32.1 54.7 35.1 51.5 18.8 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 ZNF48 "DKFZp762K013, FLJ31751, MGC43952, ZNF553" ENSG00000180035 "Zinc finger protein 48" Q96MX3 16 30378106-30400108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023806 Uncertain Supported Mitochondria Mitochondria "HPA023806: AB_1859335" "unprognostic (5.35e-2)" "unprognostic (7.91e-3)" "unprognostic (2.41e-3)" "unprognostic (2.06e-1)" "unprognostic (5.20e-2)" "unprognostic (1.66e-2)" "unprognostic (2.77e-3)" "unprognostic (4.25e-2)" "unprognostic (6.06e-2)" "unprognostic (2.19e-1)" "prognostic favourable (1.20e-6)" "unprognostic (5.36e-2)" "prognostic favourable (7.50e-5)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" 5.6 7.7 8.9 9.1 9.8 4.4 6.7 15.7 16.1 9.1 11.5 10.1 12.1 9.0 12.8 5.7 5.5 10.7 9.5 6.7 8.9 8.7 6.6 6.4 8.0 10.0 9.0 8.5 6.7 15.1 18.8 8.8 4.7 7.1 7.6 6.1 8.0 9.7 12.6 12.1 6.3 6.4 11.2 5.7 7.3 7.9 3.9 9.8 16.1 7.5 7.2 7.3 9.0 8.3 1.4 1.6 1.3 0.2 2.6 3.1 0.5 4.6 8.0 19.4 15.5 2.4 2.0 6.5 3.2 5.9 7.8 7.0 3.7 6.1 8.7 6.4 2.9 3.7 9.4 5.1 4.2 6.4 11.6 3.9 3.8 5.4 3.6 5.1 5.5 1.5 6.6 6.1 4.2 6.4 6.7 4.1 3.0 15.0 11.9 6.3 16.5 2.9 27.6 4.3 11.6 4.1 3.6 15.1 18.8 1.3 10.4 1.3 6.9 5.1 2.8 4.4 5.0 4.1 3.9 5.0 5.7 8.5 2.4 3.3 1.0 0.0 0.2 1.3 3.1 0.2 2.4 1.1 1.7 1.8 0.5 1.4 2.1 2.3 0.0 2.6 0.1 1.6 1.7 0.5 8.9 9.8 15.7 16.1 8.9 8.7 9.0 8.5 7.1 9.8